STREPTOCOCCUS PNEUMONIAE DNA SEQUENCES

Abstract: Nucleotide fragments of the genome of the bacterium Streptococcus pneumoniae are provided. Also provided are ORFs encoded by said genome.

Description: STREPTOCOCCUS PNEUMONIAE DNA SEQUENCES This invention provides DNA sequences from the Streptococcus pneumoniae genome, and methods of use of DNA fragments originating therefrom in a variety of biological and pharmaceutical applications. The recent emergence of widespread antibiotic resistance in common pathogenic bacterial species has justifiably alarmed the medical and research communities. Frequently these organisms are co-resistant to several different antibacterial agents. Particularly problematic has been the emergence and rapid spread of penicillin resistance in Streptococcus pneumoniae, which frequently causes upper respiratory tract infections. Resistance to penicillin in this organism can be due to modifications of one or more of the penicillin-binding proteins (PBPs) . Combating the phenomenon of increasing resistance to antibiotic agents among pathogenic organisms such as Streptococcus pneumoniae will require intensified research into the fundamental molecular biology of such organisms. Greater knowledge about the molecular biology of pathogenic organisms will lead to new antibacterial agents having novel and effective, actions . While inroads in the development of new antibiotics and new targets for antibiotic compounds have been made with a variety of microorganisms, progress has been less apparent in Streptococcus pneumoniae. In part, Streptococcus pneumoniae presents a special case because this organism is highly recombinogenic and readily takes up exogenous DNA from its surroundings. Thus, the need for new antibacterial compounds and new targets for antibacterial therapy in Streptococcus pneumoniae is more acute than in other organisms . The present invention relates to the genome of S. pneumoniae . The genomic information disclosed by the present invention enables: (1) preparation of molecular hybridization probes for use in PCR amplification of genes and regulatory regions, physical mapping, sequencing, mutagenesis, and mutation analysis, (2) homology comparisons with the genomes and open reading frames (ORFs) of other organisms, (3) creation of specifically mutated strains of S . pneumoniae wherein the mutation is targeted to any site or sites in the DNA sequence disclosed herein, (4) identification of S. pneumoniae promoters and other gene regulatory sequences, (5) identification of proteins/ORFs encoded by S. pneumoniae, (6) identification of virulence genes in S . pneumoniae, (7) determination of the biological function of proteins/ORFs and RNAs encoded by S. pneumoniae, (8) production of kits useful for determining gene function in the cell, and kits for isolating and analyzing genes that are mutated in antibiotic resistant clinical isolates of S. pneumoniae, (9) production of proteins and RNAs encoded by S. pneumoniae, (10) production of antibodies against proteins and other antigens encoded by S. pneumoniae, (11) methods to identify compounds that bind to proteins and RNAs encoded by S. pneumoniae as potential new antibiotic compounds. In another embodiment the invention relates to substantially purified proteins encoded by the S. pneumoniae genome . Table 1 summarizes the proteins and nucleic acids disclosed herein, contigs, SEQ ID NO' s and predicted functions . "Genome" refers to the full complement of chromosomal and extra-chromosomal DNA within a cell. The genome comprises the genetic blueprint for all proteins and RNAs encoded by the cell or organism. "ORF" (i.e. "open reading frame") designates a region of genomic DNA beginning with a Met or other initiation codon and terminating with a translation stop codon, potentially encoding a protein product. "Partial ORF" means a portion of an ORF as disclosed herein such that the initiation codon, the stop codon, or both are not disclosed. "DNA chip" or "Bio Chip" or "Bio DNA chip" refers to a solid matrix or support onto which is applied an array of oligonucleotides, or nucleotide sequences, or gene fragments, or genomic fragments, of S . pneumoniae which may further comprise a layer of S . pneumoniae cells suspended thereover in a semisolid medium such as agar or agarose. "Consensus sequence" refers to an amino acid or nucleotide sequence that may suggest the biological function of a protein, DNA, or RNA molecule. Consensus sequences are identified by comparing proteins, RNAs, and gene homologs from different species. "Contiguous fragment building" or "Contiguous fragment" or "Contig" refers to the process and result, respectively, by which a fragment of DNA is assembled from smaller constituent DNA fragments by arranging the constituent pieces in their correct order and register such that the resulting contiguous fragment accurately depicts the native DNA sequence from which the smaller fragments originated. "Computer readable medium" includes, for example, a floppy disc, hard disc, random access memory, read only memory, and CD-ROM. The terms "cleavage" or "restriction" of DNA refers to the catalytic cleavage of the DNA with a restriction enzyme that acts only at certain sequences in the DNA (viz. sequence-specific endonucleases) . The various restriction enzymes used herein are commercially available and their reaction conditions, cofactors, and other requirements are used in the manner well known to one of ordinary skill in the art. Appropriate buffers and substrate amounts for particular restriction enzymes are specified by the manufacturer or can be found in the literature. "Diagnostics" as used herein relates to in vitro or in vivo diagnosis for disease states or biological status in mammals, preferably humans. "Therapeutics" and "therapeutic/diagnostic combinations" means the treatment, or diagnosis and treatment, of disease states or biological status by in vivo administration to mammals, preferably humans, of compositions of the present invention, for example, antibodies . "Essential genes" or "essential ORFs" or "essential proteins" refer to genomic information or the protein (s) or RNAs encoded therefrom, which, when disrupted by knockout mutation, or by other mutation, produce inviability in cells harboring said mutation. "Non-essential genes" or "non-essential ORFs" or "non-essential proteins" refer to genomic information or the protein (s) or RNAs encoded therefrom, which, when disrupted by knockout mutation, or other mutation, do not result in inviability of cells harboring said mutation. "Minimal gene set" refers to a genus of about 256 genes that are conserved among different bacteria such as M. geni tali um and H. influenzae . The minimal gene set appears to be necessary and sufficient to sustain life. See e.g. A. Mushegian and E. Koonin, "A minimal gene set for cellular life derived by comparison of complete bacterial genomes" Proc . Nat . Acad. Sci . 93, 10268 - 273 (1996). The term "fragment thereof" denotes a fragment of a nucleic acid molecule described herein, wherein said fragment comprises a region of contiguity within said nucleic acid of at least 15 base pairs. The term may also refer to a peptide of at least 5 contiguous amino acid residues of a protein disclosed herein. The term "plasmid" refers to an extrachromosomal genetic element. The starting plasmids herein are either commercially available, publicly available on an unrestricted basis, or can be constructed from available plasmids in accordance with published procedures. In addition, equivalent plasmids to those described are known in the art and will be apparent to the ordinarily skilled artisan. "Recombinant DNA cloning vector" as used herein refers to any autonomously replicating agent, including, but not limited to, plasmids and phages, comprising a DNA molecule to which one or more additional DNA segments can or have been added. The term "recombinant DNA expression vector" as used herein refers to any recombinant DNA cloning vector, for example a plasmid or phage, in which a promoter and other regulatory elements are present to enable transcription of the inserted DNA. The term "vector" as used herein refers to a nucleic acid compound used for introducing exogenous DNA into host cells. A vector comprises a nucleotide sequence which may encode one or more protein molecules. Plasmids, cosmids, viruses, and bacteriophages, in the natural state or which have undergone recombinant engineering, are examples of commonly used vectors. The terms "complementary" or "complementarity" as used herein refers to the capacity of purine and pyrimidine nucleotides to associate through hydrogen bonding in double stranded nucleic acid molecules. The following base pairs are complementary: guanine and cytosine; adenine and thymine; and adenine and uracil. "Oligonucleotide" refers to a short polymeric nucleotide chain comprising from about 2 to 25 nucleotides. "Isolated nucleic acid compound" refers to any RNA or DNA sequence, however constructed or synthesized, which is locationally distinct from its natural location. A "primer" is a nucleic acid fragment which functions as an initiating substrate for enzymatic or synthetic elongation of a nucleic acid molecule. The term "promoter" refers to a DNA sequence which directs transcription of DNA to RNA. A "probe" as used herein is a labeled nucleic acid compound which can be used to hybridize with another nucleic acid compound. The term "hybridization" or "hybridize" as used herein refers to the process by which a single-stranded nucleic acid molecule joins with a complementary strand through nucleotide base pairing. "Recorded" as used herein refers to a process for storing information on a computer readable medium. "Substantially identical" means a sequence having sufficient homology to hybridize under high stringency conditions and/or at least 90% identity at the nucleotide or amino acid sequence level to a sequence disclosed herein. "Substantially purified" when used in reference to a protein or peptide means that the molecule has been largely, but not necessarily wholly, separated and purified from other cellular and non-cellular components. Typically a protein is substantially pure when it is at least about 60% by weight, free from other naturally occurring organic molecules. Preferably the purity is at least about 75%, more preferably at least about 90%, and most preferably at least about 99% by weight pure. "Selective hybridization" refers to hybridization under conditions of high stringency. Hybridization of nucleic acid molecules depends upon factors such as the degree of complementarity, stringency of hybridization conditions, and the length of hybridizing strands. The term "stringency" relates to nucleic acid hybridization conditions. High stringency conditions disfavor non-homologous base pairing. Low stringency conditions have the opposite effect. Stringency may be altered, for example, by changes in temperature and salt concentration. Typical high stringency conditions comprise hybridizing at 50°C to 65°C in 5X SSPE and 50% formamide, and washing at 50°C to 65°C in 0.5X SSPE; typical low stringency conditions comprise hybridizing at 35°C to 37°C in 5X SSPE and 40% to 45% formamide and washing at 42°C in 1X-2X SSPE. "SSPE" denotes a hybridization and wash solution comprising sodium chloride, sodium phosphate, and EDTA, at pH 7.4. A 20X solution of SSPE is made by dissolving 174 g of NaCI, 27.6 g of NaH 2 P04-H 2 0, and 7.4 g of EDTA in 800 ml of H 2 O. The pH is adjusted with NaOH and the volume brought to 1 liter. "SSC" denotes a hybridization and wash solution comprising sodium chloride and sodium citrate at pH 7. A 20X solution of SSC is made by dissolving 175 g of NaCI and 88 g of sodium citrate in 800 ml of H 2 O. The volume is brought to 1 liter after adjusting the pH with ION NaOH. "Virulence gene" as used herein means a gene from a pathogenic organism such as S. pneumoniae that is required for infection and/or pathogenicity in vivo . Some virulence genes are induced during infection of a host; others are expressed exclusively during in vivo infection. The Streptococcus pneumoniae genome contains about 2.2 million nucleotide base pairs and comprises about 2000 to 3000 ORFs and other genes. This invention provides, among other things, contiguous fragments, genes, and proteins from the S. pneumoniae genome (SEQ ID NO:l through SEQ ID NO:228) . Strain differences in S. pneumoniae may be associated with nucleotide sequence differences in one or more of the genomic fragments disclosed herein. Sequences that are substantially identical to the sequences disclosed herein are intended to be within the scope of the invention. The sequence fragments disclosed herein provide a wide variety of utilities. For example, the fragments may be used to identify regions of the S. pneumoniae genome that are expressed as proteins (viz. transcribed into mRNA). The genomic fragments disclosed herein can also be used to examine differential expression of S. pneumoniae genes under diverse environmental conditions, as occurs, for example, with the expression of virulence genes during in vivo infection of a host organism. Also contemplated by the invention are: (1) preparation of molecular hybridization probes for use in physical mapping, sequencing, mutagenesis, mutation analysis, (2) homology comparisons of the sequences disclosed herein with the genomes and ORFs of other organisms, (3) creation of specifically mutated strains of S . pneumoniae wherein the mutation is targeted to any site in the DNA sequence disclosed herein, (4) identification of S. pneumoniae promoters and other gene regulatory sequences, (5) identification of proteins and RNAs encoded by S. pneumoniae, (6) amplification of S. pneumoniae genes using the PCR, and (7) production of kits for isolating and analyzing genes that are mutated in antibiotic resistant clinical isolates of S . pneumoniae . Genome Analysis In one embodiment, the invention comprises the ORFs and fragments thereof encoded by the nucleotide sequences disclosed herein. Some of the nucleotide sequences disclosed herein encode ORFs and fragments of ORFs (Table 1) . The ORFs or fragments thereof were identified by translation of the nucleic acid sequences disclosed herein. The biological function of a protein disclosed in Table 1 was determined by homology comparison with known proteins from other organisms. A number of computer programs are available to assist in homology comparisons, for example Genemark (Borodovsky and Mclninch, Computers Chem. 17 (2) , 123, 1993) . Computer-Related Applications The nucleotide and/or amino acid sequence information of this invention may be provided in a variety of media to facilitate use. In one embodiment the present invention comprises one or more of the sequences disclosed herein recorded on a computer readable medium. A variety of media are contemplated, for example, magnetic storage media such as floppy discs, hard disc storage, magnetic tape, and CD- ROM. A skilled artisan can readily adopt any presently known method for recording information on a computer readable medium to generate manufactures comprising the nucleotide or amino acid sequence information of the present invention. These embodiments are contemplated within the scope of this invention. The choice of a data storage structure will generally be based on the means chosen to access the stored information. A variety of data processor programs and formats can be used to store the sequence information of the invention on computer readable medium. For example, the sequence can be represented in a word processing text file that is formatted in commercially available software such as WordPerfect and Microsoft Word, or it can be represented in the form of a text only file such as ASCII. Having S. pneumoniae genomic sequence information in a computer readable format enables a skilled artisan to access the information for a variety of purposes. For example, computer-assisted searching algorithms may be used to identify open reading frames, and ascertain biological function based on homology to known proteins from other organisms. Suitable algorithms for sequence comparisons include BLAST (Altschul et al . , J. Mol . Biol . 215, 403-410, 1990) and BLAZE (Brutlag et al . , Comp. Chem. 17, 203-207 (1993) . For identification of ORFs a number of commercially available software programs are suitable, such as FRAMES (Genetic Center Group, Madison, WI) . The genomic information of this invention in computer- readable form can be manipulated further using bioinformatics to identify the biological function of proteins encoded by ORFs as well as the cellular location of said proteins. The skilled artisan will recognize several computer-assisted algorithms for this purpose, for example, PSORT which is useful for determining the likely location of a protein within a cell (See K. Nakai & M. Kanehisa. "Expert system for predicting protein localization sites in Gram- negative bacteria", Proteins : Structure, Function, and Genetics, 11, 95-110 (1991) . Open Reading Frames and Proteins The invention also provides proteins encoded by the S. pneumoniae genome in substantially purified form (See Table 1) . The proteins are classified herein as (1) Hypothetical, (2) Cell wall biosynthetic, (3) External target, or (4) Minimal gene set proteins. Cells that carry knockout mutations in proteins of the hypothetical class are nonviable. Loss of viability suggests that these proteins may be essential for viability. Two such proteins, whose genes map to contigs m014 and m016, correspond respectively to Haemophill us infl uenzae ORFs HI1146 and HI1648. Two other hypothetical proteins, yyaF and ywbL, correspond to a GTP binding protein and transcriptional regulator, respectively. The proteins of this invention can be used to raise antibodies. Antibodies against the hypothetical class of proteins are especially attractive. In targeting presumptively essential cellular functions, antibodies against "hypothetical proteins" could have therapeutic or prophylactic applications. Additionally, the "hypothetical" proteins can be used to screen for agents that bind or otherwise interact with said proteins. Such agents could lead to the identification of new antibacterial agents. Proteins classified in Table 1 as cell wall biosynthetic proteins, and external target proteins, were identified by homology with known proteins. These proteins are useful for identifying agents that bind and inhibit bacterial growth. Therefore, in another embodiment of the invention, the proteins of these classifications are prepared, preferably by recombinant means as described herein, substantially purified, and used in a screen to identify compounds that bind and/or inhibit the activity of said proteins. A variety of suitable screens are contemplated for this purpose. For example, the protein (s) can be labeled by known techniques such as radiolabeling or fluorescent tagging, or by labeling with biotin/avidin; thereafter binding of a test compound to a labeled protein can be determined by any suitable means, well known to the skilled artisan. The proteins categorized as "minimal gene set" are homologous to a set of highly conserved proteins found in other bacteria. The minimal gene set proteins are thought to be essential for viability, and are useful targets for the development of new antibacterial compounds. DNA Chips and Applications The nucleic acids disclosed herein, or subfragments thereof, may be arrayed on any suitable solid surface, thereby constructing a "chip." DNA chip hybridizations provide greater sensitivity than do conventional hybridization means, such as Southern hybridization or Northern hybridization. DNA chips are useful for a variety of purposes, for example, in mutation and gene expression analysis, and in probing the structure, function, and expression of the genome. This aspect of the invention relates to any one or more of the DNA fragments disclosed herein, wherein said fragments are attached to a solid support (i.e. "chip" or "DNA chip" or "Bio chip"). Attachment of a nucleic acid to a support can be, but is not necessarily, accomplished by chemical or enzymatic means. In one embodiment, DNA fragments of this invention are arrayed onto a solid support as a means for assessing gene expression in S. pneumoniae . The DNA fragments attached to a chip may be of any size that is suitable for hybridization to other nucleic acid molecules such as cDNAs, genomic DNAs, or RNAs. Suitably-sized DNA fragments are from 10 nucleotide residues to approximately several thousand residues. The preferred length is about 50 to 500 nucleotides. Analysis of gene expression using the chips of this invention is assessed by hybridization of a chip to RNA samples, or cDNA samples prepared from S. pneumoniae grown under any suitable conditions. Preferred samples for hybridization to a chip comprise cDNA. Methods for preparing RNA or cDNA are well known in the art. A variety of suitable methods are known for fixing DNA fragments to solid support matrices [See e . g. D. Stimpson et al . "Real-time detection of DNA hybridization and melting on oligonucleotide arrays by using optical wave guides" Proc. Nat . Acad. Sci . 92, 6379 (1995)] Preferred surfaces for producing a chip are glass or polystyrene. Convenient surfaces are microscope slides, or cover slips (Corning) , treated with silicon or silane to minimize non-specific binding by DNA or proteins. Also suitable for this purpose are 96-well microtiter plates. A light-directed method may be used for attaching oligonucleotides, enabling nucleotide synthesis directly on the solid surface using photolabile 5'protected N-acyl- deoxynucleotide phosphoramidites and surface linker chemistry (See Pease et al . "Light-generated oligonucleotide arrays for rapid DNA sequence analysis" Proc . Nat . Acad. Sci . 91, 5022-5026, 1994). Alternatively, DNA fragments can be bound to a surface via interaction with a specific DNA binding protein. Any suitable DNA binding protein may be used, for example bacteriophage DNA binding proteins, Adenovirus binding protein, the E. coli lac-repressor protein, or 1-repressor protein. DNA binding proteins are attached to the surface of a chip by covalent chemical binding, essentially as described in U.S. Patent 5,561,071, the entire contents of which is incorporated by reference. The latter method requires that DNA fragments contain a recognition sequence that enables binding by the DNA binding protein. Specific sequences for a number of DNA binding proteins are known. Methods for incorporating specific binding sequences into the genomic DNA fragments disclosed herein are well known in the cloning arts. DNA chip technology enables monitoring S. pneumoniae gene expression on a genome-wide level. This feature of the invention is particularly attractive for identifying (1) genes that are expressed or not expressed during the life cycle or infection cycle of S. pneumoniae, and (2) changes in gene expression that correlate with environmental change. For example, virulence genes in S. pneumoniae can be identified by the DNA chip method disclosed herein. Identification of virulence genes in S. pneumoniae will provide new targets for developing novel antibiotics. For this aspect of the invention any suitable encapsulated strain of S. pneumoniae is introduced into a mouse, for example, by intraperitoneal injection, or by introduction directly into the lungs, or by any other suitable method. Approximatly 2 days after infection a peripheral blood titre level is reached of about 10 8 S. pneumoniae cells/ml. Cells recovered from peripheral blood, or other suitable tissue, are used in identifying virulence genes. For this purpose, cDNAs are prepared from cells recovered from an in vivo infection and from cells grown in vi tro . After labeling, the cDNAs are hybridized against the DNA chip(s) disclosed herein. Genomic fragments that hybridize to the in vivo probe but not to the in vi tro probe identify candidate virulence genes. Also contemplated by this aspect of the invention is a method for analyzing gene expression in S. pneumoniae cells grown or harvested from any desireable in vi tro or in vivo environment, wherein said environment may include compounds whose effects on gene expression are to be determined. In another embodiment, the present invention relates to a DNA bio-chip, useful for correlating DNA sequence with biological function. The bio-chip comprises an array of the genomic DNA fragments disclosed herein, or portions thereof, attached to the surface of any suitable solid support material. The bio chip further comprises a layer of competent S. pneumoniae cells suspended over the DNA array in any suitable semi-solid medium such as agar or agarose. The cells suspended on the bio chip comprise known or unknown mutant strains, or they may be wild-type cells. The cell layer is in contact with the DNA matrix such that DNA on the chip can be taken up by the cells. The bio-chip is useful for several purposes. For example, the bio-chip can be used to localize an unknown mutation to a specific region of the genome by complementation. The bio-chip enables correlating a phenotype with a genetic locus. For example, mutant cells harboring one or more mutations and having at least one screenable or selectable phenotype can be applied to a bio chip and subjected to an environment that allows for selection, or for screening by complementation. If said phenotype is the result of a chromosomal mutation or mutations that map to a genomic fragment present on the chip, DNA uptake by the cells and repair of the mutation by recombination will be identifiable by a suitable screen or selection. In a preferred embodiment, the bio-chip is overlayed with competent S. pneumoniae cells. Methods for preparing competent cells are known (See e.g. LeBlanc et . al . Plasmid 28, 130-145, 1992; Pozzi et al . J. Bacteriol .178 , 6087-6090, 1996) . Other embodiments of this aspect of the invention are contemplated. For example the genomic fragments disclosed herein could be prepared and dispensed into individual wells of a 96-well micro titre plate. Competent S. pneumoniae cells could then be added to the wells under conditions suitable for DNA uptake followed by plating onto any suitable selection or screening medium, for example an agar plate containing suitable growth and/or selection/screening components . Diagnostic Kits and Assays The present invention further relates to kits and assays that can be used for rapid and efficient detection of S. pneumoniae cells. Also contemplated are kits for detecting mutations carried by S. pneumoniae cells. Kits of this nature are particularly attractive in the clinical environment where knowledge about the identity of a pathogen and/or of the basis for resistance to antibiotic treatments is essential for effective medical treatment. In the long term, knowledge of the mutations that lead to resistance will enable the design of new antibacterial agents. A kit for detecting S. pneumoniae cells can be based on antibody recognition of S. pneumoniae specific antigens or epitopes, or by nucleic acid hybridization techniques for the detection of S. pneumoniae specific nucleic acid molecules . A variety of embodiments are contemplated in this aspect of the invention. In one embodiment a kit is provided for detecting mutations in drug-resistant S. pneumoniae . For this purpose, DNA is prepared from a resistant isolate and from a wild-type strain. In a preferred embodiment, the polymerase chain reaction (i.e. PCR) is used to amplify DNA samples representing any one or all of the genomic fragments disclosed herein. The amplified DNAs from the mutant and wild-type cells are hybridized to a DNA chip having fixed thereon any one or more of the genomic fragments disclosed herein. Amplified DNA samples from the mutant and wild-type strain are labeled by any suitable means, for example using radioisotopes or fluorescent labeling. Hybridization of the amplified DNAs to the chip under conditions that can discriminate single or multiple base pair mismatches enables the detection of differences between the mutant and wild- type samples. This method identifies a specific fragment of the genome that is altered in the mutant strain. The specific mutation can be determined by conventional DNA sequence analysis. This aspect of the invention also relates to the detection of S. pneumoniae proteins in a sample using antibody molecules raised against any suitable ORF disclosed herein. Antibody detection methods are well known to those skilled in the art including, for example, a variety of radioimmunological assays. (See e.g. P. Tijssen, Practice and Theory of Enzyme Immunoassays : Laboratory Techniques in Biochemistry and Molecular Biology, Elsevier Science Publishers, Amsterdam, The Netherlands, 1985) . Test samples suitable for use in this aspect of the invention include but are not limited to biological fluids such as sputum, blood, serum, plasma, urine, and to biopsy samples . Skilled artisans will recognize that the disclosed method and reagents can be readily incorporated into a kit. For example, a kit would contain one or more receptacles comprising one or more of the following: PCR reagents, DNA chip reagents, labeling reagents, assorted buffers, and/or antibodies . Production of Antibodies The proteins of this invention and fragments thereof may be used in the production of antibodies. The term "antibody" as used herein describes antibodies, fragments of antibodies (such as, but not limited, to Fab, Fab 1 , Fab 2 ' , and Fv fragments), and chimeric, humanized, veneered, resurfaced, or CDR-grafted antibodies capable of binding antigens of a similar nature as the parent antibody molecule from which they are derived. The instant invention also encompasses single chain polypeptide binding molecules. The production of antibodies, both monoclonal and polyclonal, in animals is well known in the art. See, e. g. , C. Milstein, Handbook of Experimental Immunology, (Blackwell Scientific Pub., 1986); J. Goding, Monoclonal Antibodies: Principles and Practice, (Academic Press, 1983) . For the production of monoclonal antibodies the process begins with injecting a mouse, or other suitable animal, with an immunogen. The mouse is subsequently sacrificed and cells taken from its spleen are fused with myeloma cells, resulting in a hybridoma that can be cultured in vi tro . Hybridomas are screened for clones that secrete a single antibody species, specific for the immunogen. Chimeric antibodies, described in U.S. Patent No. 4,816,567, herein incorporated by reference, teaches methods and vectors for preparing chimeric antibodies. An alternative approach is provided in U.S. Patent No. 4,816,397, the entire contents of which is herein incorporated by reference. This patent teaches co- expression of heavy and light chains in the same host cell. The method taught in U.S. Patent 4,816,397 has been further refined in European Patent Publication No. 0 239 400. The teachings of this publication are preferred for engineering monoclonal antibodies. In this technology the complementarity determining regions (CDRs) of a human antibody are replaced with the CDRs of a murine monoclonal antibody, thereby converting the specificity of the human antibody to the specificity of the murine antibody. Single chain antibodies and libraries thereof provide yet another means for genetically engineering antibody molecules. ( See, e. g. R.E. Bird, et al . , Science 242:423-426 (1988); PCT Publication Nos. WO 88/01649, WO 90/14430, and WO 91/10737. Single chain antibody technology involves covalently joining the binding regions of heavy and light chains thereby generating a single polypeptide chain having the binding specificity of an intact antibody molecule . The antibodies contemplated by the present invention are useful in diagnostics, therapeutics, or in diagnostic/therapeutic combinations . The proteins of this invention, or suitable fragments thereof, can be used to generate polyclonal or monoclonal antibodies, and various inter-species hybrids, or humanized antibodies, or antibody fragments, or single-chain antibodies. The techniques for producing antibodies are well known to skilled artisans. (See e.g. A.M. Campbell, Monoclonal Antibody Technology: Laboratory Techniques in Biochemsitry and Molecular Biology, Elsevier Science Publishers, Amsterdam (1984) ; Kohler and Milstein, Nature 256, 495-497 (1975); Monoclonal Antibodies: Principles & Applications Ed. J.R.Birch & E.S. Lennox, Wiley-Liss, 1995. A protein or peptide to be used as an immunogen may be administered in an adjuvant by subcutaneous or intraperitoneal injection into, for example, a mouse or a rabbit. For the production of monoclonal antibodies, spleen cells from immunized animals are removed, fused with myeloma cells, such as SP2/0-Agl4 cells, and allowed to become monoclonal antibody producing hybridoma cells in the manner known to the skilled artisan. Hybrido as that secrete the desired antibody molecule can be screened by a variety of well known methods, for example ELISA assay, western blot analysis, or radioimmunoassay (Lutz et al . Exp. Cell Res . 175, 109-124 (1988); Monoclonal Antibodies: Principles & Applications Ed. J.R. Birch & E.S. Lennox, Wiley-Liss, 1995). For some applications it is desireable to have an antibody labeled in some fashion. Procedures for labeling antibody molecules with radioisotopes, affinity labels, such as biotin or avidin, enzymatic labels, for example horseradish peroxidase, and fluorescent labels such as FITC or rhodamine, are widely known (See e.g. Enzyme-Mediated Immunoassay, Ed. T. Ngo, H. Lenhoff, Plenum Press 1985; Principles of Immunology and Immunodiagnostics, R.M. Aloisi, Lea & Febiger, 1988) . Labeled antibodies are useful for a variety of diagnostic applications. In one embodiment, the present invention relates to the use of labeled antibodies to detect the presence of S. pneumoniae cells and proteins. Also contemplated are applications that use antibodies, preferably single chain antibodies, directed against a S. pneumoniae protein. Proteins identified as "external targets" are preferred for the generation of single chain antibodies. Single chain antibody libraries directed against S. pneumoniae surface proteins and cell wall proteins can be produced by applying the phage display technique to crude membrane preparations. Antibodies that recognize and bind to external target proteins and/or cell wall proteins could be used as therapeutic agents to inhibit the growth of S. pneumoniae . Alternatively, the antibodies could be used in a screen to identify potential inhibitors of an external target protein. For example, in a competitive displacement assay, an antibody or compound to be tested is labeled by any suitable method. Competitive displacement of an antibody from an antibody-antigen complex by a test compound provides a means to identify new antibacterial compounds. Protein Production Methods The present invention relates further to substantially purified proteins encoded by the ORFs disclosed herein (SEQ ID NO:87 through SEQ ID NO:228). Skilled artisans will recognize that proteins can be synthesized by different methods, for example, chemical methods or recombinant methods, as described in U.S. Patent 4,617,149, hereby incorporated by reference. The principles of solid phase chemical synthesis of polypeptides are well known in the art and may be found in general texts relating to this area. See, e . g. , H. Dugas and C. Penney, Bioorganic Chemistry (1981) Springer-Verlag, New York, 54-92. Peptides may be synthesized by solid-phase methodology utilizing an Applied Biosystems 430A peptide synthesizer (Applied Biosystems, Foster City, CA) and synthesis cycles supplied by Applied Biosystems. Protected amino acids, such as t-butoxycarbonyl-protected amino acids, and other reagents are commercially available from many chemical supply houses . The proteins and peptides of the present invention can also be made by recombinant DNA methods. Recombinant methods are preferred if a high yield is desired. Recombinant methods involve expressing a cloned ORF/gene in a suitable host cell. A gene is introduced into a host cell by any suitable means, well known to those skilled in the art. While chromosomal integration of a cloned gene is within the scope of the present invention, it is preferred that a cloned gene be maintained extra-chromosomally, as part of a vector wherein the gene is in operable-linkage to a constitutive or inducible promoter. Recombinant methods are also useful in overproducing a membrane-bound or membrane-associated protein. In some cases, membranes prepared from recombinant cells that overexpress such proteins provide an enriched source of the protein. Such membranes are useful for evaluating the function of the protein and/or for evaluating inhibitors of the protein. Expressing Recombinant Proteins in Procaryotic and Eucaryotic Host Cells Procaryotes are generally used for cloning DNA sequences and for constructing vectors. For example, the Escherichia coli K12 strain 294 (ATCC No. 31446) is particularly useful for expression of foreign proteins. Other strains of E. coli , bacilli such as Bacillus subtilis, enterobacteriaceae such as Salmonella typhimurium or Serratia marcescans, various Pseudomonas species may also be employed as host cells in cloning and expressing the recombinant proteins of this invention. Also contemplated are various strains of Streptococcus and Streptocmyces . For effective expression of a recombinant protein a gene or ORF may be linked to a known promoter sequence. Suitable bacterial promoters include b -lactamase [e.g. vector pGX2907, ATCC 39344, contains a replicon and b - lactamase gene], lactose systems [Chang et al . , Nature (London), 275:615 (1978); Goeddel et al . , Nature (London), 281:544 (1979)], alkaline phosphatase, and the tryptophan (trp) promoter system [vector pATHl (ATCC 37695) ] designed for the expression of a trpE fusion protein. Hybrid promoters such as the tac promoter (isolatable from plasmid pDR540, ATCC-37282) are also suitable. Promoters for use in bacterial systems also will contain a Shine-Dalgarno sequence operably linked to the DNA encoding the desired polypeptides. These examples are illustrative rather than limiting. A variety of mammalian cell systems and yeasts are also suitable host cells. The yeast Saccharomyces cerevisiae is a commonly used eucaryotic microorganism. Other yeasts such as Kl uyveromyces lactis are also suitable. For expression of recombinant genes in Saccharomyces, the plasmid YRp7 (ATCC-40053) , for example, may be used. See, e. g. , L. Stinchcomb, et al . , Nature, 282:39 (1979); J. Kingsman et al . , Gene, 7:141 (1979); S. Tschemper et al . , Gene, 10:157 (1980). Plasmid YRp7 contains the TRP1 gene that provides a selectable marker in a trpl mutant. Purification of Recombinantly-Produced Protein An expression vector carrying an ORF of the present invention is transformed or transfected into a suitable host cell using standard methods. Cells which contain the vector are propagated under conditions suitable for expression of the encoded protein. If the gene is under the control of an inducible promoter then suitable growth conditions would incorporate the appropriate inducer. The recombinantly-produced protein may be purified from cellular extracts of transformed cells by any suitable means. In a preferred process for protein purification a gene/ORF is modified at the 5' end, or some other position, to incorporate a plurality of histidine residues at the amino terminus of the encoded protein. The "histidine tag" produced thereby enables a single-step protein purification method referred to as "immobilized metal ion affinity chromatography" (IMAC), essentially as described in U.S. Patent 4,569,794, hereby incorporated by reference. The IMAC method enables rapid isolation of substantially pure protein starting from a crude cellular extract. As skilled artisans will recognize, the proteins of the invention can be encoded by a multitude of different nucleic acid sequences owing to the degeneracy of the genetic code. The present invention further comprises these alternate nucleic acid sequences. The ribonucleic acid compounds of the present invention may be prepared using the polynucleotide synthetic methods discussed supra , or they may be prepared enzymatically using RNA polymerase to transcribe a DNA template. The most preferred systems for preparing the ribonucleic acids of the present invention employ the RNA polymerase from the bacteriophage T7 or the bacteriophage SP6. These RNA polymerases are highly specific, requiring the insertion of bacteriophage-specific sequences at the 5' end of the template to be transcribed. See, J. Sambrook, et al . , supra, at 18.82-18.84. This invention also provides nucleic acids, RNA or DNA, which are complementary to the sequences disclosed herein. The present invention also provides probes and primers useful for a variety of molecular biology techniques including, for example, hybridization screens of genomic or subgenomic libraries, detection and quantification of mRNA species as a means to analyzing gene expression, and amplification of any region of the Streptococcus pneumoniae genome disclosed by the sequences herein. A nucleic acid compound is provided comprising any of the sequences disclosed herein, or a complementary sequence thereof, or a fragment thereof, which is at least 15 base pairs in length, and which will hybridize selectively to Streptococcus pneumoniae DNA or mRNA. Preferably, the 15 or more base pair compound is DNA. A probe or primer length of at least 15 base pairs is dictated by theoretical and practical considerations. See e.g. B. Wallace and G. Miyada, "Oligonucleotide Probes for the Screening of Recombinant DNA Libraries," In Methods in Enzymology, Vol. 152, 432-442, Academic Press (1987) . The probes and primers of this invention can be prepared by methods well known to those skilled in the art (See e.g. Sambrook et al . supra) . In a most preferred embodiment these probes and primers are synthesized by the polymerase chain reaction (PCR) . The present invention also relates to recombinant DNA cloning vectors and expression vectors comprising the nucleic acids of the present invention. Preferred nucleic acid vectors are those which comprise DNA. The skilled artisan understands that choosing the most appropriate cloning vector or expression vector depends on a number of factors including the availability of restriction enzyme sites, the type of host cell into which the vector is to be transfected or transformed, the purpose of the transfection or transformation (e.g., stable transformation as an extrachromosomal element, or integration into the host chromosome) , the presence or absence of readily assayable or selectable markers (e.g., antibiotic resistance and metabolic markers of one type and another) , and the number of gene copies desired in the host cell. Vectors suitable to carry the nucleic acids of the present invention comprise RNA viruses, DNA viruses, lytic bacteriophages, lysogenic bacteriophages, stable bacteriophages, plasmids, viroids, and the like. The most preferred vectors are plasmids. Host cells harboring the nucleic acids disclosed herein are also provided by the present invention. A preferred host is E. coli which has been transfected or transformed with a vector that comprises a nucleic acid of the present invention. The present invention also provides a method for constructing a recombinant host cell capable of expressing an ORF disclosed herein, said method comprising transforming or otherwise introducing into a host cell a recombinant DNA vector that comprises an isolated DNA sequence which encodes said ORF. The preferred host cell is any strain of E. coli which can accomodate high level expression of an exogenously introduced gene. Transformed host cells are cultured under conditions well known to skilled artisans such that said ORF is expressed, thereby producing the encoded protein in the recombinant host cell. For the purpose of discovering new inhibitors of cell wall biosynthesis, it would be desirable to determine agents that inhibit enzymes required for synthesis of the cell wall and/or agents that interact with membrane proteins. A method for identifying compounds that interact with such enzymes and membrane proteins comprises contacting said proteins with a test compound and monitoring an interaction and/or inhibition by any suitable means. The instant invention provides a screening system for compounds that interact with membrane proteins of this invention, said screening system comprising the steps of: a) preparing a membrane protein, or membranes enriched in said protein; b) exposing the protein source of (a) to a test compound; and c) quantifying the interaction of said protein with said compound by any suitable means. The screening method of this invention may be adapted to automated procedures such as a PANDEX ® (Baxter- Dade Diagnostics) system, allowing for efficient high-volume screening of compounds. In a typical screening protocol, a protein to be tested is prepared as described herein, preferably using recombinant DNA technology. A test compound is introduced into a reaction vessel containing said protein. The reaction/interaction of said protein and said compound is monitored by any suitable means. For example, a radioactively-labeled or chemically-labeled compound or protein may be used. Specific association between a test compound and protein is monitored by any suitable means. The following examples more fully describe the present invention. Those skilled in the art will recognize that the particular reagents, equipment, and procedures described are merely illustrative and are not intended to limit the present invention in any manner. EXAMPLE 1 Vector for Expressing S. pneumoniae ORF in a Host Cell An expression vector suitable for expressing a S. pneumoniae gene or fragment thereof in a variety of procaryotic host cells, such as E. coli , is easily made. A suitable parent vector contains an origin of replication (Ori) , a marker for selecting transformants, for example, an ampicillin resistance gene (Amp) , and further comprises suitable transcriptional and translational signals, for example, the T7 promoter and T7 terminator sequences, in operable-linkage to a S. pneumoniae coding region. For example, pETllA (obtained from Novogen, Madison WI) is linearized by restriction with endonucleases Ndel and BamHI. Linearized pETllA is ligated to a DNA fragment bearing Ndel and BamHI sticky ends and comprising a coding region for a S. pneumoniae ORF. The ORF used in this construction may be modified at the 5' end (amino terminus of encoded protein or peptide) to simplify purification of the encoded protein or peptide. For this purpose, an oligonucleotide encoding 8 histidine residues is inserted after the transcriptional and translational start sites. Placement of the histidine residues at the amino terminus of the encoded protein enables the IMAC one-step protein purification procedure. Example2 Recombinant Expression and Purification of a Protein Encoded by a S. pneumoniae ORF An expression vector that carries an ORF from the S. pneumoniae genome, as disclosed in Example 1, and which ORF is operably-linked to an expression promoter, is transformed into E. coli BL21 (DE3) (hsdS gal lclts857 in lSam7nin5JacUV5-T7gene 1) using standard methods. Transformants, selected for resistance to ampicillin, are chosen at random and tested for the presence of the vector by agarose gel electrophoresis using quick plasmid preparations. Colonies that contain the vector are grown in L broth and the protein produced by the vector-borne ORF is purified by IMAC, essentially as described in US Patent 4,569,794. Briefly, the IMAC column is prepared as follows. A metal-free chelating resin (e.g. Sepharose 6B IDA, Pharmacia) is washed in distilled water to remove preservatives and then infused with a suitable metal ion [e.g. Ni(II), Co (II), or Cu(II)] by adding a 50mM metal chloride or metal sulfate aqueous solution until about 75% of the interstitial spaces of the resin are saturated with colored metal ion. The column is then ready to receive a crude cellular extract containing the recombinant protein product. Unbound proteins and other materials are removed by washing the column with any suitable buffer, pH 7.5. Bound protein is eluted in any suitable buffer at pH 4.3, or preferably with an imidizole-containing buffer at pH 7.5. Example 3 DNA Chip Production Any one or more of the S. pneumoniae genome DNA fragments disclosed herein, or fragments thereof, are arrayed onto a solid support. It is preferred that fragments be in the size range of 14 base pairs to 500 base pairs. The DNA samples are most conveniently synthesized by PCR using standard methods to amplify regions disclosed by the genomic sequences herein. The method of Schena et al . is used to spot about 1 ng to 10 ng of a DNA sample onto glass microscope slides that have been treated with poly-L-lysine (M. Schena et al . "Quantitative monitoring of gene expression patterns with a complementary DNA microarray" Science, 270, 467-470, 1995) . After spotting DNA samples onto the chip and air-drying, the chips are rehydrated by incubation for about 2 hours in a humid chamber. Chips are then placed at 100° C for 1 minute, rinsed in 0.1% SDS, and treated with 0.05% succinic anhydride in 50% l-methyl-2- pyrrolidinone and 50% boric acid. Example 4 S. pneumoniae Gene Expression Analysis using DNA Chips RNA prepared from cells grown under any desireable conditions is used to prime cDNA synthesis by reverse transcription, using methods well known to the skilled artisan (See e.g. Molecular Cloning, 2d Ed. J. Sambrook, E. Fritsch, T. Maniatis, 1989) . For example, total RNA of strain R6 is prepared according to the method of Logeman et . al . , (Analytical Biochemistry, 1987, 163, 16-20) using guanidine hydrochloride. After ethanol precipitation, the total RNA is dissolved in a buffered solution such as Tris- EDTA (TE) . Complementary DNA's are synthesized with the aid of the StrataScript RT-PCR kit (Stratagene, Inc. ) in accordance with the supplier's recommendations (See Schena et al . Id. ) . Briefly, a 50 ul reaction contains about 0.1 ug/ul of RNA. First strand synthesis is primed using random primers, IX first strand buffer, 0.03 U/ul ribonuclease block, 500 uM dATP, 500 uM dTTP, 40 uM dGTP, 40 uM fluorescein-12-dCTP (New England Nuclear), and 0.03 U/ul reverse transcriptase . Reactions are incubated for 60 minutes at 37° C, precipitated with ethanol, and resuspended in 10 ul TE pH 8. Samples are heated for 3 minutes at 94° C and chilled on ice. The RNA is degraded by adding 0.25 ul of 10 N NaOH, followed by a 10 minute incubation at 37° C. The samples are neutralized with 2.5 ul of IM Tris-HCl, pH 8 and 0.25 ul of 10 N HCI. After ethanol precipitation, the nucleic acid pellet is washed and dried in vaccuo . Prior to hyrbrization, DNA chips prepared as in Example 3 are denatured by heating to 90°C for 2 minutes. Hybridization reactions contain about 1 ul of fluorescently- labeled cDNA, and 1 ul of hybridization buffer (lOx SSC and 0.2% SDS) . Probe mixtures are transferred to the surface of the chip, covered with a cover slip, and incubated for 18 hours at 65° C. Chips are washed 5 minutes at room temperature in IX SSC, 0.1% SDS, then for 10 minutes at room temperature in 0. IX SSC, 0.1% SDS. After hybridization, chips are scanned with a laser-scanning device. Example 5 A DNA Bio Chip for mutation analysis Duplicate DNA chips are prepared as in Example 3. Each chip is overlayed with S. pneumoniae cells in a semi-solid medium, wherein said cells carry a temperature-sensitive (ts) mutation in a gene required for autolytic activity (Lyt-) . This mutation leads to resistance to lysis at 37° C, but sensitivity to lytic treatments at 30° C. S. pneumoniae strain cwl is resistant to lysis by detergent and penicillin when grown at 37° C, but remains sensitive when grown at 30° C (cwl is derived from strain R6; See P. Garcia et al . "Mutants of Streptococcus pneumoniae that contain a temperature-senstive autolysin" J. Gen . Microbiol . 132, 1401-05, 1986) . Strain cwl is grown at 30° C and competent cells are prepared according to any suitable method (e.g. LeBlanc et . al . Plasmid 28, 130-145, 1992; Pozzi et al . J. Bacteriol .178 , 6087-6090, 1996). Competent cwl cells are harvested by centrifugation and resuspended at about 10 5 cells per ml in 1% melted agar supplemented with 0.1% (w/v) yeast extract (Difco) and containing 1% to 2% Triton X-100. Approximately 100 ul to 500 ul of the cell mixture is deposited per square centimeter onto the bio chip by pipetting onto the chip surface. After solidification of the agar layer, one of the bio-chips is incubated at 37° C and the other at 30° C. Cells that take up a complementing genomic DNA fragment from the chip surface will be lysed at both 30° C and 37° C, while non-complemented cells are lysed only at 30° C. Cells that are complemented by the bio-chip are recognizable by this phenotypic difference and can be further purified by well known methods. TABLE 1 pneumoniae Genes and proteins Contig Associated ORF(s) Nucleotide SEQ ID NO Gene Comments ID (Amino Acid SEQ ID NO) category jOOl yyaF 1 (123) hypothet yyaF= GTP-binding ical protein J002 obg 2 (124) external obg=GTP-binding protein J003 IspA; 3 (126) cell lsp=prolipoprotein yw l 3 (125) wall signal peptidase synth; ywblhypothetical hypothet transcriptional ical regulator J004 pstA 4 (127) external pstA=high-affinity phosphate-specific transport J005 pilB 5 (128) external pilB=fimbrial transcription regulation repressor J008 pgsA 6, 111 external pgsA=phosphatidylglyce rophosphate synthase 009 potC; 7 (130) external potC, potF=spermidine/p potF 7 (131) utrescine transport system permease proteins J010 pbuX; S, 9 (132) external pbuX=xanthine permease uraA(pyrP (133) uraA=uracil permease external J012 nanB/A 10 134 ' external |nanB/A=neuraminidase J013 014 mOOl m002 m003 m004 m005 m007 m008 mOll m012 m014 m015 m016 m017 m018 m019 m021 m022 m023 m024 m027 m028 p005 p006 p007 p016 ATPase; p017 livH; braC p018 riml; gcp PunkOl unk; Punk02 unk Punk03 unk Punk04 unk Punk05 unk; Punk06 unk; PunkOδ unk Punk09 unk; PunklO unk Punkl2 unk sOOl AtpF s002 DnaG s003 elongation factor G; DNA polymerase III s004 FAD synthetase regulatory protein s005 LPS-heptosyl-2- transferase, small prot. s006 chromosomal replication initiator s008 replicative DNA helicase s009 prolipoprotein diacylglyceryl transferase sOlO UDPgalactose Epimerase ι CO I dpj-acps 101 SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: Baltz, Richard H. Burgett, Stanley G. DeHoff, Bradley S. Jaskunas Jr., Stanley R. Mills, Bradley J. Norris, Franklin H. Peery, Robert B. Rosteck Jr. , Paul R. Skatrud, Paul L. Smith, Michele C. Rockey, Pamela K. Young-Bellido, Michele (ii) TITLE OF INVENTION: Streptococcus Pneumoniae DNA Sequences (iii) NUMBER OF SEQUENCES: 122 (iv) CORRESPONDENCE ADDRESS: (A) ADDRESSEE: Eli Lilly and Company (B) STREET: Lilly Corporate Center (C) CITY: Indianapolis (D) STATE: Indiana (E) COUNTRY: U.S. (F) ZIP: 46285 (v) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: Patentin Release #1.0, Version #1.30 (vi) CURRENT APPLICATION DATA: (A) APPLICATION NUMBER: (B) FILING DATE: (C) CLASSIFICATION: (viii) ATTORNEY/AGENT INFORMATION: (A) NAME: Webster, Thomas D. (B) REGISTRATION NUMBER: 39,872 (C) REFERENCE/DOCKET NUMBER: X-11162 (ix) TELECOMMUNICATION INFORMATION: (A) TELEPHONE: 317-276-3334 (2) INFORMATION FOR SEQ ID Nθ:l: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1267 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID Nθ:l: ATGGTGGAAG TTCCAGATGA ACGCCTACAA AAACTAACTG AAATGATAAC TCCTAAAAAG 60 ACAGTTCCCA CAACATTTGA ATTTACAGAT ATTGCAGGGA TTGTAAAAGG AGCTTCAAAA 120 GGAGAAGGGC TAGGGAATAA ATTCTTGGCC AATATTCGTG AAGTAGATGC GATTGTTCAC 180 GTAGTTCGTG CTTTTGATGA TGAAAATGTA ATGCGCGAGC AAGGACGTGA AGACGCCTTT 240 GTAGATCCAC TTGCAGATAT TGATACAATT AATCTGGAAT TAATTCTTGC TGACTTAGAA 300 TCAGTGAACA AACGATATGC GCGTGTAGAA AAGATGGCAC GTACGCAAAA AGATAAAGAA 360 TCAGTAGCAG AATTCAATGT TCTTCAAAAG ATTAAACCAG TCCTAGAAGA CGGGAAATCA 420 GCTCGTACCA TTGAATTTAC AGATGAGGAA CAAAAGGTTG TCAAAGGTCT TTTCCTTTTG 480 ACGACTAAAC CAGTTCTTTA TGTAGCTAAT GTGGACGAGG ATGTGGTTTC AGAACCTGAC 540 TCTATCGACT ATGTCAAACA AATTCGTGAA TTTGCAGCGA CAGAAAATGC TGAAGTAGTC 600 GTTATTTCTG CGCGTGCTGA GGAAGAAATT TCTGAATTGG ATGATGAAGA TAAAAAAGAG 660 TTTCTTGAAG CCATTGGTTT GACAGAATCA GGTGTAGATA AGTTGACGCG TGCAGCTTAC 720 CACTTGCTTG GATTGGGAAC TTACTTCACA GCTGGTGAAA AAGAAGTTCG CGCTTGGACT 780 TTCAAACGTG GTATGAAGGC TCCTCAAGCA GCTGGTATTA TCCACTCAGA CTTTGAAAAA 840 GGCTTTATTC GTGCAGTAAC CATGTCATAT GAAGATCTAG TGAAATACGG ATCTGAAAAG 900 GCCGTAAAAG AAGCTGGACG CTTGCGTGAA GAAGGAAAAG AATATATCGT TCAAGATGGC 960 GATATCATGG AATTCCGCTT TAATGTCTAA AAATTAATAA ATGGTGTCAA TTAGGTTGGA 1020 AAAAAATTCC AACCCTTTTG GCTTTTGAAA GGAAAAATAA ATGACCAAAT TACTTGTAGG 1080 TTTGGGAAAT CCAGGGGATA AATATTTTGA AACAAACACA ATGTTGGTTT TATGTTGATT 1140 GATCAACTAG CGAAGAAACA GAATGTCACT TTTACACACG ATAAGATATT TCAAGCTGAC 1200 CTAGCATCCT TTTTCCTAAA TGGAGAAAAA ATTTATCTGG GTTAAACCAA CGACCTTTAT 1260 GGATTGA 1267 (2) INFORMATION FOR SEQ ID NO: 2: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1255 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2: TGGTCCGTGG TGCTGAGGAC CCTTAGAGTT CGAGTACCAC AAGGTACCGA CTGTTCGTGA 60 TGCGGAGCTG GCAAGGTTTT AACAGATTTG ATTGAACATG GGCAAGAATT TATCGTTGCC 120 CACGGTGGTC GTGGTGGACG TGGAAATATT CGTTTCGCGA CACCAAAAAT CCTGCACCGG 180 AATCTCTGAA AATGGAGAAC CAGGTCAGGA ACGTGAGTTA CAATTGGAAC TAAAAATCTT 240 GGCAGATGTC GGTTTAGTAG GATTCCCATC TGTAGGGAAG TCAACACTTT TAAGTGTTAT 300 TACCTCAGCT AAGCCTAAAA TTGGTGCCTA CCACTTTACC ACTATTGTAC CAAATTTAGG 360 TATGGTTCGC ACCCAATCCA GGTGAATCCT TTGCAGTAGC CGACTTGCCA GGTTTGATTG 420 AAGGGGCTAG TCCAAGGTGT TGGTTTGGGA ACTCAGTTCC TCCGTCACAT CGAGCGTACA 480 CGTGTTATCC TTCACATCAT TGATATGTCA GCTAGCGAAG GCCGTGATCC ATATGAGGAT 540 TACCTAGCTA TCAATAAAGA GCTGGAGTCT TACAATCTTC GCCTCATGGA GCGTCCACAG 600 ATTATTGTAA CTAATAAGAT GGACATGCCT GAGAGTCAGG AAAATCTTGA AGAATTTAAG 660 AAAAAATTGG CTGAAAATTA TGATGAATTT GAAGAGTTAC CAGCTATCTT CCCAATTTCT 720 GGATTGACCA AGCAAGGTCT GGCAACACTT TTAGATGCTA CAGCTGAATT GTTAGACAAG 780 ACACCAGAAT TTTTGCTCTA CGACGAGTCC GATATGGAAG AAGAAGTTTA CTATGGATTT 840 GACGAAGAAG AAAAAGCCTT TGAAATTAGT CGTGATGACG ATGCGACATG GGTACTTTCT 900 GGTGAAAAAC TCATGAAACT CTTTAATATG ACCAACTTTG ATCGTGATGA ATCTGTCATG 960 AAATTTGCCC GTCAGCTTCG TGGTATGGGG GTTGATGAAG CCCTTCGTGC GCGTGGAGCT 1020 AAAGATGGGG ATTTGGTCCG CATTGGTAAA TTTGAGTTTG AATTTGTAGA CTAGGAGACT 1080 GGTATGGGAG ATAAACCGAT ATCTTTCCGA GATGCGGATG GTAATTTTGT TTCCGCCGCA 1140 GACGTTTGGA ATGAAAAGAA ATTGGAAGAA CTATTTAATC GTCTCAATCC AAATCGTGCC 1200 TTGAGATTGG CACGAACTAC AAAGGAAAAT CCATCTCAGT AAAGAAGCTA AAAAA 1255 (2) INFORMATION FOR SEQ ID NO: 3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1609 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3: TTACCCATCG CATGACTAAA AATCTCTACT ATCCAATACT AGTTCATATT CTCATCAATA 60 TCACTGCCTT CTGGGATGTT TGGTTACTCC TATTTTCAGG AAGTTAGCTT ACTAAAAAAA 120 TGTCGGAATT TTCCGGCATT TTCTTTTTTC ACAAATAGTC AACGTTTTTC TTTCCGATAC 180 TGAAGTGGTG TGTAGCCACT TATTTTTTTG AATTGATTTT GAAAATAAGA TTGGCGTGAG 240 AAAGGCAGAT AGTGAAGATA GTTAAGAAGA ATAGGATGTT CTTTTTTCCT TTTTGGAAAA 300 CTTCTAAAAT ATGGTATAAT GAAAAGATAA AGAAGTTGGG GGTAGAAGAT GAACATTCAA 360 CAATTACGCT ATGTTGTGGC TATTGCCAAT AGTGGTACTT TTCGTGAAGC TGCTGAAAAG 420 ATGTATGTTA GTCAGCCGAG TCTGTCTATT TCTGTTCGTG ATTTGGAAAA AGAGTTGGGC 480 TTTAAGATTT TCCGTCGGAC CAGCTCAGGG ACTTTCTTGA CCCGTCGTGG GATGGAATTT 540 TATGAAAAAG CGCAAGAATT GGTTAAAGGA TTTGATATTT TTCAAAATCA GTATGCCAAT 600 CCTGAAGAAG AAAAAGATGA ATTTTCCGTT GCTAGCCAGC ACTATGACTT CTTACCACCA 660 ACTATTACGG CCTTTTCAGA GCGCTATCCT GACTATAAGA ACTTCCGTAT TTTTGAATCA 720 ACTACTGTTC AAATATTAGA TGAAGTGGCG CAAGGGCATA GTGAGATTGG GATTATCTAC 780 CTCAACAATC AAAATAAAAA GGGGATTATG CAACGGGTTG AAAAGTTAGG TCTGGAGGTC 840 ATCGAATTGA TTCCTTTCCA TACCCATATT TATCTCTGTG AGGGTCATCC TTTAGCCCAG 900 AAAGAGGAAT TAGTCATGGA GGATTTAGCG GATTTACCAA CGGTTCGTTT CACTCAAGAG 960 AAAGACGAGT ACCTTTATTA TTCAGAGAAC TTTGTCGATA CCAGCGCTAC TCACAGATGT 1020 TTAATGTGAC AGACCGTGCC ACCTTGAATG GTATTTTGGA GCGGACGGAC GCCTATGCGA 1080 CAGGTTCTGG ATTTTTAGAT AGTGACAGTG TTAATGGCAT TACAGTTATT CGTCTCAAGG 1140 ATAACCTAGA TAACCGCATG GTCTATGTTA AACGTGAAGA AGTGGAGCTT AGTCAAGCTG 1200 GGACTCTCTT CGTAGAAGTC ATGCAAGAAT ATTTTGATCA AAAGAGGAAA TCATGAAAAA 1260 AAGAGCAATA GTGGCAGTCA TTGTACTGCT TTTAATTGGG CTGGATCAGT TGGTCAAATC 1320 CTATATCGTC CAGCAGATTC CACTGGGTGA AGTGCGCTCC TGGATTCCCA ATTTCGTTAG 1380 CTTGACCTAC CTGCAAAATC GAGGTGCAGC CTTTTCTATC TTACAAGATC AGCAGCTGTT 1440 ATTCGCTGTC ATTACTCTGG TTGTCGTGAT AGGTGCCATT TGGTATTTAC ATAAACACAT 1500 GGAGGACTCA TTCTGGATGG TCTTGGGTTT GACTCTAATA ATCGCGGGTG GTCCTGGAAA 1560 CTTTATTGAC AGGGTCAGTC AGGGCTTTGT TGTGGATATG TTCCACCTT 1609 (2) INFORMATION FOR SEQ ID NO: 4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 763 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 4: GTAACTTAGG GCCCCAAGTC CATAACTTGC TTGACGCATG CTATCACTAA CAGATAAAAG 60 GGCTTCTTCT GTTGAGCGAA TAATGACTGG CAACACCATG ATGACTGAGG TTAAGATTCC 120 TGATAACAGA GAGTATTGAA AACCTAAGAA GACTACAAAG AAGAGCATGC CAAACAGACC 180 AAAAACAATG GAAGGAATCC CAGACAAGGT ATCTGAGGCC AATCGCATGA TTTTAACACA 240 AAGGGAATCT TTTTTTGTAT ATTCCACAAG ATAAAAACCA GCAAAAATCC CTATGGGCAA 300 GGCTAAAAGA AGAGCACCAA AGACCAGAAT AACGGTGGAA ATAATCGCTG GCATAAGGGA 360 AATGTTCTCA GAAGTATAAG TCCAAGAAAA GAGGGATAGA CTTAGATGAG GTAAACCTTT 420 GATGAGGATA AAACCAATGA TTAAAAAGAG AGAGCCAAAG GTTAAAGCTG AAAAACAATA 480 AACGAGAAGT TTTAGCAGGT ATTTACTCAT AAGATGATTT TCCTTTCAAG TAGCCAAAGT 540 AGGCATTAAT CAAGAGAATA AGGAAAΛAGA GAACTGCTGA GGTTGCAATA AGGGCTTCCC 600 TATGCTGACC TGATGCGTAA GCCATTTCCA GAACAATATT GGTTGTTAAG GTTCTGGTTC 660 CTGAAAAGAG TCCACTTGGA ATAATCGGCT GGTTGCCTGC CACCAAAATA ACTGCCATGG 720 TTTCACCTAC TGCGCGACCG ATGCCTAAAA TAACTGCTGA AAA 763 (2) INFORMATION FOR SEQ ID NO: 5: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 897 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5: GGGTCTGTTT TGGCCTTGGC GGCTTCAGGT GGTTCAGGAG CTTGGCAGGG AGCTGGTCTC 60 ATGTTGGTGT ATACGCTGGG CTTGGCGCTA CCATTCTTGC TTCTAGCTCT GACCTCTAGT 120 TATGTTTTGA AACATTTCCG AAAACTTCAT CCCTATCTCG GAATCCTCAA AAAAGTGGGT 180 GGTTTTCTCA TTATTGTGAT GGGATTCTTG GTTCTGTTTG GAAATGCTTC AATTTTAAGT 240 CAATTATTTG AATAAAATGG AAAGGAATAT CAATATGAAA AAATGGCAAA CATGTGTTCT 300 TGGAGCAGGT TCGCTCCTTT GTTTGACGGC TTGTTCAGGC AAGTCCGTGA CTAGTGAACA 360 CCAAACGAAA GATGAAATGA AGACGGAGCA GACAGCTAGT AAAACAAGCG CACTAAAAGG 420 GAAAGAGGTG GCTGATTTTG AATTGATGGG AGTAGATGGC AAGACCTACC GTTTATCTGA 480 TTACAAGGGC AAGAAAGTCT ATCTCAAATT CTGGGCTTCT TGGTGTTCCA TCTGTCTGGC 540 TAGTCTTCCA GATACGGATG AGATTGCTAA AGAAGCTGGT GATGACTATG TGGTCTTGAC 600 AGTAGTGTCA CCAGGACATA AGGGAGAGCA ATCTGAAGCG GACTTTAAGA ATTGGTATAA 660 GGGATTGGAT TATAAAAATC TCCCAGTCCT AGTTGACCCA TCAGGCAAAC TTTTGGAAAC 720 TTATGGTGTC CGTTCTTACC CAACCCAAGC CTTTATAGAC AAAGAAGGCA AGCTGGTCAA 780 AACACATCCA GGATTCATGG AAAAAGATGC AATTTTGCAA ACTTTGAAGG AATTATCCTA 840 GGAGGCGTCT TATGAATGAT AAGTTAAAAA TCTTCTTGTT GCTAGGAGTA TTTTTTC 897 (2) INFORMATION FOR SEQ ID NO: 6: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 3499 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6: TTTCTTTTTC CTAGGTGATT TTAATGAGGT TGAAATTCAA AATGTATTAG AATCATTTGG 60 CTTTAAAGGT CGAAAAGGAG ATGTGAAGGT TCAGTATTGT CAACCTTATT CTAATATCCT 120 TCAGGAAGGT ATGGTTCGGA AAAATGTGGG ACAATCCATT TTGGAATTAG GTTATCATTA 180 CCGTTCTAAA TATGGTGATG AGCAACATTT ACCCATGATT GTAATGAATG GTTTACTTGG 240 TGGATTTGCT CACTCTAAGC TCTTTACAAA TGTCCGTGAA AATGCTGGAT TAGCTTATAC 300 CATTTCAAGT GAGCTTGATT TATTTAGTGG ATTCTTGAGG ATGTATGCTG GTATCAATCG 360 AGAAAATCGT AACCAGGCTC GTAAAATGAT GAATAATCAA CTGCTTGATT TAAAAAAAGG 420 TTATTTTACA GAGTTTGAGT TAAATCAGAC CAAGGAAATG ATTCGTTGGT CGTTGTTACT 480 TTCTCAAGAT AATCAATCTT CATTGATTGA ACGTGCTTAT CAAAATGCCT TATTTGGAAA 540 ATCTTCAGCA GACTTTAAAA GTTGGATTGC AAAGCTTGAA CAAATTGACA AAGATGCTAT 600 TTGTAGAGTA GCTAATAATG TGAAACTACA AGCGATTTAC TTTATGGAAG GAATAGAATG 660 ACAAAGGTTG TTTTTGAAGA AAAATACTAT CCAGCTGTAA AAGAAAAGGT TTATCGAACT 720 CGTTTGGCCA ACGGATTGAC AGTTGCTCTT TTGCCTAAAA AGGAATTTAA AGAGGTTTAC 780 GGGAGTGTCA CTGTACAGTT TGGTTCGGTA GATACGTTTG TCACAGAAGT TGACGGATAT 840 GTAAAACAAT ATCCTGGAGG AATTGCTCAT TTTCTTGAAC ATAAATTATT TGAGAGAGAA 900 GATTCTAGTG ATTTGATGTC GGCTTTTACG AGTCTAGGTG CAGATAGTAA TGCCTTTACA 960 AGCTTTACAA AAACAAACTA TCTTTTTTCA GCAACGGATT ATTTTTTAGA AAATTTAGAT 1020 TTACTTGATG AATTGGTAAC ATCAGCACAC TTTACTGAAG CTTCCATTCT GACAGAGCAG 1080 GATATTATTC AGCAAGAACG AGAAATGTAC CAAGATGATC CAGATTCGTG TTTATTCTTT 1140 TCAACTTTAG CGAATTTGTA TCCTGGTACA CCTTTAGCAA CTGATATAGT TGGAAGTGAG 1200 GAGTCCATTT CCCAAATCAA TCTAACTAAT TTGCAAGAAA ATTTTACAAA GTTTTACAAA 1260 CCTGTAAACA TGTCTCTGTT TTTAGTTGGT AATTTTGATG TGGAGCGAGT ACAGGACTAT 1320 TTTGAAAGCA AAGAACTGAA AGATTCAGAT TTTCAGGAAG TAGCAAGAGA AAAGTTGTTT 1380 TTACAGCCTG TAAAGCCAAC AGATAGTATG AGAATGGAAG TATCTTCTCC CAAACTAGCG 1440 ATTGGAGTTA GAGGTAAGCG AGAAGTTTCT GAAGCGGATT GCTATCGACA TCATATTTTA 1500 TTAAAATTAT TGTTTGCAAT GATGTTTGGT TGGACTTCGG GATCGTTTTC AAAAATGTTA 1560 TGAATCAGGT AAAATTGATG CGTCCTTATC TCTGGAAGTT AAATAACAAG TCGCTTTCAT 1620 TTTGTCATGT TGACAATAGA TACGAAAGAG CCAGTTGCTT TGTCTCATCA ATTTAGGAAG 1680 GCTATTCGTA ATTTTACAAA GGATTTAGAT ATTACAGAGG AACATTTAGA TATTATCAAA 1740 AGAGAGATGT TTGGCGAATT TTTCAGTAGC ATGAACTCTC TTGAATTTAT TGCAACGCAA 1800 TATGATGCTT TTGAAAATGG TGAGACAATT TTTGATTTGC CGAAAATTTT ACAGGAAATT 1860 ACTTTAGAGG ATGTCCTTGA TGCTGGACAT CATTTAATAG ATGATGGTGA CATAGTTGAT 1920 TTTACAATAT TCCCATCGTA GTAACCTATC ATAATAGACA CTAGAAAGAA GGGATGACAA 1980 GTATGAGAAA AAAAACAATT GGAGAGGTTT TACGATTAGC TAGAATCAAT CAGGGATTGA 2040 GTTTAGATGA ATTGCAGAAA AAGACAGAAA TCCAGTTAGA TATGTTGGAA GCAATGGAAG 2100 CAGACGATTT CGATCAACTT CCAAGTCCTT TTTACACGCG TTCTTTCTTG AAAAAATATG 2160 CATGGGCTGT TGAGTTAGAT GACCAAATTG TTTTGGATGC TTATGATTCT GGGAGTATGA 2220 TTACTTATGA GGAAGTAGAT GTTGATGAAG ATGAGTTGAC AGGTCGTAGA CGTTCAAGTA 2280 AGAAAAAGAA GAAAAAAACA TCATTTTTAC CTTTATTTTA TTTTATCCTT TTTGCTTTAT 2340 CGATTTTAAT TTTTGTGACT TATTATGTTT GGAACTATAT TCAAACTCAA CCAGAGGAGC 2400 CTTCTCTTTC TAATTACAGT GTGGTTCAAT CAACAAGTTC AACTAGCTCT GTTCCCCACT 2460 CCTCAAGTAG TAGTTCTTCT AGTATAGAAT CAGCTATAAG TGTATCAGGC GAAGGAAATC 2520 ATGTAGAAAT CGCTTATAAG ACAAGTAAGG AAACAGTTAA ATTGCAATTG GCAGTTTCAG 2580 ATGTTACAAG TTGGGTCAGT GTTTCAGAAA GCGAACTTGA GGGCGGTGTA ACCTTATCGC 2640 CAAAGAAGAA AAGTGCAGAA GCAACAGTTG CAACTAAAAG TCCTGTAACA ATTACGTTAG 2700 GTGTTGTAAA AGGTGTTGAT TTGACAGTAG ATAATCAGAC TGTTGATTTA TCGAAATTAA 2760 CAGCTCAGAC TGGACAAATC ACTGTAACCT TTACTAAAAA TTAAGGAAAA ACGAATGAAA 2820 AAAGAACAAA TTCCCAATCT CTTAACAATA GGTCGAATTC TCTTTATACC TATTTTTATC 2880 TTTATTTTAA CGATAGGAAA TTCGATAGAG AGTCATATAG TTGCAGCTAT TATCTTTGCT 2940 GTTGCCAGTA TTACCGACTA TTTAGATGGA TATTTAGCTC GTAAATGGAA TGTGGTCAGT 3000 AATTTTGGTA AATTTGCAGA TCCTATGGCG GATAAGTTAC TAGTTATGTC GGCTTTTATT 3060 ATGTTGATTG AGTTAGGTAT GGCTCCGGCT TGGATTGTTG CAGTGATTAT CTGTCGTGAG 3120 TTAGCTGTGA CAGGTTTAAG GCTTTTATTG GTTGAAACTG GTGGAACAAT TTTAGCAGCA 3180 GCAATGCCTG GAAAAATTAA AACTTTTAGT CAGATGTTTG CTATTATTTT CTTGCTATTA 3240 CATTGGACTT TGCTTGGTCA AGTTCTACTT TATGTAGCCT TATTTTTCAC TATCTACTCT 3300 GGCTATGACT ATTTCAAGGG TAGTGCCTAT GTATTTAAAG GGACATTTGG TTCGAAATGA 3360 AATCAATAAT TGATGTAAAA AATCTTTCTT TTCGCTATAA AGAAAATCAG AACTACTACG 3420 ATGTGAAGGA TATTACGTTT CACGTGAAAC GTGGAGAATG GCTTTCGATT GTAGGGCATA 3480 ATGG AGTGG TAAATCAAC 3499 (2) INFORMATION FOR SEQ ID NO: 7: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 821 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 7: ATTTTTGAAT AATCAAGCGG AACCAAGAGG TCTTCGTCCT TCATCTTGTT AATCATGTAT 60 TCACTTGGAA TGGCAATATC GTAGGTCGTT CCACCCTGCT TTATCTTAGT GTACATGGCT 120 TCGTTGGAGT CAAAAGCCTC GTACTGAACT TGAATTCCTG TTTCTTCTGT AAACTGAGTC 180 AAGAGTTCAG GATCGATATA GTCTCCCCAG TTATAGATAA CCAATTTTTG ACTATCTCGA 240 CTATTGATTT TACTATCTAA ATGAGTCGCA ATTCCCCACA AGACAAGGAT AATCGCTGCA 300 ATTCCTGCTA AAATGAATAG ATTTTTTTCA TGCTTGCTCC TCCTTCTCAC GAGAGATAAA 360 GTAATAACCT ACAACTAGGA TAATACTAAA GAGAAAGACT AGAGCAGAAA GGGCATTGAT 420 TTCTAGCGAA ATCCCCTTGC GAGCACGAGA GTAAATCTCG ACTGATAGGG TTGAAAAGCC 480 ATTTCCTGTT ACAAAGAAGG TCACGGCAAA GTCATCTAAC GAATAGGTGA AGGCCATGAA 540 ATAACCAGCA ATGATAGACG GAGTCAGGTA AGGAAGCATG ATTTCCTTAA ACATCTGAAA 600 TTGACTAGCT CCCAAGTCAT AGGCCGCATG AATCATGTCG CCATTCATTT CCTTGAGTCG 660 GAGGCAAGAC CATCAAGACC ACGATAGGAA TGGAGAAGGC CACATGACTA GATAGAACGG 720 TCAAAAAGCC AAGTGAAAAC TTGAGTTGGG TAAAGAGAAT CAAGAAGTAG CACCAATCAT 780 AACGTCAGGC GCAACCATGA GGATATTATT GAGTGATAGA A 821 (2) INFORMATION FOR SEQ ID NO: 8: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1309 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 8: GGCCGGTGCC ACAGTCCAAG CTATCGGTAT CGTGATTGAG AAATCCTTCC AAGATGGTCG 60 TGATTTGCTT GAAAAAGCAG GCTACCCTGT CCTATCACTT GCTCGCTTGG ATCGTTTTGA 120 AAATGGTCAG GTCGTATTTA AGGAGGCAGA TCTCTAATGC AAACTCAAGA AAAACACTCG 180 CAAGCAGCCG TTCTCGGCTT GCAGCACTTA CTAGCCATGT ACTCAGGATC TATCCTGGTT 240 CCCATCATGA TTGCGACAGC CCTTGGCTAT TCAGCTGAGC AGTTGACCTA CCTGATTTCT 300 ACAGATATCT TCATGTGTGG GGTGGCAACC TTCCTCCAAC TCCAACTCAA CAAATACTTT 360 GGGATTGGAC TCCCAGTCGT TCTTGGAGTT GCATTCCAGT CGGTCGCTCC CTTGATTATG 420 ATTGGGCAAA GCCATGGTAG TGGCGCTATG TTTGGTGCCC TTATCGCATC TGGGATTTAC 480 GTGGTTCTTG TTTCAGGCAT CTTCTCAAAA GTAGCCAATC TCTTCCCATC TATCGTAACA 540 GGATCTGTTA TTACCACGAT TGGTTTAACC TTGATCCCTG TCGCTATTGG AAATATGGGA 600 AATAACGTTC CAGAGCCAAC TGGTCAAAGT CTCTTGCTTG CAGCTATTAC TGTTCTGATT 660 ATCCTCTTGA TCAACATCTT TACCAAAGGA TTTATCAAGT CTATCTCTAT TTTGATTGGT 720 CTGGTTGTTG GAACTGCCAT TGCTGCTACT ATGGGCTTGG TGGACTTCTC TCCTGTTGCG 780 GTAGTCCACT TGTCCATGTC CCAACTCCAC TCTACTTTGG GATGCCAACC TTTGAAATCT 840 CATCTATTGT CATGATGTGT ATCATCGCAA CGGTGTCTAT GGTTGAGTCA ACTGGTGTTT 900 ATCTAGCCTT GTCTGATATC ACAAAAGATC CAATCGACAG CACGCGCCTT CGCAACGGTT 960 ACCGCGCAGA AGGTTTGGCG GTACTTCTCG GAGGAATCTT TAACACCTTC CCTTACACCG 1020 GATTTTCACA AAACGTTGGT TTGGTTAAAT TGTCAGGCAT CAAAAAACGC CTGCCAATCT 1080 ACTACGCAGG TGGTTTCCTG GTTCTCCTTG GACTGCTTCC TAAGTTTGGT GCCCTTGCCC 1140 AAATCATTCC AAGCTCCGTC CTCGGCGGTG CCATGCTGGT GATGTTTGGT TTTGTATCTA 1200 TTCAAGGGAT GCAAATCCTC GCCCGAGTTG ACTTTGTAAC AATGAACACA ACTTCCTTAT 1260 CGCAGTGTTT CAATCGCTGC AGGTGTCGGT CTCAACAACA AGTAATCTC 1309 (2) INFORMATION FOR SEQ ID NO: 9: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1031 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 9: TTAAAGTTCC AGTTTATCTA GGTTCTTCAT TTGCCTTTAT CACAGCTATG TCACTGGCTA 60 TGAAAGAAAT GGGGGGTGAT GTATCTGCTG CCCAAACAGG GGTTATCTTG ACTGGTTTGG 120 TCTATGTCCT TGTTGCTACC AGCATCCGAT TTGTAGGAAC AAAATGGATT GATAAACTCT 180 TGCCACCAAT CATTATCGGT CCTATGATCA TCGTTATCGG TCTTGGACTT GCAGGTTCAG 240 CTGTTACCAA TGCAGGTCTT GTAGCAGACG GAAATTGGAA AAATGCTCTG GTAGCCGTTG 300 TTACTTTCCT AATTGCTGCC TTTATCAATA CAAAAGGAAA AGGCTTCCTA CGAATCATTC 360 CATTCCTCTT TGCCATTATC GGTGGTTACC TTTTCGCACT AACTCTTGGC TTGGTTGACT 420 TTACACCAGT TCTTAAAGCC AACTGGTTCG AAATTCCTGG TTTCTACTTG CCATTTAGCA 480 CAGGTGGTGC CTTTAAAGAG TACAATCTTT ACTTTGGTCC AGAAGCCATC GCTATCTTGC 540 CAATCGCTAT CGTAACAATT TCTGAACATA TCGGAGACCA TACTGTTTTG GGTCAAATCT 600 GTGGCCGTCA ATTCTTAAAA GAACCAGGTC TTCATCGTAC TCTTCTTGGT GACGGTATCG 660 CAACTTCTGT TTCTGCCTTC CTTGGTGGAC CAGCCAATAC AACTTACGGA GAAAATACAG 720 GGGTTATCGG TATGACTCGT ATCGCTTCTG TCTCAGTTAT CCGTAACGCT GCCTTCATCG 780 CGATTGCCCT CAGCTTCCTT GGTAAATTCA CTGCCTTGAT TTCAACTATT CCAAACGCTG 840 TACTTGGTGG TATGTCAATC CTTCTCTATG GGGTTATCGC CAGCAATGGT TTGAAAGTCT 900 TGATTAAAGA ACGTGTTGAT TTCGCTCAAA TGCGAAACCT CATCATCGCA AGTGCTATGT 960 TGGTTCTTGG ACTTGGAGGA GCTATCCTTA AACTTGGTCC AGTACACTTT CAGGTACTGC 1020 CCTTTCAGCC A 1031 (2) INFORMATION FOR SEQ ID NO: 10: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 568 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 10: ACAGTTTAAT CATTGCCTTG GCTACAACCC TCATTGCGAT TATTATTTCT GCTATGGCAG 60 CCTATGGTAT TGTTCGATTC TTTCCTAAAT TGGGAGCAAT CATGTCGAGA CTACTCGTCA 120 TTACCTACAT TTTCCCACCA ATTTTGTTAG CAATTCCCTA TTCAATTGCC ATTGCTAAAG 180 TTGGGTTAAC AAATAGTTTA TTTGGCTTGA TGATGGTTTA TCTATCTTTT AGTGTTCCAT 240 ATGCAGTTTG GCTCTTAGTT GGATTTTTCC AAACAGTTCC AATTGGAATT GAAGAAGCGG 300 CTAGAATTGA TGGTGCAAAT AAATTTGTTA CGTTTTATAA AGTTGTGCTA CCGATTGTAG 360 CACCAGGTAT TGTAGCAACA GCTATTTATA CATTTATCAA TGCTTGGAAT GAATTTCTGT 420 ATGCCTTGAT TTTGATTAAC AATACAGGAA AGATGACAGT AGCAGTAGCC CTTCGTTCAC 480 TTAATGGTTC AGAAATACTA GACTGGGGAG ATATGATGGC AGCGTCTGTT ATTGTAGTTC 540 TTCCATCAAT TATTTCTTCT CTATCACC 568 (2) INFORMATION FOR SEQ ID NO: 11: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 468 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 11: ACCAAAGACT TAGCTTCTTC AAAAAGCGGA TCACCACCAG CATCTCCATC CGAAAATTCT 60 CCTTCATTTT CAGAAACCTC ACCTGGATCA AAACTCTCAT CGTAGTCTGC ATCTGCCTGA 120 GTCTTGATGA AGTTCACAAT GCGCTCAACA TCGTCATCCG AGATAAAGGA GCCTTGGAGA 180 CGAACTGGAT GATTTTCATC AATCGGTTTA AAGAGCATGT CTCCTCGACC AAGAAGTTTT 240 TCTGCTCCAT TTTCATCCAA AATCGTACGG GAGTCTGTTC CTGATGAAAC CGCAAATGCT 300 ACACGAGATG GAACATTGGC CTTAATCAAA CCAGAGATGA CATCAACAGA TGGACGCTGA 360 GTTGCAAGAA TCATGTGGAT ACCTGCAGCA CGCGCCTTCT GCCCAAGACG GATGATAGCA 420 TCTTCCACTT CCTTGCTGGC CACCATCATG AGGTCAGCCA ACTCATCC 468 (2) INFORMATION FOR SEQ ID NO: 12: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 466 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO ( iv) ANTI-SENSE : NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 12: AAGCTGACAA TCTTTTCTGC AGTTGGAGCA TCCCAGAAGG ATACACCACT AAGGATGCGA 60 CCTGCCTTGC TATCAACAAT AATGTCTTGA ACCTTGTAGT CATCTCCATA GACCAAGAAC 120 CATTCGTTGG TACAATCTTC ACGATAAACA CTAAAATAAG TCGAACGAGT CAAATCATTG 180 CGGAACATAT TTTTAAAGAG ATAGTTATCT GCATCAATAA CATAGCTGTT GGCCAATTCT 240 TCTTTTACAA GATAGAGAGA GTAAAAGTTA TTGTAGTCAG CGTATTTATC ATTGAAAACG 300 AGACGAACAC CGTATTTCTC TTTCAAGTAA TCGAATTGTT CTTTAAGATA ACCAACAATG 360 ATGATGATGT CATTGATTCC TTTTTCTTTG AGAAACTCAA TTTGGTACTC AATCAAAGGT 420 TTTTGATTAA CCTGAACCAA GGCTTTAGGG GTATTTTCAG TCATAG 466 (2) INFORMATION FOR SEQ ID NO: 13: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1040 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 13: CACATAATCT GTATATTGAC TATAAGTTTT AAAAAACAAT TTTTAAGCTC TTCCTTGTCT 60 TCTCTAACCA AGCGTGTTAT AATGAATACT GCTCAAGCGA CCTTCAATCG TGAAGCACAC 120 ACGACCTTCA ATCGTGAATA AACGAATAGA TGGGAGACTT ACCATGAGTG ATAACTCTAA 180 AACACGTGTT GTCGTGGGGA TGAGTGGTGG TGTTGATTCG TCGGTGACGG CTCTTTTGCT 240 CAAGGAGCAG GGCTACGATG TGATCGGTAT CTTCATGAAG AACTGGGATG ACACAGATGA 300 AAACGGCGTC TGTACGGCGA CCGAAGATTA CAAGGATGTG GTTGCGGTGG CAGATCAGAT 360 TGGCATTCCC TACTACTCTG TCAATTTTGA AAAAGAGTAC TGGGACCGCG TTTTTGAGTA 420 TTTCCTAGCT GAATACCGTG CAGGGCGCAC GCCAAATCCG GACGTTATGT GCAACAAGGA 480 AATCAAGTTC AAGGCCTTTT TGGACTATGC CATGACCTTG GGGGCAGACT ATGTAGCGAC 540 TGGGCACTAT GCTCGAGTGG CGCGTGATGA GGATGGCACT GTTCACATGC TTCGTGGCGT 600 GGACAATGGC AAGGATCAGA CCTATTTCCT CAGCCAACTT TCGCAAGAAC AACTTCAAAA 660 AACCATGTTC CCACTAGGAC ATTTGAAAAA GCCTGAAGTT CGAAAACTAG CAGAAGAAGC 720 AGGTCTTTCG ACTGCTAAGA AGAAAGACTC GACAGGGATT TGCTTTATCG GAGAAAAGAA 780 CTTTAAAAAC TTTCTCAGCA ACTACCTGCC AGCTCAGCCT GGTCGTATGA TGACTGTGGA 840 TGGTCGTGAT ATGGGCGAGC ATGCTGGTCT TATGTACTAT ACAATCGGTC AGCGTGGCGG 900 ACTCGGTATC GGTGGGCAAC ACGGTGGTGA CAATGCCCCT TGGTTCGTTG TCGGAAAAGA 960 TCTAAGCAAG AATATTCTCT ATGTAGGCCA AGGTTTCTAC CATGATTCGC TCATGTCAAC 1020 CACTAGAGGC TAGCCAAGTC 1040 (2) INFORMATION FOR SEQ ID NO: 14: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 3071 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 14: CCGGGGATCT GATAGCCAAT AGAAAACCGC AGAGTCAAAG GGTTTTGTAT GAATTGCGAG 60 ATCGTTTGAA GAGAAATCAG TTTATACTCA ATGATACCAA TCCGGATATT GTCATTTCCA 120 TTGGCGGGGA TGGTATGCTC TTGTCGGCCT TTCATAAGTA CGAAAATCAG CTTGACAAGG 180 TCCGCTTTAT CGGTCTTCAT ACTGGACATT TGGGCTTCTA TACAGATTAT CGTGATTTTG 240 AGTTGGACAA GCTAGTGACT AATTTGCAAC TAGATACTGG GGCAAGGGTT TCTTACCCTG 300 TTCTGAATGT GAAGGTCTTT CTTGAAAATG GTGAAGTTAA GATTTTCAGA GCACTCAACG 360 AAGCCAGCAT CCGCAGTCTG ATCGAACCAT GGTGGCAGAT ATTGTAATAA ATGGTGTTCC 420 CTTTGAACGT TTTCGTGGAG ACGGGCTAAC AGTTTCGACA CCGACTGGTA GTACTGCCTA 480 TAACAAGTCT CTTGGCGGTG CTGTTTTACA CCCTACCATT GAAGCTTTGC AATTAACGGA 540 GATTGCCAGC CTTAATAATC GTGTCTATCG AACATTGGGC TCTTCCATTA TTGTGCCTAA 600 GAAGGATAAG ATTGAACTTA TTCCAACAAG AAACGATTAT CATACTATTT CGGTTGACAA 660 TAGCGTTTAT TCTTTCCGTA ATATTGAGCG TATTGAGTAT CAAATCGACC ATCATAAGAT 720 TCACTTTGTC GCGACTCCTA GCCATACCAG TTTCTGGAAC CGTGTTAAGG ATGCCTTTAT 780 CGGTGAGGTG GATGAATGAG GTTTGAATTT ATCGCAGATG AACATGTCAA GGTTAAGACC 840 TTTTTAAAAA AGCACGAGGT TTCTAAGGGA TTGCTGGCCA AGATTAAGTT TCGAGGTGGA 900 GCTATTCTGG TCAATAATCA ACCGCAAAAT GCAACGTATC TATTGGACGT TGGAGACTAC 960 GTTACCATTG ACATTCCCGC TGAGAAAGGC TTTGAAACCT TGGAGGCTAT TGAGCTTCCA 1020 TTAGATATTC TCTATGAGGA TGACCACTTT CTAGTCTTGA ATAAACCCTA TGGAGTGGCT 1080 TCTATTCCTA GTGTTAATCA CTCTAATACC ATTGCCAATT TTATCAAGGG TTACTATGTC 1140 AAGCAAAATT ATGAAAATCA GCAGGTTCAC ATTGTTACCA GACTAGATAG GGACACTTCT 1200 GGCTTGATGC TCTTTGCCAA GCACGGTTAT GCCCATGCAC GATTAGACAA GCAGTTGCAG 1260 AAGAAATCTA TCGAGAAACG CTACTTTGCT TTGGTTAAGG GAGATGGACA TTTGGAGCCA 1320 GAAGGGGAAA TTATTGCTCC GATTGCGCGT GATGAAGATT CCATTATTAC CAGACGAGTG 1380 GCTAAAGGCG GAAAGTATGC CCATACTTCA TACAAGATTG TAGCTTCTTA TGGAAATATT 1440 CACTTGGTCT ATATTCACCT GCACACTGGT CGAACCCATC AAATCCGAGT CCATTTTTCT 1500 CATATCGGTT TTCCTTTGCT GGGAGATGAT TTGTATGGTG GTAGTCTGGA AGATGGTATT 1560 CAACGTCAGG CTCTGCATTG CCATTACCTA TCCTTTTATC ATCCATTTTT AGAGCAAGAC 1620 TTGCAGTTAG AAAGTCCCTT GCCGGATGAT TTCAGTAACC TTATTACCCA GTTATCAACT 1680 AATACTCTAT AAAAACTGTC TCAGAGTATA ATTATTATCT TAAAGGAGAA AACTCATGGA 1740 AGTTTTTGAA AGTCTCAAAG CCAACCTTGT TGGTAAAAAT GCTCGTATCG TTCTCCCTGA 1800 AGGGGAAGAG CCTCGTATTC TTCAAGCAAC AAAACGCTTA GTAAAAGAAA CAGAAGTGAT 1860 TCCTGTTTTG CTTGGAAATC CTGAAAAAAT TAAAATTTAT CTTGAAATTG AAGGAATCAT 1920 GGATGGTTAT GAGGTCATCG ACCCTCAACA TTATCCTCAA TTTGAAGAAA TGGTTTCTGC 1980 CTTGGTGGAG CGTCGCAAGG GCAAAATGAC TGAAGAAGAT GTACGCAAGG TTTTGGTTGA 2040 AGATGTCAAC TACTTTGGTG TGATGTTGGT TTACTTGGGC TTGGTTGATG GAATGGTGTC 2100 AGGAGCGATT CACTCAACAG CTTCAACAGT TCGCCCAGCT CTACAAATCA TCAAAACTCG 2160 TCCAAATGTA ACTCGTACTT CAGGAGCCTT CCTCATGGTT CGTGGTACGG AACGTTACCT 2220 ATTTGGAGAC TGTGCCATTA ATATCAATCC AGATGCAGAA GCCTTGGCTG AAATTGCCAT 2280 CAACTCAGCA ATCACAGCTA AGATGTTTGG CATCGAACCT AAAATTGCCA TGTTGAGCTA 2340 TTCTACTAAA GGTTCAGGGT TTGGTGAAAG CGTTGATAAG GTCGTTGAAG CAACTAAAAT 2400 TGCTCACGAC TTGCGTCCTG ACCTTGAAAT CGATGGTGAG TTGCAATTTG ATGCGGCCTT 2460 TGTTCCCGAA ACTGCAGCTC TGAAAGCTCC GGGAAGTACA GTAGCTGGTC AAGCAAATGT 2520 CTTCATCTTC CCAGGTATCG AGGCAGGAAA TATCGGTTAC AAGATGGCTG AACGCCTGGG 2580 TGGCTTTGCG GCTGTAGGAC CTGTTTTGCA AGGTTTAAAC AAGCCAGTTA ATGATCTTTC 2640 TCGTGGATGT AATGCAGATG ATGTTTACAA GTTGACCCTC ATCACAGCAG CTCAAGCAGT 2700 TCATCAATAG TGAAAACTAT AAAGTGATAT ACTATGCTAT ACTGTAGTTA TGAAACTATG 2760 TACGAAAAGC ACTGCCATTA ATTCCTGAGA ACTAAATTAC TGATTGGTGT CAAAAAGGAA 2820 AACTTCCAAG CGATGATATC CTGTCTATAC ACGACCTATA GAAATCTGTA ATATACATGT 2880 CCGTAAAACG ATAAATTCCC TTTTTGATTT TAAATGAGTA TGAAAAGAGA ATTTTCCGGC 2940 TCTTTGTCAA CTGTAGTGGG TTGAAAAAAA GCTAAGCTCG AGAAAGGACA AATTTTGTCC 3000 TTTCTTTTTT GATATTCAGA GCGATAAAAA TCCGTTTTTT GAAGTTTTCA AAGTTTCGAC 3060 TCTAGAGGAT C 3071 (2) INFORMATION FOR SEQ ID NO: 15: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 720 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 15: TTTCCATGGT ATGGTAAAGG TTTTTCTTTT TTTTAAAAGG AAAACGAGAA GAGGAGGTTC 60 TTATGAAAGC AAGCATTGCC TTGCAAGTTT TACCCCTAGC ACAGGGGATT GATCGGATAG 120 CTGTTATTGA TCAGGTCATT GCTTATCTGC AAACTCAAGA AGTGACGATG GTAGTGACAC 180 CATTTGAAAC GGTCTTGGAA GGGGAGTTTG ATGAGCTTAT GCGCATTCTA AAAGAAGCGC 240 TGGAAGTGGC AGGGCAGGAG GCAGACAATG TCTTTGCCAA TGTCAAAATA AATGTAGGAG 300 AGATTTTAAG TATTGATGAG AAACTTGAAA AGTATACTGA GACGACACAT TAGTCTATTG 360 GGCTTTCTCG GAGTATTGTC AATCTGGCAG TTAGCAGGTT TTCTTAAACT TCTCCCCAAG 420 TTTATCCTGC CGACACCTCT TGAAATTCTC CAGCCCTTTG TTCGTGACAG AGAATTTCTC 480 TGGCACCATA GCTGGGCGAC CTTGAGAGTG GCTTTACTGG GGCTGATTTT GGGAGTTTTG 540 ATTGCCTGTC TTATGGCTGT GCTCATGGAT AGTTTGACTT GGCTCAATGA CCTGATTTAC 600 CCTATGATGG TGGTCATTCA GACCATTCCG ACCATTGCCA TAGCTCCTAT CCTGGTCTTG 660 TGGCTGGGTT ATGGGATTTT TGCCCAAGAT TGTCTTGATT ATCTTAACAA CAACCTTTCC 720 (2) INFORMATION FOR SEQ ID NO: 16: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 852 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 16: GCCGTCATAA TCATGCGCCG AATCCGTCCC CATTAAAATC TGGGTCTGTA AAGACAATGA 60 CTCCATGACG TTGGTGTAGA CGCTGAATCC GCTCTATGTC CTGGTCATTG ATGGCAGAAC 120 CTCGAGTCTC ATAGGTCTCC ACATCGAAAT AACGCTTGAG ATTGACCGTA TCATCACGAC 180 CTTCAACCAC GATAACTTGG GAAATTCTCT CTTTCATTAC TTGCTGTCCA ATCCCAAAAA 240 TGCGTTCTGC ATTTGCAGTC GTTGCTACCG CCAGCTCTTC TGTCGTCATA CCACGCAAGT 300 CAGCGATAAA GTCGACCACA TAGCGAGTAT AGGCTGTTTT ATTTTCACGA CCACGCTTGG 360 GTACAGGTGC TAAGTAAGGC GCATCTGTTT CTACCAACAT CTTGTCCAAA GGTAACTCTT 420 TAGCTGCTTC TTGGAGGTCA GTTGCCTTCT TGAAGGTCAC CACTCCTGAG AAGGAAATGG 480 TCATACCAAG ATCCCGGTAC CGAGCCCACT CAAGCGTCCC TGAAAATGAA TGCATGATAC 540 CACCACGAGG ACCAACGCCC TCACTCTTGA TAATCTCATA GGTATCTTCC AGCGCATCAC 600 GGGTATGGAC AACAAAAGGC AAATCCAAGT CCTTAGATAG CTGAATCTGA CGGCGAAAAA 660 CCTGCTCCTG CACCTCTTGG GCGCTGTCAT CCAATGGTAG TCTAAGCCAA TTTCACCTAA 720 AGCCACAACC TTGGAATGTT TTAACTTATC CAACAAGTAA GCCTCAACTT CCTCTGTATA 780 AGTACCAGCT TCTGTAGGAT GCCAACCAAT AGTCGCATAG AGCTGCTCAT ACTCATCTAC 840 CAAACTCCAA GG 852 (2) INFORMATION FOR SEQ ID NO: 17: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 868 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 17: GGGGATCCTC TAGAGTCGAT ATCTACGGTC TCAACCGTAC AGGACTGTTG AACGATGTAC 60 TGCAAGTTCT TTCAAATACA ACCAAGAATA TTTCAACGGT CAATGCCCAA CCAACCAAGG 120 ATATGAAGTT TGCTAATATC CATGTGTCCT TCGGTATTGC CAACCTCTCT ACACTGACCA 180 CGGTTGTCGA TAAAATTAAG AGTGTGCCAG AAGTTTACTC TGTCAAACGG ACCAACGGCT 240 AGTTGTCCTA GCTCTTACTA GAAAGGCTAT TATGAAAATC ATTATCCAAC GGGTTAAAAA 300 AGCCCAAGTG AGTATAGAAG GCCAGATTCA GGGAAAAATC AATCAGGGAC TTTTATTGCT 360 GGTTGGTGTT GGACCAGAGG ACCAAGAGGA AGATTTGGAC TATGCTGTGA GAAAACTGGT 420 CAATATGCGG ATTTTTTCAG ACGCAGAAGG CAAGATGAAC CTGTCTGTCA AAGATATTGA 480 AGGAGAAATC CTCTCTATTT CTCAGTTTAC CCTCTTTGCG GATACTAAGA AAGGCAATCG 540 TCCAGCCTTT ACAGGGGCAG CTAAACCTGA TATGGCATCA GACTTCTATG ATGCTTTCAA 600 TCAAAAATTA GCGCAAGAAG TGCCCGTTCA GACAGGTATC TTTGGAGCAG ATATGCAGGT 660 TGAGCTGGTT AATAACGGAC CTGTTACCAT TATCCTAGAT ACTAAAAAGA GATAAGAAAG 720 ACCAAGCCCA GTCGGCTTGG TCTTTCTCAT CGATCATAAA AATACTCCAA AAAGAAATCG 780 GTTCTTGATA TGCTTGGGGG ACTCTTTTCA GGCTTTGGCA GATGCGATAG GAAGGGATGA 840 GATGTCCTAG GGTGAGGAGA GTTCCCTG 868 (2) INFORMATION FOR SEQ ID NO: 18: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1399 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 18: CGGTCCTCGT CCGATTGACT CACACCTTAA GGCGTTTGAA GCTATGGGTG CCACTGCTAG 60 CTACGAGGGA GATAACATGA AGTTATCTGC TAAAGATACA GGACTTCATG GTGCAAGTAT 120 TTACATGGAT ACGGTTAGTG TGGGAGCAAC GATTAATACG ATGATTGCTG CGGTTAAAGC 180 AAATGGTCGT ACTATTATTG AAAATGCAGC CCGTGAACCT GAGATTATTG ATGTAGCTAC 240 TCTCTTGAAT AATATGGGTG CCCATATCCG TGGGGCAGGA ACTAATATCA TCATTATTGA 300 TGGTGTTGAA AGATTACATG GGACACGTCA TCAGGTGATT CCAGACCGCA TTGAAGCTGG 360 AACATATATA TCTTTAGCTG CTGCAGTTGG TAAAGGAATT CGTATAAATA ATGTTCTTTA 420 CGAACACCTG GAAGGGTTTG TTGCTAAGTT GGAAGAAATG GGAGTGAGAA TGACTGTATC 480 TGAAGACAGC ATTTTTGTCG AGGAACAGTC TAATTTGAAA GCAATCAATA TTAAGACAGC 540 TCCTTACCCA GGCTTTGCAA CTGATTTGCA ACAACCGCTT ACCCCTCTTT TACTAAGAGC 600 GAATGGTCGT GGTACAATTG TCGAGTCGAT ACGATTTACG AAAAACGTGT AAATCATGTT 660 TTTGAACTAG CAAAGATGGA TGCGGATATT TCGACAACAA ATGGTCATAT TTTGTACACG 720 GGTGGACGTG ATTTACGTGG GGCCAGTGTT AAAGCGACCG ACTTAAGAGC TGGGGCTGCA 780 CTAGTCATTG CTGGGCTTAT GGCTGAAGGC AAAACTGAAA TTACCAATAT CGAGTTTATC 840 TTACGTGGTT ATTCTGATAT TATCGAAAAA TTACGTAATT TAGGAGCGGA TATTAGACTT 900 GTTGAGGATT AAACCGTAGA GGTGTTTATG AATATTTGGA CCAAATTAGC AATGTTTTCT 960 TTTTTTGAAA CGGATCGCTT GTATTTGCGT CCTTTCTTTT TTAGTGATAG TCAGGACTTC 1020 CGCGAGATAG CTTCAAATCC AGAAAATCTT CAATTTATTT TCCCAACGCA GGCAAGTCTG 1080 GAAGAAAGTC AATATGCACT GGCCAATTAC TTTATGAAGT CCCCTTTGGG AGTGTGGGCA 1140 ATTTGTGACC AGAAAAATCA ACAAATGATT GGTTCTATTA AATTTGAGAA GTTAGATGAA 1200 ATCAAAAAAG AAGCTGAGCT TGGCTATTTT TTGAGAAAAG ATGCTTGGTC GCAAGGATTT 1260 ATGACAGAGG TTGTTAGAAA AATTTGTCAG CTTTCTTTTG AGGAATTTGG CTTAAAACAA 1320 TTATCTATCA TTACCCACCT TGAAAATGAA GCTAGCCAAA GAGTTGCTCT TAAGTCTGGA 1380 TTTAGTTTGT TCCGTCAGT 1399 (2) INFORMATION FOR SEQ ID NO:19: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1779 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO ( iv) ANTI-SENSE : NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 19: AGATTGCTCT TGAACACGAT GAAATACCAA TTGGTTGTGT GATTGTCAAA GATGGGAAAA 60 TCATTGGTCG TGGGCATAAT GCGCGTGAGG AATTACAGCG ACGGTTATGC ATGCGGAAAT 120 TATGGCTATA GAGGATGCGA ACTTGAGTGC AGGAGACTGG CGCTTGCTGG ATTGCACACT 180 TTTTGTGACC ATTGAACCAT GTGTCATGTG TAGTGGGGCG ATTGGGCTTG CCCGTATTCC 240 AAATGTGGTC TATGGGGCTA AAAACCAGAA ATTTGGCGCT GCTGGAAGTT TGTACGATAT 300 CTTGACAGAT GAGCGTCTTA ACCATCGTGT AGAGGTTGAA ACGGGAATTT TGGAAGATGA 360 ATGTGCAGCT ATCATGCAGG ACTTTTTTAG AAATAGACGG AAAAAATAAT TTTGCTTTTA 420 AAATGAATAG GAATGTGATA TAATAAATAG TGGAGCAACA GTTCTGCGTG AAGCGGGTCA 480 GGGGAGGAAT CCCAGCAGCC CTAAGCGATT TGAATTGTGT GCTCTTTTTT TCGTGCTTTT 540 TTCCGAATAA ATAAGATAGA ATAATCTAGA ATAAATGATA ATAGAAAAGA GAAAATTATG 600 AAAATTCGTG GTTTTGAATT GGTTTCGAGT TTTACAGATG AAAATTTATT GCCCAAGCGT 660 GAGACAGCGC ATGCGGCTGG TTACGACTTA AAGGTTGCTG TGCGTACAGT TGTTGCGCCA 720 GGAGAGATTG TCTTGGTTCC GACAGGGGTT AAGGCTTATA TGCAGCCGAC TGAGGTTCTC 780 TACCTCTATG ATCGTTCTTC AAATCCTCGT AAGAAGGGCT TGGTTTTAAT TAACTCAGTT 840 GGGGTCATTG ATGGGGATTA TTATGGAAAT CCTGGAAATG AAGGGCATAT TTTTGCGCAG 900 ATGAAGAATA TCACAGACCA AGAGGTTGTT CTTGAAGTTG GGGAGCGTAT TGTCCAGGCT 960 GTTTTTGCTA CTTTCTTAAT TGCAGATGGA GATGCAGCTG ATGGCGTTCG AACTGGTGGA 1020 TTTGGATCGA CAGGGCACTA GAATGAAGAT TATCTTTGTA CGTCATGGGG AGCCAGATTA 1080 CCGTGAGTTA GAGGAGCGTT CTTATATAGG ATTTGGGATA GATTTGGCAC CCTTGTCTGA 1140 GATGGGACGG CAGCAAGTCC AGAAATTGAG CAAAAATCCT TTACTCTCGT CAGCTGAAAT 1200 AATCGTATCT TCTGCAGTCA CAAGAGCTTT AGAAACGGCT TCGTATGTGG TCTGTGCTAC 1260 GGGTCTTCCT TTAAGAGTAG AGCCTTTATT ACATGAATGG CAGGTCTATA AAACAGGAAT 1320 AGAAAACTTT GAAACAGCTA GAAGACTGTT TTTAGAAAAC AAGGGGGAGT TGCTTCCTAA 1380 TAGTCCTATT CAATATGAGA CAGCTACGGA AATGAAGTCT CGGTTTCTAG AATGTATGTC 1440 TAAGTATCGA GAACATCAGA CTGTGGTAGT TGTTGCTCAT CGACTCTAGA GGAGCCAGTT 1500 TGTGCCAAAT GAGAAGATTG ATTTTTGCCA AGTGATTGAG TGTGAGTTAG AGATATAGAA 1560 AGAGGTTTGT CATCGCAAAG AAAAAAGCGA CATTTGTATG TCAAAATTGT GGGTATAATT 1620 CCCCTAAATA TCTGGGACGT TGCCCCAACT GTGGGTCTTG GTCTTCTTTT GTGGAAGAGG 1680 TTGAGGTTGC CGAAGTTAAG AATGCGCGTG TGTCCTTGAC AGGTGAGAAA ACCAAGCCCA 1740 TGAAACTAGC TGAGGTGACT TCCATCAATG TCAATCGAC 1779 (2) INFORMATION FOR SEQ ID NO:20: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 3725 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 20: GCGGATCCTC TAGAGTCGAA AGATTACGAA GGTAAGAACC CTCTTTATTA CTGGTCACAT 60 CATGGTACAA CAAGCTGCAA CAGTATCTCT TATGGTTCTA TTCTTAGTAC CACAATTGCG 120 CAATGCTTAC GGTACAGCAG CGATTGGTAT CATCTGTGGA CTTTACTGGG CAGTTAGTTC 180 AAATATGACT GTTGAGGCAA CTCAACGCTT GACTGGTGGT GGCGGATTTG CGATTGGTCA 240 CCAACAGCAA TTTGCAATCT GGTTTGTAGA TAAAGTAGCA GGACGCTTTG GTAAGAAAGA 300 AGAAAGTTTA GACAATCTTA AATTACCTAA GTTCCTCTCA ATCTTCCACG ATACAGTTGT 360 TGCATCTGCT ACCTTGATGC TCGTATTCTT CGGGGCCATT CTTTTAATCT TGGGTCCAGA 420 CATTATGTCT AATAAAGAAG TCATCACTTC AGGAACTCTA TTCAATCCTG CTAAACAAGA 480 TTTCTTTATG TACATTATCC AAACAGCCTT TACCTTCTCA GTTTACTTGT TCGTTTTGAT 540 GCAAGGTGTC CGAATGTTCG TATCTGAGTT AACAAACGCT TTCCAAGGTA TTTCAAACAA 600 ATTGTTGCCA GGTTCATTCC CAGCGGTTGA CGTTGCAGCT TCTTATGGAT TTGGTTCTCC 660 AAATGCTGTC TTGTCAGGAT TTACCTTTGG TTTGATTGGT CAATTGATTA CAATTGTCTT 720 GCTCATCGTC TTTAAAAATC CGATTCTTAT TATTACAGGA TTTGTACCAG TGTTCTTTGA 780 CAATGCAGCC ATTGCGGTCT ACGCTGATAA ACGCGGCGGA TGGAAAGCGG CTGTTATCCT 840 TTCCTTTATA TCAGGTGTCC TTCAAGTTGC TCTAGGAGCT CTTTGTGTGG CCCTTCTCGA 900 TTTGGCATCT TATGGTGGCT ACCATGGAAA TATCGACTTT GAATTCCCAT GGCTTGGATT 960 TGGATATATC TTCAAATACC TTGGTATTGT TGGTTATGTA CTTGTGTGTC TCTTCTTGCT 1020 TGTTATTCCT CAACTTCAAT TTGCCAAAGC AAAAGATAAA GAGAAATATT ACAACGGTGA 1080 AGTTCAAGAA GAAGCTTAGT ATCTAGAAAA GGAGAAATAA AATGGTTAAA GTATTAGCAG 1140 CGTGCGGAAA TGGAATGGGT TCATCAATGG TTATCAAGAT GAAGGTTGAA AATGCTCTCC 1200 GTAAGCTTAA TCAAACAGAT TTTACAGTCA ATTCATGCAG TGTCGGTGAA GCTAAAGGTT 1260 TAGCAGTAGG ATATGACATC GTAATCGCTT CTCTTCATTT GATTCAAGAA TTGGAAGGGC 1320 GAACTAATGG GAAGTTAATT GGACTTGATA ACTTGATGGA TGATAAAGAA ATCACCGAAA 1380 AACTCAGTCA AGCACTACAG TAAAAGGTTG GAGGGGGCTG GACAGAAACT GAGAGTTATC 1440 GTTTCTGTCC TTCTCCCTCT TTAAATAAAG GAGGCAGATA TGAATTTAAA ACAAGCTTTA 1500 ATTGACAATG ACTCGATCCG ACTAGGTTTA GAGGCTAACA ATTGGAAAGA AGCAGTCAAG 1560 GTAGCAGTAG ATCCCTTAAT TGAAAGTGGG GCAATTTTGC CAGAGTATTA CGATGCTATC 1620 ATTGAATCGA CTGAAGAGTA TGGGCCTTAC TATATCTTGA TGCCAGGTAT GGCTATGCCC 1680 CACGCTAGAC CTGAAGCTGG TGTGCAAAGT GATGCCTTTT CATTGATTAC CTTACAAAAT 1740 CCTGTTGTAT TTTCAGATGG GAAAGAGGTA TCTGTTTTGT TGGCACTAGC AGCAACAAGC 1800 TCAAAAATTC ACACAAGTGT AGCCATTCCA CAAATTATTG CCCTGTTTGA ATTAGAAGAT 1860 TCTATTGCAC GTTTACAGGC TTGCCAGACT AAAGAAGATG TCTTGGCTAT GATTGAAGAA 1920 TCTAAGGATA GCCCTTATCT CGAAGGATTG GATTTGGAAA GTTAGAAAGA GGAATAAAGA 1980 AATGACAAAA AGAATACCTA ATTTACAAGT TGCATTAGAC CATTCAGACT TGCAAGGAGC 2040 GATTAAAGCA GCTGTTTCTG TTGGTCAGGA AGTAGATATT ATCGAAGCTG GAACTGTTTG 2100 CTTGCTTCAA GTTGGAAGTG AACTGGCTGA AGTCTTGCGT AGCCTTTTCC CAGATAAGAT 2160 TATTGTGGCA GACACAAAAT GTGCTGATGC TGGTGGAACA GTTGCTAAAA ATAATGCGGT 2220 TCGTGGAGCA GACTGGATGA CTTGTATCTG TTGTGCAACC ATCCCTACTA TGGAAGCAGC 2280 TCTAAAGGCT ATCAAGACTG AACGAGGAGA ACGAGGCGAA ATCCAGATCG AGCTTTATGG 2340 CGATTGGACT TTTGAACAAG CTCAGCTTTG GCTAGATGCA GGTATTTCAC AAGCTATTTA 2400 TCACCAATCT CGTGATGCTC TTCTTGCTGG TGAAACTTGG GGTGAAAAAG ACCTTAATAA 2460 GGTTAAAAAA CTCATTGACA TGGGCTTCCG TGTATCTGTA ACAGGTGGTC TAGATGTAGA 2520 TACTCTCAAA CTCTTTGAAG GTGTTGATGT CTTTACCTTT ATCGCAGGTC GTGGAATTAC 2580 AGAGGCTGCG GATCCAGCAG GAGCAGCGCG TGCCTTCAAG GATGAAATCA AACGAATTTG 2640 GGGGTAAATC ATGGTACGTC CAATTGGAAT TTATGAAAAG GCAACCCCAA CACACTTTAC 2700 TTGGCTAGAA CGTTTAAATT TTGCCAAGGA GTTAGGCTTT GATTTTGTCG AGATGTCTAT 2760 TGACGAACGT GACGAGCGTT TAGCAAGACT TGACTGGAGT AAGGAAGAAC GCTTGGAAGT 2820 TGTCAAAGCA ATCTATGAAA CTGGTGTTCG TATTCCTTCT ATCTGTTTTT CAGGCCATCG 2880 TCGCTACCCA TTGGGTTCAA AAGATCCAGT TCTAGAGGAA AAATCTCTAG AACTCATGAA 2940 AAAATGTATC GAATTAGCTC AAGACTTGGG AGTTCGTACG ATTCAATTAG CTGGTTACGA 3000 TGTTTACTAT GAGGAAAAGT CACCCCAGAC ACGCCAACGT TTTATCAAAA ATTTGAGAAA 3060 AGCCTGTGAC TGGGCTGAAG AAGCTCAGGT GGTACTTGCT ATTGAAATTA TGGATGATCC 3120 TTTCATCAAT AGCATCGAAA AATATTTGGC TATAGAAAAA GAGATTGACT CTCCCTTCCT 3180 CTTTGTATAT CCAGATATTG GTAATGTGTC TGCATGGCAT AATGATATCT ATAGTGAGTT 3240 TTATCTTGGT CATCATGCCA TCGCAGCTCT CCATCTCAAG GATACTTATG CAGTGACAGA 3300 AAGTTCAAAG GGCCAGTTCC GAGATGTACC TTTCGGGCAA GGTTGTGTCA AATGGGAAGA 3360 AGCTTTCGAT ATTTTAAAGG AAACCAATTA TAATGGACCT TTCCTAATCG AAATGTGGTC 3420 TGAAAATTGT GAAACAGTAG AAGAAACACG CGCAGCCGTT CAAGAGGCGC AAGCTTTTCT 3480 CTATCCACTC ATTAAGAAAG CAGGTTTGAT GTAAGATGAA TCAAGTAATC AATGCTATGC 3540 GTAAACGAGT CTGTGATGCC AATCAATCAT TGCCAAAACA TGGACTTGTC AAATTTACCT 3600 GGGGGAATGT ATCTGAAGTT AATCGCGAAC TCGGTGTCAT TGTTATCAAA CCATCAGGCG 3660 TGGATTATGA CGAATTGACA CCTGAAAACA TGGTAGTGAC TGATCTAGAT GGTAAGATCC 3720 CCGGT 3725 (2) INFORMATION FOR SEQ ID Nθ:21: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2483 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:21: TCTAGAATCA TTTCCCAGCA GTTGGCTCAG GAAGTCGCAA TTATCTGGGT GAGTTTTCAG 60 CGTGTTGGAC TGAAGTGGAG ATTGATGAGA TATACCGCGC CTTTGTCATG GCACATTTCA 120 AGAGTTCGCG TCCAGATGCC CAGACCTTGA TTTTCTATAC CCACTATGAC ACTGTGCCAG 180 CGGATGGGGA TCAGGTCTGG ACAGAGGATC CTTTTACGCT TTCGGTCCGC AATGGCTCAT 240 GTATGGGCGT GGGGTTGATG ACGACAGGGT CATATCACAG CTCGCTTGAG TGCTTGAGAA 300 AATATATGCA GCCCTGATGA TTACCTGTCA ATATCAGCTT TATCATGGAG GGAGCGGAGG 360 AATCGGCTTC AACAGACCTA GATAAGTATT TGGAAAAGCA TGCAGACAAA CTCCGTGGGG 420 CGGATTTGTT GGTCTGGGAA CAAGGGACCA AAAATGCCTT GGAACAGCTG GAAATTTCTG 480 GTGGCAATAA GGGGATTGTG ACCTTTGATG CCAAGGTAAA AAGCGCTGAT GTGGATATCC 540 ACTCGAGTTA TGGTGGTGTT GTGGAATCAG CTCCTTGGTA TCTCCTCCAA GCCTTACAGT 600 CTCTTCGTGC TGCGGATGGC CGTATCTTGG TTGAAGGCTT GTACGAAGAA GTACAAGAGC 660 CCAATGAACG AGAAATGGCC TTGCTAGAAA CTTATGGTCA ACGAAACCCA GAGGAAGTTA 720 GTCGGATTTA TGGATTGGAG TTGCCTCTCT TACAGGAGGA GCGGATGGCC TTTCTAAAAC 780 GTTTCTTTTT CGAGCCAGCG CTTAATATCG AAGGAATCCA GTCTGGTTAT CAAGGTCAGG 840 GTGTTAAGAC TATTTTGCCT GCAGAAGCCA GTGCCAAGCT AGAGGTTCGT CTGGTTCCGG 900 GCCTAGAACC GCATGATGTT CTGGAAAAAA TTCGGAAACA GCTAGACAAA AATGGCTTTG 960 ATAAGGTAGA ATTATACTAT ACCTTGGGAG AGATACTAGA GTCGAAGCGA TATGAGCGCA 1020 CCAGCCATTC TCAATGTGAT CGAGTTGGCC AAGAAATTCT ATCCACAGGG CGTTTCAGTC 1080 TTGCCGACGA CAGCGGGGAC AGGACCTATG CATACGGTCT TTGATGCCCT AGAGGTACCA 1140 ATGGTTGCAT TCGGTCTAGG AAATGCCAAT AGCCGAGACC ACGGTGGAGA TGAAAATGTG 1200 CGAATCGCTG ATTATTACAC CCATATCGAA TTAGTAGAGG AGCTGATTAG AAGCTATGAG 1260 TAGAGATATT ATCAAGTTAG ATCAGATCGA TGTGACTTTT CACCAAAAGA AGAGAACCAT 1320 CACAGCGGTT AAGGATGTGA CCATTCACAT CCAAGAAGGG GATATCTACG GAATCGTTGG 1380 ATATTCTGGA GCAGGGAAAT CAACCCTTGT ACGGGTGATT AACCTCTTGC AAAAACCATC 1440 TGCAGGGAAA ATTACCATTG ACGACGATGT GATTTTTGAC GGCAAGGTGA CCTTGACGGC 1500 AGAGCAGTTG CGTCGTAAAC GTCAAGATAT CGGGATGATT TTCCAGCATT TTAACCTGAT 1560 GAGCCAAAAG ACAGCAGAGG AGAATGTAGC CTTTGCCCTT AAACACTCTG GACTCAGCAA 1620 GGAAGAAAAG AAGGCTAAAG TAGCTAAGTT GTTGGACTTG GTTGGTTTGG CAGATCGTGC 1680 TGAAAACTAC CCTTCACAAC TATCTGGAGG GCAAAAACAG CGTGTGGCAA TTGCGCGTGC 1740 CTTGGCCAAT GATCCAAAAA TCTTGATTTC AGACGAGTCA ACTTCTGCCC TTGACCCTAA 1800 GACAACCAAG CAGATTTTGG CCTTGTTGCA AGATTTGAAC CAAAAATTAG GATTGACAGT 1860 TGTCTTGATT ACGCATGAAA TGAGATTGTC AAAGACATTG CCAACCGTGT GGCGGTTATG 1920 CAGGATGGGC ATTTGATTGA AGAGGGAAGT GTCCTTGAAA TCTTCTCAAA CCCTAAACAA 1980 CCTTTGACTC AAGACTTTAT CTCAACAGCC ACAGGTATTG ACGAAGCCAT GGTCAAAATC 2040 GAGAAGCAAG AAATCGTGGA ACACTTGTCT GAAAACAGTC TCTTGGTGCA ACTTCAAGTA 2100 CGCTGGAGCT TCAACAGACG AGCCACTTTT GAATGAATTG TACAAGCATT ACCAAGTAAT 2160 GGCTAATATT CTCTATGGGA ATATCGAAAT TCTCGATGGT ACTCCTGTTG GAGGAATTGG 2220 TGGTGGTCTT GTCAGGTGAA AAAGCAGCGT TGGCAGGTGC CCAAGAAGCC ATTCGTCAAG 2280 CAGGTGTACA ACTAAAAGTA TTGAAGGGAG TACAGTAAGA TGGAATCATT GATTCAAACC 2340 TATTTACCAA ATGTCTATAA AATGGGTTGG GCTGTCAGGC AGGCTGGGGG ACGGCTATCT 2400 ACTTAACTCT TTATATGCAG TTCTTTCCTT CATTATTCGG GTTCTTGGGG CTAGTGGCAG 2460 GTCTTCTCGT CTTAAGCGCC AGT 2483 (2) INFORMATION FOR SEQ ID NO:22: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1010 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 22: CCAATTAATG TGAGTTAGCT CACTCATTAG GCACCCCAGG CTTTACACTT TATGCTTCCG 60 GCTCGTATGT TGTGTGGAAT TGTGAGCGGA TAACAATTTC ACACAGGAAA CAGCTATGAC 120 CATGATTACG CCAAGCTTGC ATGCCTGCAG GTCGACTCTA GAGGATCCAA GCCATAGTTA 180 GACATGACTG CCAAATCTAA GGTTTGAGCA GTTGTTAAAT AAGCATTAGC TGTCGCCTCC 240 ATGTTGGGAC TGGTTACTTT GAGGCCTACT AAGGCTAGAG ATCCCAACAT CATCAGGATC 300 AAGATGGATA AAAAACGCCC TTGGAGCCTG TGAAGGACTG AATTAAGTCC TTCCGAATAA 360 GTTTTTCGCT TGATCATGCT AGTACTCCAA ACTGTCAATA TCCTGAGGAT GCTGGTTGAG 420 CACCACATCC TTGACACTGG CATCGTGCAT TTGAATCACG CGATCAGCAA TGGGCGCCAA 480 AGCTCCATTA TGAGTCACGA TGATCACCGT CGCTCCCTTT TGACGAGACA TGTCTTGGAG 540 AATTTTCAAA ACCTGCTTGC CCGTCTGATA ATCCAAGGCT CCAGTCGGTT CATCACAAAG 600 GAGAATTTTA GGATTTTTGG CTACCGCGCG TGCAATGGAG ACTCGCTGTT GCTCCCCTCC 660 AGAAAGCTGG GCTGGAAAGT TATTTAGACG ATGAGCCAGA CCTACATCTG TCAAGACCTG 720 ATCAGAATTC AAGGCATCTG TCACAATTTC AGAAGCAGTT CCACATTTTC CTTAGCTGTC 780 AGATTAGAAA CTAGATTATA AAACTGAAAA ACAAACCCCA CATCATTTCT ACGGTAATTG 840 GTGCGCTGGT GGGAACTATA ATCCGCAATA TTAACACCAT CAATCCAGAT TTCCCCTTCA 900 TCATTGGTAT CCATTCCCCC AAGAAGGTTA AGAACTGTTG ACTTGCCTGC ACCTGAAGCA 960 CCAAGGATAA TAACCAGTTC CCCCTTTTCA ATCTCAAAAT TCACATCACG 1010 (2) INFORMATION FOR SEQ ID NO: 23: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1299 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 23: TCGATCGCAC CGTCCTCTCC TCGTTCTGCT CTTGCTGGGC TATAGTTCCC TCTTCTAGTC 60 TTGATTTTCT TTGCCCATGC GTTCTTACCA CTTCTACTGT TTGCAGGTTT TACATGTCTG 120 GATATACTAT TTGTGCTAGG CTTAGCTTCT AGGATGGAGA AAAGAAGTCT AGTAGAGTTA 180 TTGAAAGGGG GCATCTTATG ATTGAGTTGA AAAATATTAC CAAAACCATT GGGGGAAAAG 240 TGATTTTGGA TAACTTATCT CTCAGGATTG ATCAGGGGGA TTTGGTAGCT ATTGTTGGTA 300 AGAGTGGTAG TGGGAAGTCG ACCTTGTTAA ATTTATTGGG TTTGATAGAT GGTGATTATA 360 GCGGACGGTA TGAGATTTTT GGTCAGACAA ATCTAGCGGT TAATTCTGCT AAGTCGCAAA 420 CAATAATCCG TGAACATATC TCTTATCTGT TTCAAAATTT TGCCCTGATT GATGATGAAA 480 CGGTCGAGTA CAATCTCATG CTGGCGCTGA AATATGTGAA ATTGCCTAAG AAAGACAAGC 540 TCAAAAAGGT GGAAGAGATT TTAGAGAGAG TAGGTTTGTC AGCTACTTTG CATCAAAGGG 600 TCTCCGAGTT GTCTGGGGGC GAACAACAAC GAATTGCAGT TGCTAGAGCC ATCTTAAAAC 660 CCAGCCAGCT GATTTTAGCC GATGAACCTA CAGGTTCGCT GGATCCTGAA AATAGAGATT 720 TGGTCTTGAA GTTTCTCTTA GAGATGAATC GAGAAGGGAA AACAGTCATT ATTGTGACCC 780 ACGATGCTTA TGTAGCCCAA CAATGTCATC GTGTCATTGA ATTGGGCGAG GGAAAATGAG 840 TTCATTCAGC TCCTTTTGAC TGGCTGAATA CTCATGTTTT CCAGAGAAAA ATAGCATAAA 900 TACGCCTAGG AATGACATTT TATGTAGCAT TTCTAGGTTT TTTTGTTTCA AATTGAAAAT 960 TTTTTCAATT TAGGCTTGAC AAAGGATGAG TATAGGAGTA TTATTTATAC AATAAAAAAG 1020 AATAAACATA AAGAAGGCTT TGTTATGAAT AAGATGAAGA AGGTGTTGAT GACGATGTTT 1080 GGTTTAGTGA TGCTCCCCCT ACTATTTGCT TGTAGTAACA ATCAATCGGC TGGAATTGAA 1140 GCCATCAAGT CCAAAGGAAA ATTGGTTGTA GCCCTCAATC CAGATTTTGC TCCATTTGAA 1200 TATCAAAAAG TGGTTGATGG GAAAAATCAG ATTGTGGGTT CAGATATCGA CTTAGCCAAG 1260 CTATCGCAAC AGAACTAGGT GTCGACTCTA GAGGATCCC 1299 (2) INFORMATION FOR SEQ ID NO: 24: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 252 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 24: GCCAAACCAA AACAACTCTC AGGTGGTCAA AAACAACGTG TGGCCATCGC TCGTGCCCTC 60 TCCATGAATC CGGACGCTAT TCTCTTTGAT GAACCAACAT CAGCTCTCGA TCCAGAAATG 120 GTTGGAGAAG TCCTCAAAAT CATGCAGGAC CTGGCTCAGG AAGGCTTGAC CATGATTGTC 180 GTAACCCATG AAATGGAATT TGCCCGTGAT GTCTCTCACC GTGTTATCTT TATGGATAAG 240 GGCGTGATCC CC 252 (2) INFORMATION FOR SEQ ID NO: 25: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 455 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 25: GATTTGGTAC CTCTTCGCAA GGAAGTCGGC ATGGTTTTTC AACATTTTAA CCTTTATCCA 60 CACAAAACGG TGTTAGAAAA CGTGACACTT GCGCCCATTA AAGTTCTAGG AATTGATAAA 120 AAAGAAGCTG AAAAAACCGC CCAAAAATAT CTGGAATTTG TAAATATGTG AGACAAGAAA 180 GATTCCTATC CCGCCATGCT ATCTGGTGGA CAAAAACAGC GGATCGCCAT CGCTCGTGGT 240 CTTGCTATGC ATCCGGAACT CCTCCTCTTT GATGAACCAA CATCTGCTCT TGATCCTGAG 300 ACTATCGGAG ATGTTCTAGC AGTTATGCAG AAACTGGCGC ATGATGGGAT GAACATGATC 360 ATCGTTACCC ACGAAATGGG CTTTGCTCGA GAGGTTGCGG ACCGCATTAT CTTTATGGCC 420 GACGGAGAAG TTTTAGTAGA TACGACAGAT GTCGA 455 (2) INFORMATION FOR SEQ ID NO: 26: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 913 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:26: AAACACTGCT TCTTGAGCGA ATGACGCTTT GTCCTTTTAA TGAGGTTACC AACGGCTTCA 60 AAGAGGATTC CCAGCTCGTT CAGCTGTGGA GGTAGCTCGT CTTCCTCGTG ATGTAAAAGT 120 CGAAATTGAA GTCATCGCAG AGATTGGATA AGCTAGTTGA AGTTTGGTGT TGCCAAACTT 180 CTTTTGATAT AAGGAGAAAA AGATGACAAA GAAACAACTT CACTTGGTGA TTGTGACAGG 240 GATGGGTGGC GCAGGGAAAA CTGTAGCCAT TCAGTCCTTC GAGGATCTAG GTTATTTCAC 300 CATTGATAAT ATGCCGCCAG CTCTCTTGCC TAAGTTTTTG CAGCTGGTTG AAATTAAGGA 360 AGACAATCCT AAGTTGGCCT TGGTAGTGGA TATGCGTAGT CGTTCTTTCT TTTCAGAGAT 420 TCAAGCTGTT TTGGATGAGT TGGAAAATCA AGATGGTTTG GATTTCAAAA TCCTCTTTTT 480 GGATGCGGCT GATAAGGAAT TGGTCGCTCG TTACAAGGAA ACCAGACGGA GTCACCCACT 540 AGCAGCAGAC GGTCGTATTT TAGATGGAAT CAAGTTGGAA CGTGAACTCT TGGCACCTTT 600 GAAAAATATG AGCCAAAATG TGGTGGATAC GACTGAACTC ACTCCACGTG AGCTGCGCAA 660 AACCCTTGCA GAGCAGTTTT CAGACCAAGA ACAAGCTCAG TCTTTCCGTA TCGAAGTCAT 720 GTCTTTCGGA TTTAAGTATG GAATCCCGAT TGATGCGGAC TTGGTCTTTG ATGTCCGTTT 780 CTTGCCAAAT CCCTATTATT TACCAGAACT GAGAAACCAA ACGGGTGTGG ATGAACCTGT 840 TTATGATTAT GTCATGAACC ATCCTGAGTC AGAAGACTTT TATCAACATT TATTGGCCTT 900 GATTGAGCCG ATT 913 (2) INFORMATION FOR SEQ ID NO: 27: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 5919 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:27: TCGATTCGTG GAGCAGGAAA TCTTTTAGGA AAATCCCAGT CTGGTTTCAT TGATTCTGTT 60 GGTTTTGAAT TGTATTCGCA GTTATTAGAG GAAGCTATTG CTAAACGAAA CGGTAATGCT 120 AACGCTAACA CAAGAACCAA AGGGAATGCT GAGTTGATTT TGCAAATTGA TGCCTATCTT 180 CCTGATACTT ATATTTCTGA TCAACGACAT AAGATTGAAA TTTACAAGAA AATTCGTCAA 240 ATTGACAACC GTGTCAATTA TGAAGAGTTA CAAGAGGAGT TGATAGACCG TTTTGGAGAA 300 TACCCAGATG TAGTAGCCTA TCTTTTAGAG ATTGGTTTGG TCAAATCATA CTTGGACAAG 360 GTCTTTGTTC AACGTGTGGA AAGAAAAGAT AATAAAATTA CAATTCAATT TGAAAAAGTC 420 ACTCAACGAC TGTTTTTAGC TCAAGATTAT TTTAAAGCTT TATCCGTAAC GAACTTAAAA 480 GCAGGCATCG CTGAGAATAA GGGATTAATG GAGCTTGTAT TTGATGTCCA AAATAAGAAA 540 GATTATGAAA TTTTAGAAGG TCTGCTGATT TTTGGAGAAA GTTTATTAGA GATAAAAGAG 600 TCTAAGGAAA AAAATTCCAT TTGATATTTT TCTTCTATAA AATAGATAAA ATGGTACAAT 660 AATAAATTGA GGTAATAAGG ATGAGATTAG ATAAATATTT AAAAGTATCG CGAATTATCA 720 AGCGTCGTAC AGTCGCAAAG GAAGTAGCAG ATAAAGGTAG AATCAAGGTT AATGGAATCT 780 TGGCCAAAAG TTCAACGGAC TTGAAAGTTA ATGACCAAGT GAAATCGCTT GGCAATAAGT 840 TGCTGCTTGT AAAGGTACTA GAGATGAAAG ATAGTACAAA AAAAGAAGAT GCAGCAGGAA 900 TGTATGAAAT TATCAGTGAA ACACGGGTAG AAGAAAATGT CTAAAAATAT TGTACAATTG 960 AATAATTCTT TTATTCAAAA TGAATACCAA CGTCGTCGCT ACCTGATGAA AGAACGACAA 1020 AAACGGAATC GTTTTATGGG AGGGGTATTG ATTTTGATTA TGCTATTATT TATCTTGCCA 1080 ACTTTTAATT TAGCGCAGAG TTATCAGCAA TTACTCCAAA GACGTCAGCA ATTAGCAGAC 1140 TTGCAAACTC AGTATCAAAC TTTGAGTGAT GAAAAGGATA AGGAGACAGC ATTTGCTACC 1200 AAGTTGAAAG ATGAAGATTA TGCTGCTAAA TATACACGAG CGAAGTACTA TTATTCTAAG 1260 TCGAGGGAAA AAGTTTATAC GATTCCTGAC TTGCTTCAAA GGTGATAAAA TGGAAAATTT 1320 ATTAGACGTA ATAGAGCAAT TTTTGAGTTT GTCAGATGAA AAGCTGGAAG AATTGGCTGA 1380 TAAAAATCAA TTATTGCGTT TACAAGAAGA AAAGGAAAGG AAGAATGCGT AAATTCTTAA 1440 TTATTTTGTT GCTACCAAGT TTTTTGACCA TTTCAAAAGT CGTTAGCACA GAAAAAGAAG 1500 TCGTCTATAC TTCGAAAGAA ATTTATTACC TTTCACAATC TGACTTTGGT ATTTATTTTA 1560 GAGAAAAATT AAGTTCTCCC ATGGTTTATG GAGAGGTTCC TGTTTATGCG AATGAAGATT 1620 TAGTAGTGGA ATCTGGGAAA TTGACTCCCA AAACAAGTTT TCAAATAACC GAGTGGCGCT 1680 TAAATAAACA AGGAATTCCA GTATTTAAGC TATCAAATCA TCAATTTATA GCTGCGGACA 1740 AACGATTTTT ATATGATCAA TCAGAGGTAA CTCCAACAAT AAAAAAAGTA TGGTTAGAAT 1800 CTGACTTTAA ACTGTACAAT AGTCCTTATG ATTTAAAAGA AGTGAAATCA TCCTTATCAG 1860 CTTATTCGCA AGTATCAATC GACAAGACCA TGTTTGTAGA AGGAAGAGAA TTTCTACATA 1920 TTGATCAGGC TGGATGGGTA GCTAAAGAAT CAACTTCTGA AGAAGATAAT CGGATGAGTA 1980 AAGTTCAAGA AATGTTATCT GAAAAATATC AGAAAGATTC TTTCTCTATT TATGTTAAGC 2040 AACTGACTAC TGGAAAAGAA GCTGGTATCA ATCAAGATGA AAAGATGTAT GCAGCCAGCG 2100 TTTTGAAACT CTCTTATCTC TATTATACGC AAGAAAAAAA TAAATGAGGG TCTTTATCAG 2160 TTAGATACGA CTGTAAAATA CGTATCTGCA GTCAATGATT TTCCAGGTTC TTATAAACCA 2220 GAGGGAAGTG GTAGTCTTCC TAAAAAAGAA GATAATAAAG AATATTCTTT AAAGGATTTA 2280 ATTACGAAAG TATCAAAAGA ATCTGATAAT GTAGCTCATA ATCTATTGGG ATATTACATT 2340 TCAAACCAAT CTGATGCCAC ATTCAAATCC AAGATGTCTG CCATTATGGG AGATGATTGG 2400 GATCCAAAAG AAAAATTGAT TTCTTCTAAG ATGGCCGGGA AGTTTATGGA AGCTATTTAT 2460 AATCAAAATG GATTTGTGCT AGAGTCTTTG ACTAAAACAG ATTTTGATAG TCAGCGAATT 2520 GCCAAAGGTG TTTCTGTTAA AGTAGCTCAT AAAATTGGAG ATGCGGATGG ATTTAAGCAT 2580 GATACGGGTG TTGTCTATGC AGATCCTCCA TTTATTCTTT CTATTTTCAC TAAGAATTCT 2640 GATTATGATA CGATTTCTAA GATAGCCAAG GATGTTTATG AGGTTCTAAA ATGAGGGAAC 2700 CAGATTTTTT AAATCATTTT CTCAAGAAGG GATATTTCAA AAAGCATGCT AAGGCGGTTC 2760 TAGCTCTTTC TGGTGGATTA GATTCCATGT TTCTATTTAA GGTATTGTCT ACTTATCAAA 2820 AAGAGTTAGA GATTGAATTG ATTCTAGCTC ATGTGAATCA TAAGCAGAGA ATTGAATCAG 2880 ATTGGGAAGA AAAGGAATTA AGGAAGTTGG CTGCTGAAGC AGAGCTTCCT ATTTATATCA 2940 GCAATTTTTC AGGAGAATTT TCAGAAGCGC GTGCACGAAA TTTTCGTTAT GATTTTTTTC 3000 AAGAGGTCCA TGAAAAAGAC AGGTGCGACA GCTTTAGTCA CTGCCCACCA TGCTGATGAT 3060 CAGGTGGAAA CGATTTTTAT GCGCTTGATT CGAGGAACCT CCTTGCGCTA TCTATCAGGA 3120 ATTAAGGAGA AGCAAGTAGT CGGAGAGATA GAAATCATTC GTCCCTTCTT GCATTTTCAG 3180 AAAAAAGACT TTCCATCAAT TTTTCACTTT GAAGATACAT CAAATCAGGA GAATCATTAT 3240 TTTCGAAATC GTATTCGAAA TTCTTACTTA CCAGAATTGG AAAAAGAAAA TCCTCGATTT 3300 AGGGATGCAA TCCTTAGGCA TTGGCAATGA AATTTTAGAT TATGATTTGG CAATAGCTGA 3360 ATTATCTAAC AATATTAATG TGGAAGATTT ACAGCAGTTA TTTTCTTACT CTGAGTCTAC 3420 ACAAAGAGTT TTACTTCAAA CTTATCTGAA TCGTTTTCCA GATTTGAATC TTACAAAAGC 3480 TCAGTTTGCT GAAGTTCAGC AGATTTTAAA ATTTAAAAGC CAGTATCGTC ATCCGATTAA 3540 AAATGGCTAT GAATTGATAA AAGAGTACCA ACAGTTTCAG ATTTGTAAAA TCAGTCCGCA 3600 GGCTGATGAA AAGGAAGATG AACTTGTGTT ACACTATCAA AATCAGGTAG CTTATCAAGG 3660 ATATTTATTT TCTTTTGGAC TTCCATTAGA AGGTGAATTA ATTCAACAAA TACCTGTTTC 3720 ACGTGAAACA TCCATACACA TTCGTCATCG AAAAACAGGA GATGTTTTGA TTAAAAATGG 3780 GCATAGAAAA AAACTCAGAC GTTTATTTAT TGATTTGAAA ATCCCTATGG AAAAGAGAAA 3840 CTCTGCTCTT ATTATTGAGC AATTTGGTGA AATTGTCTCA ATTTTGGGAA TTGCGACCAA 3900 TAATTTGAGT AAAAAAACGA AAAATGATAT AATGAACACT GTACTTTATA TAGAAAAAAT 3960 AGATAGGTAA AAAATGTTAG AAAACGATAT TAAAAAAGTC CTCGTTTCAC ACGATGAAAT 4020 TACAGAAGCA GCTAAAAAAC TAGGTGCTCA ATTAACTAAA GACTATGCAG GAAAAAATCC 4080 AATCTTAGTT GGGATTTTAA AAGGATCTAT TCCTTTTATG GCTGAATTGG TCAAACATAT 4140 TGATACACAT ATTGAAATGG ACTTCATGAT GGTTTCTAGC TACCATGGTG GAACAGCAAG 4200 TAGTGGTGTT ATCAATATTA AACAAGATGT GACTCAAGAT ATCAAAGGAA GACATGTTCT 4260 ATTTGTAGAA GATATCATTG ATACAGGTCA AACTTTGAAG AATTTGCGAG ATATGTTTAA 4320 AGAAAGAGAA GCAGCTTCTG TTAAAATTGC AACCTTGTTG GATAAACCAG AAGGACGTGT 4380 TGTAGAAATT GAGGCAGACT ATACCTGCTT TACTATCCCA AATGAGTTTG TAGTAGGTTA 4440 TGGTTTAGAC TACAAAGAAA ATTATCGTAA TCTTCCTTAT ATTGGAGTAT TGAAAGAGGA 4500 AGTGTATTCA AATTAGAAAG AATAATCTTT AATGAAAAAA CAAAATAATG GTTTAATTAA 4560 AAATCCTTTT CTATGGTTAT TATTTATCTT TTTCCTTGTG ACAGGATTCC AGTATTTCCT 4620 ATTCTGGGAA TAACTCAGGA GGAAGTCAGC AAATCAACTA TACTGAGTTG GTACAAGAAA 4680 TTACCGATGG TAATGTAAAA GAATTAACTT ACCAACCAAA TGGTAGTGTT TCGAAGTTTC 4740 TGGTGTCTAT AAAAATCCTA AAACAAGTAA AGAAGGAACA GGTATTCAGT TTTTCACGCC 4800 ATCTGTTACT AAGGTAGAGA AATTTACCAG CACTATTCTT CCTGCAGATA CTACCGTATC 4860 AGAATTGCAA AAACTTGCTA CTGACCATAA AGCAGAAGTA ACTGTTAAGC ATGAAAGTTC 4920 AAGTGGTATA TGGATTAATC TACTCGTATC CATTGTGCCA TTTGGAATTC TATTCTTCTT 4980 CCTATTCTCT ATGATGGGAA ATATGGGAGG AGGCAATGGC CGTAATCCAA TGAGTTTTGG 5040 ACGTAGTAAG GCTAAAGCAG CAAATAAAGA AGATATTAAA GTAAGATTTT CAGATGTTGC 5100 TGGAGCTGAG GAAGAAAAAC AAGAACTAGT TGAAGTTGTT GAGTTCTTAA AAGATCCAAA 5160 ACGATTCACA AAACTTGGAG CCCGTATTCC AGCAGGTGTT CTTTTGGAGG GACCTCCGGG 5220 GACAGGTAAG ACTTTGCTTG CTAAGGCAGT CGCTGGAGAA GCAGGTGTTC CATTCTTTAG 5280 TATCTCAGGT TCTGACTTTG TAGAAATGTT TGTCGGAGTT GGAGCTAGTC GTGTTCGCTC 5340 TCTTTTTGAG GATGCCAAAA AAGCAGCACC AGCTATCATC TTTATCGACT GAAATGGATG 5400 CCCGTGGGAC GTCAACGTGG AGTCGGTCTC GGCGGAGGTA ATGACGAACG TGAACAAACC 5460 TTGAACCAAC TTTTGATTGA GATGGATGGT TTTGAGGGAA ATGAAGGGAT TATCGTCATC 5520 GCTGCGACAA ACCGTTCAGA TGTACTTGAT CCTGCCCTTT TGCGTCCAGG ACGTTTTGAT 5580 AGAAAAGTAT TGGTTGGCCG TCCTGATGTT AAAGGTCGTG AAGCAATCTT GAAAGTTCAC 5640 GCTAAGAACA AGCCTTTAGC AGAAGATGTT GATTTGAAAT TAGTGGCTCA ACAAACTCCA 5700 GGCTTTGTTG GTGCTGATTT AGAGAATGTC TTGAATGAAG CAGCTTTAGT TGCTGCTCGT 5760 CGCAATAAAT CGATAATTGA TGCTTCAGAT ATGATGAAAG CAGAAGATAG AGTTATTGCT 5820 GGACCTTCTA AGAAAGATAA GACAGTTTCA CAAAAAGAAC GAGAATTGGT TGCTTACCAT 5880 GAGGCAGGAC ATACCATTGT TGGTCTAGTC TTGTCGACT 5919 (2) INFORMATION FOR SEQ ID NO: 28: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1863 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:28: GAGCTCGGTA CCCGGGGATC ATACTCAAGA GGAGGTAATC CAATGAACAC TAGTCTTAAA 60 CTCAGCAAAC AACTCAGTTT TGGAGAGGAG ATTGCTAATA GCGTGACCCA TGCTGTGGGT 120 GCAGTCATCA TGCTTATCTT GCTGCCTATT TCATCCATCT ATAGTTATGA AGCACACGGA 180 TTTTTATCCT CTATCGGCGT TTCCATTTTC GTCATCAGTC TCTTTCTCAT GTTCCTATCA 240 TCCACCATTT ATCACTCTAT GGCCTATGGT TCGACCCACA AATATGTTTT GCGAATCATT 300 GACCATTCTA TGATTTACGT TGCCATTGCC GGCTCATACA CGCCCGTTGT CTTGACCTTG 360 ATGAATAACT GGTTTGGCTA TCTGATTATT GTCATCCAAT GGGGAACGAC CATCTTTGGT 420 ATTCTCTATA AAATCTTTGC TAAAAAGGTC AATGAGAAAT TTAGCCTTGC TCTTTACCTG 480 ATTATGGGCT GGTTGGTTCT GGCTATCATT CCTGCCATTA TCAGTCAAAC GACACCCGTT 540 TTCTGGAGTC TCATGGTAAC TGGCGGACTC TGTTATACAG TTGGAGCTGG ATTTTATGCC 600 AAGAAAAAAC CTTATTTCCA CATGATTTGG CATCTCTTTA TCCTAGCTGC GTCCGCACTC 660 CAATACATCG CTATTGTTTA TTACATGTAA AAAAGTTGAG AAATTCAATC TCAACTTTTT 720 TCTTTACACA TATTGATAAA GTACTGGTGC AAGCGCACAT CATCAGTCAA TTCTGGATGA 780 AAAGAACTTA CCAACATATT TTTTTCTTGG GCTGCAACAA TTTGATTGTT CACTATTGCT 840 AAAATTTCTA CACCCTCACC AACACTACTG ATAATCGGAC CACGGATAAA GGTCATTGGA 900 ATCTTGCCAA CTCCCTTACA TTCTGCTTCC GTGTAGAAAC TTCCTAATTG GCGCCCATAA 960 GCATTACGCT CGACCACCAT ATCCATAGTT CCTAGATGAC TCTCTTTCTG AGAAGTGATT 1020 TCCTTAGCCA GCAAAATTAA GCCCGCACAG GTCCCAAACA CTGGTAAGCC AGATAGAATG 1080 GCTTCTCGTA TGGGAAGTAG CATGTTCTGG TCACGTAAGA GCTTGCCCAT GGTTGTAGAC 1140 TCACCACCAG GCAAAATAAA CCCGACAAGT CACTCTGATC TTGCTGAAAA CATCTAGATT 1200 TCTGAGTTCT ACACTCTCGA CACCTAATTG ATCTAGCACT TTTGCATGTT CTGCAAAGGC 1260 CCCTTGCAAG GCCAATATTC CGATTTTCAT CTATTTTCCT CGTTCAGCCA TGAGAATTTG 1320 GATTCATTTT CATTAATACC AACCATGGCT TCTCCTAAAT CTTCAGAGAT TTGAGCTAGG 1380 ATTTGAGGAT TACGGAAGTT AGTCACAGCC TTAACAATGG CACTCGCTCG TTTAACAGGA 1440 TCTCCTGACT TGAAAATACC TGAACCGACA AAGACCCCCT CTGCCCCTAA TTGCATCATT 1500 AACGCAGCAT CTGCTGGCGT TGCAACACCT CCAGCAGCGA AATTTACAAC TGGCAATTTT 1560 CCATGTTCAT GAACATATTG GACCAATTCT ACAGGGACTT GCAAATCCTT GGCAGCAACA 1620 TAAAGCTCGT CCTCACGTAA GTTTTGAATG CGGCGAATTT CCTGATTCAT CATACGCATA 1680 TGACGAACAG CTTGGACTAT ATCCCCTGTC CCTGGTTCTC CTTTAGTACG AATCATGGAA 1740 GCACCTTCAG CGATACGACG CAAGGCTTCA CCCAAATCCT TAGCACCACA GACAAAAGGA 1800 ACTTGGAATT CTTTCTTGTC CACATGGAAA CGGTCATCAG CTGGAGATAG AACTTCACTC 1860 TCG 1863 (2) INFORMATION FOR SEQ ID NO: 29: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 5448 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:29: TAAAGAAGGT GGATTTGAAG TTAACGGTAA ATTCATCAAA GTTTCTGCTG AACGTGATCC 60 AGAACAAATC GACTGGGCTA CTGACGGTGT AGAAATCGTT CTTGAAGCTA CTGGTTTCTT 120 TGCTAAGAAA GAAGCAGCTG AAAAACACCT TAAAGGTGGA GCTAAAAAAG TTGTTATCAC 180 TGCTCCTGGT GGAAACGACG TTAAAACAGT TGTATTCAAC ACTAACCACG ACGTTCTTGA 240 CGGTACTGAA ACAGTTATCT CAGGTGCTTC ATGTACTACA AACTGCTTGG CTCCAATGGC 300 TAAAGCTCTT CAAGACAACT TTGGTGTTGT TGAAGGATTG ATGACTACTA TCCACGCTTA 360 CACTGGTGAC CAAATGATCC TTGACGGACC ACACCGTGTG GTGACCTTCG CCGTGCTCGC 420 GCTGGTGCTG CAAACATCGT TCCTAACTCA ACTGGTGCTG CAAAAGCTAT CGGTCTTGTA 480 ATCCCAGAAT TGAATGGTAA ACTTGATGGA TCTGCACAAC GCGTTCCAAC TCCAACTGGA 540 TCAGTTACTG AATTGGTCGC AGTTCTTGAA AAGAACGTTA CTGTTGATGA AGTGAACGCA 600 GCTATGAAAG CAGCTTCAAA CGAATCATAC GGTTACACAG AAGATCCAAT CGTATCTTCA 660 GATATCGTAG GTATGTCTTA CGGTTCATTG TTTGACGCAA CTCAAACTAA AGTTCTTGAC 720 GTTGACGGTA AACAATTGGT TAAAGTTGTA TCATGGTACG ACAACGAAAT GTCATACACT 780 GCACAACTTG TTCGTACTCT TGAATACTTC GCAAAGATTG CTAAATAATT CTTGAGTTGA 840 TAGAAAGCAA GGCTTTGTGG TCTTGCTTTT TTATATGGAA AAATGGATGA CACGATCATC 900 CATTCTTTTT TAATTCTTTT TCAAATGTAT TTGAAAGGGT AGTGAAAGTT AGCCTCTCTA 960 AAGTAAGTGG GTGGGTAAAG GAAAGTCGGA AGGCATGAAG CATAAGCCGG CTTGTCTTTG 1020 ATTTACTATT ATAGAGAGGG TCTCCCAGGA TAGGAAGATT ATGATGCAAA AGGTGCACAC 1080 GAATCTGATG GGTTCGCCCT GTCTTTAGCT TGCAATGAGC CAAGGAAGTC TTGTTTGAGA 1140 ATTGCTTTAA TCTGCTTACA TGCGTTTCAG CATATTTCCC ATTTTTTGCA TCAACTATTC 1200 TTTTTCTACG ATCATGGCGA TCACGTCCAA TTTTGTCTCT GAAAACAAGT TCTTTTCTGT 1260 TGATATTTCC ATCAACTAGA GCCCAATATT CTCTAGAAAT CTCTTTTTTC TCCAATAAGC 1320 GATTGAGAAT GGGCAGGATA AAAGGATTTT TGGCAAAGAG AACTAAGCCA CTGGTTTCCA 1380 TGTCCAGACG ATGAACGACA TAGCAGGTTT GGCCAACATA GGTACTGACA TGGTTAAGAA 1440 GGGCAATTTC GTTTGGTTGA TTACCATGCG TTTTCATCCC CTCTGGTTTG TTTACAATAA 1500 TCAAGTGTTG ATCTTGATAA ACTTCCTGCA CTAAGTCTGG GTTGCCCCAA GGGATCGTCT 1560 TTTGGGGATA ATCTTCCTCG TCAAAAGTCA ACTGGCAAAC ATCTCCAGGA TTTACGATTT 1620 CGTTCCAGCG GACTTCTTCT TGATTTATCA AAATATGTTT CTTGATTCTC AAAAAATGAC 1680 GGATTTTTCT AGGGATGAGG AGTTGTTCCT CAAGTAATTG CTTTACCGTC ATTTGAGGTA 1740 GAGAGGCGGG TAATGTAAAT GTGAATTGCA TACAGATATT GTAACAAAAA AAGCCCTATT 1800 TGGATAGGAA ATAGCTAAAT TCTTGTCTTC CTATGATGAA GATGATAAAA TAAACGCATG 1860 AAATTAGATA AATTATTTGA GAAATTTCTT TCTCTTTTTA AAAAAGAAAC AAGTGAACTA 1920 GAGGACTCTG ATTCTACTAT CTTACGTCGC TCTCGTAGTG ATCGAAAAAA ATTAGCCCAA 1980 GTAGGTCCGA TTCGAAAATT CTGGCGTCGT TATCATCTAA CAAAGATTAT CCTTATACTA 2040 GGTTTGAGTG CAGGCTTGCT AGTTGGAATC TATTTGTTTG CTGTAGCCAA GTCGACCAAT 2100 GTCAATGATT TGCAAAATGC CTTGAAAACT CGGACTCTTA TTTTTGACCG TGAAGAAAAA 2160 GAGGCTGGTG CCTTGTCTGG TCAAAAGGGA ACCTATGTTG AGCTGACTGA CATCAGTAAA 2220 AACTTGCAGA ATGCTGTTAT TGCGACAGAA GACCGTTCTT TCTATAAAAA TGACGGGATT 2280 AACTATGGCC GTTTCTTCTT GGCTATTGTC ACTGCTGGAC GTTCAGGTGG TGGCTCTACC 2340 ATTACCCAAC AGCTGGCTAA AAACGCCTAT TTATCGCAGG ATCAAACTGT TGAGAGAAAA 2400 GCGAAAGAAT TTTTCCTTGC CTTAGAATTA AGCAAAAAAT ATAGTAAGGA GCAAATTCTA 2460 ACCATGTACC TTAACAACGC TTATTTTGGA AATGGTGTGT GGGGTGTAGA AGATGCGAGT 2520 AAGAAATACT TTGGAGTTTC TGCATCAGAA GTGAGTCTGG ATCAAGCTGC GACTCTGGCA 2580 GGGATGCTCA AGGGGCCGGA ACTGTATAAT CCCTTGAATT CCGTAGAAGA TTCTACTAAT 2640 CGGCGCGATA CTGTCTTGCA GAATATGGTT GCAGCAGGAT ATATTGATAA AAACCAAGAA 2700 ACCGAAGCTG CTGAAGTTGA TATGACTTCG CAATTGCACG ATAAGTATGA AGGAAAAATC 2760 TCAGATTACC GTTACCCCTC TTATTTTGAT GCGGTGGTTA ATGAAGCTGT TTCCAAGTAT 2820 AATCTAACAG AGGAAGAGAT TGTCAATAAT GGCTACCGCA TTTACACAGA GCTGGACCAA 2880 AACTACCAAG CAAATATGCA GATTGTTTAT GAAAACACAT CGCTATTTCC GAGGGCAGAG 2940 GATGGAACGT TTGCTCAATC AGGAAGTGTA GCTCTCGAAC CGAAAACAGG GGGAGTTCGT 3000 GGAGTTGTCG GTCAAGTTGC TGACAATGAT AAAACTGGAT TCCGGAATTT CAACTATGCA 3060 ACCCAATCAA AGCGTAGTCC TGGTTCTACA ATTAAGCCTT TAGTTGTTTA TACACCAGCA 3120 GTTGAAGCAG GCTGGGCTTT GAATAAGCAG TTGGATAACC ATACCATGCA GTATGATAGC 3180 TATAAGGTTG ATAACTATGC AGGGATCAAA ACAAGTCGAG AAGTTCCTAT GTATCAATCC 3240 TTGGCAGAAT CGCTTAATCT ACCTGCTGTT GCCACTGTTA ATGATTTGGG TGTTGACAAG 3300 GCTTTTGAGG CAGGCGAAAA ATTCGGACTC AACATGGAAA AGGTCGACCG TGTTCTTGGT 3360 GTCGCCTTGG GAAGCGGTGT TGAAACCAAC CCTCTTCAAA TGGCTCAAGC ATACGCTGCC 3420 TTTGCAAATG AAGGTTTAAT GCCTGAAGCT CATTTTATTA GTAGAATTGA AAATGCTAGT 3480 GGACAAGTTA TTGCGAGTCA TAAAAATTCA CAAAAACGGG TGATTGATAA GTCTGTAGCT 3540 GACAAGATGA CCAGTATGAT GTTGGGGACT TTCACCAACG GTACCGGTAT TAGTTCATCG 3600 CCTGCAGACT ATGTCATGGC AGGGAAAACT GGAACAACTG AAGCAGTTTT CAATCCGGAG 3660 TACACAAGTG ACCAGTGGGT AATTGGTTAT ACTCCGGATG TAGTGATTAG CCACTGGCTT 3720 GGCTTTCCGA CCACTGATGA AAATCACTAT CTAGCTGGCT CTACTTCAAA CGGTGCAGCT 3780 CATGTCTTTA GAAACATTGC CAATACTATT TTACCTTATA CGCCAGGAAG TACCTTTACG 3840 GTTGAAAATG CTTATAAGCA AAATGGAATT GCACCAGCCA ATACAAAAAG ACAAGTACAA 3900 ACCAATGATA ATAGCCAGAC AGATGATAAT TTGTCTGATA TTCGAGGGCG TGCGCAAAGT 3960 CTAGTAGATG AGGCTAGCCG GGCTATCTCA GATGCGAAGA TTAAGGAAAA GGCTCAAACA 4020 ATATGGGATT CGATAGTCAA TCTATTTCGC TAAGATGCTT GTCAAAGCCT AGCTTTCTTG 4080 TTATAATGGA TAAGATGGAG GCGTTATGGC ACTAAAAAAA GCAAGCCTAG CTTGTGCGGT 4140 TTGTGGTTCG AGAAACTATT CAATCAAGAT CAGCGGAAAC CCCAAGCCTA CACGACTAGA 4200 AGTAAATAAA TTTTGTAAGC ATTGTGGCAA GTACACTACA CACAGAGAAA CGAGATAGGA 4260 GAGAGCGATG CGTTTTATTG GAGATATTTT TAGACTTCTT AAAGACACAA CATGGCCAAC 4320 TCGCAAGGAA AGCTGGAGAG ATTTTCGTTC TATCATGGAA TACACAGCTT TCTTTGTAGT 4380 AATTATTTAC ATTTTTGACC AGTTGATTGT TTCAGGTTTG ATTCGATTTA TTAACATTTT 4440 TTAGAAGATT AGTGGAGTTA ATTACACTAG AAATCTTCTA TTTATGAAAG GAAATATCAT 4500 GGATAGTTTT GATAAAGGAT GGTTTGTTTT ACAAACTTAT TCTGGTTATG AAAATAAGGT 4560 GAAAGAAAAT CTATTACAAC GTGCACAAAC CTACAATATG TTGGATAATA TTCTACGCGT 4620 TGAAATTCCA ACACAAACAG TGCAAGTTGA AAAAAATGGA AAGAGAAAAG AAGTAGAAGA 4680 AAATCGCTTT CCAGGTTATG TTCTTGTAGA AATGGTCATG ACAGATGAAG CTTGGTTTGT 4740 TGTTCGAAAC GCACAGAGTC CTACAAAATT CATTTCAGAA CAAACAGCTT ATGAAATTGA 4800 TGAAGAGGTT CGTTCATTAT TAAATGAGGC ACGAAATAAA GCTGCTGAAA TTATTCAGTC 4860 AAATCGTGAA ACTCACAAGT TAATTGCAGA AGCATTATTG AAATACGAAA CATTGGATAG 4920 TACACAAATT AAAGCTCTTT ACGAAACAGG AAAGATGCCT GAAAGCAGTA GAAGAGGAAT 4980 CTCATGCACT ATCCTATGAT GAAGTAAAGT CAAAAATGAA TGACGAAAAA TAACCCTGAG 5040 AGAGGCTGGA GCCTCTCTTT TTTGTGCAGT TTAGGAGCTA AAGGGAACAG AATGGAGAAA 5100 ATGGAACAAA TGTGTTTTCT AATCTGTTAG ACTGTATCTA GAAAGGGGAA AATTATGATT 5160 AAAGAATTGT ATGAAGAAGT CCAAGGGACT GTGTATAAGT GTAGAAATGA ATATTACCTT 5220 CATTTATGGG AATTGTCGGA TTGGGACCAA GAAGGCATGC TCTGCTTACA TGAATTGATT 5280 AGTAGAGAAG AAGGACTGGT AGACGATATT CCACGTTTAA GGAAATATTT CAAAACCAAG 5340 TTTCGAAATC GAATTTTAGA CTATATCCGT AAGCAGGAAA GTCAGAAGCG TAGATACGAT 5400 AAAGAACCCT ATGAAGAAGT GGGTGAGATC CCCGGTACCG AGCTCGAA 5448 (2) INFORMATION FOR SEQ ID NO: 30: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1040 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 30: TAGTGAATTC GAGCTCGGTA CCCGGGGATC GTTTCTCGGT TCTTTTGGAG CACAAGGGCA 60 TCCATCCCAT TGTCTATATT TCCAAAATGG ATTTGTTGGA AGATAGGGGA GAACTGGATT 120 TTTACCAGCA GACCTATGGT GACATCGGCT ATGACTTTGT GACCAGTAAA GAGGAACTCC 180 TGTCTTTGTT AACAGGCAAG GTTACGGTCT TTATGGGGCA GACAGGTGTT GGGAAGTCAA 240 CTCTTCTCAA TAAAATCGCA CCAGACCTCA ATCTTGAAAC GGGAGAAATT TCAGACAGTC 300 TAGGTCGCGG TCGCCATACC ACTCGAGCTG TTAGTTTTTA CAATCTCAAC GGGGGTAAAA 360 TCGCAGATAC ACCAGGATTT TCATCCTTGG ACTATGAAGT ATCAAGGGCT GAAGACCTCA 420 ATCAGGCTTT CCCAGAGATT GCTACTGTTA GCCGAGATTG TAAGTTCCGT ACTTGTACCC 480 ATACCCATGA GCCGTCTTGT GCCGTCAAAC CAGCTGTTGA AGAGGGTGTT ATTGCAACCT 540 TCCGTTTTGA CAATTACCTG CAATTCCTTA GTGAAATTGA AAATCGTAGA GAAACCTATA 600 AAAAAGTCAG CAAAAAAATT CCAAAATAAG GAGAAACCTA TGTCTCAATA CAAGATTGCT 660 CCGTCAATTC TGGCAGCAGA TTATGCCAAC TTTGAACGTG AAATCAAACG TCTAGAAGCA 720 ACTGGGGCAG AATATGCCCA TATCGATTCT GGACAGTCAT TTTGTACCGC AAATCAGTTT 780 TGGTGCAGGT GTGGTCGAGA GCTTCGTCCT CATAGTAAGA TGGTTTTCGA TTGCCACTTG 840 ATGGTGTCAA ACCCTGAGCA TCATCTGGAA GATTTTGCGC GTGCAGGTGC AGACATCATC 900 AGTATCCATG TAGAAGCAAC ACCTCATATT CATGGCGCCC TCCAAAAAAT TCGTTCACTC 960 GGAGTTAAGC CTTCAGTCGT TATCAATCCT GGCACACCAG TTGAAGCCAT CAAGCACGTC 1020 CTTCATCTAG TGACAAGTTT 1040 (2) INFORMATION FOR SEQ ID NO:31: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 789 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID Nθ:31: ATATCACGAC GGAGCCATAC TACCGATTTT CTTAAGCATA GCGCCACCTT TACCGATGAT 60 AATCCCTTTT TGGCTATCGC GCTCGACCAT GATGGTTGCA CGGATGTGAA CCTTGTCTGT 120 CTCTTCGTCT CGTTTCATAG AGTCAACAAC TACTGCTACA GAATGCGGAA TCTCTTCACG 180 AGTTAGGTGC AAGACTTTCT CGCGAACCAT TTCTGAAACT AAGAAACGTT CTGGATGATC 240 TGTGATTTGA TCAGACGGGA AATATTGGAA ACCTTCATCC AGATTTTCAC TCAAAATATC 300 CACTAGACGA GACACGTTAT TTCCCTGAAG GGCTGAGATT GGAACAATTT CCTTAAAGTC 360 CATTTGATTA CGGAAGTCAT CAATCTGAGA CAAGAGCTGG TCTGGATGGA CCTTATCGAT 420 TTTATTCACC ACCAAAATCA CAGGAACCTT GGCAGCCTTG GAGACGCTCG ATAATCATAT 480 CGTCCCCCTT ACCACGCGCT TCATCAGCAG GCACCATGAA AAGAACAGTG TCCACTTCGC 540 GAAGGTACTG TAGGCAGACT CAACCATGAA ATCTCCGAGA GCTGTTTTAA GTTTGTGAAT 600 CCCTGGTGTG TCGATAAAGA CAATTTGCTC CTTATCAGTC GTGTAATTCC CATGATTTTA 660 TTGCGCGTTG TCTGCGCCTT GTCACTCATG ATGGCAATCT TTTGCCCCAT AACGTGATTT 720 AAAAAGGTTG ACTTCCCAAC ATTGGGACTC CTAAAATGGC TACAAACCTG ATTTAAAATT 780 CATAATTCC 789 (2) INFORMATION FOR SEQ ID NO: 32: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1233 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 32: TGAGATAAAC TTGCGACTCA TATGAGAATA TGAATCAAGC CGTCCTCGTG AACCCCGATA 60 TCAACGAAGG CACCGAAGTC AACAACGTTA CGCACAACAC CTTCTAGCTT CTGACCTACC 120 ACTAGGTCTT TGATATCTAG GACATCTTGG CGAAGCACAG GTGCGTCAAA GGAATCACGG 180 AAATCTCGAC CTGGTTTGAG AAGATCTGCA ATGATATCTT TAAGGGTTTC TGGACCGAGG 240 TCTAGCTCTT GAGCCATTTC CTTGACTGAA AGGGACTTGA GTTTGCTTGG GCTTCTTCGT 300 TTAGGTCTTT AATATCTAAA CGTTTGAAGA GTCCTTAACT GCAGTGTAAT TCTCTGGGTG 360 AACTCCTGTA TTATCAAGGA TATTGCTACT TTCAGGGATA CGAAGGAAAC CAGCAGCCTG 420 CTCAAAGGCC TTGGCTCCCA GACGAGGAAC TTTCTTGATT TGGGCGCGTG AAGTGATTTT 480 TCCTTCTTCC TCGCGGTATT TGACAATATT TTCAGAGATA GTTTTGTTGA GTCCAGCTAC 540 GTGTGAAAGA AGAGCTGGGC TAGCTGTATT GACATTGACA CCAACTTGGT TAACCACTGT 600 ATCGACAACA AAGTCCAGAC TCTCAGATAG TTTCTTCTGA CTGACATCGT GTTGGTATTG 660 ACCGACACCA ATTGACTTAG GATCGATTTT GACCAATTCC GCAAGAGGAT CTTGCAAACG 720 ACGGGCGATA GAAATGGCAG AGCGTTTTTC AACGGTCAAG TCTGGAAACT CCTGACGAGC 780 AAGTTCGCTG GCAGAATAGA CAGAAGCACC ACTTTCATTA ACGATAACAT AGCTGACTTC 840 AGGGAAATCT TTCAGAACTT CCGCTACAAA AGCTTCACTT TCACGACTGG CCGTTCCATT 900 TCCAATGGCA ATAATCTCTA CACCGTATTG ACCAATTAAA TCTGCTAAAT CTTTCTTGGC 960 TTCTTCGATT TGACGAGCTG ATGCTGGTTT AACAGGATAA ATAACCTGAG TTGTCAGCAT 1020 TTTTCCTGTT GCATCCACGA CAGCTAACTT GGCACCTGTA CGAAAGGCTG GGTCAAATCC 1080 AAGAACCACG CGCCCTTTCA GTGGAGCAAC CAAGAGGAGA TTGCGCAGAT TGTCAGAAAA 1140 AAGTTGGATA GCTCCCTCTT CAGCTTTCTC AGTTAATTCT GTCCGAATAC GACGCTCAAT 1200 AGCAGGCAAG ACCTTTTTCT TAACGGATTG CTG 1233 (2) INFORMATION FOR SEQ ID NO: 33: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6679 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO ( i) SEQUENCE DESCRIPTION: SEQ ID NO: 33: ACAAGGCGTC ATCCGTGTAT TTCTTAAATA CGGACCAAAT GGTGAGAAAG TTATCACTAA 60 CTTGAAACGT GTTTCTAAAC CAGGACTTCG TGTCTACAAA AAACGTGAAG ACCTTCCAAA 120 AGTTCTTAAC GGACTTGGAA TTGCCATCCT TTCAACTTCT GAAGGTTTGC TTACTGATAA 180 AGAAGCACGC CAAAAGAATG TTGGTGGTGA GGTTATCGCT TACGTTTGGT AAAATCAAGA 240 TACAAAGCTC GTAAAGAACA AAGCAAAATT AGGAAGTTGG AGAAGTTTGT TTACAAACAA 300 GCCAACTTAT CTATTTTGCA CAGTTCTTAG ATCGTGTTCA GTTCAGCTCT TGAACTAAAT 360 AAGTATCTGA ACCCCGTGAA AACTGGCCGT TCTGGCTGAC AATTTAACAG GAGAAAATAA 420 ACATGTCACG TATTGGTAAT AAAGTTATCG TGTTGCCTGC TGGTGTTGAA CTCGCTAACA 480 ATGACAACGT TGTAACTGTA AAAGGACCTA AAGGAGAACT TACTCGTGAG TTCTCAAAAG 540 ATATTGAAAT CCGTGTGGAA GGTACTGAAG TAACTCTTCA CCGTCCAAAC GATTCAAAAG 600 AAATGAAAAC TATCCACGGA ACTACTCGTG CCCTTTTGAA CAACATGGTT GTTGGTGTAT 660 CAGAAGGATT CAAGAAAGAA CTTGAAATGC GTGGGGTTGG TTACCGTGCA CAGCTTCAAG 720 GATCTAAACT TGTTTTGGCT GTTGGTAAAT CTCATCCAGA CGAAGTTGAA GCTCCAGAAG 780 GAATTACTTT TGAACTTCCA AACCCAACAA CAATCGTTGT TAGCGGAATT TCAAAAGAAG 840 TAGTTGGTCA AACAGCTGCT TACGTACGTA GCCTTCGTTC ACCAGAACCA TATAAAGGTA 900 AAGGTATCCG TTACGTTGGT GAATTCGTTC GTCGTAAAGA AGGTAAAACA GGTAAATAAT 960 GTTGAGTGGT TGATCATCAA CCACCAACCT ATTTTCCAAC TTTGTGCATA GCAACGATTT 1020 AAAACTAAAG AGGTGAAAAC TGTGATTTCA AAACCAGATA AAAACAAACT CCGCCAAAAA 1080 CGCCACCGTC GCGTTCGGGA AAACTCTCTG GAACTGCTGA TCGCCCACGT TTGAACGTAT 1140 TCCGTTCTAA TACAGGCATC TACGCTCAAG TGATTGATGA CGTAGCGGGT GTAACGCTCG 1200 CAAGTGCTTC AACTCTTGAT AAAGAAGTTT CAAAAGGAAC TAAAACTGAA CAAGCCGTTG 1260 CTGTCGGTAA ACTCGTTGCA GAACGTGCAA ACGCTAAAGG TATTTCAGAA GTGGTGTTCG 1320 ACCGCGGTGG ATATCTATAT CACGGACGTG TGAAAGCTTT GGCTGATGCA GCTCGTGAAA 1380 ACGGATTGAA ATTCTAATAG GAGGACACTA GAAAATGGCA TTTAAAGACA ATGCAGTTGA 1440 ATTAGAAGAA CGCGTAGTTG CTGTCAACCG TGTTACAAAA GTTGTTAAAG GTGGACGTCG 1500 TCTTCGTTTC GCAGCTCTTG TTGTTGTTGG TGACCACAAT GGTCGCGTAG GATTTGGTAC 1560 TGGTAAAGCT CAAGAAGTTC CAGAAGCAAT CCGTAAAGCA GTAGATGATG CTAAGAAAAA 1620 CTTGATCGAA GTTCCTATGG TTGGAACAAC AATCCCACAC GAAGTTCTTT CAGAATTCGG 1680 TGGAGCTAAA GTATTGTTGA AACCTGCTGT AGAAGGTTCT GGAGTTGCCG CTGGTGGTGC 1740 AGTTCGTGCC GTTGTGGAAT TGGCAGGTGT GGCAGATATT ACATCTAAAT CACTTGGTTC 1800 TAACACTCCA ATCAACATTG TTCGTGCAAC TGTTGAAGGT TTGAAACAAT TGAAACGCGC 1860 TGAAGAAATT GCTGCCCTTC GTGGTATTTC AGTTTCTGAT TTGGCATAAG AAAGGGGATA 1920 AAATGGCTCA AATTAAAATT ACTTTGACTA AGTCTCCAAT CGGACGCATT CCATCACAAC 1980 GTAAAACTGT TGTAGCACTT GGACTTGGCA AATTGAACAG CTCTGTTATT AAAGAAGATA 2040 ACGCTGCTAT CCGTGGTATG ATTACAGCAG TATCTCACTT AGTAACAGTT GAAGAAGTAA 2100 ACTAATGAAG TTTTAGGGGA TGTGCACTGT ACCATCCCCT AAAACTAGAT ATAGTCATCT 2160 ATGATGACAT CGTATAGGCG AGTTGATGGG GGAGACAACC TTTTCTCCCT TATCGGCGCT 2220 AGCATTTTAC AAAAGAGGAG AAAATAAAAA TGAAACTTCA TGAATTGAAA CCTGCAGAAG 2280 GTTCTCGTAA AGTACGTAAC CGCGTTGGTC GTGGTACTTC ATCAGGTAAC GGTAAAACAT 2340 CTGGTCGTGG TCAAAAAGGT CAAAAAGCTC GTAGCGGTGG CGGAGTTCGC CTTGGTTTTG 2400 AAGGTGGACA AACTCCATTG TTCCGTCGTC TTCCAAAACG TGGATTCACT AACATCAACG 2460 CTAAAGAATA CGCAATTGTG AACCTTGACC AATTGAACGT CTTTGAAGAT GGTGCTGAAG 2520 TAACTCCAGT TGTTCTTATC GAAGCAGGAA TTGTTAAAGC TGAAAAGTCA GGTATTAAAA 2580 TTCTTGGTAA CGGTGAGTTG ACTAAGAAAT TGACTGTGAA AGCAGCTAAA TTCTCTAAAT 2640 CAGCTGAAGA AGCTATCACT GCTAAAGGTG GTTCAGTAGA AGTCATCTAA GAGAGGTGAC 2700 CTATGTTTTT TAAATTATTA AGAGAAGCTC TTAAAGTCAA GCAGGTTCGA TCAAAAATTT 2760 TATTTACAAT TTTTATCGTT TTGGTCTTTC GTATCGGAAC TAGCATTACA GTTCCTGGTG 2820 TGAATGCCAA TAGCTTGAAT GCTTTAAGTG GATTATCCTT CTTAAACATG TTGAGCTTGG 2880 TGTCGGGGAA TGCCCTAAAA AACTTTTCGA TTTTTGCCCT AGGAGTTAGT CCCTATATCA 2940 CCGCTTCTAT TGTTGTCCAA CTCTTGCAAA TGGATATTTT ACCCAAGTTT GTAGAGTGGG 3000 GTAAACAAGG GGAAGTAGGT CGAAGAAAAT TGAATCAAGC TACTCGTTAT ATTGCTCTAG 3060 TTCTCGCTTT TGTGCAATCT ATCGGGATTA CAGCTGGTTT TAATACCTTG GCTGGAGCTC 3120 AATTGATTAA AACTGCTTTA ACTCCACAAG TTTTTCTGAC GATTGGTATC ATCTTAACAG 3180 CTGGTAGTAT GATTGTCACT TGGTTGGGTG AGCAAATTAC AGATAAGGGA TACGGAAACG 3240 GTGTTTCCAT GATTATCTTT GCCGGGATTG TTTCCTCAAT TCCAGAGATG ATTCAGGGCA 3300 TCTATGTGGA CTACTTTGTG AACGTCCCAA GTAGCCGTAT CACTTCATCT ATCATTTTCG 3360 TAATCATTTT GATTATTACT GTATTGTTGA TTATTTACTT TACAACTTAT GTTCAACAAG 3420 CAGAATACAA AATTCCAATC CAATATACTA AGGTTGCACA AGGTGCTCCA TCTAGCTCTT 3480 ACCTTCCGTT AAAGGTAAAT CCTGCTGGAG TTATCCCTGT TATCTTTGCC AGTTCGATTA 3540 CTGCAGCGCC TGCGGCTATT CTTCAGTTTT TGAGTGCCAC AGGTCATGAT TGGGCTTGGG 3600 TAAGGGTAGC ACAAGAGATG TTGGCAACTA CTTCTCCAAC TGGTATTGCC ATGTATGCTT 3660 TGTTGATTAT TCTCTTTACA TTCTTCTATA CGTTTGTACA GATTAATCCT GAAAAAGCAG 3720 CAGAGAGCCT ACAAAAGAGT GGTGCCTATA TCCATGGAGT TCGTCCTGGT AAAGGTACAG 3780 AAGAATATAT GTCTAAACTT CTTCGTCGTC TTGCAACTGT TGGTTCCCTC TTCCTTGGTG 3840 TGATTTCCAT TTTACCGATT GCAGCTAAAG ATGTATTTGG TCTTTCTGAT GTTGTTGCCT 3900 TTGGTGGAAC AAGTCTCTTG ATCATTATCT CTACAGGTAT CGAAGGAATC AAGCAATTGG 3960 AAGGTTACCT ATTGAAACGT AAGTATGTTG GTTTCATGGA CAGAACAGAA TAAAAGTATT 4020 TACTGAATCA GTAAATACTG AGGGAGTGGA GGTTTAAACT CTGACATTTG TAAGAGTTGG 4080 ATCTCCCCTC TTCTATTTTG TTTTTAAATC GGGGTGAAAA AACTTTTTGC TTCTATTTAA 4140 AAACAAAATA AGGAGATCAA ATCATGAATC TTTTGATTAT GGGCTTACCT GGTGCAGGTA 4200 AGGGAACTCA AGCAGCAAAA ATCGTAGAAC AATTCCATGT TGCACATATC TCAACAGGTG 4260 ATATGTTCCG CGCTGCAATG GCAAATCAAA CTGAAATGGG TGTTCTTGCT AAGTCATATA 4320 TTGACAAGGG TGAATTGGTT CCTGACGAAG TTACAAATGG AATCGTAAAA GAACGCCTTT 4380 CACAAGATGA TATTAAAGAA ACAGGATTCT TATTGGATGG TTACCCACGT ACAATTGAAC 4440 AAGCTCATGC CTTGGACAAA ACATTGGCTG AACTTGGCAT TGAACTAGAA GGTATTATCA 4500 ATATTGAAGT GAACCCTGAC AGCCTCTTGG AACGTTTGAG TGGCCGTATC ATCCACCGCG 4560 TAACTGGAGA AACTTTCCAC AAGGTCTTTA ACCCACCAGT TGACTATAAA GAAGAAGATT 4620 ACTACCAACG TGAAGATGAT AAGCCTGAGA CAGTAAAACG TCGTTTGGAT GTTAATATTG 4680 CTCAAGGAGA ACCAATCATT GCTCACTACC GTGCCAAAGG TTTGGTTCAT GACATCGAAG 4740 GTAATCAAGA TATCAATGAT GTCTTCTCAG ATATTGAAAA AGTATTGACA AATTTGAAAT 4800 AAAGCGTTTT TCACACTTGC AAAAATCCGC TACAAATGTT ATACTGAAAT AGTCTGACTT 4860 ATAATTGTTG TCTCTGTGTC TAGAGGCATC GAATCGAAAT TTATGGAGGT GCTTTTGCGT 4920 GGCAAAAGAC GATGTGATTG AAGTTGAAGG CAAAGTAGTT GATACAATGC CGAATGCAAT 4980 GTTTACGGTT GAACTTGAAA ATGGACATCA GATTTTAGCA ACAGTTTCTG GTAAAATTCG 5040 TAAAAACTAT ATTCGTATTT TAGCGGGAGA TCGTGTTACT GTCGAAATGA GTCCATATGA 5100 CTTGACACGT GGACGTATCA CTTACCGCTT TAAATAATCG AAAAACTTGG AGGGATAAGA 5160 AATGAAAGTA AGACCATCGG TCAAACCAAT TTGCGAATAC TGTAAAGTTA TTCGTCGTAA 5220 TGGTCGTGTT ATGGTAATTT GCCCAGCAAA TCCAAAACAC AAACAACGTC AAGGATAAGA 5280 TAGAAAGGAG AAAACATGGC TCGTATTGCT GGAGTTGATA TTCCAAATGA CAAACGCGTA 5340 GTAATCTCAT TGACTTATGT TTATGGTATC GGACTTGCAA CATCTAAGAA AATTTTGGCT 5400 GCTGCTGGAA TCTCAGAAGA TGTTCGTGTA CGTGATCTTA CATCAGATCA AGAAGATGCT 5460 ATCCGTCGTG AAGTGGATGC AATCAAAGTT GAAGGTGACC TTCGTCGTGA AGTAAACTTG 5520 AACATCAAAC GTTTGATGGA AATCGGTTCA TACCGTGGTA TCCGTCACCG TCGTGGACTT 5580 CCTGTCCGTG GACAAAATAC TAAAAACAAC GCTCGCACTC GTAAAGGTAA AGCTGTTGCG 5640 ATTGCTGGTA AGAAAAAATA ATATAGGAGG TAAAAGTCTT GGCTAAACCA ACACGTAAAC 5700 GTCGTGTGAA AAAGAATATC GAATCTGGTA TTGCTCATAT TCACGCTACA TTTAATAACA 5760 CTATTGTTAT GATTACTGAT GTGCATGGTA ATGCAATTGC TTGGTCATCA GCTGGTGCTC 5820 TTGGTTTCAA AGGTTCTCGT AAATCTACAC CATTCGCTGC TCAAATGGCT TCTGAAGCTG 5880 CTGCTAAATC TGCACAAGAA CACGGTCTTA AATCAGTTGA AGTTACTGTA AAAGGTCCAG 5940 GTTCTGGTCG TGAGTCAGCT ATTCGTGCGC TTGCTGCCGC TGGTCTTGAA GTAACAGCAA 6000 TTCGTGATGT GACTCCAGTG CCACACAATG GTGCTCGTCC TCCAAAACGT CGCCGTGTAT 6060 AATCATCGCA TTACACTGCT TTTCGTTTAA GAGGGAGTAA CTAAATGATC GAGTTTGAAA 6120 AACCAAATAT AACAAAAATT GATGAAAATA AAGATTATGG CAAGTTTGTA ATCGAACCAC 6180 TTGAACGTGG CTACGGTACA ACTCTTGGTA ACTCTCTTCG TCGTGTACTT CTAGCTTCTC 6240 TACCAGGAGC AGCTGTGACA TCTATCAACA TTGATGGTGT GTTACATGAG TTTGACACAG 6300 TTCCAGGTGT TCGTGAAGAC GTGATGCAAA TCATTCTGAA CATTAAAGGA ATTGCAGTGA 6360 AATCGTACGT TGAAGACGAA AAAATCATCG AACTGGATGT TGAAGGTCCT GCTGAAGTAA 6420 CAGCTGGTGA CATTTTGACA GATAGCGATA TTGAAATTGT AAATCCAGAT CATTATCTCT 6480 TTACAATCGG TGAAGGTTCT TCTCTAAAAG CGACTATGAC TGTTAACAGT GGTCGTGGAT 6540 ATGTACCTGC TGACGAAAAT AAAAAGGATA ATGCACCAGT TGGAACACTT GCTGTAGATT 6600 CTATTTATAC ACCAGTTACA AAAGTCAACT ATCAAGTGGA ACCTGCTCGT GTAGGTAGCA 6660 ATGATGGTTT CGACTCTAG 6679 (2) INFORMATION FOR SEQ ID NO: 34: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1703 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 34: AGAATACCTT GGGGCAACTG TTCAAGTCAT TCCTCATATC ACAGATGCTT TGAAAGAAAA 60 AATCAAGAGT GCCGCTCTAA CGACCGACTC TGATGTCATT ATCACAGAGG TTGGTGGAAC 120 AGTAGGAGAT ATCGAGTCCT TGCCATTCCT AGAGGCTCTT CGCAGATGAA GGCAGATGTG 180 GGGCGGATAA TGTCATGTAT ATCCATACAA CCTTCTTCCT TACCTCAAGG CTGCTGGTGA 240 AATGAAACCA AACCAACCCA ACACTCTGTC AAAGATTGCG TGGCTTGGGA ATCCAACCAA 300 ATATGTTGGT TATTCGTACA GAAGAGCCAG CTGGTCAAGG AATTAAAAAT AAACTGGCCC 360 AGTTCTGTGA TGTGGCACCA GAATCCCTAA TCGAATCGTT GGATGTTGAA CACCTTTACC 420 AAATTCCACT GAACTTGCAG GCACAAGGGA TGGACCAAAT TGTTTGTGAT CATTTGAAAT 480 TAGACGCACC AGCAGCGGAT ATGACAGAAT GGTCAGCCAT GGTGGACAAG GTCATGAACC 540 TCAAGAAACA AGTTAAGATT TCCCTTGTTG GTAAGTATGT GGAGTTGCAA GATGCCTATA 600 TCTCAGTGGT CGAAGCCTTG AAACACTCTG GCTATGTCAA TGATGTAGAA GTTAAAATCA 660 ATTGGGTCAA TGCCAATGAT GTGACAGCAG AGAATGTAGC AGAACTCTTG TCTGATGCGG 720 ACGGGATCAT CGTACCAGGT GGTTTTGGTC AACGTGGTAC AGAAGGGAAA ATCCAAGCCA 780 TCCGCTATGC GCGTGAAAAT GATGTTCCAA TGTTGGGAGT CTGCTTGGGA ATGCAGTTGA 840 CATGTATCGA GTTTGCTCGT CACGTTTTAG GTCTTGAAGG TGCCAATTCT GCAGAGCTTG 900 CACCAGAAAC AAAATACCCT ATCATTGATA TCATGCGTGA TCAGATTGAT ATTGAGGATA 960 TGGGTGGAAC CCTTCGTTTG GGACTTTATC CGTCTAAGTT GAAACGTGGC TCTAAGGCTG 1020 CTGCTGCTTA TCACAATCAA GAAGTGGTGC AACGCCGTCA CCGTCACCGT TATGAGTTTA 1080 AATAATGCCT TCCGTGAGCA GTTTGAGGCA GCAGGTTTGT CTTTTCAGGA GTTTCTCCAG 1140 ACAATCGTTT GGTAGAAATC GTGGAAATCC TGAAAATAAA TTCTTTGTAG CTTGTCAGTA 1200 TCACCCTGAA CTGTCAGCCG TCCAACCGAC CAGAAGAACT CTACACTGCC TTTGTTACTG 1260 CAGCGGTTGA GAACAGCAAT TAGCAAAATC AGAACCTTTG AGAAAAATCT CAGAGGTTTT 1320 TTGCATACGA TGATATTGCA GTATATCTGA GGTAGGAGTC CTCTGTATGT ACCTGCTACC 1380 GTTGAAATCA ATAGCGACTC CCTCTTGCCC TGTGCTAGTG AATGGATTTA TCAGTATATT 1440 GAAATGAAAT AAAATTTGAA CAAATTAATT CGGAAAGCCA AATCAATTTC TAGCAAAGTT 1500 TTAGGAACTG GATTGTATAG TGAATTGAAA TAAGATGTGA ACATCTCTAT CAGGAAAGTC 1560 AAATTAATTT ATAGAAATAT TTTAGCAGTC AAGATGGACT GTTATAGATT CAATATACTA 1620 TACTTTTTTA ATTTAATCCA CTATAATAAA ATGAAATAAT AACAGGACAA ATCGTTCAGG 1680 ACAGTCAAAT CGACTCTAGA GGA 1703 (2) INFORMATION FOR SEQ ID NO: 35: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1620 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:35: ATTGTAAAAC ACCAAGGAAA AACAGCTAAA GAAGCGAAAG AATTGGCCAT TGACTACATG 60 AATAAGGTTG GCATTCCAGA CGCAGATAGA CGTTTTAATG AATACCCATT CCAATATTCT 120 GGAGGAATGC GTCAACGTAT CGTTATTGCG ATTGCCCTTG CCTGCCGACC TGATGTCTTG 180 ATCTGTGATG AGCCAACAAC TGCCTTGGAT GTAACTATTC AAGCTCAGAT TATTGATTTG 240 CTAAAATCTT TACAAAACGA GTATCATTTC ACAACAATCT TTATTACCCA CGACCTTGGT 300 GTGGTGGCAA GTATTGCGGA TAAGGTAGCG GTTATGTATG CAGGAGAAAT CGTTGAGTAT 360 GGAACGGTTG AGGAAGTCTT CTATGACCCT CGCCATCCAT ATACATGGAG TCTCTTGTCT 420 AGCTTGCCTC AGCTTGCTGA TGATAAAGGG GATCTTTACT CAATCCCAGG AACACCTCCG 480 TCACTTTATA CTGACCTGAA AGGGGATGCT TTTGCCTTGC GTTCTGACTA CGCAATGCAG 540 ATTGACTTCG AACAAAAAGC TCCTCAATTC TCAGTATCAG AGACACATTG GGCTAAAACT 600 TGGCTTCTTC ATGAGGATGC TCCAAAAGTA GAAAAACCAG CTGTGATTGC AAATCTCCAT 660 GATAAGATCC GTGAAAAAAT GGGATTTGCC CATCTGGCTG ACTAGGAGGA AGGAAATGTC 720 TGAAAAATTA GTAGAAATCA AAGATTTAGA AATTTCCTTC GGTGAAGGAA GTAAGAAGTT 780 TGTCGCGGTT AAAAATGCTA ACTTCTTTAT CAACAAGGGA GAAACTTTCT CGCTTGTAGG 840 TGAGTCCGGT AGTGGGAAAA CAACTATTGG TCGTGCTATC ATCGGTCTAA ATGATACAAG 900 TAATGGAGAT ATCATTTTTG ATGGTCAAAA GATTAATGGT AAGAAATCGC GTGAACAAGC 960 TGCGGAATTG ATTCGTCGAA TCCAGATGAT TTTCCAAGAC CCTGCCGCAA GTTTGAATGA 1020 ACGTGCGACT GTTGATTATA TTATTTCTGA AGGTCTTTAC AATCACCGTT TATTTAAGGA 1080 TGAAGAAGAA CGTAAAGAGA AAGTTCAAAG TATTATCCGT GAAGTAGGTC TTCTTGCTGA 1140 GCACTTGACT CGTTACCCTC ATGAATTCTC AGGCGGTCAA CGTCAACGTA TCGGTATTGC 1200 CCGTGCCTTG GTCATGCAAC CAGACTTTGT TATTGCAGAT GAGCCAATTT CAGCCTTGGA 1260 CGTTTCTGTA CGTGCCCAAG TCTTGAACTT GCTCAAAAAA TTCCAAAAAG AGCTCGGCTT 1320 GACCTATCTC TTCATCGCCC ATGACTTGTC GGTTGTTCGC TTTATTTCAG ATCGTATCGC 1380 AGTTATTTAC AAGGGTGTTA TTGTAGAGGT TGCAGAAACA GAAGAATTGT TTAACAATCC 1440 AATTCACCCA TATACTCAAG CCTTGCTTTC AGCGGTACCA ATCCCAGATC CAATCTTGGA 1500 ACGTAAGAAG GTCTTGAAGG TTTACGACCC AAGTCAACAC GACTATGAGA CTGATAAGCC 1560 ATCTATGGTA GAAATCCGTC CAGGTCACTA TGTTTGGGCG AACCAAGCCG AATTAGCACG 1620 (2) INFORMATION FOR SEQ ID NO:36: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 984 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 36: GTACCCGGGG ATCAGGTTTT ACGGATTCTT GAAGTTCTCT GTGGGCAGGA CCTCTTGCAG 60 GTAAGAGTAA GAGTGATTCT ACAAGATTTA CTAGAAGCTA GAAAAATGTG GCAAGCTAAT 120 GTCAGCTTTC AAAATGCCAT GGAATATCTG GTCTTGAAAG AAATATAAAC TCAAAAATGA 180 ATGATAAAGA AAGGAAAGGG CTGTTTTATG GACAAAAAAG AATTATTTGA CGCGCTGGAT 240 GATTTTTCCC AACAGTTATT GGTAACCTTG GCCGATGTGG AAGCCATCAA GAAAAATCTC 300 AAGAGCCTGG TAGAGGAAAA TACAGCTCTT CGTTTGGAAA ATTCTAAGTT GCGAGAACGC 360 TTGGGTGAGG TGGAAGCAGA TGCTCCTGTC AAGGCCAAGC ATGTTCGTGA AAGTGTCCGT 420 CGCATTTACC GTGATGGATT TCACGTATGT AATGATTTTT ATGGACAACG TCGAGAGCAG 480 GACGAGGAAT GTATGTTTTG TGACGAGTTG CTATACAGGG AGTAGGCATG CAGATTCAAA 540 AAAGTTTTAA GGGGCAGTCT CCCTATGGCA AGCTGTATCT AGTGGCAACG CCGATTGGCA 600 ATCTAGATGA TATGACCTTT CGAGCTATCC AGACCTTGAA AGAAGTAGAT TGGATTGCTG 660 CTGAGGATAC GCGCAATACA GGTCTTTTGC TCAAGCATTT TGACATTTCC ACCAAGCAGA 720 TCAGTTTTCA TGAGCACAAT GCCAAGGAAA AAATTCCTGA TTTGATTGGT TTCTTGAAAG 780 CAGGGCAAAG TATTGCTCAG GTCTCTGATG CCGGTTTGCC TAGCATTTCA GACCCTGGTC 840 ATGATTTAGT TAAGGCAGCT ATTGAGGAAG AAATTGCAGT TGTGACAGTT CCAGGTGCCT 900 CTGCAGGAAT TTCTGCCTTG ATTGCCAGTG GTTTAGCGCC ACAGCCACAT ATCTTTTACG 960 GTTTTTTACC GAGAAAATCA GGTC 984 (2) INFORMATION FOR SEQ ID NO: 37: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1554 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 37: CTAGAGTCGA AAAGACAAGC AGGAGCGTAT TTCCAAAGAA ACCATGGAAA TCTATGCCCC 60 GCTTGCCCAT CGTTTGGGGA TTTCCAGTGT CAAATGGGAA TTAGAAGACT TGTCTTTCCG 120 TTATCTCAAT CCAACGGAGT TTTACAAGAT TACCCATATG ATGAAGGAAA AGCGCAGGGA 180 GCGTGAGGCC TTGGTGGATG AGGTAGTCAC AAAATTAGAG GAGTATACGA CAGAACGTCA 240 CTTGAAAGGG AAGATTTATG GTCGTCCCAA GCATATTTAC TCAATTTTCC GCAAAATGCA 300 GGACAAGAGA AAACGGTTTG AGGAAATCTA TGATCTGATT GCTATTCGTT GTATTTTAGA 360 TACCCAAAGT GATGTTTATG CCATGCTTGG TTACGTGCAT GAATTTTGGA AACCGATGCC 420 AGGTCGCTTC AAAGACTATA TCGCCAACCG CAAGGCCAAT GGTTATCAGT CTATCCATAC 480 GACTGTTTAT GGACCAAAAG GGCCGATTGA ATTCCAGATT CGAACCAAGG AAATGCACGA 540 GGTGGCTGAG TACGGGGTTG CGGCTCACTG GGCTTATAAG AAAGGTATAA AGGGGCAAGT 600 TAACAGCAAG GAATCAGCTA TTGGAATGAA CTGGATCAAG GAGATGATGG AGCTCCAAGA 660 CCAGGCTGAT GATGCTAAGG AATTTGTGGA CTCTGTTAAG GAAAACTATT TGGCTGAGGA 720 GATTACCGTT TTACCCCAGA TGGAGCTGTC CGTTCCTTCC CAAAGATTCA GGACCGATTG 780 ATTTTGCCTA CGAAATCCAT ACCAAGGTCG GTGAAAAGCA ACTGGTGCCA AGGTCAATGG 840 CCGCATGGTT CCACTGACAC CCAAGTTAAA GGACAGGGGA TCAGGTTGAA ATTATCGCCA 900 ACCCGAACTC CTTTGGACCT TAGCCGTGAC TGGCTCAATA TGGTCAAGAC TAGCAAGGCG 960 CGCAATAAGA TTCGCCAGTT CTTTAAAAAC CAAGATAAGG AATTGTCTGT CAACAAGGGT 1020 CGTGAGATGC TGATGGCTCA GTTCCAAGAA AATGGCTATG TGGCAAATAA ATTTATGGAC 1080 AAGCGCCACA TGGATCAAGT TCTGCAAAAG ACCAGTTACA AGACAGAAGA CTCCCTCTTT 1140 GCGGCCATTG GTTTTGGGGA AATCGGTGCG ATTACCGTCT TTAACCGTCT GACTGAAAAG 1200 GAGCGCCGTG AGGAAGAGCG TGCCAAGGCC AAGGCTGAGG CAGAGGAGCT TGTCAAAGGT 1260 GGCGAGGTCA AGGTTGAAAA TAAAGAAACT CTCAAGGTCA AGCATGAGGG GGGAGTGGTT 1320 ATTGAAGGTG CTTCTGGTCT CCTAGTGCGG ATTGCTAAGT GTTGTAACCC CGTGCCTGGT 1380 GACGATATTG TTGGCTACAT TACCAAGGGT CGTGGTGTGG CTATTCACCG TGTGGACTGT 1440 ATGAACCTGC GTGCCCAAGA AAACTACGAG CAACGTCTCC TTGATGTGGA ATGGGAAGAC 1500 CAGTACTCTA GCTCAAATAA GGAGTATATG GCCCATATCG ACTCTAGAGG ATCC 1554 (2) INFORMATION FOR SEQ ID NO: 38: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 3190 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 38: CGTCAGTGCT AAAACAGGGG AAATTCTGGC AACAACGCAA CGACCGACCT TTGATGCAGA 60 TACAAAAGAA GGCATTACAG AGGACTTTTT TGGCGTGATA TCCTTTACCA AAGTAACTAT 120 GAGCCAGGTT CCACTATGAA AGTGATGATG TTGGCTGCTG CTATTGATAA TAATACCTTT 180 CCAGGAGGAG AAGTCTTTAA TAGTAGTGAG TTAAAAATTG CAGATGCCAC GATTCGAGAT 240 TGGGACGTTA ATGAAGGATT GACTGGTGGC AGAATGATGT CTTTTTCTCA AGGTTTTGCA 300 CACTCAAGTA ACGTTGGGAT GACCCTCCTT GAGCAAAAGA TGGGAGATGC TACCTGGCTT 360 GATTATCTTA ATCGTTTTAA ATTTGGTGTT CCGACCCGTT TCGGTTTGAC GGATGAGTAT 420 GCTGGTCAGC TTCCTGCGGA TAATATTGTC AACATTGCGC AAAGCTCATT TGGACAAGGG 480 ATTTCAGTGA CCCAGACGCA AATGATTCGT GCCTTTACAG CTATTGCTAA TGACGGTGTC 540 ATGCTGGAGC CTAAATTTAT TAGTGCCATT TATGATCCAA ATGATCAAAC TGCTCGGAAA 600 TCTCAAAAAG AAATTGTGGG AAATCCTGTT TCTAAAGATG CAGCTAGTCT AACTCGGACT 660 AACATGGTTT TGGTAGGGAC GGATCCGGTT TATGGAACCA TGTATAACCA CAGCACAGGC 720 AAGCCAACTG TAACTGTTCC TGGGCAAAAT GTAGCCCTCA AGTCTGGTAC GGCTCAGATT 780 GCTGACGAGA AAAATGGTGG TTATCTAGTC GGGTTAACCG ACTATATTTT CTCGGCTGTT 840 CGATGAGTCC GGCTGAAAAT CCTGGATTTT ATCTTGTATG TGACGGTCCA ACAACCTGGA 900 ACATTATTCA GGTATTCAGT TGGGAGAATT TGCCAATCCT ATCTTGGAGC GGGCTTCAGC 960 TATGAAAGAC TCTCTCAATC TTCAAACAAC AGCTAAGGCT TTGGAGCAAG TAAGTCAACA 1020 AAGTCCTTAT CCTATGCCCA GTGTCAAGGA TATTTCACCT GGTGATTTAG CAGAAGAATT 1080 GCGTCGCAAT CTTGTACAAC CCATCGTTGT GGGAACAGGA ACGAAGATTA AAAACAGTTC 1140 TGCTGAAGAA GGGAAGAATC TTGCCCCGAA CCAGCAAGTC CTTATCTTAT CTGATAAAGC 1200 AGAGGAGGTT CCAGATATGT ATGGTTGGAC AAAGGAGACT GCTGAGACCC TTGCTAAGTG 1260 GCTCAATATA GAACTTGAAT TTCAAGGCTC GGGCTCTACT GTGCAGAAGC AAGATGTTCG 1320 TGCTAACACA GCTATCAAGG ACATTAAAAA AATTACATTA ACTTTAGGAG ACTAATATGT 1380 TTATTTCCAT CAGTGCTGGA ATTGTGACAT TTTTACTAAC TTTAGTAGGA ATTCCGGCCT 1440 TTATCCAATT TTATAGAAAG GCGCAAATTA CAGGCCAGCA GATGCATGAG GATGTCAAAC 1500 AGCATCAGGC AAAAGCTGGG ATTCCTACAA TGGGAGGTTT GGTTTTCTTG ATTACTTCTG 1560 TTTTGGTTGC TTTCTTTTTC GCCCTATTTA GTAGCCAATT CAGCAATAAT GTGGGAATGA 1620 TTTTGTTCAT CTTGGTCTTG TATGGCTTGG TCGGATTTTT AGATGACTTT CTCAAGGTCT 1680 TTCGTAAAAT CAATGAGGGG CTTAATCCTA AGCAAAAATT AGCTCTTCAG CTTCTAGGTG 1740 GAGTTATCTT CTATCTTTTC TATGAGCGCG GTGGCGATAT CCTGTCTGTC TTTGGTTATC 1800 CAGTTCATTT GGGATTTTTC TATATTTTCT TCGCTCTTTT CTGGCTAGTC GGTTTTTCAA 1860 ACGCAGTAAA CTTGACAGAC GGTGTTGTAC GGTTTAGCTA GTATTTCCGT TGTGATTAGT 1920 TTGTTTGCCT ATGGAGTTAT TGCCTATGTG CAAGGTCAGA TGGATATTCT TCTAGTGATT 1980 CTTGCCATGA TTGGTGGTTT GCTCGGTTTC TTCATCTTTA ACCATAAGCC TGCCAAGGTC 2040 TTTATGGGTG ATGTGGGAAG TTTGGCCCTA GGTGGGATGC TGGCAGCTAT CTCTATGGCT 2100 CTCCACCAGG AATGGACTCT CTTGATTATC GGAATTGTGT ATGTTTTTGA AACAACTTCT 2160 GTTATGATGC AAGTCAGTTA TTTCAAACTG ACAGGTGGTA AACGTATTTT CCGTATGACG 2220 CCTGTACATC ACCATTTTGA GCTTGGGGGA TTGTCTGGTA AAGGAAATCC TTGGAGCGAG 2280 TGGAAGGTTG ACTTCTTCTT TTGGGGAGTT GGGCTTCTAG CAAGTCTCCT GACCCTCGCA 2340 ATTTTGTATT TGATGTAAGA ATGGCACCCT GATGTTTCAG GGTGTTTTTG TGTTTAAATA 2400 CACAATGAAA ATCAAAGAAC AAACTAGAAA GCTAACTTTA GGCTGCTCAA AATATAATAT 2460 ATTGAAACTA GAATAGTACA CCTCTACTTC TAAAACATTG TTAGAAATCG ATTTGACTGT 2520 CCTGAACGAT TTATCCTGTT CTTATTTCAT TTTACTATAC AGTTTCGAGG TTGTAGATAA 2580 GGCGAAGCTG ATGTGGTTTG AAGAGATTTT CTGAAAAGTG TTAACACCTA CAGACAAGCC 2640 TGACGATAGC AAGAACTACC CTACTCGATA GGTATCGGCT TTTGCTTTCT GAAAAAAATT 2700 ATTTTAAGCA TTTGACAAAT CTAGCAACAA AAAATTCTAT AAATATAATA GATTGAAACT 2760 AGAATAGTAC ACATCTACTT CTAAAACATT GTTAGAAATC GATTTGACTG TCCTGATCGA 2820 TTTGTCCTGT TCTTGTTTCA TTTTACTATA TTTCTATGAT AAAACGCATA GTATCAAGTT 2880 TTCTTAATCC CCTGATACTA TGCGTGTTTG TAATTTTTAA GATTTTGTGC TTAGAGTCGA 2940 CTCCTTATTT TAGATATTTA AAAGGAATCT CACTTCCACA GAGCCAGTTG TAGACTTGGT 3000 CATTAACAAA TACATTCATG GCTTCGTGAG CATACTCAGG CATGATACGA TAGGTTTTAT 3060 CGCAGGTCAG ACGATTATAA ATCGCAAACT GGGTAATGGG ATAGCAAACA TCGTCGTCCA 3120 AGCCCGTAAT CATCTTAACC TCACCTTGGA TACGATGGGC AAGATTTTTG ACATCGACTC 3180 TAGAGGATCC 3190 (2) INFORMATION FOR SEQ ID NO:39: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 5992 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 39: TTGTTCTTAG TGTTCCGACA AAGATTCTTC AAAATCAAAT CATGGAAGAA GAAGGTAAAC 60 GTCTCAAGGA AGTGTTCCAT ACAGATATTC ATAGCTTAAA GGGACCACAA AATTATCTGA 120 AGTTGGATGC CTTTTATCAT TCTTGCAGGA AAATGATGAA AATCGCTTAT TTAGACGCTT 180 TAAAATGCAA GTCTTGGTCT GGCTTACTGA GACAGAGACA GGAGATTTGG ATGAAATCGG 240 GCAACTCTAC CGTTACCAAC ATTTTCTAGC AGACCTTCGT CATAATGGGA ATTTATCATC 300 CCAGAGCTTA TTTGTGACGG AAGATTTTTG GAAACGTAGT CAAGAAAGGG CAGAGACTTG 360 CAAGCTTTTA GTGACTAATC ATGCCTATCT CGTAACCAGA CTTGAAGATA ATCCTGAATT 420 TGTCAGTGAC CGTTTACTGA TTATTGATGA AGTCCAAAAG ATTTTGTTAG CTCTAGAAAA 480 TCTGCTTCAA GAGACCTACG ATATACAATC TATTATCGAT TTAATTGATA AGGCTTTAGT 540 AGGAGAAGAA AACAGGGTTC AACAACGGAT ACTAGAAAGT ATTCGCTTTG AGTGCCTCTA 600 CTTGATAGAA CAATTTCAGT CTGGCAAATC TAGGAAAAAT ATCTTAGATT CTCTGGACAA 660 TCTCCATCAG TATTTTTCAG AATTAGAAGT GGAAGGCTTT GATGAGCTGG TTCGCTATTT 720 TACAGCTGAA GGTGATTACT GGCTTGAAGT AACTGAAACG AGTCAAAAGA AAATTCAGAT 780 TTCTTCTACA AAATCAGGCC GTACTCTTCT GTCCTCTTTA CTTCCTGAGA GTTGCCAAGT 840 CTTGGGAGTA TCGGCTACTC TTGAGATTAG TCAGAGGGTT TCTTTGGCAG ACCTTTTAGG 900 CTATCCTGAA GCCAAATTTG TCAAGATTGA ATCTCGGGGA AAACAGGAAC AAGAAGTGGT 960 TATGGTCAAA GATTTCCCTC TGGTAACAGA AACCTCCTTA GAAGTCTATG CCAGAGAGGT 1020 AGCTGCTTTA CTAGTGGAAA TTCAAGCTTT CCAGCAACCG ATTTTGGTTC TCTTTACCGC 1080 TAAAGACATG CTTCTAGCAG TATCGGATTT ACTTACAGTT AGCCACTTGG CCCAGTATAA 1140 AAATGGGGAT GTTCATCAGC TAAAGAAACG CTTTGAAAAA GGTGAACAAC AAATCTTGCT 1200 TGGTGCAGCA AGTTTCTGGG AGGGAGTTGA TTTTTCAAGC CATCCTTTTG TGATTCAAGT 1260 TGTACCGAGG CTTCCTTTCC AAAATCCTCA AGAACCCTTG ACGAAAAAGA TTAATCAAGA 1320 ACTGAATCAA GAAGGGAAAA ATGCCTTTTA TGATTATCAA TTGCCAATGG CCATTATTCG 1380 TTTAAAACAG GCTTTGGGAA GAAGTATGAG ACGTGAATAC CAACGTTCCT TAACTCTTAT 1440 TTTGGATAGG AGAATCATCG GAAAACGATA CGGCAAACAA ATAGTAGCAT CTCTAGCAGA 1500 AGAAGCGACT GTTAAAACCA TCTCTCGATC CGAAGTTGAC GAGGCTATTG ATAGATTTTT 1560 TAATGAACTT TGATAAATAG TATTGTATGA AAGTATAAGG TTAGTACATA TGAAACGTTC 1620 TCTCGACTCT AGAGTCGATT ATAGTTTGCT CTTGCCAGTA TTTTTTCTAC TGGTCATCGG 1680 TGTGGTGGCT ATCTATATAG CCGTTAGTCA TGATTATCCC AATAATATTC TGCCCATTTT 1740 AGGGCAGCAG GTCGCCTGGA TTGCCTTGGG GCTTGTGATT GGTTTTGTGG TCATGCTCTT 1800 TAATACAGAA TTTCTTTGGA AGGTGACCCC CTTTCTATAT ATTTTAGGCT TGGGACTTAT 1860 GATCTTGCCG ATTGTATTTT ATAATCCAAG CTTAGTTGCA TCAACGGGTG CCAAAAACTG 1920 GGTATCAATA AATGGAATTA CCCTATTTCA ACCGTCAGAA TTTATGAAGA TATCCTATAT 1980 CCTCATGTTG GCTCGTGTCA TTGTCCAATT TACAAAGAAA CATAAGGAAT GGAGACGCAC 2040 GGTTCCGCTG GACTTTTTGT TAATTTTCTG GATGATTCTC TTTACCATTC CAGTCCTAGT 2100 TCTTTTAGCA CTTCAAAGTG ACTTGGGGAC GGCTTTGGTT TTTGTAGCCA TTTTCTCAGG 2160 AATCGTTTTA TTATCAGGGG TTTCTTGGAA AATTATTATC CCAGTATTTG TGACTGCTGT 2220 AACAGGAGTT GCTGGTTTCT TAGCTATCTT TATTAGCAAG GACGGACGAG CTTTTCTTCA 2280 CCAGATTGGA ATGCCGACCT ACCAAATCAA TCGGATTTTG GCTTGGCTCA ATCCCTTTGA 2340 GTTTGCCCAA ACAACGACTT ACCAGCAGGC TCAAGGGCAG ATTGCCATTG GGAGTGGTGG 2400 CTTATTTGGT CAGGGATTTA ATGCTTCGAA TCTGCTTATC CCAGTTCGAG AGTCAGATAT 2460 GATTTTTACG GTTATTGCAG AAGATTTTGG CTTTATTGGC TCTGTCCTGG TTATTGCCCT 2520 CTATCTCATG TTGATTTACC GTATGTTGAA GATTACTCTT AAATCAAATA ACCAGTTCTA 2580 CACTTATATT TCCACAGGTT TGATTATGAT GTTGCTCTTC CACATCTTTG AGAATATCGG 2640 TGCTGTGACT GGACTACTTC CTTTGACGGG GATTCCCTTG CCTTTCATTT CGCAAGGGGG 2700 ATCAGCGATT ATCAGTAATC TGATTGGTGT TGGTTTGCTT TTATCGATGA GTTACCAGAC 2760 TAATCTAGCT GAAGAAAAGA GCGGAAAAGT CCCATTCAAA CGGAAAAAGG TTGTATTAAA 2820 ACAAATTAAA TAAGGAGAAA ATCATGGTAA AAGTAGCAGT TATGTTAGCT CAGGGCTTTG 2880 AAGAAATTGA AGCCTTGACA GTTGTAGATG TCTTGCGTCG AGCCAATATC ACATGTGATA 2940 TGGTTGGTTT TGAAGAGCAA GTAACGGGTT CGCATGCAAT CCAAGTAAGA GCAGATCATG 3000 TCTTTGATGG AGATTTATCA GACTATGATA TGATTGTTCT TCCTGGAGGT ATGCCTGGTT 3060 CTGCACATTT ACGTGATAAT CAGACCTTGA TTCAAGAATT GCAAAGCTTC GAGCAAGAAG 3120 GGAAGAAACT AGCAGCCATT TGTGCGGCAC CAATTGCCCT CAATCAAGCA GAGATATTGA 3180 AAAATAAGCG ATACACTTGT TATGACGGCG TTCAAGAGCA AATCCTTGAT GGTCACTACG 3240 TCAAGGAAAC AGTAGTGGTA GATGGTCAGT TGACAACCAG TCGGGGTCCT TCAACAGCCC 3300 TTGCCTTTGC CTACGAGTTG GTGGAGCAAC TAGGAGGGGA CGCAGAGAGT TTACGAACAG 3360 GAATGCTCTA TCGAGATGTC TTTGGGTAAA AATCAGTAAA ACGGGAGTTA TTCTCTCGTT 3420 TTTTATGTGG AAAACTCAGG GAAATCATCG CTTTTTTCAT AAAAAAATGC TATAATGAAG 3480 GGTATGAAAT ATCACGATTA CATCTGGGAT TTAGGTGGAA CTTTACTGGA TAATTATGAA 3540 ACTTCAACAG CTGCATTTGT TGAAACATTG GCACTGTATG GTATCACACA AGACCATGAC 3600 AGTGTCTATC AAGCTTTAAA GGTTTCTACT CCTTTTGCGA TTGAGACATT CGCTCCCAAT 3660 TTAGAGAATT TTTTAGAAAA GTACAAGGAA AATGAAGCCA GAGAGCTTGA ACACCCGATT 3720 TTATTTGAAG GAGTTTCTGA CCTATTGGAA GACATTTTAA ATCAAGGTGG CCGTCATTTT 3780 TTGGTCTCTC ATCGAAATGA TCAGGTTTTG GAAATTTTAG AAAAAACCTC TATAGCAGCT 3840 TATTTTACAG AAGTGGTGAC TTCTAGCTCA GGCTTTAAGA GAAAGCCAAA TCCCGAATCC 3900 ATGCTTTATT TAAGAGAAAA GTATCAGATT AGCTCTGGTC TTGTCATTGG TGATCGGCCG 3960 ATTGATATCG AAGCAGGTCA AGCTGCAGGA CTTGATACCC ACTTGTTTAC CAGTATCGTG 4020 AATTTAAGAC AAGTATTAGA CATATAAGAA AAAGGAATAA GATGACAGAA GAAATCAAAA 4080 ATCTGCAGGC ACAGGATTAT GATGCCAGTC AAATTCAAGT TTTAGAGGGC TTAGAGGCTG 4140 TTCGTATGCG TCCAGGGATG TACATTGGAT CAACCTCAAA AGAAGGTCTT CACCATCTAG 4200 TCTGGGAAAT TGTTGATAAC TCAATTGACG AGGCCTTGGC AGGATTTGCC AGCCATATTC 4260 AAGTTTTTAT TGAGCCAGAT GATTCGATTA CTGTTGTGGA TGATGGGCGT GGTATCCCAG 4320 TCGATATTCA GGAAAAAACA GGTCGTCCTG CTGTTGAGAC CGTCTTTACA GTCCTTCACG 4380 CTGGAGGAAA GTTCGGCGGT GGTGGATACA AGGTTTCAGG TGGTCTTCAC GGGGTGGGGT 4440 CGTCAGTTGT TAATGCCCTT TCCACTCAAT TAGACGTTCA TGTCCATAAA AACGGTAAGA 4500 TTCATTACCA AGAATACCGT CGTGGTCATG TTGTCGCAGA TCTTGAAATA GTTGGAGATA 4560 CGGATAAAAC AGGAACAACT GTTCACTTCA CACCGGACCC AAAAATCTTC ACTGAAACAA 4620 CAATCTTTGA TTTTGATAAA TTAAATAAAC GGATTCAAGA GTTGGCCTTT CTAAATCGCG 4680 GTCTTCAAAT TTCTATCACT GATAAGCGCC AAGGTTTGGA ACAAACCAAG CATTATCATT 4740 ATGAAGGTGG GATTGCTAGT TACGTTGAAT ATATCAACGA GAACAAGGAT GTAATCTTTG 4800 ATACACCAAT CTATACAGAC GGTGAGATGG ATGATATCAC AGTTGAGGTA GCCATGCAGT 4860 ACACAACGGG TTACCATGAA AAATGTCATG AGTTTCGCCA ATAATATTCA TACACATGAA 4920 GGTGGAACGC ATGAACAAGG TTTCCGTACA GCCTTGACAC GTGTTATCAA CGATTATGCT 4980 CGTAAGAATA AGTTACTGAA AGACAATGAA GACAATCTAA CAGGGGAAGA TGTTCGCGAA 5040 GGCTTAACTG CAGTTATCTC AGTTAAACAC CCAAATCCAC AGTTTGAAGG ACAAACGAAG 5100 ACCAAATTGG GAAATAGCGA AGTGGTCAAG ATTACCAATC GCCTCTTCAG TGAAGCCTTC 5160 TCCGATTTCC TCATGGAAAA TCCACAGATT GCCAAACGTA TCGTAGAAAA AGGAATTTTG 5220 GCTGCCAAGG CTCGTGTGGC TGCCAAGCGT GCGCGTGAAG TCACACGTAA AAAATCTGGT 5280 TTGGAAATTT CCAACCTTCC AGGGAAACTA GCAGACTGTT CTTCTAATAA CCCTGCTGAA 5340 ACAGAACTCT TCATCGTCGA AGGAGACTCA GCTGGTGGAT CAGCCAAATC TGGTCGTAAC 5400 CGTGAGTTTC AGGCTATCCT TCCAATTCGC GGTAAGATTT TGAACGTTGA AAAAGCAAGT 5460 ATGGATAAGA TTCTAGCTAA CGAAGAAATT CGTAGTCTTT TCACAGCCAT GGGAACAGGA 5520 TTTGGCGCAG AATTTGATGT TTCGAAAGCC CGTTACCAAA AACTCGTTTT GATGACCGAT 5580 GCCGATGTCG ATGGAGCCCA CATTCGTACC CTTCTTTTAA CCTTGATTTA TCGTTATATG 5640 AAACCAATCC TAGAAGCTGG CTATGTTTAT ATTGCCCAAC CACCAATCTA TGGTGTCAAG 5700 GTTGGAAGCG AGATTAAAGA ATATATCCAG CCGGGTGCAG ATCAAGAAAT CAAACTCCAA 5760 GAAGCTTTAG CCCGTTATAG TGAAGGTCGT ACCAAACCGA CTATTCAGCG TTATAAGGGG 5820 CTAGGTGAAA TGGACGATCA TCAGCTGTGG GAAACAACCA TGGATCCCGA ACATCGCTTG 5880 ATGGCTAGAG TTTCTGTAGA TGATGCTGCA GAAGCAGATA AAATCTTTGA TATGTTGATG 5940 GGGGATCGAG TAGAGCCTCG TCGTGAGTTT ATCGACTCTA GAGGATCCCC GG 5992 (2) INFORMATION FOR SEQ ID NO: 40: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 907 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:40: TACAAAAGTA GGTGGAGAGG CTGATTATTT GGTCTTTCCA CGAAATCGTT TTGAGTTGGC 60 TCGCGTTGTG AAATTTGCCA ACCAAGAAAA TATCCCTTGG ATGGTTCTTG GCAATGCAAG 120 CAATATCATC GTTCGTGATG GTGGGATTCG TGGATTTGTC ATCTTGTGTG ACAAGCTCAA 180 TAACGTTTCT GTTGATGGCT ATACCATTGA AGCAGAAGCT GGGGCTAACT TGATTGAAAC 240 AACTCGCATT GCCCTCCGTC ATAGTTTAAC TGGCTTTGAG TTTGCTTGTG GTATTCCAGG 300 AAGCGTTGGC GGTGCTGTCT TTATGAATGC GGGTGCCTAT GGTGGCGAGA TTGCTCACAT 360 CTTGCAGTCT TGTAAGGTCT TGACCAAGGA TGGAGAAATC GAAACCCTGT CTGCTAAAGA 420 CTTGGCTTTT GGTTACCGCC ATTCAGCTAT TCAGGAGTCT GGTGCAGTTG TCTTGTCAGT 480 TAAATTTGCC CTAGCTCCAG GAACCCATCA GGTTATCAAG CAGGAAATGG ACCGCTTGAC 540 GCACCTACGT GAACTCAAGC AACCTTTGGA ATACCCATCT TGTGGCTCGG TCTTTAAGCG 600 TCCAGTCGGG CATTTTGCAG GTCAGTTAAT TTCAGAAGCT GGCTTGAAAG GCTATCGTAT 660 CGGTGGCGTA GAAGTGTCAG AAAAGCATGC AGGATTTATG ATCAATGTCG CAGATGGAAC 720 GGCCAAAGAC TACGAGGACT TGATCCAATC GGTTATCGAA AAAGTCAAGG AACACTCAGG 780 TATTACGCTT GAAAGAGAAG TCCGGATCTT GGGTGAAAGC CTATCGGTAG CGAAGATGTA 840 TGCAGGTGGT TTTACTCCCT GCAAGAGGTA GTGGGGACCT GACAGAGCCC CGATCGGTTA 900 AGCTATG 907 (2) INFORMATION FOR SEQ ID NO: 41: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2764 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 41: AGAACCCTTG GATGCAGCCA TTCAGAAGAT TTCTCCAGAA TTGTTTGACC AATATGAAAT 60 CTTTAAATCA CGTGAAATGT TGCTAGAATG GTCACCAAAG AATGTTCATA AAGCAACAGG 120 TTTGGCAAAA CTAATCAGCC ATCTTGGAAT CGACCAAAGT CAAGTGATGG CTTGTGGTGA 180 CGAGGCCAAT GACCTCTCTA TGATTGAATG GGCAGGTCTT GGTGTTGCTA TGCAAAACGC 240 TGTTCCTGAA GTAAAGGCAG CCGCAAATGT AGTGACGCCG ATGACCAACG ATGAGGAAGC 300 TGTCGCCTGG GCTATCGAAG AATATGTGCT AAAGGAGAAC TAAGATATGG GATTGTTTGA 360 CCGTCTATTC GGAAAAAAAG AAGAACCTAA AATCGAAGAA GTTGTAAAAG AAGCTCTGGA 420 AAATCTTGAT TTGTCTGAAG ATGTTGATCC TACCTTCACA GAAGTTGAGG AAGTTTCTCA 480 GGAAGAAGCA GAGGTTGAAA TTGTTGAACA AGCTGTGTTC CAAGAAGAGG AAATCCAAGA 540 CACAGTTGAA GAAAGTCTGG ATTTAGAGCC AGTTGTAGAA GTTTCTCAAA AAGAAGTCGA 600 AGAATTTCCA CACTCAGAAG AAGGGAATAC TGAGTTTCTA GAGACTATAG AAGAAAATAA 660 TTCTGAAGTT CTTGAACCAG AAAGGCCTCA AGCAGAAGAA ACCGTTCAGG AAAAATATGA 720 CCGCAGTCTT AAGAAAACTC GTACAGGTTT CGGTGCCCGC TTGAATGCCT TCTTTGCTAA 780 CTTCCGCTCT GTTGACGAAG AATTTTTCGA GGAACTGGAA GAACTGCTGA TTATGAGTGA 840 TGTTGGTGTC CAAGTCGCTT CTAACTTAAC GGAGGAACTA CGTTACGAAG CCAAGCTTGA 900 AAATGCCAAG AAACCTGATG CACTTCGTCG TGTCATCATT GAGAAATTGG TTGAGCTTTA 960 TGAAAAGGAT GGTAGCTACG ATGAAAGCAT CCACTTCCAA GATAACTTGA CAGTTATGCT 1020 CTTTGTTGGT GTGAATGGTG TTGGGAAAAC AACTTCTATC GGAAAACTAG CCCACCGCTA 1080 CAAACAAGCT GGTAAGAAGG TCATGCTGGT TGCAGCAGAT ACCTTCCGTG CGGGTGCAGT 1140 AGCTCAGCTA GCTGAATGGG GCCGACGAGT AGATGTTCCA GTAGTAACTG GACCTGAAAA 1200 AGCTGATCCA GCCAGCGTGG TCTTTGATGG TATGGAACGT GCCGTGGCTG AAGGTATCGA 1260 TATTCTCATG ATTGATACTG CTGGTCGTCT GCAAAATAAG GATAACCTTA TGGCTGAGTT 1320 GGAAAAGATT GGTCGTATTA TCAAACGTGT TGTGCCAGAA GCACCACATG AAACCTTCTT 1380 GGCACTTGAT GCATCAACAG GTCAAAATGC CCTAGTACAG GCCAAAGAAT TTTCGAAAAT 1440 CACACCTTTA ACGGGAATTG TTTTGACTAA GATTGATGGA ACTGCTCGAG GAGGTGTGGT 1500 TCTAGCCATT CGTGAAGAAC TCAATATTCC TGTAAAATTG ATTGGTTTTG GTGAAAAAAT 1560 CGATGATATT GGAGAGTTTA ACTCAGAAAA CTTTATGAAA GGTCTCTTGG AAGGTTTAAT 1620 CTAATCAGAA GCAAAAATCC TGCAAGGCAT AAACTTGCAG GAAATTTTTT TATTCTAAGC 1680 GACCATCTTG ACGATAGGTG ATATCTGGTT GCCAAGTCCA TTTGGCACCG AATTTTTCAA 1740 GTAGGTCAAA GCTGGCTTGA GGTCCCATGC TTCCAGCTTT ATAGTCATGA AGTGGGGCAC 1800 CATTTTCAGC CCAGAGCTTT TCAATACGGT CAATCAACTT CCATGACGCA CAAACTTCAT 1860 CCCAGTGGCT AAAGTTAGTT GAGTTGTTAT TTAGGACATC ATAAATCAAT TTTTCGTATG 1920 GTTCTGGAGA AGCACCAGTT GCAGTCGCAT CTGTACGGTA ATCAAGTGAG TTAGGAGCCA 1980 AGTTAAATTC TTCTCCTACT TGCTTCCCAT TTAGGCTAAG AGAGAAGCCT TCTGTTGGTT 2040 GAATATAGAT GGTCAAAATA TTTGGAGCAA GTGGTTCTCC AAAGATAGAA TCCATTTGTT 2100 TAAAGACGAT GTTGACATGA GTTCCTTTTT CAGTCAGTCG TTTACCTGTA CGGAAAAAGA 2160 AAGGAACACC ACGGAATCGA TCGCTGTCTA CAAAGAAGGC ACCAGATGTA AAGGTTTCAG 2220 TTGTTGATTC TGGATTCACA TTTGGCTCGC TACGATAAGA GATGTATTTC ATGCCATCAA 2280 TCTTACCAGA GCGGTATTGC CCACGGATAA AGTGTTCTTT GAGTTCTTCA TCAGTTGGAT 2340 GATAGAGGTT TTTAAAGACC TTAATCTTTT CAGCACGAAT CTCGTCTTTT GTGAAGCTTG 2400 CTGGTTTGTC CATGGCGAGG AGCGAAAGAA GTTGTAGAGT GTGGTTTTGG ACCATGTCAC 2460 GGAGGGCACC GGATTGGTCA TAGTAGCCAC CACGTTCTTC TACACCCAAG CTCCGCAAAG 2520 GTAATTTGAA CATTGTCGAA AAATCCTTGT TCCAAACGTT TTCAAAAATC AAGTTTGCAA 2580 AGCGAACTGC AAAGATGCTT TGGATCATTT CCTTACCAAG ATAATGGTCG ATACGGAAAA 2640 TTTGTTCTTC GTCAAATGTT GCTAGGAGTT CGTCATTCAA CTTGTTTGCA GTTGCGTAAT 2700 CTGTACCAAA TGGTTTTTCA ACGATCAAGC GCTCAAAACC TTTGCCATCG ACTCTAGAGG 2760 ATCC 2764 (2) INFORMATION FOR SEQ ID NO: 42: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 3189 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 42: ACACTGTTTA CGATGATGGT CGTATTGATT ACGTGAAAAA CACTTGGAGA TCTTGTCTGA 60 TGCGATTGCA GATGGAGCTA ATGTAAAAGG TTACTTCATT TGGTCATTAA TGGATGTCTT 120 CTCATGGTCA AACGGTTATG AGAAACGTTA TGGTCTCTTC TACGTAGATT TTGAAACTCA 180 AGAACGTTAT CCTAAGAAAT CAGCTCACTG GTACAAGAAA GTAGCGGAAA CTCAGATTAT 240 AGACTAGTAG AATTAGTCAT TAGATATAGA ATTTTAGTGA GTCCAAAAGA TGTTCAAAGA 300 TTTTATCCAA TCTATTTATG AAAAAGTTTA TATTATAAAT TTCGAAAAAT GCTCTCAAAT 360 ACCGTGTTTG ACGAGTGAAG AATTGAAAGT CTTGGAAAAT GGTATGTCTC GACTGGTAAA 420 GAATGGATTT GTCATTCAGA TGATGAGCTG GAAGAATTTA AAAATCTATT TTTAAATTTT 480 ATCAATCCTG AAGAATGGGA TACTATCTCC TTTGATTCAG ATTTTATGCC GTTTCAACAA 540 TCGTAACCAA TTTCTCAAAA AAGTTAAATC TTATATTTAG TACTCTGTAA AACTCTTATC 600 TAATCACGTT GCTTATACTC AATGAAAATC ATAGAAAAAA GCATAGTATC AGGTGTTGAA 660 ACACCTGATA CTATGCTTTT TATTGTGGGA AGATTTACTT TTTTTCTTCT GAAATTGAGT 720 TGTTACCCAG GCTCTTTCAG TTTATTAAGG CTTGATGACT TTAATGTGTT TAGATAGCTT 780 AAAAAGGATT GAATCACTTA GTTTAGAATC TGAAACAATA GTATCAAGAT TTGATATATT 840 ATAAAAAGTA TAAAAATCAA ACTTATTGAA CTTACTATGA TCTGCGAGTA AATATTTTTT 900 ATTAGAATTA TTTAAAGCGA TGCGTTGAGC CTCTCCCTCT TCCTCGCTAA AAGTAGCTAG 960 AGCTCCGTTT TGAATACCAT TACAGCTAAC GAAAGCTTTA GAAAATTGGA GATTAGAGAG 1020 ATTTTGTAGG GTCAATGTGC CAACAAAAGC ACCTGTAATA TCGCGATAAT TTCCACCTAT 1080 CAAAATCAAA TCTGTTAATT TTCGTTCGCT TAAAATCAGA AAAACAGGTA GACTGTTGGT 1140 TACGACGCGG ATATTGTCAA TAGGCAACTC ACGCGCAAAA AACTCTAATG TTGTTCCTGG 1200 TCCAATGAAA ATAGTTTCTC TTTCTTCTAC TAGACTGCCT GCAAAATGGG CTATTTCTTG 1260 TTTTTCTGCC GTTTGGAGGG CTTGTTTTTC AATATTTGAT CGCTCATTAG TCAAAAGGGA 1320 GTTGGTTCGA AGTTTTTCAG CTCCACCATG CACACGAATC AGCAAATCTT TATCAGCTAA 1380 TTCCTGTAAA TAGCGCCTTG CAGTCATATC TGAAACGGCT ATTTCGTCCA TAATCTGTTT 1440 AACTGTTATG GTTCCTTTAC TATTTACTAT CTCTAAAATT TTGGCTAATT TTTCTTGTTT 1500 GAGCATATTA TCACCTCGTT TCCTACTACT ATCTTACCAT AAACAAACTC ATCATTCAAA 1560 TACAAAAACA ACAAAATGAA ACAAAAACAA AAATATCGAA GTTTGTTTTC AAAACTTTCG 1620 ATATTTTTGT TGGGTTATAA CTTTGATGTT TCTAGTTTAC TTTTTGATGA TTGAGAGTGA 1680 TGGAGAATTA GTCTAAACCG TAGTTATAGT CATCGTCTTG CATGGCTTCA ACTTCGCCAA 1740 GAAGGTAACC ATTTCCGACT TGAGAGAAGA AGTCATGGTT GGAAGTTCCT GTTGAAATAC 1800 CGTTCATAAC GATTGGGTTG ACATCTTCAG CTGAATCTGG GAAAAGTGGA TCTTGTCCCA 1860 TGTTCATGAG AGCTTTATTG GCATTGTAGC GAAGGAAGGT TTTAACCTCT TCAGTCCAAC 1920 CAACACCGTC ATAAAGACTC TCTGTGTAGC CTTCTTCATT TTCATAAAGA GTATAGAGTA 1980 GGTCGTACAT CCATTCTTTG AGTTTTTCTT GCTCTTCTTC AGGCAATTCA TTGAAACCAA 2040 GTTGGAATTT GTAACCAATG TAGGTTCCGT GAACAGACTC GTCACGAATA ATCAATTTAA 2100 TGATTTCTGC AACGTTGGCT AGTTTGTTGT TACCGAGATA GTAGAGGGGA GTGAAGAAAC 2160 CAGAGTAGAA GAGGAAGGTT TCGAGGAAGA CGCTGGCAAC TTTCTTTTCA AGTGGGCTGC 2220 CGTTTAGGTA GATTTCGTTG ACAATCTCAG CCTTCTTTTG TAGGTAAGGA TTGGTATTGG 2280 TCCATTCGAA AATTTCTTCA ATCTCAGCCT TAGTATTCAA GGTAGAAAAG ATTGATGAGT 2340 AAGATTTAGC GTGGACAGAT TCCATAAATT GGATGTTATT GAAAACAGCT TCCTCATGTG 2400 GTGTACGGAT GTCTGCGCGA AGGGCTTGAA CCCCAGTTTC AGATTGCATA GTGTCAAGAA 2460 GGGTTAAACC ACCAAAAACT TTTCCGACCA AGTCTTTCTC TTTGTTAGAT AGCTTTCTCC 2520 AGTCATCCAA GTCGTTTGAT AAGGGAATAC GTGTATCGAG CCAAAATTGC TCCGTCAGTT 2580 TTTCCCAAGT TGATTTGTCG ATGACATCTT CGATGGCATT CCAGTTAATG GCTTTGTAGT 2640 AAGTTTCCAT TTAAAATCTC TTTCTGTGTT TAGTATTGCG AACTCACAAT TATTTCTACT 2700 TTACCATAAT TCTATAGGAG TATCGCACAA AAAGTCGGAA GCCCGACTTT TAAAATGTTA 2760 CATAAATTAT GTTATGACAT AGTAGATTTG ATTTTATCAG TGCTGCTTAG GGAAAAATAA 2820 TGTTTCTATG CTAGAAACTA AATCACACAG CTTTCACATT GGTTGGCGCC GACTTCTCCA 2880 CCGTCATCTG TAAAGGTACG GACGTAGTAG ATAGACTTGA TTCCCTTGTT AAAGGCATAG 2940 TTACGAAGGA TGGACAAGTC ACGTGTCGTT TGTTTATTTT CCCTCTTCCA TTCGTAAAGG 3000 CCTTTTGGAA TGTCACTACG CATGAAGAGG GTGAGTGAAA GTCCTTGATC CACGTGTTCA 3060 GTCGCAGCAG CGTAAACATC GATGACTTTA CGCATATCCA TATCGTAGGC AGAAGTGTAG 3120 TAAGGAATGG TTTCTGTAGA CAAGCCAGCA GCAGGGTAGT AGATTTTACC AATTTTCTTC 3180 TCTTGGCGT 3189 (2) INFORMATION FOR SEQ ID NO:43: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 3580 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 43: TTATTGAAGA AGGTGTTAAA GTTGTCACAA CAGGAGCAGG AAATCCAAGC AAGTATATGG 60 AACGTTTCCA TGAAGCTGGG ATAATCGTTA TTCCTGTCGT TCCTAGTGTC GCTTTAGCTA 120 AACGCATGGA AAAAATCGGT GCAGACGCTG TTATTGCAGA AGGAATGGAA GCTGGGGGGC 180 ATATCGGTAA ATTAACAACC ATGACCTTGG TGCGACAGGT AGCCACAGCT GTATCTATTC 240 CTGTTATTGC TGCAGGAGGA ATTGCGGATG GTGAAGGTGC TGCGGCTGGC TTTATGCTAG 300 GTGCAGAGGC TGTACAGGTG GGGACACGGT TTGTAGTTGC AAAAGAGTCG AATGCCCATC 360 CAAACTACAA GGAGAAAATT TTAAAAGCAA GGGATATTGA CACTACGATT TCAGCTCAGC 420 ACTTTGGTCA TGCTGTTCGT GCTATTAAAA ATCAGTTGAC TAGAGATTTT GAACTGGCTG 480 AAAAAGATGC CTTTAAGCAG GAAGATCCTG ATTTAGAAAT CTTTGAACAA ATGGGAGCAG 540 GTGCCCTAGC CAAAGCAGTT GTTCACGGTG ATGTGGAGGG TGGCTCTGTC ATGGCAGGTC 600 AAATCGCAGG GCTTGTTTCT AAAGAAGAAA CAGCTGAAGA AATCCTAAAA GATTTGTATT 660 ACGGAGCCGC TAAGAAAATT CAAGAAGAAG CCTCTCGCTG GACAGGAGTT GTAAGAAATG 720 ACTAAAACAG CCTTTTTATT TGCTGGTCAA GGTGCCCAGT ATCTAGGGAT GGGACGGGAT 780 TTCTATGATC AGTATCCGAT TGTTAAAGAA ACGATTGATC GAGCGAGTCA GGTGCTAGGT 840 TATGATTTGC GTTATCTCAT CGATACGGAA GAAGACAAAC TCAATCAGAC CCGCTATACG 900 CAACCAGCCA TTCTAGCGAC TTCGGTTGCT ATCTACCGTT TATTGCAAGA AAAGGGCTAT 960 CAGCCTGATA TGGTTGCTGG TTTGTCTCTT GGAGAATACT CTGCCTTGGT GGCAAGCGGC 1020 GCCTTGGATT TTGAAGATGC GGTTGCCTTG GTAGCTAAGC GTGGAGCCTA TATGGAAGAA 1080 GCGGCTCCTG CTGACTCTGG CAAGATGGTA GCAGTTCTCA ATACGCCAGT AGAGGTCATT 1140 GAAGAAGCCT GTCAAAAAGC TTCTGAACTT GGAGTGGTTA CTCCAGCCAA CTATAACACA 1200 CCTGCACAAA TCGTCATTGC TGGAGAAGTG GTTGCAGTTG ATCGAGCGGT TGAACTTTTG 1260 CAAGAAGCAG GTGCCAAACG CTTGATTCCT CTTAAGGTGT CAGGTCCCTT TCACACCTCT 1320 CTCCTTGAAC CTGCTAGCCA GAAACTAGCT GAAACTCTGG CTCAGGTAAG TTTTTCAGAT 1380 TTTACTTGTC CCCTAGTCGG CAATACAGAA GCTGCTGTGA TGCAAAAAGA GGACATTGCT 1440 CAGCTCTTGA CGCGTCAGGT CAAGGAACCC GTTCGTTTCT ATGAAAGTAT TGGGGTCATG 1500 CAAGAAGCAG GCATAAGCAA CTTTATCGAG ATTGGACCGG GGAAAGTCTT GTCAGGTTTT 1560 GTTAAAAAAA TTGATCAAAC TGCTCACTTA GCTCATGTGG AAGATCAAGC GAGTTTAGTA 1620 GCACTTTTAG AAAAATAGAC TAAAATAAGT AGAAGTTTTG AAAGGAAAAA AATGAAACTA 1680 GAACATAAAA ATATCTTTAT TACAGGTTCG AGTCGTGGAA TTGGTCTTGC CATCGCCCAC 1740 AAGTTTGCTC AAGCAGGAGC CAACATTGTC TTAAACAGTC GTGGGGCAAT CTCAGAAGAA 1800 TTGCTCGCTG AGTTTTCAAA CTATGGTATC AAGGTGGTTC CCATTTCAGG AGATGTATCA 1860 GATTTTGCAG ACGCTAAGCG TATGATTGAT CAAGCTATTG CAGAACTGGG TTCAGTAGAT 1920 GTTTTGGTCA ACAATGCAGG GATTACCCAA GATACTCTTA TGCTCAAGAT GACAGAAGCA 1980 GATTTTGAAA AAGTGCTCAA GGTCAATCTG ACTGGTGCCT TTAATATGAC ACAATCAGTC 2040 TTGAAACCGA TGATGAAAGC CAGAGAAGGT GCTATCATTA ATATGTCTAG TGTTGTTGGT 2100 TTGATGGGGA ATATTGGTCA AGCTAACTAT GCTGCTTCTA AGGCTGGCTT GATTGGCTTT 2160 ACCAAGTCTG TGGCACGCGA GGTCGCTAGT CGGAATATAC GAGTCAATGT GATTGCTCCA 2220 GGAATGATTG AGTCTGATAT GACAGCTATC TTATCAGATA AGATTAAGGA AGCTACACTA 2280 GCTCAGATTC CGATGAAAGA ATTTGGGCAG GCAGAGCAGG TTGCAGATTT GACAGTATTT 2340 TTAGCAGGCC AAGATTATCT AACTGGTCAA GTGATTGCCA TTGATGGTGG CTTAAGTATG 2400 TAGCGAAAGC TAGAGGTGAA AAGAATGAAA CTAAATCGAG TAGTGGTAAC AGGTTATGGA 2460 GTAACATCTC CAATCGGAAA TACACCAGAA GAATTTTGGA ATAGTTTAGC AACTGGGAAA 2520 ATCGGCATTG GTGGCATTAC AAAATTTGAT CATAGTGACT TTGATGTGCA TAATGCGGCA 2580 GAAATCCAAG ATTTTCCGTT CGATAAATAC TTTGTAAAAA AAGATACCAA CCGTTTTGAT 2640 AACTATTCTT TATATGCCTT GTATGCAGCC CAAGAGGCTG TAAACCAGCC AATCTTGATG 2700 TAGAGGCTCT TAATAGGGAT CGTTTTGGTG TTATCGTTGC ATCTGGTATT GGTGGAATCA 2760 AGGAAATTGA AGATCAGGTA CTTCGCCTTC ATGAAAAAGG ACCCAAACGT GTCAAACCAA 2820 TGACTCTTCC AAAAGCTTTA CCAAATATGG CTTCTGGGAA TGTAGCCATG CGTTTTGGTG 2880 CAAACGGTGT TTGTAAATCT ATCAATACTG CCTGCTCTTC ATCAAATGAT GCGATTGGGG 2940 ATGCCTTCCG CTCCATTAAG TTTGGTTTCC AAGATGTGAT GTTGGTGGGA GGAACAGAAG 3000 CTTCTATCAC ACCTTTTGCC ATCGCTGGTT TCCAAGCCTT AACAGCTCTC TCTACTACAG 3060 AGGATCCAAC TCGTGCTTCG ATCCCATTTG ATAAGGATCG CAATGGGTTT GTTATGGGTG 3120 AAGGTTCAGG GATGTTGGTT CTAGAAAGTC TTGAACACGC TGAAAAACGT GGAGCTACTA 3180 TCCTGGCTGA AGTGGTTGGT TACGGAAATA CTTGTGATGC CTACCACATG ACTTCTCCAC 3240 ATCCAGAAGG TCAGGGAGCT ATCAAGGCCA TCAAACTAGC CTTGGAAGAA GCTGAGATTT 3300 CTCCAGAGCA AGTAGCTATG TTAATGCTCA CGGAACGTCA ACTCCTGCCA ATGAAAAAGG 3360 AGAAAGTGGT GCTATCGTAG CTGTTCTTGG TAAGGAAGTA CCTGTATCAT CAACCAAGTC 3420 TTTTACAGGA CATTTGCTGG GGGCTGCGGG TGCAGTAGAG CTATCGCACC ATCGAGCTAT 3480 GCGTCATACT TTGTACCATG CCAGCTGGGC AAGTGAGGTA TCAGATATAT CGAGCTAATG 3540 TCGTTATGGC AGGTTTGAGA AGAATTCATA CGTATTCAAA 3580 (2) INFORMATION FOR SEQ ID NO: 44: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1780 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 44: ATGTCCGCAA GAATGTGATT AATCAGCAAT CATCCTTGAT CGGAGATGAA TCGATCTTGG 60 CTTTTGGAGT GAACCAGCCT TTTAGCGGAT TTGGTGTTAA AGGAGAAAGA CAGCAACAGC 120 ATCAGCCTAT GACCTCTATG TACTGAAGCG ACCACTTCCC CAAGTAGGAC CTCGATGTCA 180 TTTTAGATAG TCAAAATCAG GCTGTCTGCA TTGTCGAAAT TACAAAGGTT TCTGTTGAAC 240 TCTTCAATCA AGTTTCTGCG CAACATGCCT TTAAGGAAGG TGAGGGAGAC AAATCACTTG 300 CCTATTGGCG CCAGGTTCAT GAGGACTTTT TCACAGACTG TTTGGGTGAA GTAGGGCTGA 360 CTTTTACACC TGAAAGCAAG GTTGTTTTAG AAGAATTTCG CAAGGTCTAC CCACTGTAGA 420 CTATTAGAAG GAAGAAAGTT TTGGAAATCG CTGTCCAATC CTTTTTTCTC AAGCAAAATA 480 TGATATAATA AGTTTGTTTG AAGAAGAGCA GCAGCTCTTA AACTTAGAAT AGGAGAAAAC 540 TATGCAAGCA GTTGAACATT TTATTAAGCA ATTTGTTCCT GAACATTATG ATTTATTTTT 600 AGATTTGAGT CGTGAGACCA AGACTTTTTC TGGGAAAGTG ACCATCACTG GTCAAGCACA 660 GAGTGACCGC ATCTCCCTCC ACCAAAAAGA CTTGGAAATC ACCTCTGTAG AAGTTGCAGG 720 TCAAGCTCGT CCATTTACAG TTGACCATGA CAATGAAGCC CTTCATATCG AATTGGCTGA 780 GGCTGGTCAA GTTGAATTGG TTCTTGCCTT TTCTGGTAAA ATTACAGACA ACATGACAGG 840 GATTTACCCT TCTTATTATA CAGTTGATGG AGTCAAGAAG GAGGTCTTGT CTACTCAGTT 900 CGAGAGCCAT TTTGCGCGCG AAGCTTTCCC ATGTGTGGAT GAGCCTGAAG CCAAAGCAAC 960 TTTTGACCTC TCTCTTCGCT TTGACCAAGC AGAAGGTGAA TTGGCCTTGT CAAACATGCC 1020 AGAAATCGAT GTTGAAAACC GTAAGGAAAC AGGTATCTGG AAGTTTGAGA CAACACCTCG 1080 CATGTCTTCT TACTTGTTGG CCTTTGTTGC TGGTGATTTG CAAGGGGTGA CCGCTAAAAC 1140 TAAAAATGGT ACCCTGGTAG GTGTCTACTC AACCAAAGCA CATCCACTTT CAAATCTTGA 1200 TTTCTCACTG GATATCGCTG TTCGCTCTAT CGAGTTTTAC GAAGATTACT ATGGAGTTAA 1260 GTACCCAATT CCTCAATCTC TCCACATCGC CCTTCCTGAC TTCTCAGCTG GTGCTATGGA 1320 AAACTGGGGT CTTGTGACCT ACCGTGAAGT TTACTTGGTT GTCGATGAGA ACTCTACATT 1380 TGCTAGCCGT CAACAAGTTG CCCTTGTTGT GGCCCATGAA TTGGCTCACC AATGGTTTGG 1440 GAACCTCGTG ACTATGAAAT GGTGGGATGA CCTTTGGCTC AATGAAAGTT TCGCTAATAT 1500 GATGGAATAC GTCTGTGTGG ATACCATCGA ACCAAGCTGG AATATCTTTG AAGATTTCCA 1560 AACAGGTGGA GTACCTCTTG CTCTTGAACG TGACGCTACT GATGGCGTTC AGTCTGTCCA 1620 CGTCGAAGTT AAACATCCAG ATGAGATCAA TACACTCTTT GACGGCGCTA TCGTCTATGC 1680 AAGGAAGCGT CTCATGCACA TGCTTCGCGT TGCTAGAGAT GCTGATTTGT AAGGTTGCAC 1740 GCCTACTTTG GAAACACCAT ACAGCACACC ATTGGAGTGA 1780 (2) INFORMATION FOR SEQ ID NO: 45: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 671 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 45: GTCTTTTGTA GCGAGGCCAG TGTCTTTTGC CCATCATTTG TCAGGCAGAT AAAACTAGAG 60 CGTCTATCTT GATGGCAACA CATGCGACTG AGTAGACCGC AATTTTTAGC TTCCAAGCGA 120 GCCACCATCC TAGAAACTGC GCTCGGGCTC AGATGAAGCT TATCTGGCAG GTCAATCTGG 180 CGTAGAGATT TTTCTTCAGC CAAGTCCAGA TAGTAGAGCA GGTAGAACTC TTTCAAGGTC 240 AGACTTTGCT CGCTCTGTTG GGCAATGGTC TCTTCCAAGA GACTTTCAAT TTCTTTCTGA 300 CGCCGATTGA AGTCAAACCA TTTTTCCAAA TAGGTCATAG TGTCTCCTTT CTTTTTAGAG 360 TCATAAAATA GAAGAAAGTC CATTAACGGG CAGTCTCTGC GTCACAAGAT GATTGCGCAT 420 GCAATAATTA TACTACTTTT CAAGAATGCT GGCAAGCTCT GTTTTTTAGT GGTTTTCTTT 480 TTTACTGTCT ATATTTTTGG TAAAAATCAA CTTTTACTTG GATGAAGGTT TTGGCTTCAC 540 GTAGGAGTTG AAGAAGGGTG GCGCGGGTTT CAATTCTTCT CTTGTCTTGG GCAGACTGCG 600 GTTCCGGAAG ACTTCCAGAT AACGTTCAAT TTCATCTAGC AATCAGAGCA GGATTGGTCT 660 GGCTCAGTGA C 671 (2) INFORMATION FOR SEQ ID NO: 46: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1557 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 46: TTTCAGCTCA CAAATATAGG TCGGATGAGC CACTTCCTTA CGAACACGCG CATCAAAAGC 60 ATCTAGCTCC TCACGTGAAA AAGCATCCTG CAAACTATAA AGAGGATACT GATGACTGTA 120 TTTTTCAAAA CCATCTAAAA CCTTGCCACC AACACGATGA GTCGGACTGT CTGCTAGCAC 180 TTGCTCTGGA TAAGCAGTTT CTAACTCGAC CAACTCACGG TAAAGGCGGT CATACTCACT 240 GTCTGAAACC GAGGGATTAT CGCTGGTATA GTACTCAGTC GCATAGCGAT TGAGCAAAGC 300 GACTAACTCA TTCATTCTTT TATTCATAAG ACCATTTTAC CATAAAACAA GCCCTCCTCA 360 CAAACGAGAA GGGCGGAAAA AACACTTAGT TTGAAATTAT TTTTGAAACT CAAGCAACCT 420 TATATCAATT TTTCAAAATG AGTTCGAACA TAAATAAACG ATATACAAGA CAAGATGATA 480 ACACCACTTC CAATTATCAG GAAAGAAGAG AGATGTACAC TTGGCAAGAC TGTCATAAAT 540 CCTTTTGCAA TAGGCATAAA TAGAATAGCT AAGGTAAAAA TTGTACTCAG TACTCTTCCA 600 AGAAATTCGC TCTCAACCTT GGTTTGTACT TGAGTAAAAA AGTGAATATT AAAAATCGTC 660 ATAAACAATT CACAAACTAA ATTTCCAGAA AAGGAAAGAA AAGTTGGAAG TGGTAATCCC 720 ATCATAAAAA CTCCGACACC TGTCAAAGCC AGTAAAATCA AAAGATTATA AATATTAGCT 780 TTAATTTTAC TAGCTAGAAG AGCCCCAATG ATGGAACCAA TAGCCCCCAT AGTTAAAATA 840 CTTGCATAGG CTCCTTCTGA CCCGTAAAGC TGATTCGAAA AGGGAAGTAG AAATTCAAAA 900 GCTGCAAAAA AGAAATTAAC GCTGGAAGCT ACCAGCAAAA GGAAGAAAAT TTCTTGCTGA 960 TGCCAGATAT AGTGTAACCC ATCCTTGATA TCTACAAAAA TATCTCTCCC AGTAAAAGCC 1020 TTTTTCTCTT GAACTTTTGC TTCCTCTTTT GGAAGGAAAG CCACTAGAAC AAAAGCAATG 1080 AAAAAAGTCA GCGAGTCTAG CAGTAGCGTC ATATGGAGAC TTGCAAACTG TAAAACAAGG 1140 AAGGAAAGAA CAGGAGAGCT AACACCTACA ACCTGCAAAA CCAGCTCTAA GCGAGAATTA 1200 TAGATCACAA TCTCATTTTT CTCCACCACT TCAGTTATGA TAGCTTTATT GGCTGTGCGA 1260 GAAAAGGCAA AAGCAATAGC CTGCACAATG TTAGCAACAA TCAAAGCGCC AATCATCCAG 1320 CTATCATTCC TTATGAAAGA AATAGCCAGA CAAAGAATCC CACAAACAAG ATCTGCCGTC 1380 ATTAAAATCT TACGACGAGA AAAACGGTCT GAAATAACTC CGCCAAAGGG ATTGACGAGA 1440 ATAGATGTGA CGAGCTCAGA AATCTGATAC ATTCCTAAAA CTGTCTGTCC TATAGTCCCC 1500 ATAGAAGCCA ACCAGACACT ATTTCCATAA TCATAGAGCA TATTCCCATT TTATTGA 1557 (2) INFORMATION FOR SEQ ID NO: 47: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 658 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 47: CTTATTTGGT TTGGGAATTC GTCATGTCGG AAGCAAGGCT AGTCAGCTTT TACTTCAATA 60 TTTCCATTCA ATTGAAAATC TGTATCAGGC AGATTCAGAG GAAGTGGCTA GTATTGAAAG 120 TCTAGGTGGC GTGATTGCCA AAAGTCTTCA GACTTATTTT GCGGCAGAAG GCTCTGAAAT 180 TCTGCTCAGA GAATTGAAAG AAACTGGGGT CAATCTGGAC TATAAAGGAC AGACGGTAGT 240 AGCGGATGCG GCCTTGTCAG GTTTGACCGT GGTATTGACA GGAAAATTGG AACGACTCAA 300 GCGCTCAGAA GCTAAAAGTA AACTCGAAAG TCTGGGTGCC AAAGTGACAG GTAGTGTTTC 360 TAAAAAGACC GACCTCGTCG TGGTAGGTGC AGACGCTGGA AGTAAACTGC AAAAAGCACA 420 AGAACTTGGT ATCCAGGTCA GAGATGAGGC ATGGCTAGAA AGTTTGTAAT GGATCGTTTA 480 AAAACAGAGT TTAGAGAATA TGACTATGTC TGTTAATTGA GACGAGATTG ACAAAAATTT 540 ATTAGTGAAA TAGGAAACAA AGTAAAAAGG AAAAATAAAA AATGTATACT ACCCTATGCG 600 CATTCATTAC CATCGTAAGA ATGGAGAATA TGACCTTGCT CCTTTGTAAA AGTCAGGA 658 (2) INFORMATION FOR SEQ ID NO: 48: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2474 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 48: ACAATCGATC AGACAGTCAA TCGATTTCTA AAATGTTTAG AGTAGAGATG TACCTATTCT 60 AGTTCAATAT ACTATATAAC TGAAAATTTA GATAAATTAG TTTTGGAAAT GACTAACCAA 120 AGATATCCAA AGTAGTCTAA AATTGTCTAT ACTTTATGAG TGTTTTAGTT AGGAAAAAGG 180 CTTGTTGTCT ATAATTGGCG CATTAGTCTA GATTTTATTT ATAGAAAATG TTATAATAGA 240 CTGTATTTAA AAAATTTTAA GGAGAAATGA CAGAATGTCT GTATCATTTG AAAACAAAGA 300 AACAAACCGT GGTGTCTTGA CTTTCACTAT CTCTCAAGAC CAAATCAAAC CAGAATTGGA 360 CCGTGTCTTC AAGTCAGTGA AGAAATCTCT TAATGTTCCA GGTTTCCGTA AAGGTCACCT 420 TCCACGCCCT ATCTTCGACC AAAAATTTGG TGAAGAAGCT CTTTATCAAG ATGCAATGAA 480 CGCACTTTTG CCAAACGCTT ATGAAGCAGC TGTAAAAGAA GCTGGTCTTG AAGTGGTTGC 540 CCAACCAAAA ATTGACGTAA CTTCAATGGA AAAAGGTCAA GACTGGGTTA TCACTGCTGA 600 AGTCGTTACA AAACCTGAAG TAAAATTGGG TGACTACAAA AACCTTGAAG TATCAGTTGA 660 TGTAGAAAAA GAAGTAACTG ACGCTGATGT CGAAGAGCGT ATCGAACGCG AACGCAACAA 720 CCTGGCTGAA TTGGTTATCA AGGAAGCTGC TGCTGAAAAC GGCGACACTG TTGTGATCGA 780 CTTCGTTGGT TCTATCGACG GTGTTGAATT TGACGGTGGA AAAGGTGAAA ACTTCTCACT 840 TGGACTTGGT TCAGGTCAAT TCATCCCTGG TTTCGAAGAC CAATTGGTAG GTCACTCAGC 900 TGGCGAAACC GTTGATGTTA TCGTAACATT CCCAGAAGAC TACCAAGCAG AAGACCTTGC 960 AGGTAAAGAA GCTAAATTCG TGACAACTAT CCACGAAGTA AAAGCTAAAG AAGTTCCAGC 1020 TCTTGACGAT GAACTTGCAA AAGACATTGA TGAAGAAGTT GAAACACTTG CTGACTTGAA 1080 AGAAAAATAC CGCAAAGAAT TGGCTGCTGC TAAAGAAGAA ACTTACAAAG ATGCAGTTGA 1140 AGGTGCAGCA ATTGATACAG CTGTAGAAAA CGCTGAAATC GTAGAACTTC CAGAAGAAAT 1200 GATCCATGAA GAAGTTCACC GTTCAGTAAA TGAATTCCTT GGGAACTTGC AACGTCAAGG 1260 GATCAACCCT GACATGTACT TCCAAATCAC TGGAACTACT CAAGAAGACC TTCACAACCA 1320 ATACCAAGCA GAAGCTGAGT CACGTACTAA GACTAACCTT GTTATCGAAG CAGTTGCCAA 1380 AGCTGAAGGA TTTGATGCTT CAGAAGAAGA AATACAAAAA GAAGTTGAGC AATTGGCAGC 1440 AGACTACAAC ATGGAAGTTG CACAAGTTCA AAACTTGCTT TCAGCTGACA TGTTGAAACA 1500 TGATATCACT ATCAAAAAAG CTGTTGAATT GATCACAAGC ACAGCAACAG TAAAATAATC 1560 TTAATAAACA GAAAACCCAC CTGAATTGGT GGGTTTTCTG ATGCACTATT TTCCAAAAAT 1620 CTCTTTGAGG TCTGTGTCTG TAATCCCAAT CATGGCTGGG ATGCGGTCCC AGTTTTCTTC 1680 GGTTAGGATG TAGGATTGTT CAGAGGCACT TGATGTGACT GTTTCAGAGA CAGCTTGTTG 1740 CTTTTCTTCA ACATTCTCCA GTAGATCACT GAAGCGTTCA ATCAGATAGG TTTTTCGGGC 1800 AGTTCCGATG TGTTGGGTAG CATAGTCGAA GGCTTGTAAT TCGCCTAGTA AGATGAGTTT 1860 GCTTTTGGCA CGTGTAATGG CTGTGTAGAT GAGATTTCGC TCCAGCATAC GTCGGCTAGC 1920 ACTAGTAATC GGTAGGATGA CAACTGGGAA CTCACTTCCC TGAGACTTAT GAATACTCAT 1980 GGCATAGGCC AAGCGAATCT TGTACCATTC GTTACGGGGG TAAGAGACTT CATTACTATC 2040 AAAATCAATG ACAATCTCGT CTTGTTTCGA TTCGGTGTAT TTACCAGGAA TCAGGTCTGT 2100 GATAGCTCCT AAATCCCCAT TAAAGACATT GATTTCAGCA TCGTTAACCA AATGAATGAC 2160 CTTGTCTCTC TTACGATAGT GACACTGAGG AGCTTCAAAA CTGAGTTGAT CTTTTTGTGG 2220 GGGATTGAGC AGGTCTTGCA TGAGCTGATT GATAGCATCA ATCCCTGCCG TCCCTCGGTA 2280 CATAGGAGCC AGAACTTGGA TATCACGGGC GGGAATACCA TTTCTGAGGG CGGCACCTAA 2340 GATTTTTTCA ATGGTGGCAG GAATATGGCC ACTAGCAATT TCAAAGTAGG AACGGTCAGC 2400 TTTTTTTTGG GTGAAATCAG CTGGCAAGAT GCCCTGTCGA ATCTGACTAG CTAGGGTGAC 2460 GATGGTTGAT TCTT 2474 (2) INFORMATION FOR SEQ ID NO: 49: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 716 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 49: ATCAAAATTA ACGTATTCTT TTTGAAGTTC AAGAACTTCT TCCATTGTTG AGCATTCTGT 60 AAGGGCACGG TTTGCGTACT CTTCCATCTT AGCTGTGTCG AGTTTCTTCA TCAAGCTGCG 120 TGTACGAAGT ACAGATGTTG CTGACATAGA GAACTCATCC AAGCCCATTC CGACAAGAAG 180 TGGAACAGCT TGTTGGTCAC CAGCCATCTC ACCACACATA CCAGCCCATT TACCTTCAGC 240 GTGAGCTGCT TTGATCACAT TGTTAATCAA GCGTAGGATT GATGGGTTGT ATGGTTGGTA 300 AAGGTATGAA ACTTGTTCGT TCATACGGTC TGCTGCCATT GTATATTGGA TCAAGTCGTT 360 TGTACCAATT GAGAAGAAGT CAACTTCTTT AGCAAATTGG TCTGCAAGCA TAGCCGCTGC 420 AGGAATCTCG ATCATGATAC CAACTTGAAT GTTATCCGCA ACTGCAACAC CTTCAGCAAG 480 AAGGTTTGCT TTTTCTTCAT CAAAGACTGC TTTCGCTGCA CGGAATTCTT TCAAGAGCGC 540 AACCATTGGG AACATGATAC GCAATTGACC GTGAACAGAC GCACGAAGAA GAGCACGGAT 600 TTGTGTGCGG AACATAGCAT CTCCAGTCTC AGAGATAGAG ATACGAAGAG CACGGAATCC 660 AAGGAATGGG TCATTCGTGA GGCATATCGA AGTAAGGAAG TCCTTATCTC CACCGA 716 (2) INFORMATION FOR SEQ ID NO: 50: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 962 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 50: AGTAACCTAA ATCAATTATG GTGTTATGAG TCTTGGTGTG CCCAAAGTGC TGACGTAACT 60 ATCTCAGCTG AAGGTGCAGA TGCAGATGGC CTATCGCTGC AATCTCAGAA ACAATGGAAA 120 AAGAAGGATT GGCATAAGGG AAATGACAGA AATGCTTAAA GGAATCGCAG CATCTGACGG 180 TGTTGCAGTT GCAAAAGCAT ATCTACTCGT TCAGCCGGAT TTGTCATTTG AGACTATTAC 240 AGTCGAAGAT ACAAACGCAG AAGAAGCTCG CCTTGATGCC GCTCTACAGG CATCACAAGA 300 CGAGCTTTCT GTTATTCGCG AGAAAGCAGT AGGTACGCTC GGTGAAGAAG CAGCTCAAGT 360 TTTTGATGCT CACTTAATGG TTCTTGCTGA CCCAGAAATG ATCAGCCAAA TCAAGGAAAC 420 TATCCGTGCG AAGAAAGTGA ATGCAGAAGC AGGTCTGAAA GAAGTTACAG ATATGTTTAT 480 CACTATCTTT GAAGGCATGG AAGACAACCC ATACATGCAA GAACGCGCAC GGATATCCGC 540 GACGTGACAA AACGTGTATT GGCAAACCTT CTTGGTAAAA AATTGCCAAA CCCAGCTTCT 600 ATCAATGAAG AAGTGATTGT GATTGCGCAT GACTTGACTC CTTCAGATAC AGCTCAATTG 660 GACAAAAACT TTGTAAAAGC TTTTGTAACC AACATTGGTG GACGTACAAG CCACTCAGCT 720 ATCATGGCAC GTACACTTGA AATTGCTGCT GTATTAGGTA CAAACAACAT CACTGAAATC 780 GTTAAAGACG GTGACATCCT TGCTGTTAAC GGGATCACTG GAGAAGTGAT TATCAACCCA 840 ACAGATGAAC AAGCGGCAGA ATTTAAAGCA GCTGGTGAAG CCTATGCGAA CAAAAAGCTG 900 AATGGGCACT TTTGAAAGAT GCTCAACAGT GACTGCTGAC GGTAACACTC GAGTTGGCTG 960 CC 962 (2) INFORMATION FOR SEQ ID NO: 51: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2702 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 51: GATCGTTTCC GTGGCTTGAT CGGAAGCATG TTTGACGAAT AAAGAGGAAA AATAAATTAT 60 GACATTTTCA TTTGATACAG CTGCTGCTCA AGGGGCAGTG ATTAAAGTAA TTGGTGTCGG 120 TGGAGGTGGT GGCAATGCCA TCAACCGTAT GGTCGACGAA GGTGTTACAG GCGTAGAATT 180 TATCGCAGCA AACACAGATG TACAAGCATT GAGTAGTACA AAAGCTGAGA CTGTTATTCA 240 GTTGGGACCT AAATTGACTC GTGGTTTGGG TGCAGGAGGT CAACCTGAGG TTGGTCGTAA 300 AGCCGCTGAA GAAAGCGAAG AAACACTGAC GGAAGCTATT AGTGGTGCCG ATATGGTCTT 360 CATCACTGCT GGTATGGGAG GAGGCTCTGG AACTGGAGCT GCTCCTGTTA TTGCTCGTAT 420 CGCCAAAGAT TTAGGTGCGC TTACAGTTGG TGTTGTAACA CGTCCCTTTG GTTTTGAAGG 480 AAGTAAGCGT GGACAATTTG CTGTAGAAGG AATCAATCAA CTTCGTGAGC ATGTAGACAC 540 TCTATTGATT ATCTCAAACA ACAATTTGCT TGAAATTGTT GATAAGAAAA CACCGCTTTT 600 GGAGGCTCTT AGCGAAGCGG ATAACGTTCT TCGTCAAGGT GTTCAAGGGA TTACCGATTT 660 GATTACCAAT CCAGGATTGA TTAACCTTGA CTTTGCCGAT GTGAAAACGG TAATGGCAAA 720 CAAAGGGAAT GCTCTTATGG GTATTGGTAT CGGTAGTGGA GAAGAACGTG TGGTAGAAGC 780 GGCACGTAAG GCAATCTATT CACCACTTCT TGAAACAACT ATTGACGGTG CTGAGGATGT 840 TATCGTCAAC GTTACTGGTG GTCTTGACTT AACCTTGATT GAGGCAGAAG AGGCTTCACA 900 AATTGTGAAC CAGGCAGCAG GTCAAGGAGT GAACATCTGG CTCGGTACTT CAATTGATGA 960 AAGTATGCGT GATGAAATTC GTGTAACAGT TGTCGCAACG GGTGTTCGTC AAGACCGCGT 1020 AGAAAAGGTT GTGGCTCCAC AAGCTAGATC ACCGCGCCTA GGATAACAAT TTTAGCAATC 1080 AAGATAAACC AAAACATCAT AACAACAAGA AGAACGGAAC CTAAAATTCG GACATCCACC 1140 AAATGATGGA CATAGTAATT GAGATAACTA GAGAACAGAG TTAGTACACC TAAAATCACC 1200 AAGAGAACAA AGGCACTGCC TGGTAGGGTA TAGCTAATTT TCCTGTTAGA TAGATTGGGA 1260 AGAAAATAAT AAAGCATGAC CAAGATAGCA AAGAGGAGGG CGTAAATCAG AGGACCTGCC 1320 AACCCTTGTA AAGCCTGATA GATAATGCCA TCTTTTGTCC AATAATGAGC AAGTAAAGCC 1380 AAAATCATCT GACCAAATAA GATCAAAAAC AAGGCAAACG CAAAGAGGAA CTGCAAGCCA 1440 AAACTGACTA GGAGACTTAG CATCTGATGG GAAATAAGTC CACGACTCTT TTCGACGCCA 1500 TAAGCCTTGT TAAAAGCTTT TTGCAAGAAA TTTATAGATT TTGAAAAACT CCATAACGCC 1560 GATAAAACAG AAAAACTCAA TAAACCTGTT GAAGGTTGCG TCAAAGACTT CTCTGGCTAT 1620 TTTTTCCACA CCTTCATAGA GGCTTGGGGG CAGGACGTCT TTCATAAAGC CCAGAAATTC 1680 TCCCACAGGA ATCTGAAAAT AGGGGAGGAT ATTGACCACC ACCAAAAGCA GGGGGAAAAT 1740 CGAAATCAAC CAATAGTACG CTACTGCGAC ACTGGTCAAA CTCACTATCT GATGCTTGAT 1800 AATAATGCAA AAAAGCTTTT AATAAAGGCT TGTCTATCAG CTCTTTCCAC CACTTTTTCA 1860 TGTCATACTC CTTCATTTAT AATCTTATAC TCAATGAAAA TCAAAGAGCA AACTAGAAAG 1920 CTAGCCGCAA GCTGCTCAAA ACACTGTTTT GAGGTTGTAG ATAAGACTGA CGAAGTCAGT 1980 CACATACATA CGGTAAGGCG ACGCTGACGT GGTTTGAAGA GATTTTCGAA GAGTATTAAC 2040 TAATTTCTTC TTACCAATTC CACCATATCA TACGGTAGGG TATTGGCAGC TTCCTTCAAG 2100 GAATAGTTCT CTAAGTTATT TACATTTTGT CGTAATTTCT TGGCATACTT AGTTGTAATT 2160 AATCGTTTTT CTTCGTATTC GAAAATCAAC TTGCGCTCCA GATAATAGCC TCTCAGCATT 2220 TCATTGATAT TGTTGGGTTT GACACGATTG ATAACCCGTT CGACAAAGGC ACCACTGCTG 2280 ATAATAGTTG TTTCTCGAAG ACGAGACTCC TGCATAAAAC TAATCAAAGA GCGTCTGTAG 2340 ACTCCCTTCA GGTTTTCCAA ACTTTCAATA ATCATCTCCG TATTGGCAAG ATAGAGCTCT 2400 GCAATTTGGT CATAATCAAG AGCACGGAGA CGGCTTTGCT CCTTGTCCTT CCAGCTACGG 2460 AAGGTCTTTC CAAGAGTAAA AACTTCATGA AGGAGAAAAC GTAAAATCCT CAAGGAAACA 2520 AGAAAATAAT AGGTCAGTCT TGAGGCAAGT TTACGATTGA TTCCTTGTTC TATATTTTTC 2580 AGATAACGTT GGTAAACTCG GTAAGCACGA TTGCTAATGT TCCCCTCTTC ATAGGCCTGT 2640 TCCAAACCAT CACTTTCAAT ACTAAGAATC AAGAGTTTCA AAGCAGCCCA GTCTTCTTGA 2700 TC 2702 (2) INFORMATION FOR SEQ ID NO: 52: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6217 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 52: GAATTCCAAG AAGCTAGCCA AGAAAGTCGT GAACGTAGTG ATCCGCTAAA TAGTTATCTC 60 CTTTTGTCAG GCTCCTTGAC GAAAGAAAAG CTTGCCGATA AATTAGGAGA TTTGGGTTAT 120 AAAGCAAGTG CTGACCGAAA GATACCGCCC TATTTTCTTG CTTTTCGAAT ATTACTAAAT 180 CCCCTTATTT TAATTAGTTT AGCAATATTT GGCTTATCTT TCTTTGCTTT AGTGATTATC 240 ACTCGGATTA AGGAAATGAG AGCAGCAGGT ATAAAACTCT TTTCTGGTCA GACTCTCTTA 300 TCCATCATGG GGCATTCTTT ATCTACTGAT ATCAAATGGC TCCTTCTATC AGCCCTCCTT 360 TCCTTCCTAG GTGGGGGTGT CGTTCTTTTT AGTCAAGGTT TGTTTTATCC TATCTTGTTA 420 GCCACCTATG GTTTTGGGAT TAGTTTCTAT CTGTTGTTTT TATTGGCGAT TTCAATTTTA 480 CTAATGCTTC TTTATCTAAT GAGTTTGAAT ACAAAGCATT AGTTCCCGTT ATTAGGGGGA 540 GATTCCCCCT GAACCCTGAT GAATAACCCA TTGTTTCAGT AGACCTGTTT TTTCAGTAGG 600 ATACGCTTTA AGACAGGTTG ACGTCTTACC AACGATTGAA AGAACTTGAA ATTTCAGACA 660 AGATGGCAGG ATAGAGTAGA CTATTATCAC GATTTCTTTT GACTTAGGTT ATAGAGGTTG 720 AGATTCAGAA AATCAGAGCA AGTGGTATGC CTTTACCAAG GGAGCAGCGA AGAAGAACAA 780 GCTCTTTATG TAAAGGATAA TCTGCTCCAT TTTGCCAATC CACAAGGAAA AAATGAACAG 840 GGAGAGACAC TGGATACCTA TAGTCCAGAT GCTAATACGC TCTATGTTAG TCCCAGTTAT 900 TTGGACAAGG AAAAGGTCGT GGTAGATGCT GAGACCAAAC AGAAGTTAGC CCATCTCCAA 960 AAAGGTGAGT TTATCCTCTT GCTCCCAGAA CATTTGCGCT CTCGAGAAGC AGAACTTAAG 1020 AAAGTTTTTG AAGAAAGATT GAGTTATTAT GGAAAATCTG GTGAGGAGGC AAGTGCTCCT 1080 TTGGATTATG AGATGAAAGC GCACGTTAGT TATCTTTCAA TGGGAGAAAA GCGGTTTGTT 1140 TATAATAACG GTGAGAATCC CGTATCTACT CAGTATTTGA CTGATCCGAT TTTAGTTGTA 1200 TTCACGCCGA CTTCTACAGG TGATAGTTTT ATATCCTTAT CTAGTTGGTC TATCAATGCT 1260 GGAAAACAAC TCTTTATCAA AGGATATGAG AGTGGGCTAG AACTCTTGAA GAAAGCTGGA 1320 ATTTATGAGC AAGTATCCTA TCTTAAAGAA GGAAGAAGTG TTTATCTAAC TCGTTATAAT 1380 GAAGTTCAAA CTGAAACAGC AACTTTAATC TTAGGAGCTA TTGTGGGGAT AGCTAGTTCC 1440 TTGTTACTCT TTTATTCTGT CAATCTTCTA TATTTCGAGC AATTCCGCCG AGATATCTTG 1500 ATTAAACGAA TTTCAGGTTT ACGATTTTTT GAAACACATG CTCAGTATAT GGTTAGTCAA 1560 TTTGCCAGTT TTGTATTTGG TGCTAGTCTC TTTATTTTAA GCAGTCGAGA CTTGGTGATT 1620 GGCTTGCTCA CTTTATTAGT CTTTCTAGCT AGTGCAGTTT TGACGCTTTA CCGTCAAGCG 1680 CAGAAAGAAT CTCGTGTTTC TATGACAATT ATGAAAGGAA AATAGGATGA TTGAACTAAA 1740 GAATATATCT AAAAAATTGG AAGCCGTCAG CTATTTTCAG ATACGAATCT TCATTTTGAA 1800 GGTGGGAAAA TTTATGCCTT AATCGGTACA AGTGGCTGTG GTAAGACAAC ACTCTCGAAT 1860 ATGATTGGAC GATTGGCGCC ATATGACAAA GGGCAAATCA TCTATGATGG CACTTCTCTT 1920 AAGGACATCA AGCCTTCTGT TTTCTTTAGA GATTACTTAG GATACTTATT TCAAGATTTT 1980 GGCTTAATTG AAAGCCAAAC CGTCAAAGAG AATCTCAATC TGGGTTTAGT TGGTAAAAAG 2040 TTGAAGGAAA AAGAGAAAAT CTCTTTGATG AAACAAGCTC TAAACCGTGT AAACCTCTCT 2100 TATTTGGATT TGAAGCAACC TATATTTGAG TTATCAGGAG GAGAAGCACA ACGTGTTGCA 2160 CTAGCGAAGA TAATTTTAAA GGATCCGCCT TTGATTCTTG CAGATGAACC AACCGCTTCC 2220 TTAGACCCCA AAAATTCTGA GGAATTACTT TCCATCCTAG AATCTTTAAA AAATCCGAAT 2280 CGGACCATTA TTATTGCGAC CCACAATCCT CTGATTTGGG AGCAAGTGGA TCAGGTCATT 2340 CGAGTTACCG ATTTATCACA TAGATGATAT GGTAAGATTC AGTTAGAAGA AAGAGTCACA 2400 AACACACTTT GTGGCTTTTT TATTTCCATA AAAATGGTAA AATAGTAGGA GTAGAAATGA 2460 GTTCGAGACA TGAAAGTAAT AGATCAATTT AAAAATAAGA AAGTTCTTGT TTTAGGTTTG 2520 GCCAAGTCTG GTGAATCTGC AGCTCGTTTG TTGGACAAGC TAGGTGCCAT TGTGACAGTA 2580 AATGATGGGA AACCTTTCGA GGACAATCCA GCTGCCCAAA GTTTGCTGGA AGAAGGGATC 2640 AAGGTCATTA CAGGTGGCCA TCCTTTGGAA CTCTTGGATG AAGAGTTTGC CCTTATGGTG 2700 AAAAATCCAG GTATCCCCTA CAACAATCCC ATGATTGAAA AGGCTTTGGC CAAGAGAATT 2760 CCAGTCTTGA CTGAGGTGGA ATTGGCTTAT TTGATTTCAG AAGCACCGAT TATTGGTATC 2820 ACAGGATCGA ACGGTAAGAC AACCACAACG ACTATGATTG GGGAAGTTTT GACTGCTGCT 2880 GGGCAACATG GTCTTTTATC AGGGAATATC GGCTATCCTG CCAGTCAGGT TGCTCAAATA 2940 GCATCAGATA AGGACACGCT TGTTATGGAA CTTTCTTCTT TCCAACTCAT GGGTGTTCAA 3000 GAATTCCATC CAGAGATTGC GGTTATTACC AACCTCATGC CAACTCATAT CGACTACCAT 3060 GGGTCATTTT CTGAATATGT AGCAGCCAAG TGGAATATCC AGAACAAGAT GACAGCAGCT 3120 GATTTCCTTG TCTTGAACTT TAATCAAGAC TTGGCAAAAG ACTTGACTTC CAAGACAGAA 3180 GCCACTGTTG TACCATTTTC AACACTTGAA AAGGTTGATG GAGCTTATCT GGAAGATGGT 3240 CAACTCTACT TCCGTGGTGA AGTAGTCATG GCAGCGAATG AAATCGGTGT TCCAGGTAGC 3300 CACAATGTGG AAAATGCCCT TGCGACTATT GCTGTAGCCA AGCTTCGTGA TGTGGACAAT 3360 CAAACCATCA AGGAAACTCT TTCAGCCTTC GGTGGTGTCA AACACCGTCT CCAGTTTGTG 3420 GATGACATCA AGGGTGTTAA ATTCTATAAC GACAGTAAAT CAACTAATAT CTTGGCTACT 3480 CAAAAAGCCT TATCAGGATT TGACAACAGC AAGGTCGTCT TGATTGCAGG TGGTTTGGAC 3540 CGTGGCAATG AGTTTGACGA ATTGGTGCCA GACATTACTG GACTCAAGAA GATGGTCATC 3600 CTGGGTCAAT CTGCAGAACG TGTCAAACGG GCAGCAGACA AGGCTGGTGT CGCTTATGTG 3660 GAGGCGACAG ATATTGCAGA TGCGACCCGC AAGGCCTATG AGCTTGCGAC TCAAGGAGAT 3720 GTGGTTCTTC TTAGTCCTGC CAATGCCAGC TGGGATATGT ATGCTAACTT TGAAGTACGT 3780 GGCGACCTCT TTATCGACAC AGTAGCGGAG TTAAAAGAAT AAAATATGAA AAAAATTGTC 3840 TTTACAGGTG GGGGGACGGT TGGACACGTT ACCCTCAATC TTTTGTTAAT GCCCAAGTTC 3900 ATCGAAGATG GTTGGGAAGT CCACTATATC GGGGACAAGC GTGGTATCGA ACACCAAGAA 3960 ATCCTTAAGT CAGGTTTGGA TGTCACTTTC CACTCCATTG CGACTGGGAA ATTGCGTCGC 4020 TATTTCTCTT GGCAAAATAT GCTGGACGTC TTCAAAGTTG GCTGGGGAAT CGTCCAATCG 4080 CTCTTTATCA TGTTGCGACT TCGTCCACAG ACCCTTTTTT CAAAGGGGGG CTTTGTCTCA 4140 GTACCGCCTG TTATCGCAGC GCGTGTGTCA GGAGTGCCTG TCTTTATTCA CGAATCTGAC 4200 CTGTCTATGG GCTTGGCCAA TAAAATCGCC TATAAATTTG CGACTAAGAT GTATTCAACC 4260 TTTGAGCAAG CTTCGAGTTT GTCTAAGGTT GAGCATGTGG GAGCAGTGAC CAAGGTTTCA 4320 GATCAAAAAA ATCCAGAACC AGATGAATTG GTGGATATTC AAACCCACTT TAATCATAAA 4380 TTGCCGACTG TATTGTTTGT TGGCGGTTCT GCAGGTGCTC GTGTCTTTAA CCAATTGGTG 4440 ACAGACCATA AGAAAGAACT AACAGAGCGC TACAATATTA TCAATCTAAC TGGAGATTCT 4500 AGTCTGAACG AGTTGAGCCA AAATCTTTTT CGTGTTGACT ATGTGACCGA TCTCTATCAA 4560 CCCTTGATGG AATTGGCTGA TATTGTTGTG ACACGAGGTG GTGCCAATAC GATTTTTGAG 4620 CTCTTGGCGA TAGCAAAATT GCATGTCATT GTGCCGCTTG GTCGTGAAGC TAGTCGTGGT 4680 GACCAGATTG AAAATGCAGC TTACTTTGTA AAAAAAGGCT ATGCAGAAGA CCTTCAAGAA 4740 AGCGATTTGA CCTTGGATAG TTTGGAAGAG AAGCTTTCTC ACTTACTAAG TCACAAGGAA 4800 GATTACCAAG CTAAGATGAA AGCTTCTAAG GAATTGAAAT CTCTAGCAGA TTTTTATCAA 4860 TTGTTGAAAA AAGATTTATC ATAAGGAAAG TAAATGTCAA AAGATAAGAA AAATGAGGAC 4920 AAAGAAACCC TCGAAGAATT GAAAGAGTTA TCAGAATGGC AGAAACGAAA CCAAGAATAT 4980 CTAAAAAAGA AGGCTGAAGA AGAGGTGGCT CTAGCTGAGG AGAAGGAAAA GGAAAGACAA 5040 GCTCGAATGG GAGAAGAATC TGAGAAGTCA GAGGACAAAC AGGACCAGGA GAGTGAAACA 5100 GACCAGGAAG ATTCAGAATC AGCTAAGGAA GAGTCTGAAG AAAAAGTAGC ATCCTCAGAG 5160 GCTGACAAAG AGAAAGAAGA ACCAGAGTCT AAAGAGAAGG AGGAACAGGA TAAAAAGCTT 5220 GCTAAAAAGG CTACAAAGGA AAAACCAGCC AAAGCAAAGA TTCCTGGTAT CCATATCTTG 5280 CGAGCCTTCA CGATTTTATT TCCAAGTCTG CTTTTATTGA TTGTCTCTGC CTACTTGCTC 5340 AGTCCTTATG CGACCATGAA AGATATTCGT GTTGAGGGAA CGGTGCAAAC TACAGCTGAT 5400 GATATTCGAC AGGCTTCAGG CATTCAGGAT TCGGATTATA CGATTAACCT TCTGCTAGAC 5460 AAGGCAAAAT ATGAAAAGCA GATTAAGTCT AACTATTGGG TTGAATCAGC TCAACTTGTC 5520 TATCAATTTC CAACTAAGTT CACTATTAAG GTCAAGGAAT ATGATATTGT GGCCTACTAT 5580 ATTTCTGGTG AAAATCATTA TCCTATTCTT TCCAGTGGTC AGCTTGAGAC TAGTTCTGTG 5640 AGTCTGAACA GTTTACCAGA AACTTATTTA TCAGTTCTCT TTAATGATAG TGAACAAATC 5700 AAGGTTTTTG TCTCAGAACT TGCTCAAATT AGCCCAGAAC TCAAGGCGGC TATCCAAAAG 5760 GTGGAATTAG CCCCAAGCAA GGTGACATCC GATTTAATTC GATTGACCAT GAATGATTCG 5820 GACGAAGTCT TGGTTCCTCT ATCTGAAATG AGTAAGAAAC TGCCATATTA CAGTAAGATT 5880 AAGCCACAAT TGTCAGAACC GAGTGTGGTC GACATGGAAG CTGGAATTTA CAGTTACACT 5940 GTGGCGGATA AATTAATTAT GGAGGCTGAG GAAAAAGCCA AACAAGAGGC CAAGGAAGCT 6000 GAGAAAAAAC AAGAAGAAGA ACAGAAAAAA CAAGAGGAAG AGAGCAATCG AAATCAAACA 6060 AATCAGCGTT CATCGCGTCG CTAGGTTTAC CTTTTCTCTT ATAGTTCTTT AGTGACCATG 6120 TTTTTACGTT TAATATTTGA CATTTGTTTT TCTTTATGTT ACATCTGCAA TGTAATCGAT 6180 TACAAAATAA TTTTTGATGA AGAAGGTAAC ACATATG 6217 (2) INFORMATION FOR SEQ ID NO: 53: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1491 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 53: CTTGACACTT GATTGCGACT GTTGAATCTT ATCTCTCCAA GAAAAACACG TGAAGATGTT 60 GAGTCTGCTG TCAGCAAGCT TGAAAGTAGC ACATCTGAGA AACATTGGAT CCATCTGCAG 120 TTTCTCGTGG GTCTAGCTTG GATCGTGATG ACAATGGTCT TTTGACTCTT GCTGGCGGTA 180 AAATCACAGA CTACCGTAAG ATGGGTGACG AGGCGCTATG GAGCGCGTGG TTGACATCCT 240 CAAAGCAGAA TTTGACCGTA GCTTTAAATT GATCAATTCT AAAACTTACC CTGTTTCAGG 300 TGGAGAATTG AACCCAGCAA ATGTGGATTC AGAAATCGAA GCCTTTGCGC AACTTGGAGT 360 TTCACGTGGT TTGGATAGCA AGGAAGCTCA TTACCTAGCA AATCTTTACG GTTCAAATGC 420 ACCGAAGGTC TTTGCACTTG CTCACAGCTT GGAACAAGCG CCAGGACTCA GCTTGGCAGA 480 TACTTTGTCC CTTCACTATG CAATGCGCAA CGAGTTGGCT CTTAGCCCAG TTGACTTCCT 540 TCTTCGTCGT ACCAACCATA TGCTCTTTAT GCGTGATAGC TTGGATAGCA TCGTTGAGCC 600 AGTTTTGGAT GAAATGGGAC GATTCTATGA CTGGACAGAA GAAGAAAAAG CAACTTACCG 660 TGCTGATGTC GAAGCAGCTC TCGCTAACAA CGATTTAGCA GAATTAAAAA ATTAAGAAAA 720 AATAAAAGAG GTGGAGGGCA GCATTCCTTG TCGCCCGTCC CTTCTTTTTA ATGGAGACAG 780 AAAGATGATG AATGAATTAT TTGGAGAATT TCTAGGGACT TTAATCCTGA TTCTTCTAGG 840 AAATGGTGTT GTTGCAGGTG TGGTTCTTCC TAAAACCAAG AGCAATAGCT CAGGTTGGAT 900 TGTGATTACT ATGGGTTGGG GGATTGCAGT TGCGGTTGCA GTCTTTGTAT CTGGCAAGCT 960 CAGTCCAGCT CATTTAAACC CAGCTGTGAC CATCGGTGTG GCCTTAAAAG GTGGTTTGCC 1020 TTGGGCTTCC GTTTTGCCTT ATATCTTAGC CCAGTTCGCA GGGGCCATGC TGGGTCAGAT 1080 TTTGGTTTGG TTGCAATTCA AACCTCACTA TGAGGCAGAA GAAAATGCAG GCAATATCCT 1140 GGCAACCTTC AGTACTGGAC CAGCCATCAA GGATACTGTA TCAAACTTGA TTAGCGAAAT 1200 CCTTGGAACC TTTGTTTTGG TGTTGACAAT CTTTGCTTTG GGTCTTTACG ATTTTCAGGC 1260 AGGTATCGGA ACCTTTGCAG TGGGAACTTT GATTGTCGGT ATCGGTCTAT CACTAGGTGG 1320 GACAACAGGT TATGCCTTGA ACCCAGCTCG TGACCTTGGA CCTCGTATCA TGCACAGCAT 1380 CTTGCCAATT CCAAACAAGG GAGACGGAGA CTGGTCTTAC GCTTGGATTC CTGTTGTAGG 1440 CCCTGTTATC GGAGCAGCCT TGGCCGTGCT TGTATTGTCA CTTTTCTAAT C 1491 (2) INFORMATION FOR SEQ ID NO: 54: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1229 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 54: ACAACGGATA ATGTCATCGA TCTCTTTGAA CACATCTTTA AGGAATGTTC AACGAAAACA 60 TTGTGATGGC GGGCAAGGTC AATCTCTTGA ATTTTGCCAA TCTAGCAGCC TATCAGTTCT 120 TTGACCAACC GCAAAAGGTG GCCTTGGAGA TTCGTGAGGG GTTGCGTGAG GATCAGATGC 180 AAAATGTTCG TGTTGCAGAC GGTCAAGAGT CCTGTTTAGC TGACCTAGCG GTGATTAGTA 240 GTAAGTTCCT CATTCCTTAT CGGGGAGTTG GAATTCTAGC CATTATCGGT CCAGTTAATC 300 TGGATTACCA ACAGCTAATC AATCAAATCA ATGTGGTCAA CCGTGTTTTG ACCATGAAGT 360 TGACAGATTT TTACCGCTAC CTCAGCAGTA ATCATTACGA AGTACATTAA GATTGAAATC 420 ATTAAAGGAG GCGAACATGG CCCAAGATAT AAAAAATGAA GAAGTAGAAG AAGTTCAAGA 480 AGAGGAAGTT GTGGAAACAG CTGAAGAAAC AACTCCTGAA AAGTCTGAGT TGGACTTGGC 540 AAATGAACGT GCAGATGAGT TCGAAAACAA ATATCTTCGC GCTCATGCAG AAATGCAAAA 600 TATCCAACGC CGTGCCAATG AAGAACGTCA AAACTTGCAA CGTTATCGTA GCCAGGACTT 660 GGCAAAAGCA ATCTTACCAT CTCTTGACAA CCTTGAGCGT GCACTTGCAG TTGAAGGTTT 720 GACAGATGAT GTGAAGAAGG GCTTGGCGAT GGTGCAAGAA AGCTTGATTC ACGCTTTGAA 780 AGAAGAAGGA ATTGAAGAAA TCGCAGCAGA TGGCGAATTT GACCATAACT ACCATATGGC 840 CATCCAAACT CTCCCAGGAG ACGATGAACA CCCAGTAGAT ACCATCGCCC AAGTCTTTCA 900 AAAAGGCTAC AAACTCCATG ACCGCATCCT ACGCCCAGCA ATGGTAGTGG TGTATAACTA 960 AGATACAAAC GCTCGTAAAA AGCTCGCAGT AAAAATAGGA GATTGACGAG TGTTCGATGA 1020 ACACAAGAAA ATCTATCTTT TTTACTCAGA GCTTAGGGCG TGTTCGATTC GGCAATTCTG 1080 ACGGTAGCTA AAGCAACTCG TCAGAAAACG GCAATCGCTA TGACGTTTGC CTAGCTTCCT 1140 TACTAACTCG TCGTCGAAAT AAAATCGATT TCGACTCCTC GTGTCGCAAT TTACATAATA 1200 GAAAACTTGT CCGAACGACA TAAACTATG 1229 (2) INFORMATION FOR SEQ ID NO: 55: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 5816 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 55: AAGAAGAAGA CTGTATGGAT AATCGACCAA TTGGTTTTTT GGATTCGGGT GTCGGGGGCT 60 TGACCGTTGT GCGCGAGCTC ATGCGCCAGC TTCCCCATGA AGAAATCGTC TATATTGGAG 120 ATTCGGCGCG GGCGCCCTAT GGCCCCCGTC CTGCTGAGCA AATTCGTGAA TATACTTGGC 180 AGCTGGTCAA CTTTCTCTTG ACCAAGGATG TCAAAATGAT TGTCATTGCT TGTAACACTG 240 CGACTGCGGT TGTCTGGGAA GAAATCAAGG CTCAACTAGA TATTCCTGTC TTGGGTGTAA 300 TTTTGCCAGG AGCTTCGGCA GCCATCAAGT CCAGTCAAGG TGGGAAAATC GGAGTGATTG 360 GAACGCCCAT GACGGTACAA TCAGACATAT ACCGTCAGAA AATCCATGAT CTGGATCCCG 420 ACTTACAGGT GGAGAGCTTG GCCTGTCCCA AGTTTGCTCC CTTGGTTGAG TCAGGTGCCC 480 TGTCAACCAG TGTTACCAAG AAGGTGGTCT ATGAAACCCT GCGTCCCTTG GTTGGAAAGG 540 TGGATAGCCT GATTTTGGGC TGTACTCATT ATCCACTCCT TCGCCCTATT ATCCAAAATG 600 TGATGGGGCC AAAGGTTCAG CTCATCGATA GTGGGGCAGA GTGCGTACGG GATATTTCAG 660 TCTTACTCAA TTATTTTGAA ATCAATCGTG GTCGCGATGC TGGACCACTC CATCACCGTT 720 TTTACACAAC AGCCAGTAGC CAAAGTTTTG CACAAATTGG TGAAGAATGG CTGGAAAAAG 780 AGATTCATGT GGAGCATGTA GAATTATGAC AAATAAAATT TATGAATATA AGGATGACCA 840 GAACTGGTAT GTTGGGTCTT ATAGTATTTT TGGTGGCGTT AACAGTTTGA GCGACTATAA 900 GGCAGATTTT CCTCTGTTTG AATTCTCCAA AATATTTGGA GATGAAGAGT ATGGTTTCCC 960 GCTTTCAGTT ACTGTTTTAC GCTATGGTTC TACCTACCGT TTGTTCTCCT TTGTGGTAGA 1020 CATGCTTAAT CAAGAAATGG GACGAAACTT GGAAGTTATT CAACGTCATG GGGCCCTGCT 1080 CTTGGTTGAA AATGGGCAAC TCTTGTATGT AGAATTGCCT AAAGAAGGGG TCAATGTTCA 1140 TGATTTCTTT GAGACAAGCA AGGTCAGAGA AACCTTGTTG ATTGCGACTC GTAACGAAGG 1200 TAAAACCAAG GAATTCCGAG CTATCTTTGA TAAGTTAGGC TACGATGTGG AAAATCTTAA 1260 TGACTACCCT GACCTGCCTG AAGTAGCAGA AACAGGTATG ACCTTTGAAG AAAATGCCCG 1320 CCTTAAGGCA GAAACCATTT CTCAATTAAC GGGCAAGATG GTTTTGGCAG ATGATTCTGG 1380 TCTCAAAGTC GATGTCCTTG GTGGCTTACC AGGCGTCTGG TCAGCTCGTT TCGCAGGTGT 1440 GGGAGCAACT GACCGTGAAA ATAATGCCAA ACTCTTGCAC GAATTGGCCA TGGTCTTTGA 1500 ACTCAAGGAC CGCTCGGCTC AGTTCCACAC AACCCTAGTC GTAGCCAGCC CAAATAAGGA 1560 AAGTTTAGTT GTTGAAGCAG ACTGGTCAGG TTATATTAAC TTTGAACCTA AGGGTGAAAA 1620 TGGCTTTGGC TATGATCCCC TCTTCCTTGT AGGAGAGACA GGTGAGTCAT CAGCTGAATT 1680 AACCCTGGAA GAAAAAAATA GTCAATCTCA CCGTGCCTTA GCCGTTAAGA AACTTTTGGA 1740 GGTATTTCCA TCATGGCAAA GCAAACCATC ATTGTAATGA GCGATTCCCA TGGCGATAGC 1800 TTGATTGTGG AAGAAGTCCG TGATCGCTAT GTGGGCAAAG TCGATGCCGT TTTTCATAAC 1860 GGCGATTCTG AACTACGTCC GGATTCTCCA CTTTGGGAGG GCATCCGCGT TGTTAAAGGG 1920 AACATGGACT TCTACGCCGG CTACCCAGAA CGTCTGGTGA CTGAGCTTGG TTCGACCAAG 1980 ATTATCCAAA CTCATGGTCA CTTGTTTGAC ATCAATTTCA ACTTTCAAAA GTTGGACTAC 2040 TGGGCTCAGG AGGAAGAGGC CGCTATCTGC CTCTATGGTC ACTTGCATGT GCCAAGTGCT 2100 TGGATGGAAG GCAAGATCCT CTTTCTAAAT CCAGGTTCTA TCAGTCAACC ACGAGGTACC 2160 ATCAGAGAAT GTCTCTATGC TCGTGTGGAG ATTGATGATA GTTACTTCAA AGTGGACTTT 2220 TTGACACGAG ATCACGAGGT GTATCCAGGT TTGTCCAAGG AGTTTAGCCG ATGATTGCCA 2280 AGGAGTTTGA GACTTTCTTG TTGGGGCAGG AGGAAACTTT TTTGACCCCT GCTAAAAATC 2340 TAGCTGTGTT GATTGATACC CACAATGCGG ATCATGCGAC CCTCTTGCTC AGTCAGATGA 2400 CCTATACCCG TGTTCCCGTT GTGACAGATG AAAAACAGTT TGTTGGGACG ATTGGACTCA 2460 GAGATATTAT GGCTTATCAG ATGGAGCATG ACTTGAGCCA AGAAATCATG GCGGATACGG 2520 ATATCGTTCA TATGACAAAA ACGGACGTAG CGGTTGTTTC GCCTGATTTC ACCATTACGG 2580 AGGTCTTGCA CAAGCTAGTA GATGAGTCCT TCTTACCGGT CGTGGATGCA GAGGGTATTT 2640 TCCAAGGGAT TATTACGCGC AAGTCCATCC TCAAGGCCGT TAATGCCCTC TTGCATGACT 2700 TTAGTAAGGA ATATGAGATT CGATGCCAAT GAGAGACAGG ATTTCAGCCT TTTTAGAGGA 2760 AAAGCAGGGC TTGTCTGTCA ATTCCAAGCA GTCCTATAAG TATGATTTGG AGCAATTTTT 2820 AGACATGGTA GGTGAGCGGA TTTCTGAGAC CAGTCTCAAG ATTTACCAAG CCCAGCTAGC 2880 CAATCTAAAA ATCAGCGCCC AGAAGCGAAA GATTTCGGCC TGTAACCAAT TTCTATACTT 2940 TCTCTATCAA AAAGGAGAGG TGGACAGCTT TTACCGCTTG GAATTAGCTA AACAAGCTGA 3000 AAAGAAGACG GAAAAGCCAG AGATTCTATA CCTAGACTCT TTTTGGCAGG AAAGCGACCA 3060 TCCAGAGGGC CGCTTGCTAG CGCTCTTAAT CCTAGAAATG GGGCTCTTGC CCAGTGAGAT 3120 TTTAGCCATC AAGGTTGCGG ACATCAATCT GGATTTTCAG GTGCTGCGAA TCAGCAAGGC 3180 TTCCCAACAG AGGATTGTCA CCATTCCCAC GGCCTTGCTT TCAGAATTGG AACCCTTGAT 3240 GGGGCAGACC TATCTTTTTG AAAGAGGAGA GAAACCCTAT TCTCGTCAGT GGGCCTTTCG 3300 TCAGTTAGAA TCTTTTGTCA GGAGAAGGTT TCCATCCTTA TCAGCTCAAG TCTTACGTGA 3360 CAGTTTATTC TAAGCAAATA GAAACAGGTC GATTTGTACG AATTGCAAAA AATTAGGATT 3420 AAAAACAGTC CTGACCTTAG AAAATATAGA TAATGGATAT TAAATTAAAA AGATTTTTGA 3480 AGGACCCTGG ACTTGCTCTT TGCATCTGGT TTCTAAGTAC CAAGATGGAT ATCTACGATG 3540 TGCCCATTAC GGAAGTCATC GAACAGTATC TAGCCTATGT TTCAACCCTG CAGGCCATGC 3600 GTCTGGAAGT GACGGGTGAG TACATGGTCA TGGCTAGTCA GCTCATGCTG ATTAAGAGTC 3660 GTAAACTCCT TCCGAAGGTA GCAGAAGTGA CAGACTTGGG GGATGACCTG GAGCAGGACC 3720 TCCTCTCTCA AATCGAAGAA TATCGCAAGT TCAAGCTCTT GGGTGAGCAC TTGGAAGCCA 3780 AGCACCAAGA ACGGGCCCAG TATTATTCCA AAGCGCCGAC AGAGTTGATT TACGAAGATG 3840 CGGAGCTTGT GCATGACAAG ACGACCATTG ACCTCTTTTT GGCTTTTTCA AATATCCTAG 3900 CCAAGAAAAA AGAGGAGTTT GCACAAAATC ACACGACGAT CTTGCGGGAT GAGTATAAGA 3960 TTGAGGACAT GATGATTATT GTGAAAGAAT CCTTGATTGG ACGAGATCAA TTGCGCTTGC 4020 AGGATTTGTT CAAGGAAGCC CAGAATGTCC AAGAGGTCAT CACCCTCTTT TTGGCAACCC 4080 TAGAGTTAAT CAAAACCCAG GAGCTGATCC TCGTGCAAGA GGAGAGTTTC GGAGATATCT 4140 ATCTCATGGA AAAGAAGGAA GAAAGTCAAG TGCCTCAAAG CTAGACTTGA TAGAGAGGAA 4200 AGATGAGTAC TTTAGCAAAA ATAGAAGCGC TCTTGTTTGT AGCGGGTGAA GATGGGATTC 4260 GGGTCCGCCA GTTAGCTGAA CTCCTCTCTC TGCCACCGAC AGGCATCCAG CAGAGTTTAG 4320 GAAAATTAGC CCAGAAGTAT GAAAAGGACC CAGATTCCAG TTTGGCTTTG ATTGAGACAA 4380 GTGGTGCTTA TAGATTGGTG ACCAAGCCTC AATTTGCAGA GATTTTGAAG GAATACTCTA 4440 AGGCGCCTAT CAACCAGAGC TTGTCTCGGG CTGCCCTTGA GACCTTGTCC ATTATTGCCT 4500 ACAAACAGCC GATTACGCGG ATAGAAATTG ATGCCATCCG TGGGGTTAAC TCGAGTGGAG 4560 CCTTGGCAAA GTTGCAAGCT TTTGACCTGA TAAAGGAAGA CGGGAAAAAG GAAGTATTGG 4620 GGCGCCCCAA CCTCTATGTG ACTACGGATT ATTTCCTAGA TTACATGGGG ATAAACCATT 4680 TAGAAGAATT ACCAGTGATT GATGAGCTTG AGATTCAAGC CCAAGAAAGC CAATTATTTG 4740 GTGAAAGGAT AGAAGAAGAT GAGAATCAAT AAGTATATTG CCCACGCAGG TGTGGCCAGT 4800 AGGAGAAAAG CAGAAGAGCT GATCAAGCAA GGTTTGGTGA CAGTTAACGG ACAAGTGGTG 4860 CGTGAACTAG CAACCACTAT CAAGTCAGGC GACAAGGTCG AAGTTGAAGG TCAACCTATC 4920 TACAACGAAG AAAAGGTCTA TTATCTGCTT AACAAACCAC GCGGTGTCAT TTCCAGTGTA 4980 ACAGATGACA AGGGTCGCAA GACGGTTGTC GACCTCTTGC CCAATGTCAA AGAGCGCATT 5040 TACCCTGTGG GTCGTTTGGA CTGGGATACA TCAGGAGTCT TGATTTTGAC CAATGATGGG 5100 GACTTTACAG ACGAGATGAT TCACCCTCGT AATGAGATTG ACAAGGTTTA TGTCGCGCGT 5160 GTTAAAGGTG TGGCCAATAA GGACAATCTT CGCCCCTTGA CCCGTGGTCT TGAGATTGAT 5220 GGTAAGAAAA CCAAGCCAGC TGTTTATGAA ATTCTCAAAG TGGACCCAGT CAAAAATCGC 5280 TCTGTGGTGC AGTTGACCAT CCATGAAGGG CGTAACCATC AGGTTAAAAA GATGTTTGAA 5340 GCTGTTGGTC TCCAAGTAGA TAAGTTGTCT CGGACTCGTT TCGGACACCT AGACTTGACA 5400 GACTCCGTCC AGGAGAATCC CGTCGTCTTA ATAAAAAAGA AATCAGCCAA CTACACACCA 5460 TGGCTGTAAC TAAGAAATAA TGAAACGAAT TTTAATAGCG CTTGTGCGCT TTTACCAACG 5520 TTTTATCTCA CCAGTCTTTC CACCCTCTTG TCGCTTTGAG CTGACTTGTT CCAACTACAT 5580 GATTCAGGCT ATTGAAAAAC ATGGTTTTAA GGGGGTATTG ATGGGCTTGG CTCGGATTTT 5640 ACGTTGTCAT CCCTGGTCGA AAACAGGTAA GGACCCCGTT CCAGACCACT TTTCCCTTAA 5700 ACGAAATCAA GAAGGGGAAT GAGGTGGGGT AAATAGATTT CAAAATGATA AAAACGCATC 5760 CTATCAGGTT TGAGTGAACT TGATAGGATG CGTTTTAGAA TGTCAAAATT TTATAC 5816 (2) INFORMATION FOR SEQ ID NO:56: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 725 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:56: TTGAAAATAA TTATGAACCG CAATATATTA ATATCCGAGG -AAAAGGCCCT CTTATCAATG 60 ACTTGAAAAA AGAAGCTAAA AAAGCTAATA AAGTTTTTCT CGCGAGTGAC CCGGACCGTG 120 AAGGAGAAGC GATTTCTTGG CATTTGGCCC ATATTCTCAA CTTGGATGAA AATGATGCCA 180 ACCGTGTGGT CTTCAATGAA ATCACCAAGG ATGCAGTCAA AAATGCTTTT AAAGAACCTC 240 GTAAGATCGA TATGGACTTG GTCGATGCCC AACAAGCTCG TCGGATCTTG GATCGCTTGG 300 TAGGGTATTC GATTTCGCCT ATTTTGTGGA AGAAGGTCAA GAAGGGCTTG TCAGCAGGTC 360 GCGTTCAGTC CATTGCCCTT AAACTCATCA TTGACCGTGA AAATGAAATC AATGCCTTCC 420 AGCCAGAAGA ATACTGGACA GTTGATGCTG TCTTTAAAAA GGGAACCAAA CAATTTCATG 480 CTTCCTTCTA TGGAGTAGAT GGTAAAAAGA TGAAACTGAC CAGCAATAAC GAAGTCAAGG 540 AAGTCTTGTC TCGTCTGACG AGTAAAGACT TTTCAGTAGA TCAGGTGGAT AAGAAAGAGC 600 GTAAGGCAAA TGCTCCTTTA CCCTATACCA CTTCATCTAT GCAGATGGGA TGCTGCCAAT 660 AAAATCAATT TCCGTACTCG AAAAACCATG ATGGTTGCCC AACAAGCTCT ATGAAGGAAT 720 TATAT 725 (2) INFORMATION FOR SEQ ID NO: 57: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1935 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 57: AACCCATCTG AAGAACTTTT CCGTGCTGCT AGCTCAGCTA TCGATAAAGC AGAAACTAAA 60 GGTTTGATTC ACAAAAACAA AGCAAGCCGC GATAAAGCTC GTCTTTCAGC TAAACTTGCT 120 AAATAAGAAA CAGTCCATAG AGGCTGTTTT TTTGTCTCCA AATAGGAAAA GGTAGAAAAT 180 GAAAATCACA ATTATCGGAT ATTCTGGTTC TGGTAAGTCA ACTCTAGCAG AAAAGTTATC 240 TAACTACTAC TCCATTCCAA AACTGCACAT GGACACACTC CAATTTCAAC CTGGTTGGCA 300 AGACAGTGAC TGCGAATGGA TGTTAACCGA GATAAAAAAC TTTCTCACCA AGCATAAAGC 360 TTGGGTCATC GATGGTAATT ATTCTTGGTG CTACTACCAA GAACGAATGC AAGAAGCTGA 420 CCAAATCATC TTTCTCAATT TTTTGCCATT GACCTGTCTC TTTAGAGCCT TTAAGCGTTA 480 TCTTAAATAC CGTGGAAAAG TCAGAGAAAG TATGGCGGCA GATTGCCCTG AACGCTTTGA 540 GTGGGAGTTT ATCAGATGGA TTCTTTGGGA TGGGCGTAGC AAAACTCAAA AAGAAAATTA 600 CCAAAAACTT TGCCAAGAAT ATTCACATAA AGTCACTATC CTTCGAAATC AGAGAGAGCT 660 AGATCAATTT CTGGATAAGA AAAGGAAGTC CTACAATTCA TAAAGGGCTT CCTTTTTGGC 720 TATAATTATT CTGCAATCAA GGTTTCCAAA CCAACCTTCA TCATATCAGT GAAGGTATTT 780 TGACGTTCTT CTGCAGTTGT GTCTTCGTCT GGATTGACCA AGCTATCAGA GATGGTCATG 840 ATAGCTAGCG CATCAACATG GTATTGGGCA GCAAGATAGT AAAGAGCTGC TGCTTCCATT 900 TCCACAGCCT TGACTCCCCA TTTACCAAGC TCGATATTCT TTTCAAAGTA ATTTGAGTAA 960 AAGACATCAG ATGACAAAAC GTTCCCAACG TGAGTAGTCA TACCAAGTTC TTTGGCGATA 1020 TGGTAGGCTT TATCAAGCAA ATCAAAGCTA GCAATTTGTG GAAAATCGTA CTGTGGCCAG 1080 TCATTACGAA CGATGTTTGA GTTGGTTGCA GCCGCCTGCG CCAAAACTAA TTCACGAACA 1140 TGAACCTCTT CATTCAAAGA ACCTGCAGTT CCCACACGAA TCAATTTCTT CACACCGTAG 1200 TCTACGATTA ACTCACGCGC ATAAATCGAA ATAGATGGCA TTCCCATCCC AGTTCCCATG 1260 ACAGATACAC GGTGACCCTT GTAAGTACCA GTGTAACCAA ACATGTTACG CACTTCGTTA 1320 AAACAAACAG CATCACCAAG GAAATTCTCC GCAATAAACT TAGCACGAAG AGGATCCCCA 1380 GGAAGAAGAA TTTTATCAGC AATTTCACCC TGCTGAGCAG CAATATGGAT AGACATAATT 1440 TATGATACAA AGAGCGAGAA GAAAACGACT GAAAATTAGG AACCTGACGA GAAATCCTGA 1500 TTTTTCAGTC AGATTATCTA TTTTCCGAGT TTTCCGCTCG TGTTCAAATC AAAACACACG 1560 CTCTACCTTT CTTTATTTTA TATTTTATAT TGAGAAAGAT ACCAAACCCA TCAAAAAGCG 1620 AAGGGAAAAT AGGAGTTGGG CGCAGTGAGC GATGCTCGCT AGACCAACTA TCTTTTTCCC 1680 ACTGCTTTTA GGGTGGGGTC AATTCCTTTC TTTCTTAATT TTGATTTAGA GGAGAGTCGC 1740 CCGTATTCAG TTCAGCGAAT ACAGTTTACC CATCCTTTCG TTTTTATTTT TAGAAAAGTT 1800 TTCTACTCGT GTTCAAATTA GAACACGCGC TCTACCTTTC TGTTTATACT CTTCGAAAAT 1860 CTCTTCAAAC CACGTCAACG TCGACTTGGA TTATATATGT GACTGACTTC GTCATCTTTA 1920 TCTACAACCT CAAAG 1935 (2) INFORMATION FOR SEQ ID NO:58: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2221 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 58: TATTATTTTT CCCATCCTAA CTGGAACCTA TGTCGCGCGT GTCTTGGACC GAACTGACTA 60 TGGTTACTTC AACTCAGTCG ACACTATTTT GTCATTTTTC TTGCCCTTTG CAACTTATGG 120 TGTCTATAAC TACGGTTTAA GGGCTATCAG TAATGTCAAG GATAACAAAA AAGATCTTAA 180 CAGAACCTTT TCTAGTCTTT TTTATTTGTG CATCGCTTGT ACGATTTTGA CCACTGCTGT 240 CTATATCCTA GCCTATCCTC TCTTCTTTAC TGATAATCCA ATCGTCAAAA AGGTCTACCT 300 TGTTATGGGG ATTCAACTCA TTGCCCAGAT TTTTTCAATC GAATGGGTCA ATGAAGCTCT 360 GGAAAATTAC AGTTTTCTCT TTTACAAAAC TGCCTTCATC CGTATCCTGA TGCTGGTCTC 420 TATTTTCTTA TTTGTTAAAA ATGAACACGA TATTGTTGTC TATACACTTG TGATGAGTTT 480 ATCGACGCTG ATTAACTACC TGATTAGTTA TTTTTGGATT AAAAGAGACA TCAAACTTGT 540 TAAAATTCAC CTAAGTGATT TTAAACCACT CTTTCTCCCT CTGACAGCCA TGTTAGTCTT 600 TGCCAATGCC AATATGCTCT TCACTTTTTT AGATCGCCTC TTCCTCGTTA AAACAGGGAT 660 TGATGTCAAC GTTAGTTACT ATACCATAGC TCAGCGAATT GTGACCGTTA TAGCTGGGGT 720 TGTAACAGGT GCAATTGGAG TGAGTGTGCC TCGTCTCAGT TACTATCTGG GGAAAGGAGA 780 CAAAGAAGCC TATGTTTCTC TGGTTAATAG AGGTAGTCGA ATCTTTAACT TCTTTATCAT 840 TCCACTGAGT TTTGGACTCA TGGTTTTAGG ACCAAATGCC ATCCTACTTT ACGGTAGTGA 900 AAAATATATC GGAGGCGGCA TCTTGACCTC TCTCTTCGCT TTTCGTACGA TTATCCTGGC 960 CTTAGATACC ATTCTTGGTT CCCAAATTCT CTTTACCAAT GGCTATGAAA AACGTATCAC 1020 AGTCTATACA GTCTTTGCTG GGCTACTCAA TTTGGGCTTG AATAGTCTCC TTTTTTTCAA 1080 CCATATCGTG GCTCCTGAAT ACTACTTACT GACAACTATG CTATCAGAGA CTTCTCTACT 1140 TGTTTTCTAT ATCATTTTCA TCCATAGAAA ACAACTCATC CACTTGGGAC ATATCTTTAG 1200 CTATACTGTT CGATACTCTC TCTTTTCACT TTCCTTTGTA GCAATTTATT TCCTGATTAA 1260 TTTCGTGTAT CCTGTAGATA TGGTCATTAA TTTGCCATTT TTGATTAATA CTGGTTTGAT 1320 TGTCTTGCTA TCAGCTATCT CTTATATTAG TCTACTTGTC TTCACAAAAG ATAGCATTTT 1380 CTATGAATTT TTAAACCATG TCCTAGCCTT AAAAAATAAA TTTAAAAAAT CATAGGAGTT 1440 TAAAATGAAA CAACTAACCG TTGAAGATGC CAAACAAATT GAATTAGAAA TTTTGGATTA 1500 TATTGATACT CTCTGTAAAA AGCACAATAT CAACTATATT ATTAACTACG GTACTCTGAT 1560 TGGGGCGGTT CGACATGAGG GCTTTATCCC TTGGGACGAC GATATTGATC TGTCCATGCC 1620 TAGAGAAGAC TACCAACGAT TTATTAACAT TTTTCAAAAG GAAAAAAGCA AGTATAAGCT 1680 CCTATCCTTA GAAACTGATA AGAACTACTT TAACAACTTT ATCAAGATAA CCGACAGTAC 1740 GACTAAAATT ATTGATACTC GAAATACAAA AACCTATGAG TCTGGTATCT TTATCGACCT 1800 GCAGGCATGC AAGCTTGGCG TAATCATGGT CATAGCTGTT TCCTGTGTGA AATTGTTATC 1860 CGCTCACAAT TCCACACAAC ATACGAGCCG GAAGCATAAA GTGTAAAGCC TGGGGTGCCT 1920 AATGAGTGAG CTAACTCACA TTAATTGCGT TGCGCTCACT GCCGGCTTTC CAGTCGGGAA 1980 ACCTGTCGTG CCAGCTGCAT TAATGAATCG GCCAACGCGC GGGGAGAGGC GGTTTGCGTA 2040 TTGGGCGCCA GGGTGGTTTT TCTTTTTCAC CAGTGAGACG GGCAACAGCT GATTGCCCTT 2100 CACCGCCTGG CCCTGAGAGA GTTGCAGCAA GCGGTCCACG CTGGTTTGCC CCAGCAGGCG 2160 AAAATCCTGT TTGATGGTGG TTCCGCAAAT CGGCAAAATT CCTTATAAAA TCAAAAGGAA 2220 T 2221 (2) INFORMATION FOR SEQ ID NO:59: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1509 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:59: TGAATTTTGA ACAGTACACA GAATACTAAA ATATTTCTAG AAATTAATTT GAATTTTCTA 60 ATTGGATTTG TCGCATCTTA TTTCAATCTA CTATAGAAAA AAGTCTTTAA AATTATAAAA 120 CGCATCATAT CAAGGTTTTT CAAAAACCTT GATATGATGC CTTTTATTGT GGGAATATGT 180 ATTTCATTTT CTACTAAAAT TATGTTTTTG AATAACCTCT ATCTTAGTAG TTTGTATAAT 240 CCCCCTCAAT CAGTTTTTGC GATAAGCTTT AATGCTATGA CTATACCACT CTTGCATTTC 300 TTTTGATGGT GGTGTCATAT AATCGCCATA CATCTGGGTT AAAAATTGGT CATATTTTTT 360 GGGAACAGGC AACATACGGC CCTCAAACTC AGTTAAAATC AGTTCTTTAA AGGTATCAAC 420 TGGGAAGATT TCTTTCATCC CTTCCTTACC GATCCCAACT CCTCCTTCAT ATTGAGGAGT 480 GTTGGTTACA GCATTTTTGA CTAGTTGATC AATTTTCTTG TAAAAGTAGC GAGGATTGAC 540 AAATCGGAGA GCGTACCAGC TACATAATCT AAGAAAATCT TTTAGTTTGC TATCACCGTG 600 AACTGCTCGT GATTTTTTGA TATAAGCTAG TTGACGAAGA GCCACATACT TATAGCTCTT 660 GTCGACAATG CTCAAGTCTG TAAATCGATC AATTGGGAAG ACATCGATGA AAAGGCTGGT 720 ATCATGACGC TTGTACTTAA CATGGTCTTC TATAACAGTA GAAGTGTCCA AAATCGATGC 780 GAAATTATGG AAGTACCAAG AAGATGTATC GTAGGAAAGA ACCTTGTAGC GAGGGTGATT 840 TTCTTCTTCA ATAATCTTCA GTAAACGCTC ATAATCCTCA CGATAAAGGG AAATATCAAT 900 ATCATCATCC CAAGGAATCA TACCTTTGTG GCGGATGGCT CCAAGCATGG TTCCATAACT 960 GAGAAAATAA GGAATATCAT GTTTCTTACA AGTCTCATCA ATATAGTCCA GCAGGGCTAG 1020 TTGAATTTCT TTAATTTCTT TTTTTTCTAA ATATTGCATC CTAATCCTCC AATTTATAAG 1080 CGTGAAATTC ATGACTGTAG AAGCGTTTTT CTTCTGGTGG TAGGGTCATA TAATCTCCAT 1140 AAAATTGTGT CAAAATAGTA TCAAATTTTT CAGGTGCAGG AAGGCTTAAA TTCTCAAAGG 1200 GTAAATCGAT TGTTTTATCA AAGGTACCAC TTGGGAAGAC TTCCTTTTCC TTAAATTTTG 1260 AAGGGATAAA AGCCATATAT TGCCCATTTT CACGACTATA TTTTTGAATT TCTTTCTCGA 1320 TTTTATTTGC AAAATAACGA GGAGAAACCG GTCGAAGGAG TAACCAGAAG GCTGTTCGTA 1380 TCCAATCTTT TAAAAGGCTA TCCTTATAGA CAATATTTTT ATGTTTACTG AAAGACAGCA 1440 GTTTGAAGCT TTCCAGTTTA TAACAAGTAT CAATGACCTT AGGATCATCA AAGCGATCTA 1500 TAGGGAAAA 1509 (2) INFORMATION FOR SEQ ID NO: 60: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 671 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 60: ACAAGGGATT TATTCCTTGG GACGACGACC TAGACTTTTT TATGCCTCGT AAAGATTATG 60 AGAAATTAGC AGAATTATGG CCTCGTTATG CAGATGAACG TTATTTCTTG TCAAAGAGTC 120 ACAAGGATTT TGTTGATCGT AATCTTTTTA TTACCATTCG TGACAAGAAA ACCACCTGTA 180 TCAAGCCTTA TCAGCAGGAT TTGGATTTGC CACATGGTCT GGCCTTGGAT GTTTTGCCTT 240 TGGATTATTA TCCGAAAAAT CCAGCTGAGC GGAAAAAACA GGTTCGTTGG GCCTTGATTT 300 ATTCACTCTT TTGTGCGCAA ACTATTCCAG AAAAGCATGG TGATCTCATG AAATGGGGAA 360 GTCGCATTTT ACTGGGTTTG ACTCCAAAAT CTCTCCGTTA TCGCATCTGG AAAAAAGCTG 420 AGAAAGAAAT GACTAAGTAT GATTTGGCTG ATTGTGATGG CATTACAGAA TTATGCTCAG 480 GTCCTGGCTA CATGAGAAAC AAGTACCCAA TCACATCTTT TGAAGACAAT CTTTTCTTGC 540 CATTTGAAGG AACAGAGATG CCTATTCCAA TCGGCTATGA TGTCTATCTC AGAACTGCTT 600 TTGGGGATTA TATGACGCCT CCACCAGCAG ACAAGCAGGT ACCGCATCAT GATACTGTCA 660 CTGCTGATAT G 671 (2) INFORMATION FOR SEQ ID NO: 61: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2766 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 61: ATCTTATACA AGTCGTAAGC CGCTTCCTTA AAACCAGCTT CTAGTAATTC TTCCAATAAG 60 ATAGTAACCT TCACACCATT TGGTGTTCCC AGTGAATAAA GCTGAAAAGC TTGTTCTCCT 120 TTTGGCAAGT TTTGTTCGAA ACGGGCACCT GCTGTTGGTC TGTTTAGCCC CGTAAAAGCT 180 CCTTGATTAC TAGCTTCATC CTGCCATACG GTCGGTAATT GATATGCTGA CATCCGAGAC 240 CTCCCTTAAA TCGCATTCTT GTCAAAACCG AGTTTGCGTT GAATAAACTT AACGATTTCG 300 ACGATGATAA TCATTGAGAA GCTTCCAGCC ATAACAATTC CCCATTGTGA CAAGTCTAGT 360 TTGGTTACGT GGAAGATTCC TTCAAGCGGT TCTACAACGA TTGTTGCCAT GAGAAGGATA 420 AAGGATACCA AGATGGACCA GTTAAAGGTC TTAGACTTGA ATGGGCCAAC TGTCAAGATG ' 480 GATTGGTAGA CAGACTTGAC ATTGTAGGCA TGGAAGAGCT GAATCAAACC AAGGGTTGCA 540 AAGGCCATCG TTAGGGCATC TGCATGAATA GCATGATTGT CACCCACATG AACTGGGTAA 600 GCAATCGCAA GGCCATAAAC ACTCATAACA AGAGCTGCTT GGAGTACACC TTGATAAATG 660 ATAGAACTCA AAACACCACC TGAGAAGAAG CTTGCCTTGC GTCCACGTGG TTTATGATTC 720 ATGACACCAG GTTCCGCAGG TTCAACACCA AGAGCGATAG CTGGGAAGGT ATCCGTTACC 780 AAGTTGATCC ACAAAAGATG AACCGGCTGC AAGACATCCC AACCAAACAA GGTTGATAGG 840 AAGATGGTTA ATACTTCAGC AGTATTAGCA GAAAGTAGGT ACTGAATAGT CTTTTGAATG 900 TTTGAGAAGA CCTTACGTCC TTCTTCCACT GCGACGATAA TAGTCGCAAA GTTATCATCT 960 GCAAGAATCA TATCAGAAGC CCCCTTAGAA ACCTCTGTAC CAGTGATTCC CATACCGATA 1020 CCAATATCGG CTGTTTTCAG AGCTGGCGCG TCATTGACAC CGTCACCTGT CATGGCAACG 1080 ACTTTACCTT GTTTTTGCCA AGCCTTGACG ATACGAACCT TGTGTTCTGG AGACACACGG 1140 GCATAAACAG AGTATTGACC AACAACTTTT TCAAATTCTT CATCTGACAG TTCATTGAGT 1200 TCAGCACCAG TTAAAACGTG ACCTTCTGTA TCGTTTGCGT CAATGATTCC CAAACGTTTG 1260 GCAATGGCTT CCGCTGTGTC TTGGTGGTCA CCTGTAATCA TAATTGGACG GATTCCCGCT 1320 TCCTTAGCCA CACGAACAGC CTCAGCGGCT TCAGGACGTT CAGGGTCAAT CATCCCAATC 1380 AAACCAGTAA AAATTAAATC ATTTTCAAGC TCTTCAGAAG TGAGATTTTC TGGAATACTA 1440 TCGATAATCT TATAAGCACC TGCAAGGACA CGCAAGGCTT GATGAGCCAT TTCAGAATTG 1500 TTTGTATGAA TGAGATTTGT AACCTTCTCA TCAATCGGAG CAATATCCCC AGCCTTATCA 1560 CGAAGAAGAC AACGTTTTAA GAGTTGGTCT GGCGCACCCT TGACTGCTAC AAGGAAACGA 1620 CTATCTGGCA ATGGGTGAAC TGTTGACATG AGCTTACGGT CAGAGTCAAA TGGCAATTCA 1680 GCTACACGAG GATATTTCTC TAAGAAACCT TTGACATCAT AGCCCTTGTC CAAGGCATAT 1740 TGGATAAAGG CTGTTTCGGT TGGGTCACCA ATCAAGTTAC CTTCCACATC GATTTTCGTA 1800 TCATTGGCCA AGACAACTGA ACGAAGTAGT GGCATTTCAA GACCTAGTTC AATATCATCA 1860 GCTGAGTCAT GTAGAACCGC ATCGTAGAAG ACTTTTTCGA CTGTCATCTT GTTCATAGTC 1920 AGCGTACCAG TCTTATCAGA AGCGATGATT TCAGTTGAAC CAAGTGTTTC AACTGCTGGC 1980 AACTTACGAA CGATGGAATG TCGTTTGGCC AAAACTTGAG TACCAAGAGA AAGAACGATG 2040 GTAACGATAG CAGGAAGTCC TTCTGGAATG GCTGCAACAG CAAGGGCAAC AGAAGTCAAC 2100 AACTCACCAA GTGGATTTTT CCCTTGAATG AAGACACCCA CTACAAAAGT AACAAGGGCA 2160 ATGACCAAGA TAGCATAGGT CAAGACCTTA GAAAGGTTGT TCAAGTTTTG TTTGAGTGGT 2220 GTATCAGTCT CATCCGCATC TTGAAGCATA CCAGCAATAT GACCAACTTC AGTATACATA 2280 CCTGTATTGA CAACAACACC CATCCCACGA CCATAGGTTA CGTTTGAGTT TTGGAAGGCC 2340 ATGTTGACAC GGTCACCAAT GCCAGCATCT GTCGCAAGAT CGACTGACAA GTCTTTTTCG 2400 ACTGGTACAG ATTCACCTGT CAAGGCTGCT TCTTCAATTT TAAGAGAGTT GGCTTCTATC 2460 AAACGTAGGT CCGCTGGTAC CACGTCACCT GCTTCAAGGG CAACGATATC GCCTGGTACC 2520 AATTCTTTAG AGTCAATCTC TGCCATGTGT CCATCACGAA GAACGCGGGC AACTGGACTA 2580 GACATGGATT TGAGGGCTTC AATAGCTTCT TCAGCTTTTC CTTCTTGGTA AACACCAAAG 2640 GCAGCGTTGA TGATAACCAC AGCTAGGATG ATAATGGCAT CTGCGATATC TTCCCCACCA 2700 GAAGTCACGA CTGACAAGAT TCTGCCGCAA CTAGGATGAT AATCATCAAA TCCTTAAATT 2760 GCTCGA 2766 (2) INFORMATION FOR SEQ ID NO: 62: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1577 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO ( iv) ANTI-SENSE : NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 62: TGGATTTATC CTCTTTTTCG TTCTTTTGGG AGCAGTTTTT GAGGAAAAAA TGAGAAAAAA 60 TACGTCCCAA GCTGTGGAGA AATTACTGGA CTTGCAAGCT AAAACCGCAG AAGTCTTGAG 120 TGATGATAGT TATGTCCAAG TTCCTTTGGA ACAAGTCAAG GTAGGCGACC TGATTCGAGT 180 GCGTCCCGGT GAAAAGATTG CTGTTGATGG TGTCGTAGTA GAAGGTGTCT CTAGTATTGA 240 CGAATCCATG GTGACAGGTG AGAGTCTGCC TGTGGACAAG ACAGTTGGAG ATACTGTCAT 300 TGGCTCAACC ATCAATCATA GTGGAACGCT TGTCTTTAGA GCAGAAAAAG TTGGCTCAGA 360 GACTGTTTTG GCTCAGATTG TGGATTTTGT GAAGAAAGCT CAGACAAGTC GTGCGCCGAT 420 TCAGGACTTG ACGGATAAGA TTTCAGGGAT TTTTGTCCCA GTAGTTGTCA TTTTAGGAAT 480 CATGACCTTT TGGGTTTGGT TCGTCTTGCT CAGGGATAGT GTGGTCGTGC TTGGAGCTAG 540 CTTTGTGTCC TCTCTTCTCT ACGGAGTGGC GGTTTGATTA TCGCCTGTCC TTGTGCCTTG 600 GGACTTGCAA CACCGACAGC CCTTATGGTG GGGACAGGAC GTAGTGCCAA GATGGGGGTT 660 CTCCTCAAAA ATGGAACTGT CTTACAGGAA ATCCAGAAAG TTCAAACTCT TGTCTTTGAT 720 AAGACCGGGA CTTTGACGGA AGGGAAACCT GTGGTAACAG ATATCATCGG CGACGAAGTA 780 GAAGTGTTTG GATTGGCAGC CTCCTTGGAA GATGCTTCTC AACACCCACT GGCTGAGGCT 840 ATCGTTAAGC GAGCGAGTGA AGCTGGACTT GAGTTTCAAA CTGTTGAAAA TTTTCAGGCC 900 TTGCACGGGA AAGGTGTTTC AGGGCGAATC AATGGAAAAC AAGTTTTACT TGGAAATGCT 960 AAAATGCTGG ATGGCATGGA TATTTCTAAT ACTTATCAAG ATAAACTAGA AGAACTAGAA 1020 AAAGAAGCTA AGACAGTTGT GTTTTTAGCT GTTGACAATG AAATCAAAGG CTTGCTTGCT 1080 TTGCAAGATA TTCCTAAGGA AAATGCTAAG CTAGCCATCA GTCAGCTAAA AAAACGTGGT 1140 CTCCGAACAG TCATGCTGAC AGGAGACAAT GCTGGTGTGG CGCGTGCTAT TGCAGATCAA 1200 ATCGGAATTG AAGAGGTCAT TGCAGGCGTC TTGCCAGAAG AAAAAGCCCA TGAAATCCAT 1260 AAACTGCAAG CGGCTGGCAA AGTAGCCTTT GTTGGGGACG GTATCAATGA CGCTCCTGCC 1320 CTTAGTGTAG CAGATGTGGG AATTGCTATG GGTGCTGGAA CAGATATCGC CATCGAGTCA 1380 GCAGATTTGG TGTTGACAAC CAATAATCTT TTAGGAGTGG TTCGTGCCTT TGATATGAGT 1440 AAGAAAACCT TTCATCGAAT TCTACTCAAT CTTTTCTGGG CTTTTATCTA CAATGTTGTC 1500 GGAATTCCGA TTGCAGCAGG AGTCTTTTCA GGTGTTGGCT GGCTCTCAAC CCAGATTGGC 1560 AAGGCTAGCC CAATGGC 1577 (2) INFORMATION FOR SEQ ID NO: 63: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1089 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 63: AAAATGATAT AATAGAATTT ATGGATAAAA ATAAGATTAT GGGATTAACC CAAAGAGAAG 60 TCAAGGAAAG ACAGGCTGAG GGTTTGGTCA ATGACTTTAC CGCATCAGCC AGTACCAGCA 120 CTTGGCAAAT CGTTAAACGA AATGTCTTTA CCCTTTTTAA CGCTTTGAAC TTTGCCATTG 180 CTTTGGCCCT TGCCTTTGTG CAGGCTTGGA GCAATCTGGT CTTCTTTGCT GTTATCTGCT 240 TTAACGCTTT TTCTGGGATT GTGACCGAGC TACGAGCCAA ACACATGGTG GACAAGCTCA 300 ATCTCATGAC CAAGGAAAAG GTCAAAACCA TCCGTGATGT CAGGAAGTTG CTCTTAATCC 360 TGAAGAATTA GTGCTAGGAG ATGTCATTCG TTTGTCTGCA GGAGAGCAGA TTCCTAGTGA 420 TGCCTTGGTT TTGGAAGGCT TTGCGGAAGT CAATGAAGCC ATGTTAACGG GAGAAAGTGA 480 TTTGGTGCAA AAGGAAGTTG ACGGCTTACT TTTGTCAGGA AGTTTCCTAG CCAGTGGGTC 540 AGTTTTATCT CAAGTTCACC ATGTCGGTGC AGACAACTAT GCTGCCAAAC TCATGCTTGA 600 GGCTAAGACC GTTAAACCCA TCAACTCCCG TATCATGAAA TCGCTGGACA AGTTGGCTGG 660 TTTTACTGGG AAGATTATCA TTCCCTTTGG TCTGGCTCTC TTGCTGGAAG CCTTGCTTTT 720 AAAAGGCCTG CCTCTCAAGT CATCCGTTGT AAACTCGTCG ACAGCTCTTT TGGGAATGTT 780 GCCTAAGGGA ATTGCCCTTT TGACCATTAC TTCGCTCTTG ACTGCAGTGA TTAAGTTGGG 840 CTTGAAAAAG GTCTTGGTGC AGGAGATGTA CTCTGTTGAG ACCTTGGCGC GCGTGGATAT 900 GCTCTGTCTG GACAAGACGG GCACCATCAC CCAAGGAAAG ATGCAGGTGG AGGCTGTTCT 960 TCCACTGACG GAAACTTACG GTGAAGAGGC TATTGCCAGC ATCTTGACTA GCTACATGGC 1020 CCATAGTGAG GATAAGAATC CAACTGCCCA AGCCATTCGC CAGCGTTTGT GGGAGATGTT 1080 GCTTATCCT 1089 (2) INFORMATION FOR SEQ ID NO: 64: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 731 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 64: GCTAGCAATA TCATGTTTAT GCTTGATTTG GGGAATCATT TAGATCAGTG GTCCTTGAAA 60 AAAACTGCAA CAGATTTAGA ACAGAGTCTT CTTGCAAAAG AGAGCGATGT ATTCCTAGTA 120 CAGGGCGATA CGGTTGTTAG TATCAAGAGT TCCGATGTTC AAATAGGAGA TGTCTTGATC 180 TTATCTCAAG GAAATGAAAT TCTGTTTGAT GGACAAGTAG TTTCAGGTTT AGGTATGGTC 240 AACGAAAGTT CCTTGACAGG AGAGAGTTTT CCAGTTGAAA AAAGAGAGTC TGATTTGGTT 300 TGTGCAAATA CAGTATTAGA AACTGGAGAG TTACGCATTC GTGTAACAGA TAATCAGATG 360 AACAGCCGTA TTTTACAGCT GATTGAGTTG ATGAAGAAAT CTGAAGAAAA CAAGAAAACG 420 AAACAACGCT ATTTCATCAA GATGGCGGAT AAAGTCGTCA AATATAATTT CTTGGGGTCT 480 GGGCTGACTT ACCTATTGAC AGGTTCTTTT TCTAAGGCTA TTTCTTTCCT ATTGGTCGAT 540 TTCTCCTGCG CTTTGAAAAT CTCTACTCCT GTAGCTTATT TGACAGTTAT CAAGGTAGGG 600 TTGAACCGTG AAATGGTGAT TAAGGATGGA GATGTTCTGG AGAAATATCT GGTAGTTGAT 660 ACTTTCTTGT TTGATAAGAC AGGACCAATC ACAACTAGTT ATCCTATAGT TGAAAAGGTG 720 TACCCTTTGG G 731 (2) INFORMATION FOR SEQ ID NO: 65: ( ) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2197 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (m) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 65: TATATTATTC CATTTGTGGT AAATCTGTAC ATGATAGATT AAGTACTCCG ACTGAAACCA 60 GTACACTAAT CAAGCTATAG CCAGCTAACA AAAGGAGTAA CCATAGAATA TTAACTTTTA 120 AATTTTCCTT CATCGTTTAC ACCTTCTCTT TCACATTCTT ACCAAGGATA CCAGCTGGGC 180 GGACAATCAA GATCAACAAC AAGATTCCAT AAACAATGGC ATCACGGAAA TCTGACATCC 240 CAAAGGCTGT CGCAAAGGTT TCCAATAGAC CAATCACAAA GCCACCAAGA GCCGCACCAG 300 GAATAATTCC GATACCACCA AGTACTGCGG CAACGAAAGA TTTAAGACCT GGAGTAACCC 360 CCATCAAAGG CTCAAGAGAG TTATAATAAA GAGCAATCAG AACACCAGCC GCACCCGCAA 420 GAGCAGAACC CAAAGCGAAG GTAAAGCTAA TCGTACGGTT TATATTGATC CCCATCAATT 480 GCGCCGCGTC GCTATCTACT GATACTGCAC GCATGGCTTT CCCCATCTTA GTCTTTTGGA 540 CAATGACTTG TAACAAAATC ATCAAAATCA AGGAAATGCC CAAAATCATT AACTGCACAT 600 TTGTTAAGCT AATTGGTCCC AAATCATATC GAACTGTTTG AATCGCTTGA GGGAAGGCAC 660 GGGTATTGGC ACCAACCAGA TAGACCATTC CATACTCCAA TAGGAAAGAA ACCCCAATAG 720 CCGTAATCAA AACAGCAATA CGAGTAGAGT GGCGCAAAGG TCGGTAAGCA AGAAACTCAA 780 TCACGACACC AAGAATAGCT GTCGCTAGCA TAGCTACAAT AAGCGCTACA AAGAAATTCA 840 TTTGGAAAGA ATTGATCAAG AAATAACCGA TAAAGGCTCC CATCATATAA ATATCACCAT 900 GGGCGAAGTT GATGAGCTTG ATAATTCCGT AAACCATGGT ATATCCTAGG GCTAACAGCG 960 CGTAAACACT ACCTAGAATC AAACCATTTA CGAGTTGTTG GAGCATAAGA TTCACTCTTT 1020 CTATTTATAA TTCCGAGGGT TTTCCCTCAC TTTTTGATAG GTTCTTATAC TCAATGAAAA 1080 TCAAAGAGCA AACTAGGAAA CTAGCCGCAG GTTGCTCAAA GCACTGCTTT GAGGTTGTAG 1140 ATAAGACTGA CGAAGTCAGT CACATATATA ATCCAAGGCG ACGTTGACGC AGTTTGAAGA 1200 GATTTTCGAA GAGTATTAAA TATCGAAACA GGGAGTGAGT CAAAGGCTCA TTCCCTATTT 1260 CAACATTTTT CTATTATGGT TTTACAACTT CTGCTGCTTC AACTTTACCA TTGTTCATGG 1320 TCATCATGTA AGCAGTTTTG ACTGTGTTGT GGTCTGCATC GAAGCTTGTT TGACCAGTTA 1380 CACCTTCAAA ATCTTTTGTT TTAGCAAGGT TATTCTTGAT TTCACCTGAA TTTTTAGCAC 1440 CTTTTGCTGC GTTTGCTACA AGGTGAACTG AATCATAAGC CAAGGCTGCA AATGTTGAAG 1500 GCTCTTCATT GTACTTAGCA CGGTAAGCGT CAAGGAAGGC TTTAGCTTTA GCTGAAACTT 1560 CTACAGTAGT TGAGAAGCCT GAGATAAAGT AGATGTTTGA TGCTTTTTCA GCAGTTGCTT 1620 GTTGTACAAA CTCCTCACCG TTGAATCCAT CACCACCAAC GATTGGTTTG TCAATTCCCA 1680 TACCACGCGC TTGGTTTACA ATCTTACCAG CCTCATTATA GTAACCAGGA ACAACGATAG 1740 CATCAAAGTC TTTCCCTTTC ATTTTTGTAA GGGCTGCTTG GAAGTCTGTG TCACCTGCTA 1800 CGAAAGTTTC ATCTGCAACG ATTTCACCCT TGTATGACTC GCGGAAAGAT TTGGCAATCC 1860 CTTTAGCATA GTCACTGGCA TTGTCAGTGT AAAGAACAAC TTTCTTAGCA TTTAATTTTT 1920 CAGAAACATA GTTTGAGATA ATTTTTCCTT GGAAGCTATC TTGGAAAGTT CCAATAAAGA 1980 GGTAATCTTG ACCTTTAGTC AATCCATCTT GAGTCGCACT TGGTGAGATC AATGGAACAC 2040 CTGCTTTTGT AGCGTTCGCT ACCGCAGCTG CAGTCGCACC AGATGTCGCA GGTCCTACGA 2100 CTGCTGATAC TTTAGATTGG GTTACAAGGT TAGTTGTAAC TGAAGCAGCC TCAGCTGTTT 2160 CAGACTTATT ATCTTTATCG ACTACTTCGA TTTGTTT 2197 (2) INFORMATION FOR SEQ ID NO: 66: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 900 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 66: TGTCCCAAGA CCAGACTTGG TATGCTCTGG CCTATGATGG GGCAGAAGTG ATTGGCTTTC 60 TAACTGTTCA GGAGACTCTC TTTGAAGCAG AAGTCCTGCA AATCGCTGTC AAAGGAGCTT 120 ATCAGGGTCA GGGAATTGCG TCAGCCTTGT TTGCTCAATT GCCGACAGAC AAGGAAATTT 180 TCCTCGAAGT CAGACAGTCA AATCAACGAG CGCAAGCATT TTACAAGAAA GAAAAGATGG 240 CAGTTATCGC TGAGCGAAAG GCCTACTACC ATGACCCAGT CGAGGACGCC ATTATCATGA 300 AGAGAGAAAT AGATGAAGGA TAGATATATT TTAGCATTTG AGACATCCTG TGATGAGACC 360 AGTGTCGCCG TCTTGAAAAA CGACGATGAG CTCTTGTCCA ATGTCATTGC TAGTCAAATT 420 GAGAGTCACA AACGTTTTGG TGGCGTAGTG CCCGAAGTAG CCAGTCGTCA CCATGTCGAG 480 GTCATTACAG CCTGTATCGA GGAGGCATTG GCAGAAGCAG GGATTACCGA AGAGGACGTG 540 ACAGCTGTTG CGGTTACCTA CGGACCAGGC TTGGTCGGAG CCTTGCTAGT TGGTTTGTCA 600 GCTGCCAAGG CCTTTGCTTG GGCTCACGGA CTTCCACTGA TTCCTGTTAA TCACATGGCT 660 GGGCACCTCA TGGCAGCTCA GAGTGTGGAG CCTTTTGGAG TTTCCCTTGC TAGCCCTTTT 720 AGTTCAGTGG GTGGGGCACA CAGAGTTGGT CTATGTTTCT GAGGCTGGCG ATTACAAGAA 780 TTGTTGGGGA AGACACGAGA CGATGCAGTT GGGGAGGCTT ATGACAAGGT CGGTCGTGTC 840 ATGGCTTGAC CTATCCTGCA GGTCGTGAGA TTGACGAGCT GGCTCATCAG GGGCAGGATA 900 (2) INFORMATION FOR SEQ ID NO: 67: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1023 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 67: CCGGCGATCT TCCGCTAGAA ATAGTCTACC AAGATGAGGA TGTGGCTGTC GTTAACAAAC 60 CTCAGGGAAA TGGTTGTGCA CCCGAGTGCT GGTCATACCA GTGGAACCCT AGTAAATGCC 120 CTCATGTATC ATATTAAGGA CTTGTCGGGT ATCAATGGGG TTCTGCGTCC AGGGATTGTT 180 CACCGTATTG ATAAGGATAC GTCAGGTCTT CTCATGATTG CTAAAAACGA TGATGCGCAT 240 CTAGTACTTG CCCAAGAACT CAAAGATAAA AAGTCTCTCC GCAAATATTG GGCGATTGTT 300 CATGGAAATC TGCCTAATGA TCGTGGTGTA ATTGAAGCGC CGATTGGCCG GAGTGAAAAA 360 GACCGTAAGA AACAGGCTGT AACTGCTAAA GGGAAGCCTG CAGTGACGCG TTTTCACGTC 420 TTGGAACGCT TTGGCGATTA TAGCTTAGTA GAGTTGCAAC TGGAGACAGG GCGCACTCAT 480 CAAATCCGTG TCCACATGGC TTATATCGGC CATCCAGTCG CTGGTGATGA GGTCTATGGT 540 CCTGCAAGAC TTTGAAAGGA CATGGACAAT TTCTTCATGC CAAGACTTTA GGTTTTACTC 600 ATCCGAGAAC AGGTAAGACC TTGGAATTTA AAGCAGATAT CCCAGAGATT TTTAAGGAAA 660 CCTTGGAGAG ATTGAGAAAG TAAGAATGAA AAAGAAATTA ACTAGTTTAG CACTTGTAGG 720 CGCTTTTTTA GGTTTGTCAT GGTATGGGAA TGTTCAGGCT CAAGAAAGTT CCAGGAAATA 780 AAATCCACTT TATCAATGTT CAAGAAGGTG GCAGTGATGC GATTATTCTT GAAAGCAATG 840 GACATTTTGC CATGGTGGAT ACAGGAGAAG ATTATGATTT CCCAGATGGA AGTGATTCTC 900 GTTATCCATG GAGAGAAGGA ATTGAAACGT CTTATAAGCA TGTTCTAACA GACCGTGTCT 960 TTCGTCGTTT GAAGGAATTG AGTGTCCAAA AACTTGATTT TATTTTGGTG ACCCATACCC 1020 ACA 1023 (2) INFORMATION FOR SEQ ID NO: 68: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 675 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 68: GCTCGGTACC CGGGGATCCT CTAGAGTCGA TAATATCAAC CTGCAGGTTG ATGAACGAGA 60 TCGGATTGCT CTTGTTGGGA AAAATGGTGC AGGTAAGTCT ACTCTTTTGA AGATTTTAGT 120 TGGAGAAGAG GAGCCAACTA GCGGAGAAAT CAATAAGAAA AAAGATATTT CTCTGTCTTA 180 CCTAGCCCAA GATAGCCGTT TTGAGTCTGA AAATACCATC TACGATGAAA TGCTTCATGT 240 CTTTAATGAT TTGCGTCGGA CGGAGAGACA ACTGCGTCAG ATGGAGCTGG AGATGGGTGA 300 AAAGTCTGGT GAGGATTTGG ATAAACTGAT GTCAGATTAT GACCGCTTAT CTGAGAATTT 360 TCGCCAAGCA GGTGGCTTTA CCTATGAAGC TGATATTCGA GCGATTTTGA ATGGATTCAA 420 GTTTGACGAG TCTATGTGGC AGATGAAAAT TGCTGAGCTT TCTGGTGGTC AAAATACTCG 480 TTTGGCACTT GCCAAAATGC TCCTTGAAAA GCCCAATCTC TTGGTCTTGG ACGAGCCAAC 540 TAACCACTTG GATATTGAAA CCATCGCCTG GCTAGAGAAT TACTTGGTAA ACTATAGCGG 600 TGCCCTCATT ATCGTCAGCC ACGACCGTTA TTTCTTGGAC AAGGTTGCGA CAATTACGCT 660 AGATTTGACC AGCAT 675 (2) INFORMATION FOR SEQ ID NO: 69: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 582 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 69: TAGAGTCGAT AGCAATAGAT TGAGTAAGTT GTAGCCTTAC CAGCATCGAT AGAAACAAGG 60 GCACCACGGT GACGTCCACC AATTTCCCCT GGAATCAATG GCAAGTATTG GTCGAAGGTA 120 TGGTTCATGA TACCGTAACC ACGAGTCATT GACAAGAACT CAGTTGAGTA TCCAATCAAA 180 CCACGCGCTG GAACAAGGAA GACCAAACGA GTTTGACCAT TACCAGTTGA AATCATATCC 240 AACATTTCAC CTTTACGTTC AGAAAGGCTT TGGATAACAG ACCCTTGGTA TTCTTCTGGA 300 GTGTCGATTT GTACACGTTC AAATGGTTCA CATTTAACAC CGTCGATTTC TTTTACGATA 360 ACTTCTGGAC GAGATACTTG AAGTTCATAG CCCTCACGAC GCATTGTTTC GATAAGGATT 420 GACAAGTGCA ATTCTCCACG TCCTGAAACA GTCCATTTAT CTGCGTGAAT CAGTTGGGTC 480 AACACGAAGG AACGTCTGTT TGCAATTCTG CCTGCAAGCG TTCTTCCACC TTACGAGAAG 540 TTACCCATTT ACCTTCTTTA CCAGCAAATG GTGAGTTGTT GA 582 (2) INFORMATION FOR SEQ ID NO: 70: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1337 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ill) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:70: TTGGATTGAA GAACAAAGAT TTGGACTCTA TTGACCTTAT GGTTTGGGGG AAATTTGGAA 60 TTTCAAAGTC GCCCAACCCC CTCATTTCTA AAGAATTGGA AGCCGGATGG GACTCTACCA 120 AACACGTTTA ACCCAAAGAA AATTGGCAGG AAGAAATGGA AAAAATTTGA TTTTTAAAAA 180 ATACTTAAGG AAACTTTAAG CTAGGGAGTG TACCCTAAGT TCAATAAAGT TAAAGAAGAC 240 CTTAACTTAA ACTCCTAAAA CTTTTTCAAT AATAATCTCC CTATAAAAAT AAAGTCGCCC 300 AATCAGGCGG CTTAATTTTT TTGAAAAATG GGCTTGGTGC CTGAGAATAA ATAGCTTAGT 360 GATAGAAGAA AATGGGGAAA. TATGGTATAA TGAAACGATA GATTTTTGAA TAGGAATAAG 420 ATCATGTTTG GATTTTTTAA GAAAGATAAG GCTGTGGAAG TAGAGGTTCC GACACAGGTT 480 CCTGCTCATA TCGGCATCAT CATGGATGGC AATGGCCGTT GGGCTAAAAA ACGTATGCAA 540 CCGCGAGTTT TTGGACACAA GGCGGGCATG GAAGCATTGC AAACCGTGAC CAAGGCAGCC 600 AACAAACTGG GCGTCAAGGT TATTACGGTC TATGCTTTTT CTACGGAAAA CTGGACCCGT 660 CCAGATCAGG AAGTCAAGTT TTCATGAACT TGCCAGTAGA GTTTTATGAT AATTATGTCC 720 CGGAACTACA TGCGAATAAT GTTAAGATTC AAATGATTGG GGAGACAGAC CGCCTGCCTA 780 AGCAAACCTT TGAAGCTTTA ACCAAGGCTG AGGAATTGAC TAAGAACAAC ACAGGATTGA 840 TTCTTAATTT TGCTCTTAAC TATGGTGGAC GTGCTGAGAT TACACAGGCG CTTAAGTTGA 900 TTTCCCAGGA TGTTTTAGAT GCCAAAATCA ACCCAGGTGA CATCACAGAG GAATTGATTG 960 GTAACTATCT CTTTACTCAG CATTTGCCTA AGGACTTACG AGACCCAGAC TTGATTATCC 1020 GTACTAGTGG AGAATTACGT TTGAGCAATT TCCTTCCATG GCAGGGAGCC TATAGTGAGC 1080 TTTATTTTAC GGACACCTTA TGGCCTGATT TTGACGAAGC GGCCTTGCAG GAAGCTATTC 1140 TTGCCTATAA TCGTCGTCAT CGCCGATTTG GAGGAGTTTA GGAGGAAATA TGACCCAGGA 1200 TTTACAGAAA AGAACCTTGT TTGCAGGGAT TGCCCTGGCT ATTTTCCTAC CAATTTTAAT 1260 GATTGGGGGC TCTTGCTTCA GATAGCAATC GGAATCGTAG CCATGCTAGC CATGCATGAA 1320 CTTTTGAAGA TAAGAGG 1337 (2) INFORMATION FOR SEQ ID NO:71: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 818 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:71: TCGGTACCCG GGGATCCTCT AGAGTCGATA GTCGCCAAGC AGAAGAAGGG AACACCATTC 60 GTAGAAGACG TGAGTGCGAC GAATGCCAAC ACCGTTTTAC AACCTACGAA CGAGTAGAAG 120 AAAGAACCTT AGTGGTTGTT AAAAAAGATG GCACACGGGA ACAATTCTCC AGAGATAAAA 180 TCTTTAATGG GATTATCCGC TCAGCCCAGA AACGTCCTGT GTCAAGTGAT GAAATCAACA 240 TGGTGATCCT CTAGAGTCGA ACAGAAACTC CGTGGTCGAA ATGAAAATGA AATTCAAAGT 300 GAGGACATTG GTTCACTCGT CATGGAGGAG TTGGCTGAAT TGGACGAGAT TACCTATGTA 360 CGTTTTGCTA GTGTCTATCG TAGTTTTAAG GATGTCAGTG AGTTAGAGAG CTTGCTCCAA 420 CAAATCACCC AGTCCTCTAA AAAGAAAAAG GAAAGATAAA TGAAGCCAAT TGACCGTTTT 480 TCTTATCTAA AGAATAATCG GGTGTCGCAA GATACCTCAT CTCTGGTACA GTGCTACCTC 540 CCGATTATCG GTCAGGAGGC ACTGAGCCTT TATCTTTATA CGATTAGTTT TTGGGATAAT 600 GGTAGAAAGG AATATCTTTT TTCAAGTATC CTCAATCATC TTAACTTTGG AATGGATAGA 660 CTGATAAAAT CATTGAAAAT CTTATCTGCT TTTAATCTCT TGACTCTCTA TCAAAAGGGG 720 GATGTTTATC AGCTAGCCCT CCATGCTCCT CTATCTAGTC AAGACTTCTT GGGGCATCCT 780 GTTTATCGCA GACTCTTAGA GAAAAAGATT GGGGACAA 818 (2) INFORMATION FOR SEQ ID NO: 72: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 746 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 72: TTACCCGGGG ATCCTCTAGA GTCGATATGC TCTCTGAGGG TCAATTCCTC ATACAGACTA 60 GGCGTCTCAG GAATGTAGCC AATCTGCTTG CGGTAGCTAG TCGCATCTCC TTGCAGAGTC 120 AGGCCATTGA TATTGATGGA GCCACTATAA GGTGCCAACA GACCGATAAT CTCATTGATC 180 GTCGTTGATT TCCCAGCACC ATTGAGACCA ATCAAACCGA CCAACTGCCC ACTTTCAACA 240 GTAAAGGACA CATCTTTCAA AACAGGAACA TGAACATAGC CACCTGTCAG GTTTTTAATT 300 TCTAACATAT TTTCTCCAAA TCTGGTATAA TGTAGCTATA TTATATCAAA ATTCAGTACA 360 GTAGAGGTAG ATTTTATGTC AGATTGCATT TTTTGTAAAA TCATCGCAGG GGAAATTCCT 420 GCTTCGAAAG TATATGAAGA TGAGCAGGTC CTTGCCTTTC TTGATATCTC TCAAGTAACA 480 CTAGGACACA CCTTGGTCGT GCCAAAAGAA CACTATCGCA ATCTTTTGGA GATGGATGCT 540 ACGAGCGCCA CCAACTCTTT GCCCAAGTAC CAAAAGTAGC TCAAAAAGTC ATGAAAGTCA 600 CTAAGGCTGC TGGTATGAAT ATCATTTCCA ACTGTGAAGA AGTCGCTGGT CAAACAGTTT 660 TTCATACTCA CGTTCACCTT GTGCCTCGCT ACAGTGCTGA CGATGACCTC AAGATTGATT 720 TTATCGCCCA CGAAACAGAC TTTGAC 746 (2) INFORMATION FOR SEQ ID NO: 73: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 767 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:73: GATCCAAGCA GTCCGTGATG TAAGCTTTGA AGTTAATGAA GGAGAAGTTG TTTCCCTTAT 60 CGGTGCCAAC GGTGCAGGTA AGACAACTAT TCTTCGCACC TTGTCAGGTT TGGTTCGACC 120 AAGTTCAGGA AAGATTGAAT TTTTAGGTCA AGAAATCCAA AAAATGCCAG CTCAGAAAAT 180 TGTGGCAGGT GGTCTTTCAC AAGTTCCAGA AGGACGCCAC GTCTTTCCTG GCTTGACTGT 240 TATGGAAAAT CTTGAAATGG GAGCTTTCTT AAAGAAAAAT CGTGAAGAAA ATCAAGCTAA 300 CTTGAAGAAG GTTTTCTCAC GCTTTCCTCG TCTTGAAGAA CGTAAGAACC AAGATGCAGC 360 TACTCTTTCA GGAGGGGAAC AACAAATGCT TGCCATGGGA CGCGCTCTTA TGTCAACACC 420 AAAACTTCTT CTTTTAGATG AACCATCAAT GGGACTTGCC CCAATCTTCA TCCAAGAGAT 480 TTTTGATATC ATTCAAGATA TTCAGAAGCA AGGAACAACC GTCCTCTTGA TTGAACAAAA 540 TGCCAATAAA GCACTTGCAA TCTCTGACCG AGGATATGTA CTGGAACAGG GAAATCGTCT 600 ATCAGGGACA GGGAAAGACT CGCTCATCAG AGGAGTCAGA GCATATCTAG GTGGTAAACA 660 TCCAGTGGAT TTTTGTCGGC AGTGAGTTCG GGATCATCAT TTAGTTGGGG CTTGTTAGGT 720 TCAGTAAGTC GGTTATCAAA TCAGGGTTGT TTGCCGCAGT GGGGTCG 767 (2) INFORMATION FOR SEQ ID NO: 74: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 695 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 74: GAGCTCGGTA CCCGGGGATC CTCTAGAGTC GATAATTCGT TGGTTGGACG AACCTCGAAA 60 CTGGAGCATG AGATTTCTCT TAGTTCGATC ATATCTTCCA TCGACAAGAA TGTCAATCAA 120 TGATAAGAGT TCCAGTTTAT CTGGAGTTTC CGGGATCATT TCTTCCCAAG TGTAGCCCGT 180 CCAGGACCAA ATGTCCTTGT CTGGCAATTC CTTTCGGATG CGTTTAACTA GAGGCAAGAG 240 AATGCCAGTA TTGAGAAAAG GCTCCCCTCC CAGCAAAGTC AAGCCTTGAA CATAGGGTTG 300 GGCAAGGTCT GCCATAATCT GCTCTTCTAA TTCTGCTGTA TAGGGAATGC CAGCATTAAA 360 AGACCAAGTC GCAACATTAT AACATCCCTC GCAGTGAAAC ATACAGCCTG ATACATAGAG 420 AGAGTTGCGC ACGCCTTCGC CGTCCACAAA GTTAAAGGCC TTGTAGTCAA TGATACGACC 480 TTGACTAAGT TCCTCGCTTT TCCATTCTTG TGGTTTTGGA TTATTCATTC GCTACCTCTA 540 TCCAATAACG CTCGACTCCA TTGCGAGCAT CCTCAAATAT TCCACCATTT GCTAGAATGA 600 CTGCTCTGCT AGCAGGATTA TTCACGCTAC AGGGCACCAG AGCTTTCTTG ATGTCTTTTC 660 CCTAGCAACT TCAAGCCCTG ACGGAAGTCT TTTTT 695 (2) INFORMATION FOR SEQ ID NO: 75: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 723 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 75: CTCGGTACCC GGGGATCCTC TAGAGTCGAC GGCTACAATG ATATTAAGAT GGATGATGTG 60 ATTGACGCGT ATGTCATGGA AGAAATCAAG AGATAAGATT TTTTGCTCCT TTCTTAGGTG 120 GTGAGGGACG CAAGCAAACC GATGGTTTCA TTGCTTATTT TTGAGCCTAG GGTCTCAAAA 180 ATCCCCTGTG ATGGGACTGA TAAATCAGTT CCATCACTTT CACCACGGCG AAAGAAGCAG 240 ATGACTTCAA ATTGAACTTC GTTTCAATTT AAACTGAAAA TCAAGAAGTT TAAAATAGCT 300 AGGTCTGCTG GCCTAGCTTT TGGTTCAAAG TAGAGAAAGG AATATCATGG TAAATCATTT 360 CCGTATAGAT CGTGTGGGCA TGGAAATCAA GCGTGAAGTC AATGAGATTT TGCAAAAGAA 420 AGTCCGTGAT CCACGTGTCC AAGGTGTGAC CATCACAGAT GTTCAGATGC TGGGTGACTT 480 GTCTGTTGCC AAGGTTTATT ACACCATTTT GAGTAACCTT GCTTCGGATA ACCAAAAAGC 540 CCAAATCGGG CTTGAAAAAG CAACTGGTAC CATCAAACGT GAACTTGGTC GCAATTTGAA 600 ATTGTACAAA TCCCAGATTT GACCTTCGTC AAAGACGAGT CCATCGAGAT GGAACCAAGA 660 TTGACGAGAT GCTACGAAAT CTGGATAAGA CTAAAGAAGA GGGGGTTGCC CCCCTTTTTT 720 GGG 723 (2) INFORMATION FOR SEQ ID NO: 76: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 970 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 76: TGTCCTTATT TGTCTGACCA AGTGCAAGCT GGTCGGATTT GTGGTAACAT TGGATAAGAT 60 TTGACAAAGG AATTTCCATC ATGTAACGGT CTTACTCCAC GAAACGATTG ATATGCTTGA 120 CGTAAAGCCT GAAGGTATCT ACGTTGATGC GACTTTGGGC GGAGCAGGAC ATAGCGAGTA 180 TTTATTAAGT AAATTAAGTG AAAAAGGCCA TCTCTATGCC TTTGACCAGG ATCAGAATGC 240 CATTGACAAT GCGCAAAAAC GCTTGGCACC TTACATTGAG AAGGGAATGG TGACCTTTAT 300 CAAGGATAAC TTCCGTCATT TACAGGCACG TTTGCGCGAA GCTGGTGTTC AGGAAATTGA 360 TGGAATTTGT TATGACTTGG GAGTGTCTAG TCCTCAATTG GACCAGCGTG AGCGTGGTTT 420 TTCTTATAAA AAGGATGCGC CACTGGACAT GCGGATGAAT CAGGATGCTA GTCTGACAGC 480 CTATGAAGTG GTTAATCATT ATGACTATCA TGATTTGGTT CGTATTTTCT TCAAATACGG 540 TGAGGATAAA TTCTCTAAAC AGATTGCGCG TAAGATTGAG CAAGCGCGTG AAGTGAAGCC 600 GATTGAGACA ACGACTGAGT TAGCAGAGAT TATCAAGTTG GTCAAACCTG CCAAGGAACT 660 CAAGAAGAAG GGTCATCCTG CTAAGCAGAT TTTCCAGGCT ATTCGAATTG AAGTCAATGA 720 TGAACTGGGA GCGGCAGATG AGTCCATCCA GCAGGCTATG GATATGTTGG CTCTGGATGG 780 TAGAATTTCA GTGATTACCT TTCATTCCTT AGAAGACCGC TTGACCAAGC AATTGTTCAA 840 GGAGCTTCAA CAGTTGAAGT TCCAAAAGGC TTGCTTTCAT CCCAGATGAT CTCAAGCCCA 900 AGATGGAATT GGTGTCCCGT AAGCCAATCT TGCCAAGTGC GGAAGAGTTA GAAGCCAATA 960 ACCGTTGACT 970 (2) INFORMATION FOR SEQ ID NO: 77: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 954 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO ( iv) ANTI-SENSE : NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 77: GAAAGGAGTA ACTGATGCAC GTAACAGTAG GTGAATTAAT TGGTAATTTT ATTTTAATCA 60 CTGGCTCTTT TATTCTTTTG CTAGTCTTGA TTAAAAAATT TGCATGGTCT AATATTACAG 120 GCATTTTCGA AGAAAGAGCT GAAAAAATTG CTTCAGATAT TGACAGAGCT GAAGAAGCCC 180 GTCAAAAAGC AGAAGTATTG GCTCAAAAAC GCGAAGATGA ATTGGCTGGT AGCCGTAAAG 240 AAGCTAAGAC AATCATTGAA AATGCAAAGG AAACAGCTGA GCAAAGTAAG GCTAATATCT 300 TAGCAGATGC TAAACTAGAA GCGGGACACT TAAAAGAAAA AGCCAATCAA GAAATTGCTC 360 AAAATAAAGT AGAAGCTTTA CAGAGTGTTA AGGGTGAGGT CGCAGATTTG ACCATCAGCT 420 TAGCTGGTAA AATCATCTCA CAAAACCTTG ACAGTCATGC CCATAAAGCA CTCATTGATC 480 AGTATATCGA TCAGCTAGGA GAAGCTTAAT GGACAAGAAA ACAGTAAAGG TAATTGAAAA 540 ATACAGCATG CCTTTTGTCC AATTGGTACT TGAAAAAGGA GAAGAAGACC GTATCTTTTC 600 AGACTTGACT CAAATCAAGC AAGTTGTTGA AAAAACAGGT CTGCCTTCTT TTTTAAAACA 660 AGTGGCAGTA GACGAGTCGG ATAAGGAAAA AACAATTGCT TTTTTCCAAG ATTCTGTGTC 720 ACCTTTATTA CAAAACTTTA TCCAGGTTCT GGCCTACAAT CACAGAGCAA ATCTTTTTTA 780 TGATGTGCTT GTAGATTGCT TGAACCGACT TGAAAAAGAA ACAAATCGAT TTGAAGTGAC 840 GATTACGTCT GCTCATCCTC TAACTGATGA ACAGAAGACT CGTTTGCTCC CTTTGATTGA 900 GAAAAAAATG TCTCTGAAAG TAAGGAGTGT AAAAGAACAA ATCGATGAAA GTCT 954 (2) INFORMATION FOR SEQ ID NO: 78: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1602 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:78: CCTGATTATA CCCAACCTCT TTGCATCAAG TCGGAAAAAT GAGTGAAATG GGTTTCCAGT 60 TTTCCTGAAA TAAGGTATCC TATATAAAGT ACCCTATGAT AACCATGGAG GTATTGTGTA 120 TGGTTCAAAC AAGTCATTGA AGAAATACAA AACAATGCCA ACATTGTGGA AGTCATAGGA 180 GATGTGATAT CTTACAAAAG GCAGGACGGA ACTATCTAGG GCTCTGTCCT TTTCATGGTG 240 AAAAAACACC ATCTTTCAGC GTTGTAGAGA ACAAGCAGTT TTACCACTGT TTTGGTTGTG 300 GTCGCTCAGG TGATGTCTTT AAAATTCATC GAGGAGTACC AAGGGGTTAC CTTTATGGAG 360 GCTGTCCAAA TCTTAGGTCA GCGTGTCGGG ATTGAGGTTG AAAAACCGCT TTATAGTGAA 420 CAGAAGCCAG CCTCGCCTCA CCAAGCTCTT TATGATATGC ACGAAGATGC GGCTAAATTT 480 TACCATGCTA TTCTCATGAC AACGACTATG GGCGAAGAGG CCAGAAATTA CCTTTATCAG 540 CGGGGTTTGA CAGATGAAGT GCTTAAACAT TTTTGGATTG GTTTAGCACC TCCAGAACGA 600 AACTATCTCT ATCAACGTTT GTCTGATCAG TATCGTGAAG AGGATTTACT GGATTCAGGC 660 CTGTTTTATC TTTCGGATGC CAATCAATTT GTAGACACCT TTCACAATCG CATTATGTTT 720 CCCCTGACAA ATGACCAAGG AAAGGTCATT GCCTTCTCAG GTCGTATCTG GCAAAAAACG 780 GATTCACAAA CTTCTAAGTA TAAAAACAGC CGTTCGACTG TAATTTTTAA CAAAAGTTAC 840 GAATTATATC ATATGGATAG GGCAAAAAGA TCTTCTGGAA AAGCTAGTGA GATTTACCTG 900 ATGGAAGGAT TCATGGATGT TATTGCAGCC TATCGGGCTG GAATCGAAAA TGCTGTGGCG 960 TCGATGGGAA CGGCCTTGAG TCGAGAGCAT GTTGAGCATC TGAAAAGGTT AACCAAGAAA 1020 TTGGTTCTTG TTTACGATGG AGATAAGGCT GGGCAAGCCG CGACATTGAA AGCATTGGAT 1080 GAAATTGGTG ATATGCCTGT GCAAATCGTC AGCATGCCTG ATAACTTGGA TCCTGATGAA 1140 TATCTACAAA AAAATGGTCC AGAAGACTTG GCCTATCTAT TAACGAAAAC TCGTATTAGT 1200 CCGATTGAGT TCTACATTCA TCAGTACAAA CCTGAAAACG GTGAAAATCT GCAGGCTCAG 1260 ATTGAGTTTC TTGAAAAAAT AGCTCCCTTG ATTGTTCAAG AAAAGTCCAT CGCTGCTCAA 1320 AACAGCTATA TTCATATTTT AGCTGACAGT CTGGCGTCCT TTGATTATAC CCAGATTGAG 1380 CAGATTGTTA ATGAGAGTCG TCAGGTGCAA AGGCAGAATC GCATGGAAAG AATTTCCAGA 1440 CCGACGCCAA TCACCATGCC TGTCACCAAG CAGTTATCGG CTATTATGAG GGCAGAAGCC 1500 CATCTACTCT ATCGGATGAT GGAATCCCCT CTCGTTTTGA ACGATTACCG TTTGCGAGAA 1560 GACTTTGCAT TTGCTACACC TGAATTTCAG GTCTTACATG AC 1602 (2) INFORMATION FOR SEQ ID NO: 79: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 7203 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 79: CCTCCATCAA ATCTGAGACT GATTCAAAAG ACTGGCTCAT ATTACGATTT TGGTCTAAAT 60 GCGTTAACAC TTGGAGCAAC TTCCGATTTT CGTCTAGTCT AACATCAAAA GGTAATCCCT 120 GATATTGAAT TGCCTGACGA AAGGAAAATA TTAATAGCTG TTGTCATATC CATTCCCAGA 180 TTACTAAACA CCTGTTGGGC CTGCTCCTTA ACCTCACTAT CCAGACGGAT GCTCATACTC 240 ATCTTTGACA TACTCTCACC CTCTTTCCAT AGACTATTTT AACAAAAAAG AAAGCTAATG 300 TAAATCTATT GGATATACGT TAGCCTCTTC TAATAGATTA TTAAGCAATT TTTTAAAACA 360 ACTCATCAAA CAAACTCAAC TGGTTATCCT CTGGCATATT TCCAAGAATA CCCATCTCAT 420 CCATCTTTTC AACCAAGGTT GATGAGAGTC CACCACGCTT GCGTAGTTCT GTTTTAGAGA 480 GGAATTCTCC CTCTTCACGC GCCCGCACCA GTTGCTTGGC AACGTTCTCT CCCAGACCAT 540 CCATTGCTAC AAATGGTGGG ATAAGGGTAT CCCCGTCGAT GAGGAACTCT GTCGCCTGAC 600 TACGGTAGAG ATCTAATTTG CCAAACTTGA AACCTCGTTC CCACATCTCA TTGACAATCT 660 CAAGAGTTGT ATAGAGATCG ATTTCCACAT TAGAGGCTTC ATTGTTCTTC CGTTTTTCAG 720 AGATTTCTTC CATTCTGCGC TTGATGGCCT CCAAGCCCGC ACCCATGGTC TTGATATCAA 780 AAGCCTTAGC ACGAATGGAG AAGTAAGCAC AGTAGTAATA AATAGGATGG TGAACCTTGA 840 AGTAAGCTAC ACGCAAGGCC ATCATAACGT AGGCTGCCGC ATGGGCCTTA GGGAACATGT 900 ACTTAATTTT CCCACAGGAT TCGATATACC ACTCTGGCAC CTTATTAGCC TTCATGGCTT 960 CGATATAGCC ATTTCTCTCC TCTTCTGAAA TCTTTAGCCA CAAACCCTTA CGTACCCGTT 1020 CCATAATGGT AAAGGCCATC TTAGGTTCCA GACCCGCATG CATGAGGTAA ACCATGATGT 1080 CGTCCCGACA ACCGATAACA GTCGATAGGT CCGCTATTCC TTGCTTAATC AGATCCTGAG 1140 CATTCCCCAA CCAAACGTCA GTACCGTGGG ACAGACCAGA CAGCTGAAGC AATTCCGCAA 1200 AGGTTGTCGG ATGGGTTTCG TCTACCATTC CACGTACGAA ATTTGTTCCA AACTCTGGAA 1260 TCCCTAACAT ACCCGTAGCG TTCCAATTTG TTCAGGTGTT ACCCCTAGCA CATCAGTCCC 1320 AGAAAAGAGT GCCATCACGC CTTCGTCATC CATAGGAATT TTATTAGGGT CAATACCAGA 1380 CAAATCCTGA AGTTTTCGAA TCATGGTCGG ATCATCATGT CCCAGTACAT CGAGTTTGAG 1440 GACGTTCTCA TCGATATCGT GGAAGTTAAA GTGAGTGGTC TGCCATTCAG CCGTGACATC 1500 ATCTGCTGGA TACTGGACAG GCGTAAAATC GTAGACATCC ATGTAGTTCG GAATAACAAC 1560 GATTCCCCCC GGGTGTTGGC CTGTTGTCCG CTTGACACCC GCCGCTCCTT GAGCGAGGCG 1620 TTCTACTTCT GCATCACGAT AAAACTTGCC ATAATCTCGC TCGTAACCCT TGACAAATCC 1680 ATAGGCAGTC TTGGCAGCTA CCGTACCAAC TGTTCCCGCA CGGAAGGCAT ATTCTTCACC 1740 AAAGATATCA CGCACATCCA AGTGGGCGCT AGGCTGATCT TCTCCCGAGA AGTTCAAGTC 1800 AATATCAGGA ACCTTATCCC CATCAAAACC AAGGAAGGTC TCAAACGGAA TATCCTGTCC 1860 GTTTTTACTG AGTTTGTGAC CACAGTTTGG ACAGTCCTTA TGGGGCATAT CAAATCCTGA 1920 ACCGTACGAA CCATCTGTGA TAAACTCACT GTACTGACAC TGACCACAGA CATAGTGAGG 1980 AGAGAGAGGA TTGACCTCCG TAATCCCAAT CATGGTCGCA ACGAAACTAG ATCCGACAGA 2040 CCCACGAGAA CCAACCAAAT AACCCCGTTC ATTAGAACGT TGCACCAGCA TCTGCGATGC 2100 CAGATAAATC ACAGCAAATC CATTCCCCAG TATGGATGTT AATTCTTTTT CAATCCGCAA 2160 ATCAACAATA TCTGGCAGCG GATTTCCATA AATCTCAAAA GCTTTCTTAT AGGTCAACTC 2220 AGCAACTGTT TCTTCAGCCT TGTCGATGAA AGGCGTATAC AAGTCACCCT TAACGACTTC 2280 AACGGGTTCA AATATTTCTG CCAAGGCATT GGTGTTTTCA ATAACCAGTT TACGAGCCAG 2340 TTCCTCTCCC AAAAAGGCAA ATTCATCCAA CATCTCATTA GTCGTTCGAA AATGAGCCTT 2400 TGGAAGTGGT GCTGGTTGGG CATGTTCACC ATGACCGATA GTTCGGTTAA TCATCGCACC 2460 CTGTCCCAAA CTACGGACGA TAATTTCACG ATAAATCTCT TCTTCCGGTT CGATATAGTG 2520 AACATTTCCC GTAGCCAAAA CAGGCTTGCC AAGGCGGTCT CCAACCTCTA TCAAACTCTT 2580 GATAATGGTC TGGAGTTCCT CCATATCCTT GACCTGCTCT TTAGCAATCA AGGGCGCATA 2640 GATAGCCGGT GGCATGACCT CGATAAAGTC ATAATACTTG GCCACCTCAA CCGCCGCATC 2700 CACACCTTGA GAAACGACCA CGTCAAAAAC TTCACCCTCT GAACAGGCTG AACCTAAAAT 2760 CAAGCCCTCT CGATGGGCAT CTAGAACCGT TCTCGGAATC CGTGACACTC CTTCAAAATA 2820 CTTGGTATTA GACAAGGAAA CCAGCTTAAA GATATTTTTT AGACCTACCT GATTCTTGAC 2880 ATAGATGGTC GCATGCTTGA TCCGAGCTTT TTTGTAAGAA TCTGGACTGA TTAGATCAAT 2940 GTTGAGTCTA GCTAAATCGG TCACACCATG TTTTTCTGCT ACCTCTTTGA TAAAGATAAA 3000 GCAGACGACC AGTCGCTTCC GCATCGTATT GGCCATGTGG TGATGTTCCA AGCCACACCA 3060 AAACGCTTGG TCAAAGGCCC AAACCATGAT TTATACTCAG GATAGAGGTT TCAGCAAACT 3120 CCAGGTATCA ATAACGGCTG ACTAATCTTT GGCCATGACG CTCATAATTA GCATTCATAA 3180 AGCCAACGTC AAAGGTAGCA TTGTGGGCAA CTAGGACCGT ATCCTTGCAA ATTCTTGGAA 3240 TTCTTGCAAA ACTTGTTCTA GTGGTTTGGC ATTTTTGACA TGATCATCTG TAATTCCAGT 3300 TAACTCTGTA GTAAAAGCTG ACAAGGGATG CCCAGGATTG ATAAATTCAT CAAATTCAGC 3360 AATAACATTC CCCTTGTACA TCTTAGAGGC CGCAACCTGA ATCAAGTCAT TATAGATAGC 3420 TGAAAGTCCC GTCGTTTCCA CGTCAAAGAC CACGTAGGTT GCTTCTGATA AGTCCATCTA 3480 CATTCGTTAT AGACGATAGG GACACGGTCC TCCACGATAT TGGCTTCTAT CCCATAGATC 3540 AGCTGGATTC CCGCTTTCTT AGCCGCCTTA TAGCCATGTG GAAAGGACTG GACATTCCCA 3600 TGGTCTGTGA TAGCAACCGC CTTGTGTCCC CACTTAGCAG CTGTTGCAAC AATCTCTTCG 3660 ACCTCTGGCA AAGCATCCAT AGTCGACATG TTAGTATGAG CATGAAACTC AACCCGACGC 3720 TCACCTTCTG GCATCAAATC CTTCCGCTCA TAGTGAACAA CTTCCTGCAG ATCCTGTACG 3780 TTCATAGTCA AATCGCGTGT GAAGTTATTC ATCTCCACAT TCCCTCGAAC TCGGAGCCAA 3840 GAATTCTTCT TGATGAGGTC AAACTTCTGG GCCTCTTCCT CGTTTTTAAC CCACTTTTGC 3900 ATAGAAAAAC TTGAAGTATA GTCCGTCATT TTAAAGTTGA TTAAAACACG ACCTGTTCTA 3960 GTCACTTTTT GCTCCACATC AAAAACAACC CCTTCAAATA CCAGACGATT TTCCTCTGTC 4020 GTCACTTCGA TCATAGGAGT AATCTCCGCC TTATCCAGCT TGGGTTTAGC TGCAGCTTTT 4080 TTCGCTTGAA AATCAAAGAC TGGTTTCTCT TCCGCTGGAG GAGGTGCCAT CTGCTCCAGT 4140 TGTTCCATAG CACGGAGCGC TTCCTCATTG GCAGCTTGAA CAATCTGCTC ATTTTCAGCA 4200 TGAAAGGCCT CTTCCTGCTC TTGGGTCAGG ACATCATTCT TCTCGACTTG ACAGTTAAAA 4260 GTTGGAAAAC CAAACTTTTC AAGTTGTTTG GCTAAATTAG GAAGATGATT CTTCTTAAAA 4320 TGTTCCTTAT CAATCGCTTC AGATCCTTCA ATAAATAGCT GATTACCCTC AGCACGAACT 4380 TGCAAATTTT GATAAAGGGA CTTAAAACCT TGACTAGCAC ATGGACCTTC AGAGAAAGCC 4440 TCCCTATAGT AGGACTGCAA GAGCTGATTT GAAAATTCTT GAGACCGAGC CTTAATTTCA 4500 AAAACAGCTT TATTGCCTGT CTTAGAAAAT TCTTCGCTCA AACCTTTCTT TAATTCTAAA 4560 AAGATTTCAA TCGGTAAAAT ATTAGAAAAT ACGAAATGAA ACTCCCATAC CTTACTAATT 4620 TTATGAACCA CAACTCGCTC AATATTGGCC TGTGCTAAAG CAGGAGCCTG TCTCATTTCA 4680 GCAGGCATCC CCAATTGATT CATCAAAATT TCAAAACTAT TTGACATTCA TTTTCCTCAC 4740 ATTATTCTTC TACTATTTTA CCATATTTAG AGGTATTTTC TAAAGACAAA AGGAAGCCAC 4800 TAAGTGACTT CCTTCTAGAG TGAGGACGGA TTAGTCTTCA CCTTTATTTT TCTTAATAAT 4860 TTCTTCTTGT ACTGACTTAG GTACATCTTC GTAGTGGTCA AATACCATCA TGAATGTACC 4920 ACGTCCTTGA GATGCAGAAC GAAGAACTGT TGCGTAACCG AACATTTCAG CAAGTGGAAC 4980 GTAAGCACGA ACGATTTGGC TGTTACCGTG TGCTTCCATA CCATCTACAC GTCCACGACG 5040 AGCAGTTACG TGACCCATAA CATCACCAAG GTTTTCTTCT GGAACAGTGA TTGTTACAAG 5100 CATCATTGGT TCAAGGATAG CTGGTTGTGC TGATTTAGCA GCTTCTTTAA GGGAAAGTGA 5160 AGCCGCAATC TTGAAGGCAG TTTCAGATGA GTCGACATCG TGATATGAAC CATCATAAAG 5220 CTTAGCTTTA ACGTCAACCA TTGGGTAACC TGCAAGAACA CCGTTAGCCA TAGATTCTAC 5280 CAAACCTTTT TCAACCGCTG GGATAAATTC ACGAGGAACC ACACCACCGA CGATTGCGTT 5340 TTCGAATTCG AATCCTTTAC CTTCTTCGTT TGGAGTAAAT TCAATCCATA CATCACCGAA 5400 TTGACCTTTA CCACCAGACT GACGTTTGAA GAATCCGCGT GCTTGAGTAG AAGCGCGGAA 5460 TGTTTCACGG TAAGATACTT GAGGAGCACC TACGTTCGCT TCAACTTTGA ACTCACGACG 5520 CATACGATCA ACAAGGACGT CAAGGTGAAG TTCACCCATA CCTGAGATAA CTGTTTCACC 5580 AGTTTCAACG TTTGTTTCAA CGCGGAATGT TGGATCTTCT TCAGCCAATT TTTGAAGGGC 5640 GATACCCATC TTGTCTTGGT CAGCTTTAGA TTTTGGCTCA ACCATCAATT GGATAACTGG 5700 TTCTGGAACG TTGATTGACT CAAGGATGAT TTTAGCTTTT TCATCTGTCA ATGAGTCACC 5760 AGTTGTAGTA TCTTTCAAAC CAACGGCAGC AGCGATATCA CCTGAGTAAA CAGTGTCGAT 5820 TTCTTGACGG CTGTTAGCGT GCATTTGAAG GATACGTCCG ATACGTTCAC GTTTACCTTT 5880 AGAAGTATTC AATACGTATG AACCTGATTG AAGAACACCT GAGTAAACAC GGAAGAATGT 5940 CAAACGACCT ACGAATGGGT CAGTCATGAT CTTGAAGGCA AGAGCTGCAA ATGGCTCTTC 6000 GTCAGATGCT GGACGAATTT CTTCAGCGTC TGTATCTGGG TTAATACCTT TGATTGCTGG 6060 GATGTCAAGT GGACTTGGAA GGTAGTCGAT AACCGCATCA AGCATCAATT GAACACCTTT 6120 GTTTTTGAAG GCTGAACCAC ACAATACTGG GAAGAATTCA ACGTTGATAG TCGCTTTACG 6180 GATACCAGCT TTCAATTCTT CGTTAGTGAT TTCTTCACCT TCGAGGTATT TCATCATCAA 6240 TTCTTCGTCA GTTTCAGCAA CTGCTTCAAT CAATTTTTCA CGGTATTCTT GAGCTTGGTC 6300 AAGGTATTCA GCTGGGATGT CTTCTTCAAG GATATCCGTA CCAAGGTCGT TAGTATAGAT 6360 TTCAGCTTTC ATCTTGATCA AGTCAATGAT ACCACGGAAG TCATCTTCAG AACCGATTGG 6420 CAATTGGATT GGGTGTGCAT TTGCTTGAAG ACGATCGTGA AGTGTGCTTA CAGAGTAAAG 6480 GAAGTCAGCA CCGATTTTGT CCATTTTGTT GGCAAATACG ATACGTGGAA CTCCGTACTC 6540 AGTTGCTTGA CGCCAAACTG TTTCAGTTTG AGGCTCAACA CCTGATTGTG AGTCAAGAAC 6600 GGTAACCGCA CCATCCAATA CACGAAGAGA ACGTTGTACT TCGATTGTGA AGTCCACGTG 6660 TCCTGGTGTG TCGATGATGT TTACGCGGTG GTTGTTCCAT TGAGCTGTTG TCGCAGCAGA 6720 TGTGATCGTG ATACCACGTT CTTGCTCTTG CTCCATCCAG TCCATTTGTG ACGCACCTTC 6780 GTGAGTTTCA CCGATTTTGT GGATTTTACC AGTGTAGTAA AGAATACGCT CAGTAGTTGT 6840 TGTTTTACCG GCATCGACGT GAGCCATGAT ACCGATATTA CGAGTTTTTT CAAGTGAAAA 6900 TTCGCGTGCC ATGAGGTTTG TTTCTCCTAT TTATTTTTGA TTTCTATTCT ATTATAACAC 6960 GATTTTAATA AAAACGGATA GGCAGGACCT ACCCGTTCTC AATGTTTTCA TGCTATTGTT 7020 GGTTTCAACT TACGAGATGG TAAGCTGAGT TATAGCTAAT ACTAATCGAT TTAGCTAATT 7080 TGAACCCGGG CTAAAGTTAG TTAGCCGATA TGAGCTGGAA CGGGATGCTG CGCGAAAAAG 7140 ATAAAACTCC TTGTATTCAT CGAATACTGC GTCAGTTTCC TATTTTCACC TTGCATCCTT 7200 ACC 7203 (2) INFORMATION FOR SEQ ID NO: 80: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1581 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:80: GCATACAAAG GGCATCAAGA ATATCCGTGT TGCCACAAGC TGCGAGAAAG ATTTATGCCT 60 ACCGCCGTTA TGACCTTAAT GAATCTCCAA AGACCGCTTT AGACCTTATC ATCCCAGATT 120 TGTTTTTGCA TATTTTGAAC CCTGCTGAAC GTGAAAGAAA ATTAAAGCGC GAAGGTGTAG 180 AAGAATTATA TCTCCTTGAT TTTAGTAGTC AATTCGCTAG TCTCACTGCA CAAGAATTCT 240 TTGCAACTTA TATCAAGGCT ATGAATGCCA AAATTATTGT TGCAGGTTTT GATTATACAT 300 TTGGTTCTGA CAAAAAAACA GCAGAAGATT TAAAGGATTA CTTTGATGGA GAAGTTATCA 360 TTGTTCCACC TGTAGAAGAT GAGAAAGGAA AGATTAGTTC AACTCGTATC CGTCAAGCTA 420 TTTTAGATGG AAATGTGAAA GAAGCAGGAA AACTTTTGGG GGCACCGCTT CCATCAAGAG 480 GTATGGTAGT TCATGGTAAT GCTCGTGGTC GTACAATTGG TTATCCGACA GCGAATTTAG 540 TGCTTTTAGA CCGTACTTAT ATGCCAGCAG ATGGCGTTTA TGTCGTTGAT GTTGAGATTC 600 AAAGACAGAA GTATCGTGCT ATGGCTAGTG TCGGGAAAAA TGTGACCTTT GATGGAGAAG 660 AAGCACGTTT TGAAGTCAAT ATTTTTGATT TTAATCAAGA TATTTATGGG GAAACCGTCA 720 TGGTTTATTG GCTTGATCGC ATTCGTGATA TGACCAAATT TGACTCAGTT GACCAATTAG 780 TGGATCAGTT AAAGGCTGAT GAAGAAGTAA CTCGGAATTG GTCTTAAGAG CTTGAGTAAA 840 TAAAACAAAA AAGAGGTTGT CTGTAACCCA AAAGATAGAT GATTTAGTCT AACTTTTGAG 900 GTCACGACAT TACCTCTTTT TATTCTTTTT CAAAGGTGAA GCCTTCTCCT AGGATTTCAT 960 GGGCTTCTGT AATAGTTATA AAGGCTTGAG GATCGATTCG ATGAATCATT TCCTTCGTTT 1020 TCACAATTTC ATTTCTTCCG ACAATACAGT AGATGATTTT CAAATTTTCT TTACTATAGT 1080 AGCCTTGACC AGAAATAAAA GTAACACCTC TTCCGAGGTC ATCATTAATC GCCTTAGCAA 1140 GTTGGTCAGG ACGTTTTGTG ATAATCATAA AGCCTTTGCC GGCATATCCT CCTTCACCAA 1200 TCAAATCAAT AACACGAGAA ACAATAAAAT CAAACAAAAG CGTGTAGGAA ACCAATCTCA 1260 AATCCTTGAA GATTAGGAGA ATCAACATGA GAATACAAAA ATCTAAGATA AAGAGCAGTT 1320 TTCCTATGGA TATATGAGTG TATTTGTTGA GAATACGAGC TAGAATATCA GTTCCGCCAG 1380 TTGTACCTCC AGCATTAAAA ATAATTCCAA GGCCAATTCC CAATAGGATT CCCGCTATAA 1440 GGGCTGTGAT TAGTAAATCA CCTTGAAGAT CAATATGAAG GGGAATATGC TCAAAAAAAG 1500 CTAACCAGGC GGACAAAGCT AAGGTTCCTA GTAAACTAGA ATAGAGGGAT TTGGCTCCAA 1560 AGATCTTCCA AGCTAGGATG A 1581 (2) INFORMATION FOR SEQ ID NO: 81: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 879 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 81: CAAGTTTGTC GAATTGCCAA ACACAGTTGA AGGCTTGATT CACATCACTA ATCTACCTGA 60 ATTTTATCAT TTCAATGAGC GTGATTTGAC TCTTCGTGGA GAAAAATCAG GTATCACTTT 120 CCGAGTGGGT CAGCAGATCC GTATCCGTGT TGAAAGAGCG GATAAAATGA CTGGAGAGAT 180 TGATTTTTCA TTCGTACCTA GTGAGTTTGA TGTGATTGAA AAAGGCTTGA AACAGTCTAG 240 TCGTAGTGGC AGAGGGCGTG GTTCAAATCG TCGTTCGGAT AAGAAGGAAG ACAAGAGAAA 300 ATCAGGACGC TCAAATGATA AGCGTAACAT TTCACAAAAA GACAAGAAGA AAAAAGGAAA 360 GAAACCTTTT TACAAGGAAG TAGCTAAGAA AGGAGCCAAG CATGGCAAAG GGCGAGGGAA 420 AGGTCGTCGC ACAAAATAAA AAGGCACGCC ACGACTATAC AATCGTAGAT ACGCTAGAGG 480 CAGGGATGGT CCTGACTGGA ACTGAAATCA AGAGTGTACG AGCTGCTCGA ATTAATCTCA 540 AGGATGGCTT TGCTCAAGTG AAAAATGGAG AAGTTTGGCT GAGTAATGTT CATATCGCGC 600 CTTACGAAGA GGGCAATATC TGGAACCAGG AACCAGAACG TCGTCGTAAA CTCCTGCTCC 660 ATAAAAAGCA AATTCAAAAA TTGGAACAAG AGACCAAAGG GACAGGAATG ACCTTAGTTC 720 CCCTTAAGGT CTATATAGAT GGCTACGCTA AGCTTCTTTT AGGACTTGCC AAGGGAAGCA 780 TGACTATGAC AAACGGAGTC TATCAAACGT CGTGAGCAAA TCGAGATATC GCGCGTGTGA 840 TGAAGCTGTT AATCAGCGAT AAAGAGAGGA ATTGAGATG 879 (2) INFORMATION FOR SEQ ID NO: 82: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1550 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 82: AAAAGCTTAA TAAATCAATA ATTTCTTCTT TTATCCCCAA CCTGTGGATA AAGTTTGGTA 60 ACATTGTGGA TTATTTTTCA CAGCTTGTGG AAAATTCTTG CTATCTATGG TAAAATATCT 120 CTAGTATTAA ACTTTTAAAT AGTAAAGGAG GAGAAAGGAT TGAAAGAAAA ACAATTTTGG 180 AATCGTATAT TAGAATTTGC ACAAGAAAGA CTGACTCGAT CCATGTATGA TTTCTATGCT 240 ATTCAAGCTG AACTTATCAA GGTAGAGGAA AATGTTGCCA CTATATTTCT ACCTCGCTCT 300 GAAATGGAAA TGGTCTGGGA AAAACAACTA AAAGATATTA TTGTAGTAGC TGGTTTTGAA 360 ATTTATGACG CTGAAATAAC TCCCCACTAT ATTTTCACCA AACCTCAAGA TACGACTAGC 420 TCACAAGTTG AAGAAGCTAC AAATTTAACT CTTTATGACT ATAGTCCAAA GTTAGTATCT 480 ATTCCTTATT CAGATACGGG ATTAAAAGAA AAGTATACCT TTGATAACTT TATTCAAGGG 540 GATGGAAATG TTTGGGCTGT ATCAGCCGCT TTAGCTGTCT CTGAAGATTT GGCTCTGACC 600 TATAACCCTC TTTTTATCTA TGGAGGACCA GGCCTTGGTA AGACTCACTT ATTAAACGCT 660 ATTGGAAATG AAATTCTAAA AAATATTCCT AATGCGCGTG TTAAATATAT CCCTGCCGAA 720 AGCTTTATTA ATGACTTTCT TGATCACCTA AGACTTGGGG AAATGGAAAA GTTTAAAAAG 780 ACCTATCGTA GTCTTGATCT TTTGTTAATC GATGATATCC AGTCACTCAG CGGAAAAAAA 840 GTCGCAACTC AGGAAGAATT TTTCAATACC TTTAACGCCC TTCATGACAA GCAAAAACAG 900 ATTGTCCTAA CGAGTGATCG TAGTCCAAAA CATCTAGAAG GGCTCGAGGA GAGGCTTGTC 960 ACGCGTTTTA GTTGGGGATT GACACAAACT ATCACACCCC CTGACTTTGA AACACGTATT 1020 GCCATTTTAC AAAGTAAAAC GGAACATTTA GGCTACAATT TCCAAAGTGA TACTCTAGAA 1080 TACCTAGCTG GGCAATTTGA TTCAAATGTT CGAGATCTTG AGGGAGCCAT CAACGACATC 1140 ACTTTAATTG CCAGAGTAAA AAAAATCAAG GATATCACTA TTGATATTGC TGCAGAAGCC 1200 ATTAGAGCCC GCAAACAAGA TGTTAGCCAA ATGCTCGTCA TCCCAATTGA TAAAATCCAA 1260 ACTGAAGTTG GTAACTTTTA TGGTGTTAGT ATCAAAGAAA TGAAGGGAAG TAGACGCCTT 1320 CAAAATATTG TTTTGGCCCG TCAAGTAGCC ATGTATTTAT CTAGAGAACT AACAGATAAT 1380 AGTCTTCCAA AAATTGGGAA GGAATTGGGG GAAAAGTCAT ACCACAGTCA TTCATGCCCA 1440 TGCCAAAATA AAATCTTGAA TTGATCAAGA CGATAATTTA CGTTTAGAAA TTGAATCATC 1500 AAAAGGAAAA TCAAATAATT TGTGGAAACT TTAGGTTTTT ACCTTTTAGC 1550 (2) INFORMATION FOR SEQ ID NO: 83: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1292 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 83: GGTATGCGCC AAAACTTCTT ATCAAAAAGA ATCTAGCCAA AGAAGCGACT GCTCAAGCTG 60 TAGGTGAACT TCGTGGTAAA CAAAAATCGG AAGAAAAAGC TCACGCTGAG ATGATTGCAG 120 AAGGAAAAGC AATTAAAGCA CAACTTGAAG CAGAAGAAAC TGTTGTAGAA TTTGTTGAAA 180 AAGTTGGTCC AGATGGTCGT ACCTTTGGTT CTATTACCAA TAAGAAGATT GCAGAAGAAT 240 TGCAAAAGCA ATTTGGAATT AAGATTGATA AACGTCATAT TCAAGTACAA GCTCCGATTC 300 GAGCGGTTGG TTTGATTGAT GTGCCAGTGA AAATCTATCA AGATATCACA AGTGTAATCA 360 ATCTTCGTGT GAAAGAAGGA TAAGTTTACA CCTTCTTGAC AAGATTGTAA AAGGAAGGGA 420 AGTCTGATGG CAGAAGTAGA AGAGTTACGA GTACAACCTC AAGATATCTT AGCTGAGCAA 480 TCCGTTTTAG GGGCTATCTT TATTGATGAG AGTAAACTTG TTTTTGTGCG AGAATACATT 540 GAGTCTCGGG ACTTTTTTAA GTATGCCCAT CGTTTGATTT TCCAAGCCAT GGTCGATTTA 600 TCCGATCGTG GTGATGCCAT AGATGCAACA ACGGTTCGTA CTATCCTTGA TAATCAAGGT 660 GATTTACAGA ATATTGGTGG CTTGTCTTAC TTGGTTGAGA TTGTTAATTC TGTGCCAACT 720 TCTGCTAATG CGGAGTATTA TGCTAAGATT GTTGCAGAAA AAGCAATGCT ACGTCGTTTA 780 ATTGCCAAGT TGACAGAGTC TGTCAACCAA GCTTACGAAG CGTCACAACC AGCTGATGAA 840 ATTATTGCTC AGGCAGAAAA AGGGTTGATT GATGTCAGTG AAAATGCAAA TCGAAGCGGG 900 TTTAAGAACA TTCGAGATGT GTTGAATCTC AACTTTGGAA ATCTGGAAGC TCGCTCGCAA 960 CAAACGACCG ATATTACAGG TATTGCGACA GGTTATCGTG ATTTGGATCA TATGACAACA 1020 GGACTTCATG AGGAGGAGTT GATTATCTTA GCAGCTCGTC CAGCAGTTGG TAAGACAGCA 1080 TTTGCCTTGA ATATCGCTCA GAATATTGGG ACTAAGTTGG ACAAAACGGT TGCTATTTTT 1140 TCACTCGAAA TGGGTGCGGA AAGCTTGGTA GACCGTATGT TAGCTGCAGA AGGCTTGGTG 1200 GAGTCACATT CTATCCGTAC AGGGCAATTG ACAGATGAGG AGTGGCAAAA ATATACTATT 1260 GCTCAGGGTA ATCGTACTAA CGCCAGTATC TA 1292 (2) INFORMATION FOR SEQ ID NO: 84: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1876 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 84: AGGCTGATCC TGCGGTTATT GACCCATGGA AGAGCACCTA GAAGGAGATC ATTCCCAGAC 60 GATATTTTAG TTTTATCCTA GTAGCCTTCC CTGGCTATTT TAGGAGCTCG TCTCTACTAT 120 GTATTTCCGA TTTGATTACT ATAGTCAGAA TTTAGGAGAG ATTTTTGCCA TTGGAATGGT 180 GGTTGGCCAT TTACGGTGGT TGATAACTGG GGCTCTTGTG CTCTATATCT TTGCTGACCG 240 TAAACTCATC AATACTTGGG ATTTTCTAGA TATTGCGGCG CCTAGCGTTA TGATTGCTCA 300 AAGTTTGGGG CGTTGGGGTA ATTTCTTTAA CCAAGAAGCT TATGGTGCAA CAGTGGATAA 360 TCTGGATTAT CTACCTGGCT TTATCCGTGA CCAGATGTAT ATTGAGGGGA GCTACCGTCA 420 ACCGACTTTC CTTTATGAGT CTCTATGGAA TCTGCTTGGC TTTGCCTTGA TTCTGATTTT 480 TAGACGGAAA TGGAAGAGTC TCAGACGAGG TCATATCACG GCCTTTTACT TGATTTGGTA 540 TGGTTTCGGT CGTATGGTCA TCGAAGGTAT GCGAACAGAT AGTCTCATGT TCTTCGGACT 600 TCGAGTGTCC CAATGGCTGT CAGTTGTCCT TATCGGTCTC GGTATAATGA TCGTTATTTA 660 TCAAAATCGA AAGAAGGCCC CTTACTATAT TACAGAGGAG GAAAACTAAA TGTTAGAAGT 720 TGCATATATT CTTGTTGCCC TAGCTTTGAT TGTCTTTTTG GTCTATCTGA TCATTACTGT 780 ACAAAAGCTT GGTCGTGTCA TCGATGAAAC AGAAAAGACG ATTAAAACCT TGACTTCAGA 840 TGTGGATGTG ACCTTGCATC ACACCAATGA GTTGTTGGCT AAGGTCAATG TCTTGGCAGA 900 TGATATCAAT GTCAAGGTGG CTACGATTGA TCCACTCTTC AGTGCTGTTG CAGATTTATC 960 TCTATCTGTT TCAGACCTCA ATGACCATGC GCGTGTCTTG AGCAAGAAAG CTTCATCAGC 1020 TGGTTCAAAA ACACTCAAGA CTGGTGCAAG TCTGTCAGCT CTTCGTCTTG CAAGTAAATT 1080 TTTCAAAAAA TAAAAAAGGA GAATCCTTAT GGGTAAATTA TCCTCAATCC TTTTAGGAAC 1140 GGTTTCAGGT GCAGCTCTTG CCTTGTTTTT AACAAGTGAT AAGGGCAAAC AAGTTTGCAG 1200 TCAGGCTCAA GATTTTCTAG ATGATTTGAG AGAAGATCCG GAGTATGCCA AGGAGCAAGT 1260 CTGTGAAAAA CTGACAGAAG TTAAGGAGCA GGCTACAGAT TTTGTTCTGA AAACAAAAGA 1320 ACAGGTTGAG TCAGGTGAAA TCACTGTGGA CAGTATACTT GCTCAAGCTA AATCCTATGC 1380 TTTTCAAGCG ACAGAAGCAT CAAAAAATCA ATTAAATAAT CTCAAGGAAC AATGGCAAGA 1440 AAAAGCCGAA GCTCTTGATG ACTCAGAAGA GATTGTGATT CATATAACAG AAGAATAAAC 1500 CATCACCATC TCCGGACGGA CTATGTATCT GGGGATGGTG ATTTTTATCT GGAATCTAGT 1560 CTTTGTGGTA TAATAATTAC TATGCAGAAA AAACCAACGT CAGCCTATGT GCACATCCCA 1620 TTTTGTACCC AGATTTGTTA TTATTGTGAT TTTTCAAAGG TCTTCATCAA AAATCAGCCA 1680 GTCGACAGCT ATTTAGAGCA TCTGCTGGAA GAGTTTCGTT CTTATGATAT TGAAAAGTTG 1740 TCAACCCTTT ATATCGGTGG TGGAACACGA CAGCCCTGTC GGCTCCGCAA CTGGAGGTGT 1800 TACTGAATGG CTTGACTAAA AACTTGGATT TGTCTGCTTG GAGAGTGACC ATTGAAGCCA 1860 TCCAGGCGAT TTGGAA 1876 (2) INFORMATION FOR SEQ ID NO: 85: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1574 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 85: TTGGAAGATT TCCCACTTTC AGTGACCAAC CCATACGGTC GTACTAAGCT CATGCTAGAG 60 GAAATTTTGA CTGATATTTA CAAAGCAGAC TCAGAATGGA ATGTTGTCTT GCTTCGTTAC 120 TTTAACCCAA TCGGAGTCCA TGAGAGTGGT GATTTGGGAG AAAATCCAAA CGGTATTCCA 180 AACAATCTCT TGCCATATGT GACTCAAGTA GCCGTTGGAA AATTAGAGCA AGTGCAAGTG 240 TTTGGAGACG ATTACGATAC GGAAGATGGA ACAGGTGTTC GTGACTATAT CCACGTTGTC 300 GATTTGGCTA AGGGTCACGT TGCAGCTTTG AAAAAAATCC AAAAAGGTTC AGGACTAAAC 360 GTTTATAACC TTGGAACTGG TAAAGGTTAC TCAGTTCTTG AAATTATCCA AAACATGGAA 420 AAAGCGGTGG GATGTCCTAT TCCTTACCGC ATCGTAGAAC GTCGCCCAGG TGATATCGCT 480 GCCTGCTACT CAGACCCAGC AAAGGCTAAA GCAGAACTCG GTTGGGAAGC AGAACTCGAC 540 ATCACCCAAA TGTGTGAAGG CCATGGCGTT GGCAGAGCAA GCATCCAAAT GGATTTGAAG 600 ACTAAGATGA TGATTTCAAT CATCGTCCCT TGTTTAACGA AGAGGAAGTA CTTCCTCTTT 660 TTTATCAGGC TCTGGAAGCT TTACTTCCAG ATTTGGAAAC AAAATCGAGT ATGTCTTTGT 720 CGATGATGGA TCAAGTGATG GGACCTTGGA ACTCTTAAAG GCCTATCGGG AGCAAAATCC 780 GGCAGTCCAT TATATTTCTT TCTCTCGAAA TTTTGGCAAA GAAGCAGCCC TTTATGCAGG 840 CTTGCAATAT GCGACAGGAG ATTTGGTGGT GGTGATGGAT GCAGACCTCC AAGATCCTCC 900 TAGTATGTTG TTTGAGATGA AAAATGTACT AGACAAAAAT GTAGACTTGG ACTGCGTTGG 960 GACACGGAGA ACTAGTCGGG AGGGAGAACC CTTCTTTCGC AGTTTCTGTG CTGTTCTCTT 1020 TTATCGCCTC ATGCAAAAAA TCAGCCCAGT AGCTCTGCCG TCGGGTGTCC GTGATTTTCG 1080 TATGATGAGA AGGTCTGTGG TCGATGCCAT TTTAAGCTTG ACTGAGTCCA ATCGTTTTTC 1140 TAAGGGACTC TTTGCCTGGG TCGGCTTTAA AACCCACTAT CTGGACTATC CAAATGTCGA 1200 AAGGCAGGCT GGCAAGACCA GTTGGAGTTT TAGGCAACTC TTTTTTTACT CCATTGAAGG 1260 GATTGTTAAT TTTTCAGATT TCCCTTTGAC TATAGCCTTT GTAGCTGGTC TCCTATCTTG 1320 TTTTCTTTCT CTGCTGATGA CCTTTTTTGT TGTGGTTCGG ACCCTCATTT TGGGCAATCC 1380 GACATCTGGT TGGACCTCTC TGATGGCTGT TATTCTCTAT CTTGGAGGCA TTCAACTCTT 1440 GACCATTGGG ATTCTCGGTA AGTATAATCA GTAAGATTAT TTAGAGACTA AAAAAAAGAC 1500 CACTTTATCT TATCAAAGAA AAAGTGACCT TCCTGATTTT ACAGAAACCT AAAGTGAAAA 1560 GACTATAATT TTCC 1574 (2) INFORMATION FOR SEQ ID NO: 86: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 969 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 86: GTTATAATTA TTGATGATAA TTATAGTAAT GTAAATTTAA GAAATAAAAT TATCCATCAA 60 TTTGGCTATA CCAATCATAG AATTAAGTTA ATTTTAAGTA ATGAAGATTT AGGTGCAACT 120 AATGCCAGAA ACATAGGTAT CAAAAATTCT AGAGGTAAGT ATATATCATT TTTAGACGAT 180 GATGATGAAT ATATGCCAGA TCGAATTTTA AAGTTGATGG CTTGTTTTAA AAAGAGTAGA 240 ATGAAGAATT TAGCTTTAGT TTATAGTTAT GGCATAATAA TTTATCCAAA TGGTACACGA 300 GAAGAGGAGA AGACCGATTT TGTTGGAAAT CCCTTGTTTG TTCAAATGGT TCACAATATA 360 GCAGGTACGT CATTTTGGTT GTGTAAAAAA GAGGTGCTAG AATTAATTAA TGGTTTTGAG 420 AAAATAGATT CACATCAGGA CGGTGTTGTT TTATTAAAAC TACTTGCTCA AGGATACCAA 480 ATTGATATAG TGCGAGAATT CTTGGTGAAT TACTACGCTC ACAGTAAAGA AAACGGTATC 540 ACTGGAGTGA CACAAAAAAC AATTAATGCA GATGAAGAAT ATTATAATTA CTGTAGGAAA 600 TATTTTAATT TATTGAGTTT CAACGAGAGA ATATTGGTTA CAAAGAAATA TTATTCTTTA 660 AACATAAAGC GGTTACTATT AATAGGAGAC AAATGCAAGG CTTTAAAAGT AATCAAGAAG 720 GCAAGAGAAG AAAAAATTTT TAACGAATTT CTTTTTTTGA AATATATGTT ATTATATAAC 780 GTAGTTTTTT CTATTGTATA TATGACAACT ATGTTCAATT AAAATTTAGA AAGTGAGAAA 840 CTATTGTGTA TACTATTATA AATTCAATAT AAACATTTAG GTTAATTAAC GATAATTAAT 900 CGGTGCTGGG TCATTAATTG CTAATTTAAT GCAGCACTAT TAATGCTCAG GTGTTGAATG 960 AATTAATGC 969 (2) INFORMATION FOR SEQ ID NO: 87: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1353 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1350 (D) OTHER INFORMATION: DNA B (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 87: ATG GCA GAA GTA GAA GAG TTA CGA GTA CAA CCT CAA GAT ATC TTA GCT 48 Met Ala Glu Val Glu Glu Leu Arg Val Gin Pro Gin Asp lie Leu Ala 1 5 10 15 GAG CAA TCC GTT TTA GGG GCT ATC TTT ATT GAT GAG AGT AAA CTT GTT 96 Glu Gin Ser Val Leu Gly Ala He Phe He Asp Glu Ser Lys Leu Val 20 25 30 TTT GTG CGA GAA TAC ATT GAG TCT CGG GAC TTT TTT AAG TAT GCC CAT 144 Phe Val Arg Glu Tyr He Glu Ser Arg Asp Phe Phe Lys Tyr Ala His 35 40 45 CGT TTG ATT TTC CAA GCC ATG GTC GAT TTA TCC GAT CGT GGT GAT GCC 192 Arg Leu He Phe Gin Ala Met Val Asp Leu Ser Asp Arg Gly Asp Ala 50 55 60 ATA GAT GCA ACA ACG GTT CGT ACT ATC CTT GAT AAT CAA GGT GAT TTA 240 He Asp Ala Thr Thr Val Arg Thr He Leu Asp Asn Gin Gly Asp Leu 65 70 75 80 CAG AAT ATT GGT GGC TTG TCT TAC TTG GTT GAG ATT GTT AAT TCT GTG 288 Gin Asn He Gly Gly Leu Ser Tyr Leu Val Glu He Val Asn Ser Val 85 90 95 CCA ACT TCT GCT AAT GCG GAG TAT TAT GCT AAG ATT GTT GCA GAA AAA 336 Pro Thr Ser Ala Asn Ala Glu Tyr Tyr Ala Lys He Val Ala Glu Lys 100 105 110 GCA ATG CTA CGT CGT TTA ATT GCC AAG TTG ACA GAG TCT GTC AAC CAA 384 Ala Met Leu Arg Arg Leu He Ala Lys Leu Thr Glu Ser Val Asn Gin 115 120 125 GCT TAC GAA GCG TCA CAA CCA GCT GAT GAA ATT ATT GCT CAG GCA GAA 432 Ala Tyr Glu Ala Ser Gin Pro Ala Asp Glu He He Ala Gin Ala Glu 130 135 140 AAA GGG TTG ATT GAT GTC AGT GAA AAT GCA AAT CGA AGC GGG TTT AAG 480 Lys Gly Leu He Asp Val Ser Glu Asn Ala Asn Arg Ser Gly Phe Lys 145 150 155 160 AAC ATT CGA GAT GTG TTG AAT CTC AAC TTT GGA AAT CTG GAA GCT CGC 528 Asn He Arg Asp Val Leu Asn Leu Asn Phe Gly Asn Leu Glu Ala Arg 165 170 175 TCG CAA CAA ACG ACC GAT ATT ACA GGT ATT GCG ACA GGT TAT CGT GAT 576 Ser Gin Gin Thr Thr Asp He Thr Gly He Ala Thr Gly Tyr Arg Asp 180 185 190 TTG GAT CAT ATG ACA ACA GGA CTT CAT GAG GAG GAG TTG ATT ATC TTA 624 Leu Asp His Met Thr Thr Gly Leu His Glu Glu Glu Leu He He Leu 195 200 205 GCA GCT CGT CCA GCA GTT GGT AAG ACA GCA TTT GCC TTG AAT ATC GCT 672 Ala Ala Arg Pro Ala Val Gly Lys Thr Ala Phe Ala Leu Asn He Ala 210 215 220 CAG AAT ATT GGG ACT AAG TTG GAC AAA ACG GTT GCT ATT TTT TCA CTC 720 Gin Asn He Gly Thr Lys Leu Asp Lys Thr Val Ala He Phe Ser Leu 225 230 235 240 GAA ATG GGT GCG GAA AGC TTG GTA GAC CGT ATG TTA GCT GCA GAA GGC 768 Glu Met Gly Ala Glu Ser Leu Val Asp Arg Met Leu Ala Ala Glu Gly 245 250 255 TTG GTG GAG TCA CAT TCT ATC CGT ACA GGG CAA TTG ACA GAT GAG GAG 816 Leu Val Glu Ser His Ser He Arg Thr Gly Gin Leu Thr Asp Glu Glu 260 265 270 TGG CAA AAA TAT ACT ATT GCT CAG GGT AAT CTA GCT AAC GCC AGT ATC 864 Trp Gin Lys Tyr Thr He Ala Gin Gly Asn Leu Ala Asn Ala Ser He 275 280 285 TAT ATC GAT GAT ACG CCA GGT ATT CGG ATT ACA GAG ATT CGT TCT CGT 912 Tyr He Asp Asp Thr Pro Gly He Arg He Thr Glu He Arg Ser Arg 290 295 300 TCT CGT AAA TTG GCT CAA GAA ACT GGA AAT CTT GGT TTG ATT TTG ATA 960 Ser Arg Lys Leu Ala Gin Glu Thr Gly Asn Leu Gly Leu He Leu He 305 310 315 320 GAC TAT TTG CAA CTT ATC ACG GGA ACT GGT CGA GAA AAT CGT CAA CAA 1008 Asp Tyr Leu Gin Leu He Thr Gly Thr Gly Arg Glu Asn Arg Gin Gin 325 330 335 GAA GTT TCT GAA ATT TCT CGT CAG TTG AAA ATA CTA GCC AAG GAA TTG 1056 Glu Val Ser Glu He Ser Arg Gin Leu Lys He Leu Ala Lys Glu Leu 340 345 350 AAG GTT CCA GTA ATC GCT CTG AGT CAG CTT TCT CGT GGT GTA GAA CAA 1104 Lys Val Pro Val He Ala Leu Ser Gin Leu Ser Arg Gly Val Glu Gin 355 360 365 CGT CAG GAC AAG AGA CCG GTC TTG TCT GAT ATT CGT GAA TCT GGG TCT 1152 Arg Gin Asp Lys Arg Pro Val Leu Ser Asp He Arg Glu Ser Gly Ser 370 375 380 ATT GAG CAG GAC GCT GAT ATC GTA GCT TTT CTC TAT CGC GAT GAC TAC 1200 He Glu Gin Asp Ala Asp He Val Ala Phe Leu Tyr Arg Asp Asp Tyr 385 390 395 400 TAT GAA CGT GGT GGT GAA GAA GAG GAG GGT ATC CCA AAT AAT AAG GTG 1248 Tyr Glu Arg Gly Gly Glu Glu Glu Glu Gly He Pro Asn Asn Lys Val 405 410 415 GAA GTT ATT ATC GAG AAA AAC CGT AGT GGA GCT CGT GGA ACA GTG GAA 1296 Glu Val He He Glu Lys Asn Arg Ser Gly Ala Arg Gly Thr Val Glu 420 425 430 TTG ATT TTC CAA AAA GAA TAC AAT AAA TTT TCA AGT ATC TCA AAG AGG 1344 Leu He Phe Gin Lys Glu Tyr Asn Lys Phe Ser Ser He Ser Lys Arg 435 440 445 GAG GCA TAA 1353 Glu Ala 450 (2) INFORMATION FOR SEQ ID NO: 88: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 450 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 88: Met Ala Glu Val Glu Glu Leu Arg Val Gin Pro Gin Asp He Leu Ala 1 5 10 15 Glu Gin Ser Val Leu Gly Ala He Phe He Asp Glu Ser Lys Leu Val 20 25 30 Phe Val Arg Glu Tyr He Glu Ser Arg Asp Phe Phe Lys Tyr Ala His 35 40 45 Arg Leu He Phe Gin Ala Met Val Asp Leu Ser Asp Arg Gly Asp Ala 50 55 60 He Asp Ala Thr Thr Val Arg Thr He Leu Asp Asn Gin Gly Asp Leu 65 70 75 80 Gin Asn He Gly Gly Leu Ser Tyr Leu Val Glu He Val Asn Ser Val 85 90 95 Pro Thr Ser Ala Asn Ala Glu Tyr Tyr Ala Lys He Val Ala Glu Lys 100 105 110 Ala Met Leu Arg Arg Leu He Ala Lys Leu Thr Glu Ser Val Asn Gin 115 120 125 Ala Tyr Glu Ala Ser Gin Pro Ala Asp Glu He He Ala Gin Ala Glu 130 135 140 Lys Gly Leu He Asp Val Ser Glu Asn Ala Asn Arg Ser Gly Phe Lys 145 150 155 160 Asn He Arg Asp Val Leu Asn Leu Asn Phe Gly Asn Leu Glu Ala Arg 165 170 175 Ser Gin Gin Thr Thr Asp He Thr Gly He Ala Thr Gly Tyr Arg Asp 180 185 190 Leu Asp His Met Thr Thr Gly Leu His Glu Glu Glu Leu He He Leu 195 200 205 Ala Ala Arg Pro Ala Val Gly Lys Thr Ala Phe Ala Leu Asn He Ala 210 215 220 Gin Asn He Gly Thr Lys Leu Asp Lys Thr Val Ala He Phe Ser Leu 225 230 235 240 Glu Met Gly Ala Glu Ser Leu Val Asp Arg Met Leu Ala Ala Glu Gly 245 250 255 Leu Val Glu Ser His Ser He Arg Thr Gly Gin Leu Thr Asp Glu Glu 260 265 270 Trp Gin Lys Tyr Thr He Ala Gin Gly Asn Leu Ala Asn Ala Ser He 275 280 285 Tyr He Asp Asp Thr Pro Gly He Arg He Thr Glu He Arg Ser Arg 290 295 300 Ser Arg Lys Leu Ala Gin Glu Thr Gly Asn Leu Gly Leu He Leu He 305 310 315 320 Asp Tyr Leu Gin Leu He Thr Gly Thr Gly Arg Glu Asn Arg Gin Gin 325 330 335 Glu Val Ser Glu He Ser Arg Gin Leu Lys He Leu Ala Lys Glu Leu 340 345 350 Lys Val Pro Val He Ala Leu Ser Gin Leu Ser Arg Gly Val Glu Gin 355 360 365 Arg Gin Asp Lys Arg Pro Val Leu Ser Asp He Arg Glu Ser Gly Ser 370 375 380 He Glu Gin Asp Ala Asp He Val Ala Phe Leu Tyr Arg Asp Asp Tyr 385 390 395 400 Tyr Glu Arg Gly Gly Glu Glu Glu Glu Gly He Pro Asn Asn Lys Val 405 410 415 Glu Val He He Glu Lys Asn Arg Ser Gly Ala Arg Gly Thr Val Glu 420 425 430 Leu He Phe Gin Lys Glu Tyr Asn Lys Phe Ser Ser He Ser Lys Arg 435 440 445 Glu Ala 450 (2) INFORMATION FOR SEQ ID NO: 89: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1785 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1782 (D) OTHER INFORMATION: DNA G (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 89: ATG ATA ACC ATG GAG GTA TTG TGT ATG GTT GAC AAA CAA GTC ATT GAA 48 Met He Thr Met Glu Val Leu Cys Met Val Asp Lys Gin Val He Glu 1 5 10 15 GAA ATC AAA AAC AAT GCC AAC ATT GTG GAA GTC ATA GGA GAT GTG ATT 96 Glu He Lys Asn Asn Ala Asn He Val Glu Val He Gly Asp Val He 20 25 30 TCT TTA CAA AAG GCA GGA CGG AAC TAT CTA GGG CTC TGT CCT TTT CAT 144 Ser Leu Gin Lys Ala Gly Arg Asn Tyr Leu Gly Leu Cys Pro Phe His 35 40 45 GGT GAA AAA ACA CCT TCT TTC AGC GTT GTA GAG GAC AAG CAG TTT TAC 192 Gly Glu Lys Thr Pro Ser Phe Ser Val Val Glu Asp Lys Gin Phe Tyr 50 55 60 CAC TGT TTT GGT TGT GGT CGC TCA GGT GAT GTC TTT AAA TTC ATC GAG 240 His Cys Phe Gly Cys Gly Arg Ser Gly Asp Val Phe Lys Phe He Glu 65 70 75 80 GAG TAC CAA GGG GTT ACC TTT ATG GAG GCT GTC CAA ATC TTA GGT CAG 288 Glu Tyr Gin Gly Val Thr Phe Met Glu Ala Val Gin He Leu Gly Gin 85 90 95 CGT GTC GGG ATT GAG GTT GAA AAA CCG CTT TAT AGT GAA CAG AAG CCA 336 Arg Val Gly He Glu Val Glu Lys Pro Leu Tyr Ser Glu Gin Lys Pro 100 105 110 GCC TCG CCT CAC CAA GCT CTT TAT GAT ATG CAC GAA GAT GCG GCT AAA 384 Ala Ser Pro His Gin Ala Leu Tyr Asp Met His Glu Asp Ala Ala Lys 115 120 125 TTT TAC CAT GCT ATT CTC ATG ACA ACG ACT ATG GGC GAA GAG GCC AGA 432 Phe Tyr His Ala He Leu Met Thr Thr Thr Met Gly Glu Glu Ala Arg 130 135 140 AAT TAC CTT TAT CAG CGG GGT TTG ACA GAT GAA GTG CTT AAA CAT TTT 480 Asn Tyr Leu Tyr Gin Arg Gly Leu Thr Asp Glu Val Leu Lys His Phe 145 150 155 160 TGG ATT GGT TTA GCA CCT CCA GAA CGA AAC TAT CTC TAT CAA CGT TTG 528 Trp He Gly Leu Ala Pro Pro Glu Arg Asn Tyr Leu Tyr Gin Arg Leu 165 170 175 TCT GAT CAG TAT CGT GAA GAG GAT TTA CTG GAT TCA GGC CTG TTT TAT 576 Ser Asp Gin Tyr Arg Glu Glu Asp Leu Leu Asp Ser Gly Leu Phe Tyr 180 185 190 CTT TCG GAT GCC AAT CAA TTT GTA GAC ACC TTT CAC AAT CGC ATT ATG 624 Leu Ser Asp Ala Asn Gin Phe Val Asp Thr Phe His Asn Arg He Met 195 200 205 TTT CCC CTG ACA AAT GAC CAA GGA AAG GTC ATT GCC TTC TCA GGT CGT 672 Phe Pro Leu Thr Asn Asp Gin Gly Lys Val He Ala Phe Ser Gly Arg 210 215 220 ATC TGG CAA AAA ACG GAT TCA CAA ACT TCT AAG TAT AAA AAC AGC CGA 720 He Trp Gin Lys Thr Asp Ser Gin Thr Ser Lys Tyr Lys Asn Ser Arg 225 230 235 240 TCG ACT GTA ATT TTT AAC AAA AGT TAC GAA TTA TAT CAT ATG GAT AGG 768 Ser Thr Val He Phe Asn Lys Ser Tyr Glu Leu Tyr His Met Asp Arg 245 250 255 GCA AAA AGA TCT TCT GGA AAA GCT AGT GAG ATT TAC CTG ATG GAA GGA 816 Ala Lys Arg Ser Ser Gly Lys Ala Ser Glu He Tyr Leu Met Glu Gly 260 265 270 TTC ATG GAT GTT ATT GCA GCC TAT CGG GCT GGA ATC GAA AAT GCT GTG 864 Phe Met Asp Val He Ala Ala Tyr Arg Ala Gly He Glu Asn Ala Val 275 280 285 GCG TCG ATG GGA ACG GCC TTG AGT CGA GAG CAT GTT GAG CAT CTG AAA 912 Ala Ser Met Gly Thr Ala Leu Ser Arg Glu His Val Glu His Leu Lys 290 295 300 AGG TTA ACC AAG AAA TTG GTT CTT GTT TAC GAT GGA GAT AAG GCT GGG 960 Arg Leu Thr Lys Lys Leu Val Leu Val Tyr Asp Gly Asp Lys Ala Gly 305 310 315 320 CAA GCC GCG ACA TTG AAA GCA TTG GAT GAA ATT GGT GAT ATG CCT GTG 1008 Gin Ala Ala Thr Leu Lys Ala Leu Asp Glu He Gly Asp Met Pro Val 325 330 335 CAA ATC GTC AGC ATG CCT GAT AAC TTG GAT CCT GAT GAA TAT CTA CAA 1056 Gin He Val Ser Met Pro Asp Asn Leu Asp Pro Asp Glu Tyr Leu Gin 340 345 350 AAA AAT GGT CCA GAA GAC TTG GCC TAT CTA TTA ACG AAA ACT CGT ATT 1104 Lys Asn Gly Pro Glu Asp Leu Ala Tyr Leu Leu Thr Lys Thr Arg He 355 360 365 AGT CCG ATT GAG TTC TAC ATT CAT CAG TAC AAA CCT GAA AAC GGT GAA 1152 Ser Pro He Glu Phe Tyr He His Gin Tyr Lys Pro Glu Asn Gly Glu 370 375 380 AAT CTG CAG GCT CAG ATT GAG TTT CTT GAA AAA ATA GCT CCC TTG ATT 1200 Asn Leu Gin Ala Gin He Glu Phe Leu Glu Lys He Ala Pro Leu He 385 390 395 400 GTT CAA GAA AAG TCC ATC GCT GCT CAA AAC AGC TAT ATT CAT ATT TTA 1248 Val Gin Glu Lys Ser He Ala Ala Gin Asn Ser Tyr He His He Leu 405 410 415 GCT GAC AGT CTG GCG TCC TTT GAT TAT ACC CAG ATT GAG CAG ATT GTT 1296 Ala Asp Ser Leu Ala Ser Phe Asp Tyr Thr Gin He Glu Gin He Val 420 425 430 AAT GAG AGT CGT CAG GTG CAA AGG CAG AAT CGC ATG GAA AGA ATT TCC 1344 Asn Glu Ser Arg Gin Val Gin Arg Gin Asn Arg Met Glu Arg He Ser 435 440 445 AGA CCG ACG CCA ATC ACC ATG CCT GTC ACC AAG CAG TTA TCG GCT ATT 1392 Arg Pro Thr Pro He Thr Met Pro Val Thr Lys Gin Leu Ser Ala He 450 455 460 ATG AGG GCA GAA GCC CAT CTA CTC TAT CGG ATG ATG GAA TCC CCT CTT 1440 Met Arg Ala Glu Ala His Leu Leu Tyr Arg Met Met Glu Ser Pro Leu 465 470 475 480 GTT TTG AAC GAT TAC CGT TTG CGA GAA GAC TTT GCA TTT GCT ACA CCT 1488 Val Leu Asn Asp Tyr Arg Leu Arg Glu Asp Phe Ala Phe Ala Thr Pro 485 490 495 GAA TTT CAG GTC TTA CAT GAC TTG CTT GGC CAG TAT GGA AAT CTT CCT 1536 Glu Phe Gin Val Leu His Asp Leu Leu Gly Gin Tyr Gly Asn Leu Pro 500 505 510 CCA GAA GTT TTA GCA GAG CAG ACA GAG GAA GTT GAA AGA GCT TGG TAC 1584 Pro Glu Val Leu Ala Glu Gin Thr Glu Glu Val Glu Arg Ala Trp Tyr 515 520 525 CAA GTT TTA GCT CAG GAT TTG CCT GCT GAG ATA TCG CCG CAG GAA CTT 1632 Gin Val Leu Ala Gin Asp Leu Pro Ala Glu He Ser Pro Gin Glu Leu 530 535 540 AGT GAA GTA GAG ATG ACT CGA AAC AAG GCT CTC TTG AAT CAG GAC AAT 1680 Ser Glu Val Glu Met Thr Arg Asn Lys Ala Leu Leu Asn Gin Asp Asn 545 550 555 560 ATG AGA ATC AAA AAG AAG GTG CAG GAA GCT AGC CAT GTA GGA GAT ACA 1728 Met Arg He Lys Lys Lys Val Gin Glu Ala Ser His Val Gly Asp Thr 565 570 575 GAT ACA GCC CTA GAA GAA TTG GAA CGT TTA ATT TCC CAA AAG AGA AGA 1776 Asp Thr Ala Leu Glu Glu Leu Glu Arg Leu He Ser Gin Lys Arg Arg 580 585 590 ATG GAG TAA 1785 Met Glu (2) INFORMATION FOR SEQ ID NO: 90: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 594 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 90: Met He Thr Met Glu Val Leu Cys Met Val Asp Lys Gin Val He Glu 1 5 10 15 Glu He Lys Asn Asn Ala Asn He Val Glu Val He Gly Asp Val He 20 25 30 Ser Leu Gin Lys Ala Gly Arg Asn Tyr Leu Gly Leu Cys Pro Phe His 35 40 45 Gly Glu Lys Thr Pro Ser Phe Ser Val Val Glu Asp Lys Gin Phe Tyr 50 55 60 His Cys Phe Gly Cys Gly Arg Ser Gly Asp Val Phe Lys Phe He Glu 65 70 75 80 Glu Tyr Gin Gly Val Thr Phe Met Glu Ala Val Gin He Leu Gly Gin 85 90 95 Arg Val Gly He Glu Val Glu Lys Pro Leu Tyr Ser Glu Gin Lys Pro 100 105 110 Ala Ser Pro His Gin Ala Leu Tyr Asp Met His Glu Asp Ala Ala Lys 115 120 125 Phe Tyr His Ala He Leu Met Thr Thr Thr Met Gly Glu Glu Ala Arg 130 135 140 Asn Tyr Leu Tyr Gin Arg Gly Leu Thr Asp Glu Val Leu Lys His Phe 145 150 155 160 Trp He Gly Leu Ala Pro Pro Glu Arg Asn Tyr Leu Tyr Gin Arg Leu 165 170 175 Ser Asp Gin Tyr Arg Glu Glu Asp Leu Leu Asp Ser Gly Leu Phe Tyr 180 185 190 Leu Ser Asp Ala Asn Gin Phe Val Asp Thr Phe His Asn Arg He Met 195 200 205 Phe Pro Leu Thr Asn Asp Gin Gly Lys Val He Ala Phe Ser Gly Arg 210 215 220 He Trp Gin Lys Thr Asp Ser Gin Thr Ser Lys Tyr Lys Asn Ser Arg 225 230 235 240 Ser Thr Val He Phe Asn Lys Ser Tyr Glu Leu Tyr His Met Asp Arg 245 250 255 Ala Lys Arg Ser Ser Gly Lys Ala Ser Glu He Tyr Leu Met Glu Gly 260 265 270 Phe Met Asp Val He Ala Ala Tyr Arg Ala Gly He Glu Asn Ala Val 275 280 285 Ala Ser Met Gly Thr Ala Leu Ser Arg Glu His Val Glu His Leu Lys 290 295 300 Arg Leu Thr Lys Lys Leu Val Leu Val Tyr Asp Gly Asp Lys Ala Gly 305 310 315 320 Gin Ala Ala Thr Leu Lys Ala Leu Asp Glu He Gly Asp Met Pro Val 325 330 335 Gin He Val Ser Met Pro Asp Asn Leu Asp Pro Asp Glu Tyr Leu Gin 340 345 350 Lys Asn Gly Pro Glu Asp Leu Ala Tyr Leu Leu Thr Lys Thr Arg He 355 360 365 Ser Pro He Glu Phe Tyr He His Gin Tyr Lys Pro Glu Asn Gly Glu 370 375 380 Asn Leu Gin Ala Gin He Glu Phe Leu Glu Lys He Ala Pro Leu He 385 390 395 400 Val Gin Glu Lys Ser He Ala Ala Gin Asn Ser Tyr He His He Leu 405 410 415 Ala Asp Ser Leu Ala Ser Phe Asp Tyr Thr Gin He Glu Gin He Val 420 425 430 Asn Glu Ser Arg Gin Val Gin Arg Gin Asn Arg Met Glu Arg He Ser 435 440 445 Arg Pro Thr Pro He Thr Met Pro Val Thr Lys Gin Leu Ser Ala He 450 455 460 Met Arg Ala Glu Ala His Leu Leu Tyr Arg Met Met Glu Ser Pro Leu 465 470 475 Val Leu Asn Asp Tyr Arg Leu Arg Glu Asp Phe Ala Phe Ala Thr Pro 485 490 495 Glu Phe Gin Val Leu His Asp Leu Leu Gly Gin Tyr Gly Asn Leu Pro 500 505 510 Pro Glu Val Leu Ala Glu Gin Thr Glu Glu Val Glu Arg Ala Trp Tyr 515 520 525 Gin Val Leu Ala Gin Asp Leu Pro Ala Glu He Ser Pro Gin Glu Leu 530 535 540 Ser Glu Val Glu Met Thr Arg Asn Lys Ala Leu Leu Asn Gin Asp Asn 545 550 555 560 Met Arg He Lys Lys Lys Val Gin Glu Ala Ser His Val Gly Asp Thr 565 570 575 Asp Thr Ala Leu Glu Glu Leu Glu Arg Leu He Ser Gin Lys Arg Arg 580 585 590 Met Glu (2) INFORMATION FOR SEQ ID NO: 91: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 900 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..897 (D) OTHER INFORMATION: Era (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 91: ATG ACT TTT AAA TCA GGC TTT GTA GCC ATT TTA GGA CGT CCC AAT GTT 48 Met Thr Phe Lys Ser Gly Phe Val Ala He Leu Gly Arg Pro Asn Val 1 5 10 15 GGG AAG TCA ACC TTT TTA AAT CAC GTT ATG GGG CAA AAG ATT GCC ATC 96 Gly Lys Ser Thr Phe Leu Asn His Val Met Gly Gin Lys He Ala He 20 25 30 ATG AGT GAC AAG GCG CAG ACA ACG CGC AAT AAA ATC ATG GGA ATT TAC 144 Met Ser Asp Lys Ala Gin Thr Thr Arg Asn Lys He Met Gly He Tyr 35 40 45 ACG ACT GAT AAG GAG CAA ATT GTC TTT ATC GAC ACA CCA GGG ATT CAC 192 Thr Thr Asp Lys Glu Gin He Val Phe He Asp Thr Pro Gly He His 50 55 60 AAA CCT AAA ACA GCT CTC GGA GAT TTC ATG GTT GAG TCT GCC TAC AGT 240 Lys Pro Lys Thr Ala Leu Gly Asp Phe Met Val Glu Ser Ala Tyr Ser 65 70 75 80 ACC CTT CGC GAA GTG GAC ACT GTT CTT TTC ATG GTG CCT GCT GAT GAA 288 Thr Leu Arg Glu Val Asp Thr Val Leu Phe Met Val Pro Ala Asp Glu 85 90 95 GCG CGT GGT AAG GGG GAC GAT ATG ATT ATC GAG CGT CTC AAG GCT GCC 336 Ala Arg Gly Lys Gly Asp Asp Met He He Glu Arg Leu Lys Ala Ala 100 105 110 AAG GTT CCT GTG ATT TTG GTG GTG AAT AAA ATC GAT AAG GTC CAT CCA 384 Lys Val Pro Val He Leu Val Val Asn Lys He Asp Lys Val His Pro 115 120 125 GAC CAG CTC TTG TCT CAG ATT GAT GAC TTC CGT AAT CAA ATG GAC TTT 432 Asp Gin Leu Leu Ser Gin He Asp Asp Phe Arg Asn Gin Met Asp Phe 130 135 140 AAG GAA ATT GTT CCA ATC TCA GCC CTT CAG GGA AAT AAC GTG TCT CGT 480 Lys Glu He Val Pro He Ser Ala Leu Gin Gly Asn Asn Val Ser Arg 145 150 155 160 CTA GTG GAT ATT TTG AGT GAA AAT CTG GAT GAA GGT TTC CAA TAT TTC 528 Leu Val Asp He Leu Ser Glu Asn Leu Asp Glu Gly Phe Gin Tyr Phe 165 170 175 CCG TCT GAT CAA ATC ACA GAT CAT CCA GAA CGT TTC TTA GTT TCA GAA 576 Pro Ser Asp Gin He Thr Asp His Pro Glu Arg Phe Leu Val Ser Glu 180 185 190 ATG GTT CGC GAG AAA GTC TTG CAC CTA ACT CGT GAA GAG ATT CCG CAT 624 Met Val Arg Glu Lys Val Leu His Leu Thr Arg Glu Glu He Pro His 195 200 205 TCT GTA GCA GTA GTT GTT GAC TCT ATG AAA CGA GAC GAA GAG ACA GAC 672 Ser Val Ala Val Val Val Asp Ser Met Lys Arg Asp Glu Glu Thr Asp 210 215 220 AAG GTT CAC ATC CGT GCA ACC ATC ATG GTC GAG CGC GAT AGC CAA AAA 720 Lys Val His He Arg Ala Thr He Met Val Glu Arg Asp Ser Gin Lys 225 230 235 240 GGG ATT ATC ATC GGT AAA GGT GGC GCT ATG CTT AAG AAA ATC GGT AGT 768 Gly He He He Gly Lys Gly Gly Ala Met Leu Lys Lys He Gly Ser 245 250 255 ATG GCC CGT CGT GAT ATC GAA CTC ATG CTA GGA GAC AAG GTC TTC CTA 816 Met Ala Arg Arg Asp He Glu Leu Met Leu Gly Asp Lys Val Phe Leu 260 265 270 GAA ACC TGG GTC AAG GTC AAG AAA AAC TGG CGC GAT AAA AAG CTA GAT 864 Glu Thr Trp Val Lys Val Lys Lys Asn Trp Arg Asp Lys Lys Leu Asp 275 280 285 TTG GCT GAC TTT GGC TAT AAT GAA AGA GAA TAC TAA 900 Leu Ala Asp Phe Gly Tyr Asn Glu Arg Glu Tyr 290 295 (2) INFORMATION FOR SEQ ID NO: 92: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 299 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 92: Met Thr Phe Lys Ser Gly Phe Val Ala He Leu Gly Arg Pro Asn Val 1 5 10 15 Gly Lys Ser Thr Phe Leu Asn His Val Met Gly Gin Lys He Ala He 20 25 30 Met Ser Asp Lys Ala Gin Thr Thr Arg Asn Lys He Met Gly He Tyr 35 40 45 Thr Thr Asp Lys Glu Gin He Val Phe He Asp Thr Pro Gly He His 50 55 60 Lys Pro Lys Thr Ala Leu Gly Asp Phe Met Val Glu Ser Ala Tyr Ser 65 70 75 80 Thr Leu Arg Glu Val Asp Thr Val Leu Phe Met Val Pro Ala Asp Glu 85 90 95 Ala Arg Gly Lys Gly Asp Asp Met He He Glu Arg Leu Lys Ala Ala 100 105 110 Lys Val Pro Val He Leu Val Val Asn Lys He Asp Lys Val His Pro 115 120 125 Asp Gin Leu Leu Ser Gin He Asp Asp Phe Arg Asn Gin Met Asp Phe 130 135 140 Lys Glu He Val Pro He Ser Ala Leu Gin Gly Asn Asn Val Ser Arg 145 150 155 160 Leu Val Asp He Leu Ser Glu Asn Leu Asp Glu Gly Phe Gin Tyr Phe 165 170 175 Pro Ser Asp Gin He Thr Asp His Pro Glu Arg Phe Leu Val Ser Glu 180 185 190 Met Val Arg Glu Lys Val Leu His Leu Thr Arg Glu Glu He Pro His 195 200 205 Ser Val Ala Val Val Val Asp Ser Met Lys Arg Asp Glu Glu Thr Asp 210 215 220 Lys Val His He Arg Ala Thr He Met Val Glu Arg Asp Ser Gin Lys 225 230 235 240 Gly He He He Gly Lys Gly Gly Ala Met Leu Lys Lys He Gly Ser 245 250 255 Met Ala Arg Arg Asp He Glu Leu Met Leu Gly Asp Lys Val Phe Leu 260 265 270 Glu Thr Trp Val Lys Val Lys Lys Asn Trp Arg Asp Lys Lys Leu Asp 275 280 285 Leu Ala Asp Phe Gly Tyr Asn Glu Arg Glu Tyr 290 295 (2) INFORMATION FOR SEQ ID NO: 93: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1011 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1008 (D) OTHER INFORMATION: Gcp (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 93: ATG AAG GAT AGA TAT ATT TTA GCA TTT GAG ACA TCC TGT GAT GAG ACC 48 Met Lys Asp Arg Tyr He Leu Ala Phe Glu Thr Ser Cys Asp Glu Thr 1 5 10 15 AGT GTC GCC GTC TTG AAA AAC GAC GAT GAG CTC TTG TCC AAT GTC ATT 96 Ser Val Ala Val Leu Lys Asn Asp Asp Glu Leu Leu Ser Asn Val He 20 25 30 GCT AGT CAA ATT GAG AGT CAC AAA CGT TTT GGT GGC GTA GTG CCC GAA 144 Ala Ser Gin He Glu Ser His Lys Arg Phe Gly Gly Val Val Pro Glu 35 40 45 GTA GCC AGT CGT CAC CAT GTC GAG GTC ATT ACA GCC TGT ATC GAG GAG 192 Val Ala Ser Arg His His Val Glu Val He Thr Ala Cys He Glu Glu 50 55 60 GCA TTG GCA GAA GCA GGG ATT ACC GAA GAG GAC GTG ACA GCT GTT GCG 240 Ala Leu Ala Glu Ala Gly He Thr Glu Glu Asp Val Thr Ala Val Ala 65 70 75 80 GTT ACC TAC GGA CCA GGC TTG GTC GGA GCC TTG CTA GTT GGT TTG TCA 288 Val Thr Tyr Gly Pro Gly Leu Val Gly Ala Leu Leu Val Gly Leu Ser 85 90 95 GCT GCC AAG GCC TTT GCT TGG GCT CAC GGA CTT CCA CTG ATT CCT GTT 336 Ala Ala Lys Ala Phe Ala Trp Ala His Gly Leu Pro Leu He Pro Val 100 105 110 AAT CAC ATG GCT GGG CAC CTC ATG GCA GCT CAG AGT GTG GAG CCT TTG 384 Asn His Met Ala Gly His Leu Met Ala Ala Gin Ser Val Glu Pro Leu 115 120 125 GAG TTT CCC TTG CTA GCC CTT TTA GTC AGT GGT GGG CAC ACA GAG TTG 432 Glu Phe Pro Leu Leu Ala Leu Leu Val Ser Gly Gly His Thr Glu Leu 130 135 140 GTC TAT GTT TCT GAG GCT GGC GAT TAC AAG ATT GTT GGG GAG ACA CGA 480 Val Tyr Val Ser Glu Ala Gly Asp Tyr Lys He Val Gly Glu Thr Arg 145 150 155 160 GAC GAT GCA GTT GGG GAG GCT TAT GAC AAG GTC GGT CGT GTC ATG GGC 528 Asp Asp Ala Val Gly Glu Ala Tyr Asp Lys Val Gly Arg Val Met Gly 165 170 175 TTG ACC TAT CCT GCA GGT CGT GAG ATT GAC GAG CTG GCT CAT CAG GGG 576 Leu Thr Tyr Pro Ala Gly Arg Glu He Asp Glu Leu Ala His Gin Gly 180 185 190 CAC GAT ATT TAT GAT TTC CCC CGT GCC ATG ATT AAG GAA GAT AAT CTG 624 His Asp He Tyr Asp Phe Pro Arg Ala Met He Lys Glu Asp Asn Leu 195 200 205 GAG TTC TCC TTC TCA GGT TTG AAA TCT GCC TTT ATC AAT CTT CAT CAC 672 Glu Phe Ser Phe Ser Gly Leu Lys Ser Ala Phe He Asn Leu His His 210 215 220 AAT GCC GAG CAA AAG GGA GAA AGC CTG TCT ACA GAA GAT TTG TGT GCT 720 Asn Ala Glu Gin Lys Gly Glu Ser Leu Ser Thr Glu Asp Leu Cys Ala 225 230 235 240 TCC TTC CAA GCA GCA GTT ATG GAC ATT CTC ATG GCA AAA ACC AAG AAG 768 Ser Phe Gin Ala Ala Val Met Asp He Leu Met Ala Lys Thr Lys Lys 245 250 255 GCT TTG GAG AAA TAT CCT GTT AAA ACC CTA GTT GTG GCA GGT GGT GTG 816 Ala Leu Glu Lys Tyr Pro Val Lys Thr Leu Val Val Ala Gly Gly Val 260 265 270 GCA GCC AAT AAA GGT CTC AGA GAA CGC CTA GCA ACT GAA ATC ACA GAT 864 Ala Ala Asn Lys Gly Leu Arg Glu Arg Leu Ala Thr Glu He Thr Asp 275 280 285 GTC AAT GTT ATC ATT CCA CCT CTG CGT CTC TGC GGA GAC AAT GCA GGT 912 Val Asn Val He He Pro Pro Leu Arg Leu Cys Gly Asp Asn Ala Gly 290 295 300 ATG ATT GCT TAT GCC AGT GTC AGC GAG TGG AAC AAA GAA AAC TTT GCA 960 Met He Ala Tyr Ala Ser Val Ser Glu Trp Asn Lys Glu Asn Phe Ala 305 310 315 320 AAC TTG GAC CTC AAT GCC AAA CCA AGT CTT GCC TTT GAT ACC ATG GAA 1008 Asn Leu Asp Leu Asn Ala Lys Pro Ser Leu Ala Phe Asp Thr Met Glu 325 330 335 TAA 1011 (2) INFORMATION FOR SEQ ID NO: 94: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 336 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 94: Met Lys Asp Arg Tyr He Leu Ala Phe Glu Thr Ser Cys Asp Glu Thr 1 5 10 15 Ser Val Ala Val Leu Lys Asn Asp Asp Glu Leu Leu Ser Asn Val He 20 25 30 Ala Ser Gin He Glu Ser His Lys Arg Phe Gly Gly Val Val Pro Glu 35 40 45 Val Ala Ser Arg His His Val Glu Val He Thr Ala Cys He Glu Glu 50 55 60 Ala Leu Ala Glu Ala Gly He Thr Glu Glu Asp Val Thr Ala Val Ala 65 70 75 80 Val Thr Tyr Gly Pro Gly Leu Val Gly Ala Leu Leu Val Gly Leu Ser 85 90 95 Ala Ala Lys Ala Phe Ala Trp Ala His Gly Leu Pro Leu He Pro Val 100 105 110 Asn His Met Ala Gly His Leu Met Ala Ala Gin Ser Val Glu Pro Leu 115 120 125 Glu Phe Pro Leu Leu Ala Leu Leu Val Ser Gly Gly His Thr Glu Leu 130 135 140 Val Tyr Val Ser Glu Ala Gly Asp Tyr Lys He Val Gly Glu Thr Arg 145 150 155 160 Asp Asp Ala Val Gly Glu Ala Tyr Asp Lys Val Gly Arg Val Met Gly 165 170 175 Leu Thr Tyr Pro Ala Gly Arg Glu He Asp Glu Leu Ala His Gin Gly 180 185 190 His Asp He Tyr Asp Phe Pro Arg Ala Met He Lys Glu Asp Asn Leu 195 200 205 Glu Phe Ser Phe Ser Gly Leu Lys Ser Ala Phe He Asn Leu His His 210 215 220 Asn Ala Glu Gin Lys Gly Glu Ser Leu Ser Thr Glu Asp Leu Cys Ala 225 230 235 240 Ser Phe Gin Ala Ala Val Met Asp He Leu Met Ala Lys Thr Lys Lys 245 250 255 Ala Leu Glu Lys Tyr Pro Val Lys Thr Leu Val Val Ala Gly Gly Val 260 265 270 Ala Ala Asn Lys Gly Leu Arg Glu Arg Leu Ala Thr Glu He Thr Asp 275 280 285 Val Asn Val He He Pro Pro Leu Arg Leu Cys Gly Asp Asn Ala Gly 290 295 300 Met He Ala Tyr Ala Ser Val Ser Glu Trp Asn Lys Glu Asn Phe Ala 305 310 315 320 Asn Leu Asp Leu Asn Ala Lys Pro Ser Leu Ala Phe Asp Thr Met Glu 325 330 335 (2) INFORMATION FOR SEQ ID NO: 95: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 774 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..771 (D) OTHER INFORMATION: HI0454 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 95: ATG ATT TTT GAT ACA CAT ACA CAC TTG AAT GTA GAA GAA TTT GCA GGT 48 Met He Phe Asp Thr His Thr His Leu Asn Val Glu Glu Phe Ala Gly 1 5 10 15 CGT GAG GCA GAA GAA ATT GCC TTG GCT GCT GAG ATG GGT GTG ACA CAG 96 Arg Glu Ala Glu Glu He Ala Leu Ala Ala Glu Met Gly Val Thr Gin 20 25 30 ATG AAT ATT GTT GGT TTT GAT AAA CCG ACG ATT GAG CAT GCC TTG GAG 144 Met Asn He Val Gly Phe Asp Lys Pro Thr He Glu His Ala Leu Glu 35 40 45 TTG GTA GAT GAG TAT GAG CAG CTC TAT GCG ACT ATT GGT TGG CAT CCT 192 Leu Val Asp Glu Tyr Glu Gin Leu Tyr Ala Thr He Gly Trp His Pro 50 55 60 ACA GAA GCT GGT ACT TAT ACA GAG GAA GTT GAG GCT TAC TTG TTG GAT 240 Thr Glu Ala Gly Thr Tyr Thr Glu Glu Val Glu Ala Tyr Leu Leu Asp 65 70 75 80 AAG TTA AAA CAT TCC AAG GTT GTG GCT TTA GGT GAA ATT GGC TTA GAC 288 Lys Leu Lys His Ser Lys Val Val Ala Leu Gly Glu He Gly Leu Asp 85 90 95 TAC CAT TGG ATG ACA GCG CCC AAA GAG GTG CAG GAG CAG GTT TTT CGC 336 Tyr His Trp Met Thr Ala Pro Lys Glu Val Gin Glu Gin Val Phe Arg 100 105 110 CGT CAG ATT CAG CTA TCT AAG GAC TTG GAT TTG CCT TTT GTT GTC CAT 384 Arg Gin He Gin Leu Ser Lys Asp Leu Asp Leu Pro Phe Val Val His 115 120 125 ACC CGT GAT GCG CTG GAA GAT ACC TAT GAG ATT ATC AAG AGT GAG GGC 432 Thr Arg Asp Ala Leu Glu Asp Thr Tyr Glu He He Lys Ser Glu Gly 130 135 140 GTT GGT CCT CGT GGT GGT ATC ATG CAT TCA TTT TCA GGG ACG CTT GAG 480 Val Gly Pro Arg Gly Gly He Met His Ser Phe Ser Gly Thr Leu Glu 145 150 155 160 TGG GCA GAG AAG TTT GTG GAT CTT GGT ATG ACC ATT TCC TTC TCA GGA 528 Trp Ala Glu Lys Phe Val Asp Leu Gly Met Thr He Ser Phe Ser Gly 165 170 175 GTG GTG ACC TTC AAG AAG GCA ACT GAC CTC CAA GAA GCA GCT AAA GAG 576 Val Val Thr Phe Lys Lys Ala Thr Asp Leu Gin Glu Ala Ala Lys Glu 180 185 190 TTA CCT TTG GAC AAG ATG TTG GTA GAA ACA GAT GCG CCT TAC TTA GCA 624 Leu Pro Leu Asp Lys Met Leu Val Glu Thr Asp Ala Pro Tyr Leu Ala 195 200 205 CCT GTA CCC AAG CGT GGT CGT GAA AAT AAA ACA GCC TAT ACT CGC TAT 672 Pro Val Pro Lys Arg Gly Arg Glu Asn Lys Thr Ala Tyr Thr Arg Tyr 210 215 220 GTG GTC GAC TTT ATC GCT GAC TTG CGT GGT ATG ACG ACA GAA GAG CTG 720 Val Val Asp Phe He Ala Asp Leu Arg Gly Met Thr Thr Glu Glu Leu 225 230 235 240 GCG GTA GCA ACG ACT GCA AAT GCA GAA CGC ATT TTT GGA TTG GAC AGC 768 Ala Val Ala Thr Thr Ala Asn Ala Glu Arg He Phe Gly Leu Asp Ser 245 250 255 AAG TAA 774 Lys (2) INFORMATION FOR SEQ ID NO: 96: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 257 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 96: Met He Phe Asp Thr His Thr His Leu Asn Val Glu Glu Phe Ala Gly 1 5 10 15 Arg Glu Ala Glu Glu He Ala Leu Ala Ala Glu Met Gly Val Thr Gin 20 25 30 Met Asn He Val Gly Phe Asp Lys Pro Thr He Glu His Ala Leu Glu 35 40 45 Leu Val Asp Glu Tyr Glu Gin Leu Tyr Ala Thr He Gly Trp His Pro 50 55 60 Thr Glu Ala Gly Thr Tyr Thr Glu Glu Val Glu Ala Tyr Leu Leu Asp 65 70 75 80 Lys Leu Lys His Ser Lys Val Val Ala Leu Gly Glu He Gly Leu Asp 85 90 95 Tyr His Trp Met Thr Ala Pro Lys Glu Val Gin Glu Gin Val Phe Arg 100 105 110 Arg Gin He Gin Leu Ser Lys Asp Leu Asp Leu Pro Phe Val Val His 115 120 125 Thr Arg Asp Ala Leu Glu Asp Thr Tyr Glu He He Lys Ser Glu Gly 130 135 140 Val Gly Pro Arg Gly Gly He Met His Ser Phe Ser Gly Thr Leu Glu 145 150 155 160 Trp Ala Glu Lys Phe Val Asp Leu Gly Met Thr He Ser Phe Ser Gly 165 170 175 Val Val Thr Phe Lys Lys Ala Thr Asp Leu Gin Glu Ala Ala Lys Glu 180 185 190 Leu Pro Leu Asp Lys Met Leu Val Glu Thr Asp Ala Pro Tyr Leu Ala 195 200 205 Pro Val Pro Lys Arg Gly Arg Glu Asn Lys Thr Ala Tyr Thr Arg Tyr 210 215 220 Val Val Asp Phe He Ala Asp Leu Arg Gly Met Thr Thr Glu Glu Leu 225 230 235 240 Ala Val Ala Thr Thr Ala Asn Ala Glu Arg He Phe Gly Leu Asp Ser 245 250 255 Lys (2) INFORMATION FOR SEQ ID NO: 97: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1959 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1959 (D) OTHER INFORMATION: Ligase (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 97: ATG AAT AAA AGA ATG AAT GAG TTA GTC GCT TTG CTC AAT CGC TAT GCG 48 Met Asn Lys Arg Met Asn Glu Leu Val Ala Leu Leu Asn Arg Tyr Ala 1 5 10 15 ACT GAG TAC TAT ACC AGC GAT AAT CCC TCG GTT TCA GAC AGT GAG TAT 96 Thr Glu Tyr Tyr Thr Ser Asp Asn Pro Ser Val Ser Asp Ser Glu Tyr 20 25 30 GAC CGC CTT TAC CGT GAG TTG GTC GAG TTA GAA ACT GCT TAT CCA GAG 144 Asp Arg Leu Tyr Arg Glu Leu Val Glu Leu Glu Thr Ala Tyr Pro Glu 35 40 45 CAA GTG CTA GCA GAC AGT CCG ACT CAT CGT GTT GGT GGC AAG GTT TTA 192 Gin Val Leu Ala Asp Ser Pro Thr His Arg Val Gly Gly Lys Val Leu 50 55 60 GAT GGT TTT GAA AAA TAC AGT CAT CAG TAT CCT CTT TAT AGT TTG CAG 240 Asp Gly Phe Glu Lys Tyr Ser His Gin Tyr Pro Leu Tyr Ser Leu Gin 65 70 75 80 GAT GCT TTT TCA CGT GAG GAG CTA GAT GCT TTT GAT GCG CGT GTT CGT 288 Asp Ala Phe Ser Arg Glu Glu Leu Asp Ala Phe Asp Ala Arg Val Arg 85 90 95 AAG GAA GTG GCT CAT CCG ACC TAT ATT TGT GAG CTG AAA ATC GAT GGC 336 Lys Glu Val Ala His Pro Thr Tyr He Cys Glu Leu Lys He Asp Gly 100 105 110 TTA TCT ATC TCG CTG ACT TAT GAA AAG GGG ATT TTG GTT GCT GGG GTA 384 Leu Ser He Ser Leu Thr Tyr Glu Lys Gly He Leu Val Ala Gly Val 115 120 125 ACA CGT GGA GAT GGT TCA ATT GGT GAA AAT ATC ACA GAA AAC CTC AAG 432 Thr Arg Gly Asp Gly Ser He Gly Glu Asn He Thr Glu Asn Leu Lys 130 135 140 CGT GTT AAG GAC ATC CCT TTG ACT TTG CCA GAA GAA CTA GAT ATC ACA 480 Arg Val Lys Asp He Pro Leu Thr Leu Pro Glu Glu Leu Asp He Thr 145 150 155 160 GTT CGT GGG GAA TGT TAC ATG CCA CGC GCT TCC TTT GAC CAA GTT AAC 528 Val Arg Gly Glu Cys Tyr Met Pro Arg Ala Ser Phe Asp Gin Val Asn 165 170 175 CAA GCG CGC CAA GAA AAT GGA GAG CCT GAA TTT GCT AAT CCT CGT AAT 576 Gin Ala Arg Gin Glu Asn Gly Glu Pro Glu Phe Ala Asn Pro Arg Asn 180 185 190 GCG GCA GCA GGA ACT CTG CGT CAG TTG GAT ACA GCA GTA GTT GCC AAG 624 Ala Ala Ala Gly Thr Leu Arg Gin Leu Asp Thr Ala Val Val Ala Lys 195 200 205 CGT AAT CTT GCA ACG TTT CTC TAT CAA GAA GCC AGC CCT TCA ACT CGT 672 Arg Asn Leu Ala Thr Phe Leu Tyr Gin Glu Ala Ser Pro Ser Thr Arg 210 215 220 GAT AGC CAA GAA AAG GGT TTG AAG TAC CTA GAA CAA CTA GGT TTT GTG 720 Asp Ser Gin Glu Lys Gly Leu Lys Tyr Leu Glu Gin Leu Gly Phe Val 225 230 235 240 GTC AAT CCT AAG CGA ATC TTG GCT GAA AAC ATA GAT GAA ATC TGG AAT 768 Val Asn Pro Lys Arg He Leu Ala Glu Asn He Asp Glu He Trp Asn 245 250 255 TTT ATC CAA GAA GTA GGA CAG GAA CGG GAA AAT CTG CCT TAC GAT ATT 816 Phe He Gin Glu Val Gly Gin Glu Arg Glu Asn Leu Pro Tyr Asp He 260 265 270 GAT GGA GTG GTA ATC AAG GTC AAC GAC CTA GCA AGT CAA GAA GAA CTT 864 Asp Gly Val Val He Lys Val Asn Asp Leu Ala Ser Gin Glu Glu Leu 275 280 285 GGT TTT ACC GTT AAG GCT CCA AAG TGG GCA GTA GCC TAC AAG TTC CCT 912 Gly Phe Thr Val Lys Ala Pro Lys Trp Ala Val Ala Tyr Lys Phe Pro 290 295 300 GCT GAA GAA AAA GAA GCT CAA CTC TTA TCA GTT GAC TGG ACA GTT GGC 960 Ala Glu Glu Lys Glu Ala Gin Leu Leu Ser Val Asp Trp Thr Val Gly 305 310 315 320 CGT ACC GGT GTT GTA ACT CCA ACT GCT AAT CTA ACA CCA GTA CAA CTT 1008 Arg Thr Gly Val Val Thr Pro Thr Ala Asn Leu Thr Pro Val Gin Leu 325 330 335 GCC GGT ACG ACT GTT AGC CGT GCG ACC CTG CAC AAT GTA GAT TAT ATT 1056 Ala Gly Thr Thr Val Ser Arg Ala Thr Leu His Asn Val Asp Tyr He 340 345 350 GCT GAA AAA GAT ATC CGA AAA GAC GAT ACG GTC ATT GTA TAT AAG GCT 1104 Ala Glu Lys Asp He Arg Lys Asp Asp Thr Val He Val Tyr Lys Ala 355 360 365 GGT GAC ATC ATC CCT GCC GTT TTA CGT GTG GTA GAG TCC AAA CGG GTT 1152 Gly Asp He He Pro Ala Val Leu Arg Val Val Glu Ser Lys Arg Val 370 375 380 TCT GAA GAA AAA CTA GAT ATC CCT ACA AAC TGT CCA AGT TGT AAC TCT 1200 Ser Glu Glu Lys Leu Asp He Pro Thr Asn Cys Pro Ser Cys Asn Ser 385 390 395 400 GAC TTG TTG CAC TTT GAA GAT GAA GTG GCC CTA CGT TGT ATC AAT CCG 1248 Asp Leu Leu His Phe Glu Asp Glu Val Ala Leu Arg Cys He Asn Pro 405 410 415 CGT TGC CCT GCT CAA ATC ATG GAA GGC TTG ATT CAC TTT GCT TCT CGT 1296 Arg Cys Pro Ala Gin He Met Glu Gly Leu He His Phe Ala Ser Arg 420 425 430 GAT GCT ATG AAT ATT ACA GGC CTT GGT CCA TCT ATT GTT GAG AAG CTT 1344 Asp Ala Met Asn He Thr Gly Leu Gly Pro Ser He Val Glu Lys Leu 435 440 445 TTT GCT GCT AAT TTA GTC AAG GAT GTG GCG GAT ATT TAT CGT TTG CAA 1392 Phe Ala Ala Asn Leu Val Lys Asp Val Ala Asp He Tyr Arg Leu Gin 450 455 460 GAA GAG GAT TTC CTC CTT TTA GAG GGG GTT AAG GAA AAG TCC GCT GCT 1440 Glu Glu Asp Phe Leu Leu Leu Glu Gly Val Lys Glu Lys Ser Ala Ala 465 470 475 480 AAA CTG TAT CAG GCT ATC CAA GCA TCA AAG GAA AAT TCT GCC GAG AAG 1488 Lys Leu Tyr Gin Ala He Gin Ala Ser Lys Glu Asn Ser Ala Glu Lys 485 490 495 CTC TTA TTT GGT TTG GGA ATT CGT CAT GTC GGA AGC AAG GCT AGT CAG 1536 Leu Leu Phe Gly Leu Gly He Arg His Val Gly Ser Lys Ala Ser Gin 500 505 510 CTT TTA CTT CAA TAT TTC CAT TCA ATT GAA AAT CTG TAT CAG GCA GAT 1584 Leu Leu Leu Gin Tyr Phe His Ser He Glu Asn Leu Tyr Gin Ala Asp 515 520 525 TCA GAG GAA GTG GCT AGT ATT GAA AGT CTA GGT GGC GTG ATT GCC AAA 1632 Ser Glu Glu Val Ala Ser He Glu Ser Leu Gly Gly Val He Ala Lys 530 535 540 AGT CTT CAG ACT TAT TTT GCG GCA GAA GGC TCT GAA ATT CTG CTC AGA 1680 Ser Leu Gin Thr Tyr Phe Ala Ala Glu Gly Ser Glu He Leu Leu Arg 545 550 555 560 GAA TTG AAA GAA ACT GGG GTC AAT CTG GAC TAT AAA GGA CAG ACG GTA 1728 Glu Leu Lys Glu Thr Gly Val Asn Leu Asp Tyr Lys Gly Gin Thr Val 565 570 575 GTA GCG GAT GCG GCC TTG TCA GGT TTG ACC GTG GTA TTG ACA GGA AAA 1776 Val Ala Asp Ala Ala Leu Ser Gly Leu Thr Val Val Leu Thr Gly Lys 580 585 590 TTG GAA CGA CTC AAG CGC TCA GAA GCT AAA AGT AAA CTC GAA AGT CTG 1824 Leu Glu Arg Leu Lys Arg Ser Glu Ala Lys Ser Lys Leu Glu Ser Leu 595 600 605 GGT GCC AAA GTG ACA GGT AGT GTT TCT AAA AAG ACC GAC CTC GTC GTG 1872 Gly Ala Lys Val Thr Gly Ser Val Ser Lys Lys Thr Asp Leu Val Val 610 615 620 GTA GGT GCA GAC GCT GGA AGT AAA CTG CAA AAA GCA CAA GAA CTT GGT 1920 Val Gly Ala Asp Ala Gly Ser Lys Leu Gin Lys Ala Gin Glu Leu Gly 625 630 635 640 ATC CAG GTC AGA GAT GAG GCA TGG CTA GAA AGT TTG TAA 1959 He Gin Val Arg Asp Glu Ala Trp Leu Glu Ser Leu 645 650 (2) INFORMATION FOR SEQ ID NO: 98: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 653 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9£ Met Asn Lys Arg Met Asn Glu Leu Val Ala Leu Leu Asn Arg Tyr Ala 1 5 10 15 Thr Glu Tyr Tyr Thr Ser Asp Asn Pro Ser Val Ser Asp Ser Glu Tyr 20 25 30 Asp Arg Leu Tyr Arg Glu Leu Val Glu Leu Glu Thr Ala Tyr Pro Glu 35 40 45 Gin Val Leu Ala Asp Ser Pro Thr His Arg Val Gly Gly Lys Val Leu 50 55 60 Asp Gly Phe Glu Lys Tyr Ser His Gin Tyr Pro Leu Tyr Ser Leu Gin 65 70 75 80 Asp Ala Phe Ser Arg Glu Glu Leu Asp Ala Phe Asp Ala Arg Val Arg 85 90 95 Lys Glu Val Ala His Pro Thr Tyr He Cys Glu Leu Lys He Asp Gly 100 105 110 Leu Ser He Ser Leu Thr Tyr Glu Lys Gly He Leu Val Ala Gly Val 115 120 125 Thr Arg Gly Asp Gly Ser He Gly Glu Asn He Thr Glu Asn Leu Lys 130 135 140 Arg Val Lys Asp He Pro Leu Thr Leu Pro Glu Glu Leu Asp He Thr 145 150 155 160 Val Arg Gly Glu Cys Tyr Met Pro Arg Ala Ser Phe Asp Gin Val Asn 165 170 175 Gin Ala Arg Gin Glu Asn Gly Glu Pro Glu Phe Ala Asn Pro Arg Asn 180 185 190 Ala Ala Ala Gly Thr Leu Arg Gin Leu Asp Thr Ala Val Val Ala Lys 195 200 205 Arg Asn Leu Ala Thr Phe Leu Tyr Gin Glu Ala Ser Pro Ser Thr Arg 210 215 220 Asp Ser Gin Glu Lys Gly Leu Lys Tyr Leu Glu Gin Leu Gly Phe Val 225 230 235 240 Val Asn Pro Lys Arg He Leu Ala Glu Asn He Asp Glu He Trp Asn 245 250 255 Phe He Gin Glu Val Gly Gin Glu Arg Glu Asn Leu Pro Tyr Asp He 260 265 270 Asp Gly Val Val He Lys Val Asn Asp Leu Ala Ser Gin Glu Glu Leu 275 280 285 Gly Phe Thr Val Lys Ala Pro Lys Trp Ala Val Ala Tyr Lys Phe Pro 290 295 300 Ala Glu Glu Lys Glu Ala Gin Leu Leu Ser Val Asp Trp Thr Val Gly 305 310 315 320 Arg Thr Gly Val Val Thr Pro Thr Ala Asn Leu Thr Pro Val Gin Leu 325 330 335 Ala Gly Thr Thr Val Ser Arg Ala Thr Leu His Asn Val Asp Tyr He 340 345 350 Ala Glu Lys Asp He Arg Lys Asp Asp Thr Val He Val Tyr Lys Ala 355 360 365 Gly Asp He He Pro Ala Val Leu Arg Val Val Glu Ser Lys Arg Val 370 375 380 Ser Glu Glu Lys Leu Asp He Pro Thr Asn Cys Pro Ser Cys Asn Ser 385 390 395 400 Asp Leu Leu His Phe Glu Asp Glu Val Ala Leu Arg Cys He Asn Pro 405 410 415 Arg Cys Pro Ala Gin He Met Glu Gly Leu He His Phe Ala Ser Arg 420 425 430 Asp Ala Met Asn He Thr Gly Leu Gly Pro Ser He Val Glu Lys Leu 435 440 445 Phe Ala Ala Asn Leu Val Lys Asp Val Ala Asp He Tyr Arg Leu Gin 450 455 460 Glu Glu Asp Phe Leu Leu Leu Glu Gly Val Lys Glu Lys Ser Ala Ala 465 470 475 480 Lys Leu Tyr Gin Ala He Gin Ala Ser Lys Glu Asn Ser Ala Glu Lys 485 490 495 Leu Leu Phe Gly Leu Gly He Arg His Val Gly Ser Lys Ala Ser Gin 500 505 510 Leu Leu Leu Gin Tyr Phe His Ser He Glu Asn Leu Tyr Gin Ala Asp 515 520 525 Ser Glu Glu Val Ala Ser He Glu Ser Leu Gly Gly Val He Ala Lys 530 535 540 Ser Leu Gin Thr Tyr Phe Ala Ala Glu Gly Ser Glu He Leu Leu Arg 545 550 555 560 Glu Leu Lys Glu Thr Gly Val Asn Leu Asp Tyr Lys Gly Gin Thr Val 565 570 575 Val Ala Asp Ala Ala Leu Ser Gly Leu Thr Val Val Leu Thr Gly Lys 580 585 590 Leu Glu Arg Leu Lys Arg Ser Glu Ala Lys Ser Lys Leu Glu Ser Leu 595 600 605 Gly Ala Lys Val Thr Gly Ser Val Ser Lys Lys Thr Asp Leu Val Val 610 615 620 Val Gly Ala Asp Ala Gly Ser Lys Leu Gin Lys Ala Gin Glu Leu Gly 625 630 635 640 He Gin Val Arg Asp Glu Ala Trp Leu Glu Ser Leu 645 650 (2) INFORMATION FOR SEQ ID NO: 99: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 981 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..981 (D) OTHER INFORMATION: MraY (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 99: ATG TTT ATT TCC ATC AGT GCT GGA ATT GTG ACA TTT TTA CTA ACT TTA 48 Met Phe He Ser He Ser Ala Gly He Val Thr Phe Leu Leu Thr Leu 1 5 10 15 GTA GGA ATT CCG GCC TTT ATC CAA TTT TAT AGA AAG GCG CAA ATT ACA 96 Val Gly He Pro Ala Phe He Gin Phe Tyr Arg Lys Ala Gin He Thr 20 25 30 GGC CAG CAG ATG CAT GAG GAT GTC AAA CAG CAT CAG GCA AAA GCT GGG 144 Gly Gin Gin Met His Glu Asp Val Lys Gin His Gin Ala Lys Ala Gly 35 40 45 ACT CCT ACA ATG GGA GGT TTG GTT TTC TTG ATT ACT TCT GTT TTG GTT 192 Thr Pro Thr Met Gly Gly Leu Val Phe Leu He Thr Ser Val Leu Val 50 55 60 GCT TTC TTT TTC GCC CTA TTT AGT AGC CAA TTC AGC AAT AAT GTG GGA 240 Ala Phe Phe Phe Ala Leu Phe Ser Ser Gin Phe Ser Asn Asn Val Gly 65 70 75 80 ATG ATT TTG TTC ATC TTG GTC TTG TAT GGC TTG GTC GGA TTT TTA GAT 288 Met He Leu Phe He Leu Val Leu Tyr Gly Leu Val Gly Phe Leu Asp 85 90 95 GAC TTT CTC AAG GTC TTT CGT AAA ATC AAT GAG GGG CTT AAT CCT AAG 336 Asp Phe Leu Lys Val Phe Arg Lys He Asn Glu Gly Leu Asn Pro Lys 100 105 110 CAA AAA TTA GCT CTT CAG CTT CTA GGT GGA GTT ATC TTC TAT CTT TTC 384 Gin Lys Leu Ala Leu Gin Leu Leu Gly Gly Val He Phe Tyr Leu Phe 115 120 125 TAT GAG CGC GGT GGC GAT ATC CTG TCT GTC TTT GGT TAT CCA GTT CAT 432 Tyr Glu Arg Gly Gly Asp He Leu Ser Val Phe Gly Tyr Pro Val His 130 135 140 TTG GGA TTT TTC TAT ATT TTC TTC GCT CTT TTC TGG CTA GTC GGT TTT 480 Leu Gly Phe Phe Tyr He Phe Phe Ala Leu Phe Trp Leu Val Gly Phe 145 150 155 160 TCA AAC GCA GTA AAC TTG ACA GAC GGT GTT GAC GGT TTA GCT AGT ATT 528 Ser Asn Ala Val Asn Leu Thr Asp Gly Val Asp Gly Leu Ala Ser He 165 170 175 TCC GTT GTG ATT AGT TTG TTT GCC TAT GGA GTT ATT GCC TAT GTG CAA 576 Ser Val Val He Ser Leu Phe Ala Tyr Gly Val He Ala Tyr Val Gin 180 185 190 GGT CAG ATG GAT ATT CTT CTA GTG ATT CTT GCC ATG ATT GGT GGT TTG 624 Gly Gin Met Asp He Leu Leu Val He Leu Ala Met He Gly Gly Leu 195 200 205 CTC GGT TTC TTC ATC TTT AAC CAT AAG CCT GCC AAG GTC TTT ATG GGT 672 Leu Gly Phe Phe He Phe Asn His Lys Pro Ala Lys Val Phe Met Gly 210 215 220 GAT GTG GGA AGT TTG GCC CTA GGT GGG ATG CTG GCA GCT ATC TCT ATG 720 Asp Val Gly Ser Leu Ala Leu Gly Gly Met Leu Ala Ala He Ser Met 225 230 235 240 GCT CTC CAC CAG GAA TGG ACT CTC TTG ATT ATC GGA ATT GTG TAT GTT 768 Ala Leu His Gin Glu Trp Thr Leu Leu He He Gly He Val Tyr Val 245 250 255 TTT GAA ACA ACT TCT GTT ATG ATG CAA GTC AGT TAT TTC AAA CTG ACA 816 Phe Glu Thr Thr Ser Val Met Met Gin Val Ser Tyr Phe Lys Leu Thr 260 265 270 GGT GGT AAA CGT ATT TTC CGT ATG ACG CCT GTA CAT CAC CAT TTT GAG 864 Gly Gly Lys Arg He Phe Arg Met Thr Pro Val His His His Phe Glu 275 280 285 CTT GGG GGA TTG TCT GGT AAA GGA AAT CCT TGG AGC GAG TGG AAG GTT 912 Leu Gly Gly Leu Ser Gly Lys Gly Asn Pro Trp Ser Glu Trp Lys Val 290 295 300 GAC TTC TTC TTT TGG GGA GTT GGG CTT CTA GCA AGT CTC CTG ACC CTC 960 Asp Phe Phe Phe Trp Gly Val Gly Leu Leu Ala Ser Leu Leu Thr Leu 305 310 315 320 GCA ATT TTG TAT TTG ATG TAA 981 Ala He Leu Tyr Leu Met 325 (2) INFORMATION FOR SEQ ID NO: 100: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 326 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 100: Met Phe He Ser He Ser Ala Gly He Val Thr Phe Leu Leu Thr Leu 1 5 10 15 Val Gly He Pro Ala Phe He Gin Phe Tyr Arg Lys Ala Gin He Thr 20 25 30 Gly Gin Gin Met His Glu Asp Val Lys Gin His Gin Ala Lys Ala Gly 35 40 45 Thr Pro Thr Met Gly Gly Leu Val Phe Leu He Thr Ser Val Leu Val 50 55 60 Ala Phe Phe Phe Ala Leu Phe Ser Ser Gin Phe Ser Asn Asn Val Gly 65 70 75 80 Met He Leu Phe He Leu Val Leu Tyr Gly Leu Val Gly Phe Leu Asp 85 90 95 Asp Phe Leu Lys Val Phe Arg Lys He Asn Glu Gly Leu Asn Pro Lys 100 105 110 Gin Lys Leu Ala Leu Gin Leu Leu Gly Gly Val He Phe Tyr Leu Phe 115 120 125 Tyr Glu Arg Gly Gly Asp He Leu Ser Val Phe Gly Tyr Pro Val His 130 135 140 Leu Gly Phe Phe Tyr He Phe Phe Ala Leu Phe Trp Leu Val Gly Phe 145 150 155 160 Ser Asn Ala Val Asn Leu Thr Asp Gly Val Asp Gly Leu Ala Ser He 165 170 175 Ser Val Val He Ser Leu Phe Ala Tyr Gly Val He Ala Tyr Val Gin 180 185 190 Gly Gin Met Asp He Leu Leu Val He Leu Ala Met He Gly Gly Leu 195 200 205 Leu Gly Phe Phe He Phe Asn His Lys Pro Ala Lys Val Phe Met Gly 210 215 220 Asp Val Gly Ser Leu Ala Leu Gly Gly Met Leu Ala Ala He Ser Met 225 230 235 240 Ala Leu His Gin Glu Trp Thr Leu Leu He He Gly He Val Tyr Val 245 250 255 Phe Glu Thr Thr Ser Val Met Met Gin Val Ser Tyr Phe Lys Leu Thr 260 265 270 Gly Gly Lys Arg He Phe Arg Met Thr Pro Val His His His Phe Glu 275 280 285 Leu Gly Gly Leu Ser Gly Lys Gly Asn Pro Trp Ser Glu Trp Lys Val 290 295 300 Asp Phe Phe Phe Trp Gly Val Gly Leu Leu Ala Ser Leu Leu Thr Leu 305 310 315 320 Ala He Leu Tyr Leu Met 325 (2) INFORMATION FOR SEQ ID NO: 101: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 369 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..366 (D) OTHER INFORMATION: Dpj (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 101: ATG AGA ATG ATA GTT GGA CAC GGA ATT GAC ATC GAA GAA TTG GCT TCG 48 Met Arg Met He Val Gly His Gly He Asp He Glu Glu Leu Ala Ser 1 5 10 15 ATA GAA AGC GCA GTT ACA CGA CAT GAA GGA TTT GCT AAG CGT GTA CTG 96 He Glu Ser Ala Val Thr Arg His Glu Gly Phe Ala Lys Arg Val Leu 20 25 30 ACC GCT CAG GAA ATG GAG CGC TTC ACC AGT CTC AAA GGA CGC AGG CAA 144 Thr Ala Gin Glu Met Glu Arg Phe Thr Ser Leu Lys Gly Arg Arg Gin 35 40 45 ATA GAA TAT TTA GCT GGT CGC TGG TCG GCT AAG GAG GCC TTT TCC AAG 192 He Glu Tyr Leu Ala Gly Arg Trp Ser Ala Lys Glu Ala Phe Ser Lys 50 55 60 GCT ATG GGA ACG GGC ATT AGC AAG CTC GGT TTT CAG GAT TTG GAA GTC 240 Ala Met Gly Thr Gly He Ser Lys Leu Gly Phe Gin Asp Leu Glu Val 65 70 75 80 TTG AAC AAT GAA CGT GGG GCG CCT TAT TTT AGT CAG GCA CCA TTT TCA 288 Leu Asn Asn Glu Arg Gly Ala Pro Tyr Phe Ser Gin Ala Pro Phe Ser 85 90 95 GGA AAG ATT TGG CTG TCT ATC AGC CAC ACC GAT CAG TTT GTG ACA GCC 336 Gly Lys He Trp Leu Ser He Ser His Thr Asp Gin Phe Val Thr Ala 100 105 110 AGT GTC ATT TTG GAG GAA AAT CAT GAA AGC TAG 369 Ser Val He Leu Glu Glu Asn His Glu Ser 115 120 (2) INFORMATION FOR SEQ ID NO:102: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 122 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 102: Met Arg Met He Val Gly His Gly He Asp He Glu Glu Leu Ala Ser 1 5 10 15 He Glu Ser Ala Val Thr Arg His Glu Gly Phe Ala Lys Arg Val Leu 20 25 30 Thr Ala Gin Glu Met Glu Arg Phe Thr Ser Leu Lys Gly Arg Arg Gin 35 40 45 He Glu Tyr Leu Ala Gly Arg Trp Ser Ala Lys Glu Ala Phe Ser Lys 50 55 60 Ala Met Gly Thr Gly He Ser Lys Leu Gly Phe Gin Asp Leu Glu Val 65 70 75 80 Leu Asn Asn Glu Arg Gly Ala Pro Tyr Phe Ser Gin Ala Pro Phe Ser 85 90 95 Gly Lys He Trp Leu Ser He Ser His Thr Asp Gin Phe Val Thr Ala 100 105 110 Ser Val He Leu Glu Glu Asn His Glu Ser 115 120 (2) INFORMATION FOR SEQ ID NO: 103: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1260 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1260 (D) OTHER INFORMATION: MurZ (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 103: ATG AGA AAA ATT GTT ATC AAT GGT GGA TTA CCA CTG CAA GGT GAA ATC 48 Met Arg Lys He Val He Asn Gly Gly Leu Pro Leu Gin Gly Glu He 1 5 10 15 ACT ATT AGT GGT GCT AAA AAT AGT GTC GTT GCC TTA ATT CCA GCT ATT 96 Thr He Ser Gly Ala Lys Asn Ser Val Val Ala Leu He Pro Ala He 20 25 30 ATC TTG GCT GAT GAT GTG GTG ACT TTG GAT TGC GTT CCA GAT ATT TCG 144 He Leu Ala Asp Asp Val Val Thr Leu Asp Cys Val Pro Asp He Ser 35 40 45 GAT GTA GCC AGT CTT GTC GAA ATC ATG GAA TTG ATG GGA GCT ACT GTT 192 Asp Val Ala Ser Leu Val Glu He Met Glu Leu Met Gly Ala Thr Val 50 55 60 AAG CGT TAT GAC GAT GTA TTG GAG ATT GAC CCA AGA GGT GTT CAA AAT 240 Lys Arg Tyr Asp Asp Val Leu Glu He Asp Pro Arg Gly Val Gin Asn 65 70 75 80 ATT CCA ATG CCT TAT GGT AAA ATT AAC AGT CTT CGT GCA TCT TAC TAT 288 He Pro Met Pro Tyr Gly Lys He Asn Ser Leu Arg Ala Ser Tyr Tyr 85 90 95 TTT TAT GGG AGC CTC TTA GGC CGT TTT GGT GAA GCG ACA GTT GGT CTA 336 Phe Tyr Gly Ser Leu Leu Gly Arg Phe Gly Glu Ala Thr Val Gly Leu 100 105 110 CCG GGA GGA TGT GAT CTT GGT CCT CGT CCG ATT GAC TTA CAC CTT AAG 384 Pro Gly Gly Cys Asp Leu Gly Pro Arg Pro He Asp Leu His Leu Lys 115 120 125 GCG TTT GAA GCT ATG GGT GCC ACT GCT AGC TAC GAG GGA GAT AAC ATG 432 Ala Phe Glu Ala Met Gly Ala Thr Ala Ser Tyr Glu Gly Asp Asn Met 130 135 140 AAG TTA TCT GCT AAA GAT ACA GGA CTT CAT GGT GCA AGT ATT TAC ATG 480 Lys Leu Ser Ala Lys Asp Thr Gly Leu His Gly Ala Ser He Tyr Met 145 150 155 160 GAT ACG GTT AGT GTG GGA GCA ACG ATT AAT ACG ATG ATT GCT GCG GTT 528 Asp Thr Val Ser Val Gly Ala Thr He Asn Thr Met He Ala Ala Val 165 170 175 AAA GCA AAT GGT CGT ACT ATT ATT GAA AAT GCA GCC CGT GAA CCT GAG 576 Lys Ala Asn Gly Arg Thr He He Glu Asn Ala Ala Arg Glu Pro Glu 180 185 190 ATT ATT GAT GTA GCT ACT CTC TTG AAT AAT ATG GGT GCC CAT ATC CGT 624 He He Asp Val Ala Thr Leu Leu Asn Asn Met Gly Ala His He Arg 195 200 205 GGG GCA GGA ACT AAT ATC ATC ATT ATT GAT GGT GTT GAA AGA TTA CAT 672 Gly Ala Gly Thr Asn He He He He Asp Gly Val Glu Arg Leu His 210 215 220 GGG ACA CGT CAT CAG GTG ATT CCA GAC CGC ATT GAA GCT GGA ACA TAT 720 Gly Thr Arg His Gin Val He Pro Asp Arg He Glu Ala Gly Thr Tyr 225 230 235 240 ATA TCT TTA GCT GCT GCA GTT GGT AAA GGA ATT CGT ATA AAT AAT GTT 768 He Ser Leu Ala Ala Ala Val Gly Lys Gly He Arg He Asn Asn Val 245 250 255 CTT TAC GAA CAC CTG GAA GGG TTT GTT GCT AAG TTG GAA GAA ATG GGA 816 Leu Tyr Glu His Leu Glu Gly Phe Val Ala Lys Leu Glu Glu Met Gly 260 265 270 GTG AGA ATG ACT GTA TCT GAA GAC AGC ATT TTT GTC GAG GAA CAG TCT 864 Val Arg Met Thr Val Ser Glu Asp Ser He Phe Val Glu Glu Gin Ser 275 280 285 AAT TTG AAA GCA ATC AAT ATT AAG ACA GCT CCT TAC CCA GGC TTT GCA 912 Asn Leu Lys Ala He Asn He Lys Thr Ala Pro Tyr Pro Gly Phe Ala 290 295 300 ACT GAT TTG CAA CAA CCG CTT ACC CCT CTT TTA CTA AGA GCG AAT GGT 960 Thr Asp Leu Gin Gin Pro Leu Thr Pro Leu Leu Leu Arg Ala Asn Gly 305 310 315 320 CGT GGT ACA ATT GTC GAT ACG ATT TAC GAA AAA CGT GTA AAT CAT GTT 1008 Arg Gly Thr He Val Asp Thr He Tyr Glu Lys Arg Val Asn His Val 325 330 335 TTT GAA CTA GCA AAG ATG GAT GCG GAT ATT TCG ACA ACA AAT GGT CAT 1056 Phe Glu Leu Ala Lys Met Asp Ala Asp He Ser Thr Thr Asn Gly His 340 345 350 ATT TTG TAC ACG GGT GGA CGT GAT TTA CGT GGG GCC AGT GTT AAA GCG 1104 He Leu Tyr Thr Gly Gly Arg Asp Leu Arg Gly Ala Ser Val Lys Ala 355 360 365 ACC GAC TTA AGA GCT GGG GCT GCA CTA GTC ATT GCT GGG CTT ATG GCT 1152 Thr Asp Leu Arg Ala Gly Ala Ala Leu Val He Ala Gly Leu Met Ala 370 375 380 GAA GGC AAA ACT GAA ATT ACC AAT ATC GAG TTT ATC TTA CGT GGT TAT 1200 Glu Gly Lys Thr Glu He Thr Asn He Glu Phe He Leu Arg Gly Tyr 385 390 395 400 TCT GAT ATT ATC GAA AAA TTA CGT AAT TTA GGA GCG GAT ATT AGA CTT 1248 Ser Asp He He Glu Lys Leu Arg Asn Leu Gly Ala Asp He Arg Leu 405 410 415 GTT GAG GAT TAA 1260 Val Glu Asp 419 (2) INFORMATION FOR SEQ ID NO: 104: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 419 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 104: Met Arg Lys He Val He Asn Gly Gly Leu Pro Leu Gin Gly Glu He 1 5 10 15 Thr He Ser Gly Ala Lys Asn Ser Val Val Ala Leu He Pro Ala He 20 25 30 He Leu Ala Asp Asp Val Val Thr Leu Asp Cys Val Pro Asp He Ser 35 40 45 Asp Val Ala Ser Leu Val Glu He Met Glu Leu Met Gly Ala Thr Val 50 55 60 Lys Arg Tyr Asp Asp Val Leu Glu He Asp Pro Arg Gly Val Gin Asn 65 70 75 80 He Pro Met Pro Tyr Gly Lys He Asn Ser Leu Arg Ala Ser Tyr Tyr 85 90 95 Phe Tyr Gly Ser Leu Leu Gly Arg Phe Gly Glu Ala Thr Val Gly Leu 100 105 110 Pro Gly Gly Cys Asp Leu Gly Pro Arg Pro He Asp Leu His Leu Lys 115 120 125 Ala Phe Glu Ala Met Gly Ala Thr Ala Ser Tyr Glu Gly Asp Asn Met 130 135 140 Lys Leu Ser Ala Lys Asp Thr Gly Leu His Gly Ala Ser He Tyr Met 145 150 155 160 Asp Thr Val Ser Val Gly Ala Thr He Asn Thr Met He Ala Ala Val 165 170 175 Lys Ala Asn Gly Arg Thr He He Glu Asn Ala Ala Arg Glu Pro Glu 180 185 190 He He Asp Val Ala Thr Leu Leu Asn Asn Met Gly Ala His He Arg 195 200 205 Gly Ala Gly Thr Asn He He He He Asp Gly Val Glu Arg Leu His 210 215 220 Gly Thr Arg His Gin Val He Pro Asp Arg He Glu Ala Gly Thr Tyr 225 230 235 240 He Ser Leu Ala Ala Ala Val Gly Lys Gly He Arg He Asn Asn Val 245 250 255 Leu Tyr Glu His Leu Glu Gly Phe Val Ala Lys Leu Glu Glu Met Gly 260 265 270 Val Arg Met Thr Val Ser Glu Asp Ser He Phe Val Glu Glu Gin Ser 275 280 285 Asn Leu Lys Ala He Asn He Lys Thr Ala Pro Tyr Pro Gly Phe Ala 290 295 300 Thr Asp Leu Gin Gin Pro Leu Thr Pro Leu Leu Leu Arg Ala Asn Gly 305 310 315 320 Arg Gly Thr He Val Asp Thr He Tyr Glu Lys Arg Val Asn His Val 325 330 335 Phe Glu Leu Ala Lys Met Asp Ala Asp He Ser Thr Thr Asn Gly His 340 345 350 He Leu Tyr Thr Gly Gly Arg Asp Leu Arg Gly Ala Ser Val Lys Ala 355 360 365 Thr Asp Leu Arg Ala Gly Ala Ala Leu Val He Ala Gly Leu Met Ala 370 375 380 Glu Gly Lys Thr Glu He Thr Asn He Glu Phe He Leu Arg Gly Tyr 385 390 395 400 Ser Asp He He Glu Lys Leu Arg Asn Leu Gly Ala Asp He Arg Leu 405 410 415 Val Glu Asp 419 (2) INFORMATION FOR SEQ ID NO: 105: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1008 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1008 (D) OTHER INFORMATION: FtsZ (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 105: ATG ACA TTT TCA TTT GAT ACA GCT GCT GCT CAA GGG GCA GTG ATT AAA 48 Met Thr Phe Ser Phe Asp Thr Ala Ala Ala Gin Gly Ala Val He Lys 1 5 10 15 GTA ATT GGT GTC GGT GGA GGT GGT GGC AAT GCC ATC AAC CGT ATG GTC 96 Val He Gly Val Gly Gly Gly Gly Gly Asn Ala He Asn Arg Met Val 20 25 30 GAC GAA GGT GTT ACA GGC GTA GAA TTT ATC GCA GCA AAC ACA GAT GTA 144 Asp Glu Gly Val Thr Gly Val Glu Phe He Ala Ala Asn Thr Asp Val 35 40 45 CAA GCA TTG AGT AGT ACA AAA GCT GAG ACT GTT ATT CAG TTG GGA CCT 192 Gin Ala Leu Ser Ser Thr Lys Ala Glu Thr Val He Gin Leu Gly Pro 50 55 60 AAA TTG ACT CGT GGT TTG GGT GCA GGA GGT CAA CCT GAG GTT GGT CGT 240 Lys Leu Thr Arg Gly Leu Gly Ala Gly Gly Gin Pro Glu Val Gly Arg 65 70 75 80 AAA GCC GCT GAA GAA AGC GAA GAA ACA CTG ACG GAA GCT ATT AGT GGT 288 Lys Ala Ala Glu Glu Ser Glu Glu Thr Leu Thr Glu Ala He Ser Gly 85 90 95 GCC GAT ATG GTC TTC ATC ACT GCT GGT ATG GGA GGA GGC TCT GGA ACT 336 Ala Asp Met Val Phe He Thr Ala Gly Met Gly Gly Gly Ser Gly Thr 100 105 110 GGA GCT GCT CCT GTT ATT GCT CGT ATC GCC AAA GAT TTA GGT GCG CTT 384 Gly Ala Ala Pro Val He Ala Arg He Ala Lys Asp Leu Gly Ala Leu 115 120 125 ACA GTT GGT GTT GTA ACA CGT CCC TTT GGT TTT GAA GGA AGT AAG CGT 432 Thr Val Gly Val Val Thr Arg Pro Phe Gly Phe Glu Gly Ser Lys Arg 130 135 140 GGA CAA TTT GCT GTA GAA GGA ATC AAT CAA CTT CGT GAG CAT GTA GAC 480 Gly Gin Phe Ala Val Glu Gly He Asn Gin Leu Arg Glu His Val Asp 145 150 155 160 ACT CTA TTG ATT ATC TCA AAC AAC AAT TTG CTT GAA ATT GTT GAT AAG 528 Thr Leu Leu He He Ser Asn Asn Asn Leu Leu Glu He Val Asp Lys 165 170 175 AAA ACA CCG CTT TTG GAG GCT CTT AGC GAA GCG GAT AAC GTT CTT CGT 576 Lys Thr Pro Leu Leu Glu Ala Leu Ser Glu Ala Asp Asn Val Leu Arg 180 185 190 CAA GGT GTT CAA GGG ATT ACC GAT TTG ATT ACC AAT CCA GGA TTG ATT 624 Gin Gly Val Gin Gly He Thr Asp Leu He Thr Asn Pro Gly Leu He 195 200 205 AAC CTT GAC TTT GCC GAT GTG AAA ACG GTA ATG GCA AAC AAA GGG AAT 672 Asn Leu Asp Phe Ala Asp Val Lys Thr Val Met Ala Asn Lys Gly Asn 210 215 220 GCT CTT ATG GGT ATT GGT ATC GGT AGT GGA GAA GAA CGT GTG GTA GAA 720 Ala Leu Met Gly He Gly He Gly Ser Gly Glu Glu Arg Val Val Glu 225 230 235 240 GCG GCA CGT AAG GCA ATC TAT TCA CCA CTT CTT GAA ACA ACT ATT GAC 768 Ala Ala Arg Lys Ala He Tyr Ser Pro Leu Leu Glu Thr Thr He Asp 245 250 255 GGT GCT GAG GAT GTT ATC GTC AAC GTT ACT GGT GGT CTT GAC TTA ACC 816 Gly Ala Glu Asp Val He Val Asn Val Thr Gly Gly Leu Asp Leu Thr 260 265 270 TTG ATT GAG GCA GAA GAG GCT TCA CAA ATT GTG AAC CAG GCA GCA GGT 864 Leu He Glu Ala Glu Glu Ala Ser Gin He Val Asn Gin Ala Ala Gly 275 280 285 CAA GGA GTG AAC ATC TGG CTC GGT ACT TCA ATT GAT GAA AGT ATG CGT 912 Gin Gly Val Asn He Trp Leu Gly Thr Ser He Asp Glu Ser Met Arg 290 295 300 GAT GAA ATT CGT GTA ACA GTT GTC GCA ACG GGT GTT CGT CAA GAC CGC 960 Asp Glu He Arg Val Thr Val Val Ala Thr Gly Val Arg Gin Asp Arg 305 310 315 320 GTA GAA AAG GTT GTG GCT CCA CAA GCT AGA TCA CCG CGC CTA GGA TAA 1008 Val Glu Lys Val Val Ala Pro Gin Ala Arg Ser Pro Arg Leu Gly * 325 330 335 (2) INFORMATION FOR SEQ ID NO: 106: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 336 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 106: Met Thr Phe Ser Phe Asp Thr Ala Ala Ala Gin Gly Ala Val He Lys 1 5 10 15 Val He Gly Val Gly Gly Gly Gly Gly Asn Ala He Asn Arg Met Val 20 25 30 Asp Glu Gly Val Thr Gly Val Glu Phe He Ala Ala Asn Thr Asp Val 35 40 45 Gin Ala Leu Ser Ser Thr Lys Ala Glu Thr Val He Gin Leu Gly Pro 50 55 60 Lys Leu Thr Arg Gly Leu Gly Ala Gly Gly Gin Pro Glu Val Gly Arg 65 70 75 80 Lys Ala Ala Glu Glu Ser Glu Glu Thr Leu Thr Glu Ala He Ser Gly 85 90 95 Ala Asp Met Val Phe He Thr Ala Gly Met Gly Gly Gly Ser Gly Thr 100 105 110 Gly Ala Ala Pro Val He Ala Arg He Ala Lys Asp Leu Gly Ala Leu 115 120 125 Thr Val Gly Val Val Thr Arg Pro Phe Gly Phe Glu Gly Ser Lys Arg 130 135 140 Gly Gin Phe Ala Val Glu Gly He Asn Gin Leu Arg Glu His Val Asp 145 150 155 160 Thr Leu Leu He He Ser Asn Asn Asn Leu Leu Glu He Val Asp Lys 165 170 175 Lys Thr Pro Leu Leu Glu Ala Leu Ser Glu Ala Asp Asn Val Leu Arg 180 185 190 Gin Gly Val Gin Gly He Thr Asp Leu He Thr Asn Pro Gly Leu He 195 200 205 Asn Leu Asp Phe Ala Asp Val Lys Thr Val Met Ala Asn Lys Gly Asn 210 215 220 Ala Leu Met Gly He Gly He Gly Ser Gly Glu Glu Arg Val Val Glu 225 230 235 240 Ala Ala Arg Lys Ala He Tyr Ser Pro Leu Leu Glu Thr Thr He Asp 245 250 255 Gly Ala Glu Asp Val He Val Asn Val Thr Gly Gly Leu Asp Leu Thr 260 265 270 Leu He Glu Ala Glu Glu Ala Ser Gin He Val Asn Gin Ala Ala Gly 275 280 285 Gin Gly Val Asn He Trp Leu Gly Thr Ser He Asp Glu Ser Met Arg 290 295 300 Asp Glu He Arg Val Thr Val Val Ala Thr Gly Val Arg Gin Asp Arg 305 310 315 320 Val Glu Lys Val Val Ala Pro Gin Ala Arg Ser Pro Arg Leu Gly 325 330 335 (2) INFORMATION FOR SEQ ID NO: 107: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 525 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..525 (D) OTHER INFORMATION: grpE (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 107: ATG GCC CAA GAT ATA AAA AAT GAA GAA GTA GAA GAA GTT CAA GAA GAG 48 Met Ala Gin Asp He Lys Asn Glu Glu Val Glu Glu Val Gin Glu Glu 1 5 10 15 GAA GTT GTG GAA ACA GCT GAA GAA ACA ACT CCT GAA AAG TCT GAG TTG 96 Glu Val Val Glu Thr Ala Glu Glu Thr Thr Pro Glu Lys Ser Glu Leu 20 25 30 GAC TTG GCA AAT GAA CGT GCA GAT GAG TTC GAA AAC AAA TAT CTT CGC 144 Asp Leu Ala Asn Glu Arg Ala Asp Glu Phe Glu Asn Lys Tyr Leu Arg 35 40 45 GCT CAT GCA GAA ATG CAA AAT ATC CAA CGC CGT GCC AAT GAA GAA CGT 192 Ala His Ala Glu Met Gin Asn He Gin Arg Arg Ala Asn Glu Glu Arg 50 55 60 CAA AAC TTG CAA CGT TAT CGT AGC CAG GAC TTG GCA AAA GCA ATC TTA 240 Gin Asn Leu Gin Arg Tyr Arg Ser Gin Asp Leu Ala Lys Ala He Leu 65 70 75 80 CCA TCT CTT GAC AAC CTT GAG CGT GCA CTT GCA GTT GAA GGT TTG ACA 288 Pro Ser Leu Asp Asn Leu Glu Arg Ala Leu Ala Val Glu Gly Leu Thr 85 90 95 GAT GAT GTG AAG AAG GGC TTG GCG ATG GTG CAA GAA AGC TTG ATT CAC 336 Asp Asp Val Lys Lys Gly Leu Ala Met Val Gin Glu Ser Leu He His 100 105 110 GCT TTG AAA GAA GAA GGA ATT GAA GAA ATC GCA GCA GAT GGC GAA TTT 384 Ala Leu Lys Glu Glu Gly He Glu Glu He Ala Ala Asp Gly Glu Phe 115 120 125 GAC CAT AAC TAC CAT ATG GCC ATC CAA ACT CTC CCA GGA GAC GAT GAA 432 Asp His Asn Tyr His Met Ala He Gin Thr Leu Pro Gly Asp Asp Glu 130 135 140 CAC CCA GTA GAT ACC ATC GCC CAA GTC TTT CAA AAA GGC TAC AAA CTC 480 His Pro Val Asp Thr He Ala Gin Val Phe Gin Lys Gly Tyr Lys Leu 145 150 155 160 CAT GAC CGC ATC CTA CGC CCA GCA ATG GTA GTG GTG TAT AAC TAA 525 His Asp Arg He Leu Arg Pro Ala Met Val Val Val Tyr Asn * 165 170 174 (2) INFORMATION FOR SEQ ID NO: 108: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 174 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 108: Met Ala Gin Asp He Lys Asn Glu Glu Val Glu Glu Val Gin Glu Glu 1 5 10 15 Glu Val Val Glu Thr Ala Glu Glu Thr Thr Pro Glu Lys Ser Glu Leu 20 25 30 Asp Leu Ala Asn Glu Arg Ala Asp Glu Phe Glu Asn Lys Tyr Leu Arg 35 40 45 Ala His Ala Glu Met Gin Asn He Gin Arg Arg Ala Asn Glu Glu Arg 50 55 60 Gin Asn Leu Gin Arg Tyr Arg Ser Gin Asp Leu Ala Lys Ala He Leu 65 70 75 80 Pro Ser Leu Asp Asn Leu Glu Arg Ala Leu Ala Val Glu Gly Leu Thr 85 90 95 Asp Asp Val Lys Lys Gly Leu Ala Met Val Gin Glu Ser Leu He His 100 105 110 Ala Leu Lys Glu Glu Gly He Glu Glu He Ala Ala Asp Gly Glu Phe 115 120 125 Asp His Asn Tyr His Met Ala He Gin Thr Leu Pro Gly Asp Asp Glu 130 135 140 His Pro Val Asp Thr He Ala Gin Val Phe Gin Lys Gly Tyr Lys Leu 145 150 155 160 His Asp Arg He Leu Arg Pro Ala Met Val Val Val Tyr Asn 165 170 174 (2) INFORMATION FOR SEQ ID NO: 109: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 582 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..582 (D) OTHER INFORMATION: HI 1648 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 109: ATG AAA ATC GGA ATA TTG GCC TTG CAA GGG GCC TTT GCA GAA CAT GCA 48 Met Lys He Gly He Leu Ala Leu Gin Gly Ala Phe Ala Glu His Ala 1 5 10 15 AAA GTG CTA GAT CAA TTA GGT GTC GAG AGT GTA GAA CTC AGA AAT CTA 96 Lys Val Leu Asp Gin Leu Gly Val Glu Ser Val Glu Leu Arg Asn Leu 20 25 30 GAT GAT TTT CAG CAA GAT CAG AGT GAC TTG TCG GGT TTG ATT TTG CCT 144 Asp Asp Phe Gin Gin Asp Gin Ser Asp Leu Ser Gly Leu He Leu Pro 35 40 45 GGT GGT GAG TCT ACA ACC ATG GGC AAG CTC TTA CGT GAC CAG AAC ATG 192 Gly Gly Glu Ser Thr Thr Met Gly Lys Leu Leu Arg Asp Gin Asn Met 50 55 60 CTA CTT CCC ATA CGA GAA GCC ATT CTA TCT GGC TTA CCA GTG TTT GGG 240 Leu Leu Pro He Arg Glu Ala He Leu Ser Gly Leu Pro Val Phe Gly 65 70 75 80 ACC TGT GCG GGC TTA ATT TTG CTG GCT AAG GAA ATC ACT TCT CAG AAA 288 Thr Cys Ala Gly Leu He Leu Leu Ala Lys Glu He Thr Ser Gin Lys 85 90 95 GAG AGT CAT CTA GGA ACT ATG GAT ATG GTG GTC GAG CGT AAT GCT TAT 336 Glu Ser His Leu Gly Thr Met Asp Met Val Val Glu Arg Asn Ala Tyr 100 105 110 GGG CGC CAA TTA GGA AGT TTC TAC ACG GAA GCA GAA TGT AAG GGA GTT 384 Gly Arg Gin Leu Gly Ser Phe Tyr Thr Glu Ala Glu Cys Lys Gly Val 115 120 125 GGC AAG ATT CCA ATG ACC TTT ATC CGT GGT CCG ATT ATC AGT AGT GTT 432 Gly Lys He Pro Met Thr Phe He Arg Gly Pro He He Ser Ser Val 130 135 140 GGT GAG GGT GTA GAA ATT TTA GCA ATA GTG AAC AAT CAA ATT GTT GCA 480 Gly Glu Gly Val Glu He Leu Ala He Val Asn Asn Gin He Val Ala 145 150 155 160 GCC CAA GAA AAA AAT ATG TTG GTA AGT TCT TTT CAT CCA GAA TTG ACT 528 Ala Gin Glu Lys Asn Met Leu Val Ser Ser Phe His Pro Glu Leu Thr 165 170 175 GAT GAT GTG CGC TTG CAC CAG TAC TTT ATC AAT ATG TGT AAA GAA AAA 576 Asp Asp Val Arg Leu His Gin Tyr Phe He Asn Met Cys Lys Glu Lys 180 185 190 AGT TGA 582 Ser * (2) INFORMATION FOR SEQ ID NO: 110: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 194 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 110: Met Lys He Gly He Leu Ala Leu Gin Gly Ala Phe Ala Glu His Ala 1 5 10 15 Lys Val Leu Asp Gin Leu Gly Val Glu Ser Val Glu Leu Arg Asn Leu 20 25 30 Asp Asp Phe Gin Gin Asp Gin Ser Asp Leu Ser Gly Leu He Leu Pro 35 40 45 Gly Gly Glu Ser Thr Thr Met Gly Lys Leu Leu Arg Asp Gin Asn Met 50 55 60 Leu Leu Pro He Arg Glu Ala He Leu Ser Gly Leu Pro Val Phe Gly 65 70 75 80 Thr Cys Ala Gly Leu He Leu Leu Ala Lys Glu He Thr Ser Gin Lys 85 90 95 Glu Ser His Leu Gly Thr Met Asp Met Val Val Glu Arg Asn Ala Tyr 100 105 110 Gly Arg Gin Leu Gly Ser Phe Tyr Thr Glu Ala Glu Cys Lys Gly Val 115 120 125 Gly Lys He Pro Met Thr Phe He Arg Gly Pro He He Ser Ser Val 130 135 140 Gly Glu Gly Val Glu He Leu Ala He Val Asn Asn Gin He Val Ala 145 150 155 160 Ala Gin Glu Lys Asn Met Leu Val Ser Ser Phe His Pro Glu Leu Thr 165 170 175 sp Asp Val Arg Leu His Gin Tyr Phe He Asn Met Cys Lys Glu Lys 180 185 190 Ser (2) INFORMATION FOR SEQ ID NO: 111: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 546 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO ( iv) ANTI-SENSE : NO ( ix ) FEATURE : (A) NAME/KEY: CDS (B) LOCATION: 1..543 (D) OTHER INFORMATION: pgsA (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 111: ATG AAA AAA GAA CAA ATT CCC AAT CTC TTA ACA ATA GGT CGA ATT CTC 48 Met Lys Lys Glu Gin He Pro Asn Leu Leu Thr He Gly Arg He Leu 1 5 10 15 TTT ATA CCT ATT TTT ATC TTT ATT TTA ACG ATA GGA AAT TCG ATA GAG 96 Phe He Pro He Phe He Phe He Leu Thr He Gly Asn Ser He Glu 20 25 30 AGT CAT ATA GTT GCA GCT ATT ATC TTT GCT GTT GCC AGT ATT ACC GAC 144 Ser His He Val Ala Ala He He Phe Ala Val Ala Ser He Thr Asp 35 40 45 TAT TTA GAT GGA TAT TTA GCT CGT AAA TGG AAT GTG GTC AGT AAT TTT 192 Tyr Leu Asp Gly Tyr Leu Ala Arg Lys Trp Asn Val Val Ser Asn Phe 50 55 60 GGT AAA TTT GCA GAT CCT ATG GCG GAT AAG TTA CTA GTT ATG TCG GCT 240 Gly Lys Phe Ala Asp Pro Met Ala Asp Lys Leu Leu Val Met Ser Ala 65 70 75 80 TTT ATT ATG TTG ATT GAG TTA GGT ATG GCT CCG GCT TGG ATT GTT GCA 288 Phe He Met Leu He Glu Leu Gly Met Ala Pro Ala Trp He Val Ala 85 90 95 GTG ATT ATC TGT CGT GAG TTA GCT GTG ACA GGT TTA AGG CTT TTA TTG 336 Val He He Cys Arg Glu Leu Ala Val Thr Gly Leu Arg Leu Leu Leu 100 105 110 GTT GAA ACT GGT GGA ACA ATT TTA GCA GCA GCA ATG CCT GGA AAA ATT 384 Val Glu Thr Gly Gly Thr He Leu Ala Ala Ala Met Pro Gly Lys He 115 120 125 AAA ACT TTT AGT CAG ATG TTT GCT ATT ATT TTC TTG CTA TTA CAT TGG 432 Lys Thr Phe Ser Gin Met Phe Ala He He Phe Leu Leu Leu His Trp 130 135 140 ACT TTG CTT GGT CAA GTT CTA CTT TAT GTA GCC TTA TTT TTC ACT ATC 480 Thr Leu Leu Gly Gin Val Leu Leu Tyr Val Ala Leu Phe Phe Thr He 145 150 155 160 TAC TCT GGC TAT GAC TAT TTC AAG GGT AGT GCC TAT GTA TTT AAA GGG 528 Tyr Ser Gly Tyr Asp Tyr Phe Lys Gly Ser Ala Tyr Val Phe Lys Gly 165 170 175 ACA TTT GGT TCG AAA TGA 546 Thr Phe Gly Ser Lys 180 (2) INFORMATION FOR SEQ ID NO: 112: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 181 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 112: Met Lys Lys Glu Gin He Pro Asn Leu Leu Thr He Gly Arg He Leu 1 5 10 15 Phe He Pro He Phe He Phe He Leu Thr He Gly Asn Ser He Glu 20 25 30 Ser His He Val Ala Ala He He Phe Ala Val Ala Ser He Thr Asp 35 40 45 Tyr Leu Asp Gly Tyr Leu Ala Arg Lys Trp Asn Val Val Ser Asn Phe 50 55 60 Gly Lys Phe Ala Asp Pro Met Ala Asp Lys Leu Leu Val Met Ser Ala 65 70 75 80 Phe He Met Leu He Glu Leu Gly Met Ala Pro Ala Trp He Val Ala 85 90 95 Val He He Cys Arg Glu Leu Ala Val Thr Gly Leu Arg Leu Leu Leu 100 105 110 Val Glu Thr Gly Gly Thr He Leu Ala Ala Ala Met Pro Gly Lys He 115 120 125 Lys Thr Phe Ser Gin Met Phe Ala He He Phe Leu Leu Leu His Trp 130 135 140 Thr Leu Leu Gly Gin Val Leu Leu Tyr Val Ala Leu Phe Phe Thr He 145 150 155 160 Tyr Ser Gly Tyr Asp Tyr Phe Lys Gly Ser Ala Tyr Val Phe Lys Gly 165 170 175 Thr Phe Gly Ser Lys 180 (2) INFORMATION FOR SEQ ID NO: 113: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1224 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1221 (D) OTHER INFORMATION: RodA (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 113: ATG AAA CGT TCT CTC GAC TCT AGA GTC GAT TAT AGT TTG CTC TTG CCA 48 Met Lys Arg Ser Leu Asp Ser Arg Val Asp Tyr Ser Leu Leu Leu Pro 1 5 10 15 GTA TTT TTT CTA CTG GTC ATC GGT GTG GTG GCT ATC TAT ATA GCC GTT 96 Val Phe Phe Leu Leu Val He Gly Val Val Ala He Tyr He Ala Val 20 25 30 AGT CAT GAT TAT CCC AAT AAT ATT CTG CCC ATT TTA GGG CAG CAG GTC 144 Ser His Asp Tyr Pro Asn Asn He Leu Pro He Leu Gly Gin Gin Val 35 40 45 GCC TGG ATT GCC TTG GGG CTT GTG ATT GGT TTT GTG GTC ATG CTC TTT 192 Ala Trp He Ala Leu Gly Leu Val He Gly Phe Val Val Met Leu Phe 50 55 60 AAT ACA GAA TTT CTT TGG AAG GTG ACC CCC TTT CTA TAT ATT TTA GGC 240 Asn Thr Glu Phe Leu Trp Lys Val Thr Pro Phe Leu Tyr He Leu Gly 65 70 75 80 TTG GGA CTT ATG ATC TTG CCG ATT GTA TTT TAT AAT CCA AGC TTA GTT 288 Leu Gly Leu Met He Leu Pro He Val Phe Tyr Asn Pro Ser Leu Val 85 90 95 GCA TCA ACG GGT GCC AAA AAC TGG GTA TCA ATA AAT GGA ATT ACC CTA 336 Ala Ser Thr Gly Ala Lys Asn Trp Val Ser He Asn Gly He Thr Leu 100 105 110 TTT CAA CCG TCA GAA TTT ATG AAG ATA TCC TAT ATC CTC ATG TTG GCT 384 Phe Gin Pro Ser Glu Phe Met Lys He Ser Tyr He Leu Met Leu Ala 115 120 125 CGT GTC ATT GTC CAA TTT ACA AAG AAA CAT AAG GAA TGG AGA CGC ACG 432 Arg Val He Val Gin Phe Thr Lys Lys His Lys Glu Trp Arg Arg Thr 130 135 140 GTT CCG CTG GAC TTT TTG TTA ATT TTC TGG ATG ATT CTC TTT ACC ATT 480 Val Pro Leu Asp Phe Leu Leu He Phe Trp Met He Leu Phe Thr He 145 150 155 160 CCA GTC CTA GTT CTT TTA GCA CTT CAA AGT GAC TTG GGG ACG GCT TTG 528 Pro Val Leu Val Leu Leu Ala Leu Gin Ser Asp Leu Gly Thr Ala Leu 165 170 175 GTT TTT GTA GCC ATT TTC TCA GGA ATC GTT TTA TTA TCA GGG GTT TCT 576 Val Phe Val Ala He Phe Ser Gly He Val Leu Leu Ser Gly Val Ser 180 185 190 TGG AAA ATT ATT ATC CCA GTA TTT GTG ACT GCT GTA ACA GGA GTT GCT 624 Trp Lys He He He Pro Val Phe Val Thr Ala Val Thr Gly Val Ala 195 200 205 GGT TTC TTA GCT ATC TTT ATT AGC AAG GAC GGA CGA GCT TTT CTT CAC 672 Gly Phe Leu Ala He Phe He Ser Lys Asp Gly Arg Ala Phe Leu His 210 215 220 CAG ATT GGA ATG CCG ACC TAC CAA ATC AAT CGG ATT TTG GCT TGG CTC 720 Gin He Gly Met Pro Thr Tyr Gin He Asn Arg He Leu Ala Trp Leu 225 230 235 240 AAT CCC TTT GAG TTT GCC CAA ACA ACG ACT TAC CAG CAG GCT CAA GGG 768 Asn Pro Phe Glu Phe Ala Gin Thr Thr Thr Tyr Gin Gin Ala Gin Gly 245 250 255 CAG ATT GCC ATT GGG AGT GGT GGC TTA TTT GGT CAG GGA TTT AAT GCT 816 Gin He Ala He Gly Ser Gly Gly Leu Phe Gly Gin Gly Phe Asn Ala 260 265 270 TCG AAT CTG CTT ATC CCA GTT CGA GAG TCA GAT ATG ATT TTT ACG GTT 864 Ser Asn Leu Leu He Pro Val Arg Glu Ser Asp Met He Phe Thr Val 275 280 285 ATT GCA GAA GAT TTT GGC TTT ATT GGC TCT GTC CTG GTT ATT GCC CTC 912 He Ala Glu Asp Phe Gly Phe He Gly Ser Val Leu Val He Ala Leu 290 295 300 TAT CTC ATG TTG ATT TAC CGT ATG TTG AAG ATT ACT CTT AAA TCA AAT 960 Tyr Leu Met Leu He Tyr Arg Met Leu Lys He Thr Leu Lys Ser Asn 305 310 315 320 AAC CAG TTC TAC ACT TAT ATT TCC ACA GGT TTG ATT ATG ATG TTG CTC 1008 Asn Gin Phe Tyr Thr Tyr He Ser Thr Gly Leu He Met Met Leu Leu 325 330 335 TTC CAC ATC TTT GAG AAT ATC GGT GCT GTG ACT GGA CTA CTT CCT TTG 1056 Phe His He Phe Glu Asn He Gly Ala Val Thr Gly Leu Leu Pro Leu 340 345 350 ACG GGG ATT CCC TTG CCT TTC ATT TCG CAA GGG GGA TCA GCG ATT ATC 1104 Thr Gly He Pro Leu Pro Phe He Ser Gin Gly Gly Ser Ala He He 355 360 365 AGT AAT CTG ATT GGT GTT GGT TTG CTT TTA TCG ATG AGT TAC CAG ACT 1152 Ser Asn Leu He Gly Val Gly Leu Leu Leu Ser Met Ser Tyr Gin Thr 370 375 380 AAT CTA GCT GAA GAA AAG AGC GGA AAA GTC CCA TTC AAA CGG AAA AAG 1200 Asn Leu Ala Glu Glu Lys Ser Gly Lys Val Pro Phe Lys Arg Lys Lys 385 390 395 400 GTT GTA TTA AAA CAA ATT AAA TAA 1224 Val Val Leu Lys Gin He Lys 405 (2) INFORMATION FOR SEQ ID NO: 114: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 407 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 114: Met Lys Arg Ser Leu Asp Ser Arg Val Asp Tyr Ser Leu Leu Leu Pro 1 5 10 15 Val Phe Phe Leu Leu Val He Gly Val Val Ala He Tyr He Ala Val 20 25 30 Ser His Asp Tyr Pro Asn Asn He Leu Pro He Leu Gly Gin Gin Val 35 40 45 Ala Trp He Ala Leu Gly Leu Val He Gly Phe Val Val Met Leu Phe 50 55 60 Asn Thr Glu Phe Leu Trp Lys Val Thr Pro Phe Leu Tyr He Leu Gly 65 70 75 80 Leu Gly Leu Met He Leu Pro He Val Phe Tyr Asn Pro Ser Leu Val 85 90 95 Ala Ser Thr Gly Ala Lys Asn Trp Val Ser He Asn Gly He Thr Leu 100 105 110 Phe Gin Pro Ser Glu Phe Met Lys He Ser Tyr He Leu Met Leu Ala 115 120 125 Arg Val He Val Gin Phe Thr Lys Lys His Lys Glu Trp Arg Arg Thr 130 135 140 Val Pro Leu Asp Phe Leu Leu He Phe Trp Met He Leu Phe Thr He 145 150 155 160 Pro Val Leu Val Leu Leu Ala Leu Gin Ser Asp Leu Gly Thr Ala Leu 165 170 175 Val Phe Val Ala He Phe Ser Gly He Val Leu Leu Ser Gly Val Ser 180 185 190 Trp Lys He He He Pro Val Phe Val Thr Ala Val Thr Gly Val Ala 195 200 205 Gly Phe Leu Ala He Phe He Ser Lys Asp Gly Arg Ala Phe Leu His 210 215 220 Gln He Gly Met Pro Thr Tyr Gin He Asn Arg He Leu Ala Trp Leu 225 230 235 240 Asn Pro Phe Glu Phe Ala Gin Thr Thr Thr Tyr Gin Gin Ala Gin Gly 245 250 255 Gin He Ala He Gly Ser Gly Gly Leu Phe Gly Gin Gly Phe Asn Ala 260 265 270 Ser Asn Leu Leu He Pro Val Arg Glu Ser Asp Met He Phe Thr Val 275 280 285 He Ala Glu Asp Phe Gly Phe He Gly Ser Val Leu Val He Ala Leu 290 295 300 Tyr Leu Met Leu He Tyr Arg Met Leu Lys He Thr Leu Lys Ser Asn 305 310 315 320 Asn Gin Phe Tyr Thr Tyr He Ser Thr Gly Leu He Met Met Leu Leu 325 330 335 Phe His He Phe Glu Asn He Gly Ala Val Thr Gly Leu Leu Pro Leu 340 345 350 Thr Gly He Pro Leu Pro Phe He Ser Gin Gly Gly Ser Ala He He 355 360 365 Ser Asn Leu He Gly Val Gly Leu Leu Leu Ser Met Ser Tyr Gin Thr 370 375 380 Asn Leu Ala Glu Glu Lys Ser Gly Lys Val Pro Phe Lys Arg Lys Lys 385 390 395 400 Val Val Leu Lys Gin He Lys 405 (2) INFORMATION FOR SEQ ID NO: 115: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1311 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1311 (D) OTHER INFORMATION: SecY (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 115: ATG TTT TTT AAA TTA TTA AGA GAA GCT CTT AAA GTC AAG CAG GTT CGA 48 Met Phe Phe Lys Leu Leu Arg Glu Ala Leu Lys Val Lys Gin Val Arg 1 5 10 15 TCA AAA ATT TTA TTT ACA ATT TTT ATC GTT TTG GTC TTT CGT ATC GGA 96 Ser Lys He Leu Phe Thr He Phe He Val Leu Val Phe Arg He Gly 20 25 30 ACT AGC ATT ACA GTT CCT GGT GTG AAT GCC AAT AGC TTG AAT GCT TTA 144 Thr Ser He Thr Val Pro Gly Val Asn Ala Asn Ser Leu Asn Ala Leu 35 40 45 AGT GGA TTA TCC TTC TTA AAC ATG TTG AGC TTG GTG TCG GGG AAT GCC 192 Ser Gly Leu Ser Phe Leu Asn Met Leu Ser Leu Val Ser Gly Asn Ala 50 55 60 CTA AAA AAC TTT TCG ATT TTT GCC CTA GGA GTT AGT CCC TAT ATC ACC 240 Leu Lys Asn Phe Ser He Phe Ala Leu Gly Val Ser Pro Tyr He Thr 65 70 75 80 GCT TCT ATT GTT GTC CAA CTC TTG CAA ATG GAT ATT TTA CCC AAG TTT 288 Ala Ser He Val Val Gin Leu Leu Gin Met Asp He Leu Pro Lys Phe 85 90 95 GTA GAG TGG GGT AAA CAA GGG GAA GTA GGT CGA AGA AAA TTG AAT CAA 336 Val Glu Trp Gly Lys Gin Gly Glu Val Gly Arg Arg Lys Leu Asn Gin 100 105 110 GCT ACT CGT TAT ATT GCT CTA GTT CTC GCT TTT GTG CAA TCT ATC GGG 384 Ala Thr Arg Tyr He Ala Leu Val Leu Ala Phe Val Gin Ser He Gly 115 120 125 ATT ACA GCT GGT TTT AAT ACC TTG GCT GGA GCT CAA TTG ATT AAA ACT 432 He Thr Ala Gly Phe Asn Thr Leu Ala Gly Ala Gin Leu He Lys Thr 130 135 140 GCT TTA ACT CCA CAA GTT TTT CTG ACG ATT GGT ATC ATC TTA ACA GCT 480 Ala Leu Thr Pro Gin Val Phe Leu Thr He Gly He He Leu Thr Ala 145 150 155 160 GGT AGT ATG ATT GTC ACT TGG TTG GGT GAG CAA ATT ACA GAT AAG GGA 528 Gly Ser Met He Val Thr Trp Leu Gly Glu Gin He Thr Asp Lys Gly 165 170 175 TAC GGA AAC GGT GTT TCC ATG ATT ATC TTT GCC GGG ATT GTT TCC TCA 576 Tyr Gly Asn Gly Val Ser Met He He Phe Ala Gly He Val Ser Ser 180 185 190 ATT CCA GAG ATG ATT CAG GGC ATC TAT GTG GAC TAC TTT GTG AAC GTC 624 He Pro Glu Met He Gin Gly He Tyr Val Asp Tyr Phe Val Asn Val 195 200 205 CCA AGT AGC CGT ATC ACT TCA TCT ATC ATT TTC GTA ATC ATT TTG ATT 672 Pro Ser Ser Arg He Thr Ser Ser He He Phe Val He He Leu He 210 215 220 ATT ACT GTA TTG TTG ATT ATT TAC TTT ACA ACT TAT GTT CAA CAA GCA 720 He Thr Val Leu Leu He He Tyr Phe Thr Thr Tyr Val Gin Gin Ala 225 230 235 240 GAA TAC AAA ATT CCA ATC CAA TAT ACT AAG GTT GCA CAA GGT GCT CCA 768 Glu Tyr Lys He Pro He Gin Tyr Thr Lys Val Ala Gin Gly Ala Pro 245 250 255 TCT AGC TCT TAC CTT CCG TTA AAG GTA AAT CCT GCT GGA GTT ATC CCT 816 Ser Ser Ser Tyr Leu Pro Leu Lys Val Asn Pro Ala Gly Val He Pro 260 265 270 GTT ATC TTT GCC AGT TCG ATT ACT GCA GCG CCT GCG GCT ATT CTT CAG 864 Val He Phe Ala Ser Ser He Thr Ala Ala Pro Ala Ala He Leu Gin 275 280 285 TTT TTG AGT GCC ACA GGT CAT GAT TGG GCT TGG GTA AGG GTA GCA CAA 912 Phe Leu Ser Ala Thr Gly His Asp Trp Ala Trp Val Arg Val Ala Gin 290 295 300 GAG ATG TTG GCA ACT ACT TCT CCA ACT GGT ATT GCC ATG TAT GCT TTG 960 Glu Met Leu Ala Thr Thr Ser Pro Thr Gly He Ala Met Tyr Ala Leu 305 310 315 320 TTG ATT ATT CTC TTT ACA TTC TTC TAT ACG TTT GTA CAG ATT AAT CCT 1008 Leu He He Leu Phe Thr Phe Phe Tyr Thr Phe Val Gin He Asn Pro 325 330 335 GAA AAA GCA GCA GAG AGC CTA CAA AAG AGT GGT GCC TAT ATC CAT GGA 1056 Glu Lys Ala Ala Glu Ser Leu Gin Lys Ser Gly Ala Tyr He His Gly 340 345 350 GTT CGT CCT GGT AAA GGT ACA GAA GAA TAT ATG TCT AAA CTT CTT CGT 1104 Val Arg Pro Gly Lys Gly Thr Glu Glu Tyr Met Ser Lys Leu Leu Arg 355 360 365 CGT CTT GCA ACT GTT GGT TCC CTC TTC CTT GGT GTG ATT TCC ATT TTA 1152 Arg Leu Ala Thr Val Gly Ser Leu Phe Leu Gly Val He Ser He Leu 370 375 380 CCG ATT GCA GCT AAA GAT GTA TTT GGT CTT TCT GAT GTT GTT GCC TTT 1200 Pro He Ala Ala Lys Asp Val Phe Gly Leu Ser Asp Val Val Ala Phe 385 390 395 400 GGT GGA ACA AGT CTC TTG ATC ATT ATC TCT ACA GGT ATC GAA GGA ATC 1248 Gly Gly Thr Ser Leu Leu He He He Ser Thr Gly He Glu Gly He 405 410 415 AAG CAA TTG GAA GGT TAC CTA TTG AAA CGT AAG TAT GTT GGT TTC ATG 1296 Lys Gin Leu Glu Gly Tyr Leu Leu Lys Arg Lys Tyr Val Gly Phe Met 420 425 430 GAC AGA ACA GAA TAA 1311 Asp Arg Thr Glu * 435 (2) INFORMATION FOR SEQ ID NO: 116: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 437 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 116: Met Phe Phe Lys Leu Leu Arg Glu Ala Leu Lys Val Lys Gin Val Arg 1 5 10 15 Ser Lys He Leu Phe Thr He Phe He Val Leu Val Phe Arg He Gly 20 25 30 Thr Ser He Thr Val Pro Gly Val Asn Ala Asn Ser Leu Asn Ala Leu 35 40 45 Ser Gly Leu Ser Phe Leu Asn Met Leu Ser Leu Val Ser Gly Asn Ala 50 55 60 Leu Lys Asn Phe Ser He Phe Ala Leu Gly Val Ser Pro Tyr He Thr 65 70 75 80 Ala Ser He Val Val Gin Leu Leu Gin Met Asp He Leu Pro Lys Phe 85 90 95 Val Glu Trp Gly Lys Gin Gly Glu Val Gly Arg Arg Lys Leu Asn Gin 100 105 110 Ala Thr Arg Tyr He Ala Leu Val Leu Ala Phe Val Gin Ser He Gly 115 120 125 He Thr Ala Gly Phe Asn Thr Leu Ala Gly Ala Gin Leu He Lys Thr 130 135 140 Ala Leu Thr Pro Gin Val Phe Leu Thr He Gly He He Leu Thr Ala 145 150 155 160 Gly Ser Met He Val Thr Trp Leu Gly Glu Gin He Thr Asp Lys Gly 165 170 175 Tyr Gly Asn Gly Val Ser Met He He Phe Ala Gly He Val Ser Ser 180 185 190 He Pro Glu Met He Gin Gly He Tyr Val Asp Tyr Phe Val Asn Val 195 200 205 Pro Ser Ser Arg He Thr Ser Ser He He Phe Val He He Leu He 210 215 220 He Thr Val Leu Leu He He Tyr Phe Thr Thr Tyr Val Gin Gin Ala 225 230 235 240 Glu Tyr Lys He Pro He Gin Tyr Thr Lys Val Ala Gin Gly Ala Pro 245 250 255 Ser Ser Ser Tyr Leu Pro Leu Lys Val Asn Pro Ala Gly Val He Pro 260 265 270 Val He Phe Ala Ser Ser He Thr Ala Ala Pro Ala Ala He Leu Gin 275 280 285 Phe Leu Ser Ala Thr Gly His Asp Trp Ala Trp Val Arg Val Ala Gin 290 295 300 Glu Met Leu Ala Thr Thr Ser Pro Thr Gly He Ala Met Tyr Ala Leu 305 310 315 320 Leu He He Leu Phe Thr Phe Phe Tyr Thr Phe Val Gin He Asn Pro 325 330 335 Glu Lys Ala Ala Glu Ser Leu Gin Lys Ser Gly Ala Tyr He His Gly 340 345 350 Val Arg Pro Gly Lys Gly Thr Glu Glu Tyr Met Ser Lys Leu Leu Arg 355 360 365 Arg Leu Ala Thr Val Gly Ser Leu Phe Leu Gly Val He Ser He Leu 370 375 380 Pro He Ala Ala Lys Asp Val Phe Gly Leu Ser Asp Val Val Ala Phe 385 390 395 400 Gly Gly Thr Ser Leu Leu He He He Ser Thr Gly He Glu Gly He 405 410 415 Lys Gin Leu Glu Gly Tyr Leu Leu Lys Arg Lys Tyr Val Gly Phe Met 420 425 430 Asp Arg Thr Glu 435 (2) INFORMATION FOR SEQ ID NO:117: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1959 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1956 (D) OTHER INFORMATION: FtsH (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 117: ATG AAA AAA CAA AAT AAT GGT TTA ATT AAA AAT CCT TTT CTA TGG TTA 48 Met Lys Lys Gin Asn Asn Gly Leu He Lys Asn Pro Phe Leu Trp Leu 1 5 10 15 TTA TTT ATC TTT TTC CTT GTG ACA GGA TTC CAG TAT TTC TAT TCT GGG 96 Leu Phe He Phe Phe Leu Val Thr Gly Phe Gin Tyr Phe Tyr Ser Gly 20 25 30 AAT AAC TCA GGA GGA AGT CAG CAA ATC AAC TAT ACT GAG TTG GTA CAA 144 Asn Asn Ser Gly Gly Ser Gin Gin He Asn Tyr Thr Glu Leu Val Gin 35 40 45 GAA ATT ACC GAT GGT AAT GAA AAA GAA TTA ACT TAC CAA CCA AAT GTT 192 Glu He Thr Asp Gly Asn Glu Lys Glu Leu Thr Tyr Gin Pro Asn Val 50 55 60 AGT GTT ATC GAA GTT TCT GGT GTC TAT AAA AAT CCT AAA ACA AGT AAA 240 Ser Val He Glu Val Ser Gly Val Tyr Lys Asn Pro Lys Thr Ser Lys 65 70 75 80 GAA GGA ACA GGT ATT CAG TTT TTC ACG CCA TCT GTT ACT AAG GTA GAG 288 Glu Gly Thr Gly He Gin Phe Phe Thr Pro Ser Val Thr Lys Val Glu 85 90 95 AAA TTT ACC AGC ACT ATT CTT CCT GCA GAT ACT ACC GTA TCA GAA TTG 336 Lys Phe Thr Ser Thr He Leu Pro Ala Asp Thr Thr Val Ser Glu Leu 100 105 110 CAA AAA CTT GCT ACT GAC CAT AAA GCA GAA GTA ACT GTT AAG CAT GAA 384 Gin Lys Leu Ala Thr Asp His Lys Ala Glu Val Thr Val Lys His Glu 115 120 125 AGT TCA AGT GGT ATA TGG ATT AAT CTA CTC GTA TCC ATT GTG CCA TTT 432 Ser Ser Ser Gly He Trp He Asn Leu Leu Val Ser He Val Pro Phe 130 135 140 GGA ATT CTA TTC TTC TTC CTA TTC TCT ATG ATG GGA AAT ATG GGA GGA 480 Gly He Leu Phe Phe Phe Leu Phe Ser Met Met Gly Asn Met Gly Gly 145 150 155 160 GGC AAT GGC CGT AAT CCA ATG AGT TTT GGA CGT AGT AAG GCT AAA GCA 528 Gly Asn Gly Arg Asn Pro Met Ser Phe Gly Arg Ser Lys Ala Lys Ala 165 170 175 GCA AAT AAA GAA GAT ATT AAA GTA AGA TTT TCA GAT GTT GCT GGA GCT 576 Ala Asn Lys Glu Asp He Lys Val Arg Phe Ser Asp Val Ala Gly Ala 180 185 190 GAG GAA GAA AAA CAA GAA CTA GTT GAA GTT GTT GAG TTC TTA AAA GAT 624 Glu Glu Glu Lys Gin Glu Leu Val Glu Val Val Glu Phe Leu Lys Asp 195 200 205 CCA AAA CGA TTC ACA AAA CTT GGA GCC CGT ATT CCA GCA GGT GTT CTT 672 Pro Lys Arg Phe Thr Lys Leu Gly Ala Arg He Pro Ala Gly Val Leu 210 215 220 TTG GAG GGA CCT CCG GGG ACA GGT AAG ACT TTG CTT GCT AAG GCA GTC 720 Leu Glu Gly Pro Pro Gly Thr Gly Lys Thr Leu Leu Ala Lys Ala Val 225 230 235 240 GCT GGA GAA GCA GGT GTT CCA TTC TTT AGT ATC TCA GGT TCT GAC TTT 768 Ala Gly Glu Ala Gly Val Pro Phe Phe Ser He Ser Gly Ser Asp Phe 245 250 255 GTA GAA ATG TTT GTC GGA GTT GGA GCT AGT CGT GTT CGC TCT CTT TTT 816 Val Glu Met Phe Val Gly Val Gly Ala Ser Arg Val Arg Ser Leu Phe 260 265 270 GAG GAT GCC AAA AAA GCA GCA CCA GCT ATC ATC TTT ATC GAT CTA AAT 864 Glu Asp Ala Lys Lys Ala Ala Pro Ala He He Phe He Asp Leu Asn 275 280 285 GAT GCT GTT GGA CGT CAA CGT GGA GTC GGT CTC GGC GGA GGT AAT GAC 912 Asp Ala Val Gly Arg Gin Arg Gly Val Gly Leu Gly Gly Gly Asn Asp 290 295 300 GAA CGT GAA CAA ACC TTG AAC CAA CTT TTG ATT GAG ATG GAT GGT TTT 960 Glu Arg Glu Gin Thr Leu Asn Gin Leu Leu He Glu Met Asp Gly Phe 305 310 315 320 GAG GGA AAT GAA GGG ATT ATC GTC ATC GCT GCG ACA AAC CGT TCA GAT 1008 Glu Gly Asn Glu Gly He He Val He Ala Ala Thr Asn Arg Ser Asp 325 330 335 GTA CTT GAT CCT GCC CTT TTG CGT CCA GGA CGT TTT GAT AGA AAA GTA 1056 Val Leu Asp Pro Ala Leu Leu Arg Pro Gly Arg Phe Asp Arg Lys Val 340 345 350 TTG GTT GGC CGT CCT GAT GTT AAA GGT CGT GAA GCA ATC TTG AAA GTT 1104 Leu Val Gly Arg Pro Asp Val Lys Gly Arg Glu Ala He Leu Lys Val 355 360 365 CAC GCT AAG AAC AAG CCT TTA GCA GAA GAT GTT GAT TTG AAA TTA GTG 1152 His Ala Lys Asn Lys Pro Leu Ala Glu Asp Val Asp Leu Lys Leu Val 370 375 380 GCT CAA CAA ACT CCA GGC TTT GTT GGT GCT GAT TTA GAG AAT GTC TTG 1200 Ala Gin Gin Thr Pro Gly Phe Val Gly Ala Asp Leu Glu Asn Val Leu 385 390 395 400 AAT GAA GCA GCT TTA GTT GCT GCT CGT CGC AAT AAA TCG ATA ATT GAT 1248 Asn Glu Ala Ala Leu Val Ala Ala Arg Arg Asn Lys Ser He He Asp 405 410 415 GCT TCA GAT ATT GAT GAA GCA GAA GAT AGA GTT ATT GCT GGA CCT TCT 1296 Ala Ser Asp He Asp Glu Ala Glu Asp Arg Val He Ala Gly Pro Ser 420 425 430 AAG AAA GAT AAG ACA GTT TCA CAA AAA GAA CGA GAA TTG GTT GCT TAC 1344 Lys Lys Asp Lys Thr Val Ser Gin Lys Glu Arg Glu Leu Val Ala Tyr 435 440 445 CAT GAG GCA GGA CAT ACC ATT GTT GGT CTA GTC TTG TCG ACT GCT CGC 1392 His Glu Ala Gly His Thr He Val Gly Leu Val Leu Ser Thr Ala Arg 450 455 460 GTT GTC CAT AAG GTT ACA ATT GTA CCA CGC GGC CGT GCA GGC GGA TAC 1440 Val Val His Lys Val Thr He Val Pro Arg Gly Arg Ala Gly Gly Tyr 465 470 475 480 ATG ATT GCA CTT CCT AAA GAG GAT CAA ATG CTT CTA TCT AAA GAA GAT 1488 Met He Ala Leu Pro Lys Glu Asp Gin Met Leu Leu Ser Lys Glu Asp 485 490 495 ATG AAA GAG CAA TTG GCT GGC TTA ATG GGT GGA CGT GTA GCT GAA GAA 1536 Met Lys Glu Gin Leu Ala Gly Leu Met Gly Gly Arg Val Ala Glu Glu 500 505 510 ATT ATC TTT AAT GTC CAA ACT ACA GGA GCT TCA AAC GAC TTT GAA CAA 1584 He He Phe Asn Val Gin Thr Thr Gly Ala Ser Asn Asp Phe Glu Gin 515 520 525 GCG ACA CAA ATG GCA CGT GCA ATG GTT ACA GAG TAC GGT ATG AGT GAA 1632 Ala Thr Gin Met Ala Arg Ala Met Val Thr Glu Tyr Gly Met Ser Glu 530 535 540 AAA CTT GGC CCA GTA CAA TAT GAA GGA AAC CAT GCT ATG CTT GGT GCA 1680 Lys Leu Gly Pro Val Gin Tyr Glu Gly Asn His Ala Met Leu Gly Ala 545 550 555 560 CAG AGT CCT CAA AAA TCA ATT TCA GAA CAA ACA GCT TAT GAA ATT GAT 1728 Gin Ser Pro Gin Lys Ser He Ser Glu Gin Thr Ala Tyr Glu He Asp 565 570 575 GAA GAG GTT CGT TCA TTA TTA AAT GAG GCA CGA AAT AAA GCT GCT GAA 1776 Glu Glu Val Arg Ser Leu Leu Asn Glu Ala Arg Asn Lys Ala Ala Glu 580 585 590 ATT ATT CAG TCA AAT CGT GAA ACT CAC AAG TTA ATT GCA GAA GCA TTA 1824 He He Gin Ser Asn Arg Glu Thr His Lys Leu He Ala Glu Ala Leu 595 600 605 TTG AAA TAC GAA ACA TTG GAT AGT ACA CAA ATT AAA GCT CTT TAC GAA 1872 Leu Lys Tyr Glu Thr Leu Asp Ser Thr Gin He Lys Ala Leu Tyr Glu 610 615 620 ACA GGA AAG ATG CCT GAA GCA GTA GAA GAG GAA TCT CAT GCA CTA TCC 1920 Thr Gly Lys Met Pro Glu Ala Val Glu Glu Glu Ser His Ala Leu Ser 625 630 635 640 TAT GAT GAA GTA AAG TCA AAA ATG AAT GAC GAA AAA TAA 1959 Tyr Asp Glu Val Lys Ser Lys Met Asn Asp Glu Lys 645 650 (2) INFORMATION FOR SEQ ID NO:H8: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 652 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 118: Met Lys Lys Gin Asn Asn Gly Leu He Lys Asn Pro Phe Leu Trp Leu 1 5 10 15 Leu Phe He Phe Phe Leu Val Thr Gly Phe Gin Tyr Phe Tyr Ser Gly 20 25 30 Asn Asn Ser Gly Gly Ser Gin Gin He Asn Tyr Thr Glu Leu Val Gin 35 40 45 Glu He Thr Asp Gly Asn Glu Lys Glu Leu Thr Tyr Gin Pro Asn Val 50 55 60 Ser Val He Glu Val Ser Gly Val Tyr Lys Asn Pro Lys Thr Ser Lys 65 70 75 80 Glu Gly Thr Gly He Gin Phe Phe Thr Pro Ser Val Thr Lys Val Glu 85 90 95 Lys Phe Thr Ser Thr He Leu Pro Ala Asp Thr Thr Val Ser Glu Leu 100 105 110 Gln Lys Leu Ala Thr Asp His Lys Ala Glu Val Thr Val Lys His Glu 115 120 125 Ser Ser Ser Gly He Trp He Asn Leu Leu Val Ser He Val Pro Phe 130 135 140 Gly He Leu Phe Phe Phe Leu Phe Ser Met Met Gly Asn Met Gly Gly 145 150 155 160 Gly Asn Gly Arg Asn Pro Met Ser Phe Gly Arg Ser Lys Ala Lys Ala 165 170 175 Ala Asn Lys Glu Asp He Lys Val Arg Phe Ser Asp Val Ala Gly Ala 180 185 190 Glu Glu Glu Lys Gin Glu Leu Val Glu Val Val Glu Phe Leu Lys Asp 195 200 205 Pro Lys Arg Phe Thr Lys Leu Gly Ala Arg He Pro Ala Gly Val Leu 210 215 220 Leu Glu Gly Pro Pro Gly Thr Gly Lys Thr Leu Leu Ala Lys Ala Val 225 230 235 240 Ala Gly Glu Ala Gly Val Pro Phe Phe Ser He Ser Gly Ser Asp Phe 245 250 255 Val Glu Met Phe Val Gly Val Gly Ala Ser Arg Val Arg Ser Leu Phe 260 265 270 Glu Asp Ala Lys Lys Ala Ala Pro Ala He He Phe He Asp Leu Asn 275 280 285 Asp Ala Val Gly Arg Gin Arg Gly Val Gly Leu Gly Gly Gly Asn Asp 290 295 300 Glu Arg Glu Gin Thr Leu Asn Gin Leu Leu He Glu Met Asp Gly Phe 305 310 315 320 Glu Gly Asn Glu Gly He He Val He Ala Ala Thr Asn Arg Ser Asp 325 330 335 Val Leu Asp Pro Ala Leu Leu Arg Pro Gly Arg Phe Asp Arg Lys Val 340 345 350 Leu Val Gly Arg Pro Asp Val Lys Gly Arg Glu Ala He Leu Lys Val 355 360 365 His Ala Lys Asn Lys Pro Leu Ala Glu Asp Val Asp Leu Lys Leu Val 370 375 380 Ala Gin Gin Thr Pro Gly Phe Val Gly Ala Asp Leu Glu Asn Val Leu 385 390 395 400 Asn Glu Ala Ala Leu Val Ala Ala Arg Arg Asn Lys Ser He He Asp 405 410 415 Ala Ser Asp He Asp Glu Ala Glu Asp Arg Val He Ala Gly Pro Ser 420 425 430 Lys Lys Asp Lys Thr Val Ser Gin Lys Glu Arg Glu Leu Val Ala Tyr 435 440 445 His Glu Ala Gly His Thr He Val Gly Leu Val Leu Ser Thr Ala Arg 450 455 460 Val Val His Lys Val Thr He Val Pro Arg Gly Arg Ala Gly Gly Tyr 465 470 475 480 Met He Ala Leu Pro Lys Glu Asp Gin Met Leu Leu Ser Lys Glu Asp 485 490 495 Met Lys Glu Gin Leu Ala Gly Leu Met Gly Gly Arg Val Ala Glu Glu 500 505 510 He He Phe Asn Val Gin Thr Thr Gly Ala Ser Asn Asp Phe Glu Gin 515 520 525 Ala Thr Gin Met Ala Arg Ala Met Val Thr Glu Tyr Gly Met Ser Glu 530 535 540 Lys Leu Gly Pro Val Gin Tyr Glu Gly Asn His Ala Met Leu Gly Ala 545 550 555 560 Gin Ser Pro Gin Lys Ser He Ser Glu Gin Thr Ala Tyr Glu He Asp 565 570 575 Glu Glu Val Arg Ser Leu Leu Asn Glu Ala Arg Asn Lys Ala Ala Glu 580 585 590 He He Gin Ser Asn Arg Glu Thr His Lys Leu He Ala Glu Ala Leu 595 600 605 Leu Lys Tyr Glu Thr Leu Asp Ser Thr Gin He Lys Ala Leu Tyr Glu 610 615 620 Thr Gly Lys Met Pro Glu Ala Val Glu Glu Glu Ser His Ala Leu Ser 625 630 635 640 Tyr Asp Glu Val Lys Ser Lys Met Asn Asp Glu Lys 645 650 (2) INFORMATION FOR SEQ ID NO: 119: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1278 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1278 (D) OTHER INFORMATION: FtsY (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 119: ATG GGA TTG TTT GAC CGT CTA TTC GGA AAA AAA GAA GAA CCT AAA ATC 48 Met Gly Leu Phe Asp Arg Leu Phe Gly Lys Lys Glu Glu Pro Lys He 1 5 10 15 GAA GAA GTT GTA AAA GAA GCT CTG GAA AAT CTT GAT TTG TCT GAA GAT 96 Glu Glu Val Val Lys Glu Ala Leu Glu Asn Leu Asp Leu Ser Glu Asp 20 25 30 GTT GAT CCT ACC TTC ACA GAA GTT GAG GAA GTT TCT CAG GAA GAA GCA 144 Val Asp Pro Thr Phe Thr Glu Val Glu Glu Val Ser Gin Glu Glu Ala 35 40 45 GAG GTT GAA ATT GTT GAA CAA GCT GTG TTC CAA GAA GAG GAA ATC CAA 192 Glu Val Glu He Val Glu Gin Ala Val Phe Gin Glu Glu Glu He Gin 50 55 60 GAC ACA GTT GAA GAA AGT CTG GAT TTA GAG CCA GTT GTA GAA GTT TCT 240 Asp Thr Val Glu Glu Ser Leu Asp Leu Glu Pro Val Val Glu Val Ser 65 70 75 80 CAA AAA GAA GTC GAA GAA TTT CCA CAC TCA GAA GAA GGG AAT ACT GAG 288 Gin Lys Glu Val Glu Glu Phe Pro His Ser Glu Glu Gly Asn Thr Glu 85 90 95 TTT CTA GAG ACT ATA GAA GAA AAT AAT TCT GAA GTT CTT GAA CCA GAA 336 Phe Leu Glu Thr He Glu Glu Asn Asn Ser Glu Val Leu Glu Pro Glu 100 105 110 AGG CCT CAA GCA GAA GAA ACC GTT CAG GAA AAA TAT GAC CGC AGT CTT 384 Arg Pro Gin Ala Glu Glu Thr Val Gin Glu Lys Tyr Asp Arg Ser Leu 115 120 125 AAG AAA ACT CGT ACA GGT TTC GGT GCC CGC TTG AAT GCC TTC TTT GCT 432 Lys Lys Thr Arg Thr Gly Phe Gly Ala Arg Leu Asn Ala Phe Phe Ala 130 135 140 AAC TTC CGC TCT GTT GAC GAA GAA TTT TTC GAG GAA CTG GAA GAA CTG 480 Asn Phe Arg Ser Val Asp Glu Glu Phe Phe Glu Glu Leu Glu Glu Leu 145 150 155 160 CTG ATT ATG AGT GAT GTT GGT GTC CAA GTC GCT TCT AAC TTA ACG GAG 528 Leu He Met Ser Asp Val Gly Val Gin Val Ala Ser Asn Leu Thr Glu 165 170 175 GAA CTA CGT TAC GAA GCC AAG CTT GAA AAT GCC AAG AAA CCT GAT GCA 576 Glu Leu Arg Tyr Glu Ala Lys Leu Glu Asn Ala Lys Lys Pro Asp Ala 180 185 190 CTT CGT CGT GTC ATC ATT GAG AAA TTG GTT GAG CTT TAT GAA AAG GAT 624 Leu Arg Arg Val He He Glu Lys Leu Val Glu Leu Tyr Glu Lys Asp 195 200 205 GGT AGC TAC GAT GAA AGC ATC CAC TTC CAA GAT AAC TTG ACA GTT ATG 672 Gly Ser Tyr Asp Glu Ser He His Phe Gin Asp Asn Leu Thr Val Met 210 215 220 CTC TTT GTT GGT GTG AAT GGT GTT GGG AAA ACA ACT TCT ATC GGA AAA 720 Leu Phe Val Gly Val Asn Gly Val Gly Lys Thr Thr Ser He Gly Lys 225 230 235 240 CTA GCC CAC CGC TAC AAA CAA GCT GGT AAG AAG GTC ATG CTG GTT GCA 768 Leu Ala His Arg Tyr Lys Gin Ala Gly Lys Lys Val Met Leu Val Ala 245 250 255 GCA GAT ACC TTC CGT GCG GGT GCA GTA GCT CAG CTA GCT GAA TGG GGC 816 Ala Asp Thr Phe Arg Ala Gly Ala Val Ala Gin Leu Ala Glu Trp Gly 260 265 270 CGA CGA GTA GAT GTT CCA GTA GTA ACT GGA CCT GAA AAA GCT GAT CCA 864 Arg Arg Val Asp Val Pro Val Val Thr Gly Pro Glu Lys Ala Asp Pro 275 280 285 GCC AGC GTG GTC TTT GAT GGT ATG GAA CGT GCC GTG GCT GAA GGT ATC 912 Ala Ser Val Val Phe Asp Gly Met Glu Arg Ala Val Ala Glu Gly He 290 295 300 GAT ATT CTC ATG ATT GAT ACT GCT GGT CGT CTG CAA AAT AAG GAT AAC 960 Asp He Leu Met He Asp Thr Ala Gly Arg Leu Gin Asn Lys Asp Asn 305 310 315 320 CTT ATG GCT GAG TTG GAA AAG ATT GGT CGT ATT ATC AAA CGT GTT GTG 1008 Leu Met Ala Glu Leu Glu Lys He Gly Arg He He Lys Arg Val Val 325 330 335 CCA GAA GCA CCA CAT GAA ACC TTC TTG GCA CTT GAT GCA TCA ACA GGT 1056 Pro Glu Ala Pro His Glu Thr Phe Leu Ala Leu Asp Ala Ser Thr Gly 340 345 350 CAA AAT GCC CTA GTA CAG GCC AAA GAA TTT TCG AAA ATC ACA CCT TTA 1104 Gin Asn Ala Leu Val Gin Ala Lys Glu Phe Ser Lys He Thr Pro Leu 355 360 365 ACG GGA ATT GTT TTG ACT AAG ATT GAT GGA ACT GCT CGA GGA GGT GTG 1152 Thr Gly He Val Leu Thr Lys He Asp Gly Thr Ala Arg Gly Gly Val 370 375 380 GTT CTA GCC ATT CGT GAA GAA CTC AAT ATT CCT GTA AAA TTG ATT GGT 1200 Val Leu Ala He Arg Glu Glu Leu Asn He Pro Val Lys Leu He Gly 385 390 395 400 TTT GGT GAA AAA ATC GAT GAT ATT GGA GAG TTT AAC TCA GAA AAC TTT 1248 Phe Gly Glu Lys He Asp Asp He Gly Glu Phe Asn Ser Glu Asn Phe 405 410 415 ATG AAA GGT CTC TTG GAA GGT TTA ATC TAA 1271: Met Lys Gly Leu Leu Glu Gly Leu He * 420 425 (2) INFORMATION FOR SEQ ID NO: 120: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 425 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 120: Met Gly Leu Phe Asp Arg Leu Phe Gly Lys Lys Glu Glu Pro Lys He 1 5 10 15 Glu Glu Val Val Lys Glu Ala Leu Glu Asn Leu Asp Leu Ser Glu Asp 20 25 30 Val Asp Pro Thr Phe Thr Glu Val Glu Glu Val Ser Gin Glu Glu Ala 35 40 45 Glu Val Glu He Val Glu Gin Ala Val Phe Gin Glu Glu Glu He Gin 50 55 60 Asp Thr Val Glu Glu Ser Leu Asp Leu Glu Pro Val Val Glu Val Ser 65 70 75 80 Gin Lys Glu Val Glu Glu Phe Pro His Ser Glu Glu Gly Asn Thr Glu 85 90 95 Phe Leu Glu Thr He Glu Glu Asn Asn Ser Glu Val Leu Glu Pro Glu 100 105 110 Arg Pro Gin Ala Glu Glu Thr Val Gin Glu Lys Tyr Asp Arg Ser Leu 115 120 125 Lys Lys Thr Arg Thr Gly Phe Gly Ala Arg Leu Asn Ala Phe Phe Ala 130 135 140 Asn Phe Arg Ser Val Asp Glu Glu Phe Phe Glu Glu Leu Glu Glu Leu 145 150 155 160 Leu He Met Ser Asp Val Gly Val Gin Val Ala Ser Asn Leu Thr Glu 165 170 175 Glu Leu Arg Tyr Glu Ala Lys Leu Glu Asn Ala Lys Lys Pro Asp Ala 180 185 190 Leu Arg Arg Val He He Glu Lys Leu Val Glu Leu Tyr Glu Lys Asp 195 200 205 Gly Ser Tyr Asp Glu Ser He His Phe Gin Asp Asn Leu Thr Val Met 210 215 220 Leu Phe Val Gly Val Asn Gly Val Gly Lys Thr Thr Ser He Gly Lys 225 230 235 240 Leu Ala His Arg Tyr Lys Gin Ala Gly Lys Lys Val Met Leu Val Ala 245 250 255 Ala Asp Thr Phe Arg Ala Gly Ala Val Ala Gin Leu Ala Glu Trp Gly 260 265 270 Arg Arg Val Asp Val Pro Val Val Thr Gly Pro Glu Lys Ala Asp Pro 275 280 285 Ala Ser Val Val Phe Asp Gly Met Glu Arg Ala Val Ala Glu Gly He 290 295 300 Asp He Leu Met He Asp Thr Ala Gly Arg Leu Gin Asn Lys Asp Asn 305 310 315 320 Leu Met Ala Glu Leu Glu Lys He Gly Arg He He Lys Arg Val Val 325 330 335 Pro Glu Ala Pro His Glu Thr Phe Leu Ala Leu Asp Ala Ser Thr Gly 340 345 350 Gin Asn Ala Leu Val Gin Ala Lys Glu Phe Ser Lys He Thr Pro Leu 355 360 365 Thr Gly He Val Leu Thr Lys He Asp Gly Thr Ala Arg Gly Gly Val 370 375 380 Val Leu Ala He Arg Glu Glu Leu Asn He Pro Val Lys Leu He Gly 385 390 395 400 Phe Gly Glu Lys He Asp Asp He Gly Glu Phe Asn Ser Glu Asn Phe 405 410 415 Met Lys Gly Leu Leu Glu Gly Leu He 420 425 (2) INFORMATION FOR SEQ ID NO: 121: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 891 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..891 (D) OTHER INFORMATION: HI 1146 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 121: ATG ACA AAG AAA CAA CTT CAC TTG GTG ATT GTG ACA GGG ATG GGT GGC 48 Met Thr Lys Lys Gin Leu His Leu Val He Val Thr Gly Met Gly Gly 1 5 10 15 GCA GGG AAA ACT GTA GCC ATT CAG TCC TTC GAG GAT CTA GGT TAT TTC 96 Ala Gly Lys Thr Val Ala He Gin Ser Phe Glu Asp Leu Gly Tyr Phe 20 25 30 ACC ATT GAT AAT ATG CCG CCA GCT CTC TTG CCT AAG TTT TTG CAG CTG 144 Thr He Asp Asn Met Pro Pro Ala Leu Leu Pro Lys Phe Leu Gin Leu 35 40 45 GTT GAA ATT AAG GAA GAC AAT CCT AAG TTG GCC TTG GTA GTG GAT ATG 192 Val Glu He Lys Glu Asp Asn Pro Lys Leu Ala Leu Val Val Asp Met 50 55 60 CGT AGT CGT TCT TTC TTT TCA GAG ATT CAA GCT GTT TTG GAT GAG TTG 240 Arg Ser Arg Ser Phe Phe Ser Glu He Gin Ala Val Leu Asp Glu Leu 65 70 75 80 GAA AAT CAA GAT GGT TTG GAT TTC AAA ATC CTC TTT TTG GAT GCG GCT 288 Glu Asn Gin Asp Gly Leu Asp Phe Lys He Leu Phe Leu Asp Ala Ala 85 90 95 GAT AAG GAA TTG GTC GCT CGT TAC AAG GAA ACC AGA CGG AGT CAC CCA 336 Asp Lys Glu Leu Val Ala Arg Tyr Lys Glu Thr Arg Arg Ser His Pro 100 105 110 CTA GCA GCA GAC GGT CGT ATT TTA GAT GGA ATC AAG TTG GAA CGT GAA 384 Leu Ala Ala Asp Gly Arg He Leu Asp Gly He Lys Leu Glu Arg Glu 115 120 125 CTC TTG GCA CCT TTG AAA AAT ATG AGC CAA AAT GTG GTG GAT ACG ACT 432 Leu Leu Ala Pro Leu Lys Asn Met Ser Gin Asn Val Val Asp Thr Thr 130 135 140 GAA CTC ACT CCA CGT GAG CTG CGC AAA ACC CTT GCA GAG CAG TTT TCA 480 Glu Leu Thr Pro Arg Glu Leu Arg Lys Thr Leu Ala Glu Gin Phe Ser 145 150 155 160 GAC CAA GAA CAA GCT CAG TCT TTC CGT ATC GAA GTC ATG TCT TTC GGA 528 Asp Gin Glu Gin Ala Gin Ser Phe Arg He Glu Val Met Ser Phe Gly 165 170 175 TTT AAG TAT GGA ATC CCG ATT GAT GCG GAC TTG GTC TTT GAT GTC CGT 576 Phe Lys Tyr Gly He Pro He Asp Ala Asp Leu Val Phe Asp Val Arg 180 185 190 TTC TTG CCA AAT CCC TAT TAT TTA CCA GAA CTG AGA AAC CAA ACG GGT 624 Phe Leu Pro Asn Pro Tyr Tyr Leu Pro Glu Leu Arg Asn Gin Thr Gly 195 200 205 GTG GAT GAA CCT GTT TAT GAT TAT GTC ATG AAC CAT CCT GAG TCA GAA 672 Val Asp Glu Pro Val Tyr Asp Tyr Val Met Asn His Pro Glu Ser Glu 210 215 220 GAC TTT TAT CAA CAT TTA TTG GCC TTG ATT GAG CCG ATT CTG CCA AGT 720 Asp Phe Tyr Gin His Leu Leu Ala Leu He Glu Pro He Leu Pro Ser 225 230 235 240 TAC CAA AAG GAA GGT AAG TCC GTT TTG ACC ATT GCC ATG GGA TGT ACG 768 Tyr Gin Lys Glu Gly Lys Ser Val Leu Thr He Ala Met Gly Cys Thr 245 250 255 GGT GGA CAA CAC CGT AGT GTG GCA TTT GCT AAA CGC TTG GTG CAG GAC 816 Gly Gly Gin His Arg Ser Val Ala Phe Ala Lys Arg Leu Val Gin Asp 260 265 270 TTA TCC AAG AAT TGG TCT GTT AAT GAA GGG CAT CGC GAC AAA GAC CGC 864 Leu Ser Lys Asn Trp Ser Val Asn Glu Gly His Arg Asp Lys Asp Arg 275 280 285 AGA AAG GAA ACG GTA AAC CGT TCA TGA 891 Arg Lys Glu Thr Val Asn Arg Ser * 290 295 (2) INFORMATION FOR SEQ ID NO: 122: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 296 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 122: Met Thr Lys Lys Gin Leu His Leu Val He Val Thr Gly Met Gly Gly 1 5 10 15 Ala Gly Lys Thr Val Ala He Gin Ser Phe Glu Asp Leu Gly Tyr Phe 20 25 30 Thr He Asp Asn Met Pro Pro Ala Leu Leu Pro Lys Phe Leu Gin Leu 35 40 45 Val Glu He Lys Glu Asp Asn Pro Lys Leu Ala Leu Val Val Asp Met 50 55 60 Arg Ser Arg Ser Phe Phe Ser Glu He Gin Ala Val Leu Asp Glu Leu 65 70 75 80 Glu Asn Gin Asp Gly Leu Asp Phe Lys He Leu Phe Leu Asp Ala Ala 85 90 95 Asp Lys Glu Leu Val Ala Arg Tyr Lys Glu Thr Arg Arg Ser His Pro 100 105 110 Leu Ala Ala Asp Gly Arg He Leu Asp Gly He Lys Leu Glu Arg Glu 115 120 125 Leu Leu Ala Pro Leu Lys Asn Met Ser Gin Asn Val Val Asp Thr Thr 130 135 140 Glu Leu Thr Pro Arg Glu Leu Arg Lys Thr Leu Ala Glu Gin Phe Ser 145 150 155 160 Asp Gin Glu Gin Ala Gin Ser Phe Arg He Glu Val Met Ser Phe Gly 165 170 175 Phe Lys Tyr Gly He Pro He Asp Ala Asp Leu Val Phe Asp Val Arg 180 185 190 Phe Leu Pro Asn Pro Tyr Tyr Leu Pro Glu Leu Arg Asn Gin Thr Gly 195 200 205 Val Asp Glu Pro Val Tyr Asp Tyr Val Met Asn His Pro Glu Ser Glu 210 215 220 Asp Phe Tyr Gin His Leu Leu Ala Leu He Glu Pro He Leu Pro Ser 225 230 235 240 Tyr Gin Lys Glu Gly Lys Ser Val Leu Thr He Ala Met Gly Cys Thr 245 250 255 Gly Gly Gin His Arg Ser Val Ala Phe Ala Lys Arg Leu Val Gin Asp 260 265 270 Leu Ser Lys Asn Trp Ser Val Asn Glu Gly His Arg Asp Lys Asp Arg 275 280 285 Arg Lys Glu Thr Val Asn Arg Ser 290 295 (2) INFORMATION FOR SEQ ID NO: 123: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 329 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 123: Met Val Glu Val Pro Asp Glu Arg Leu Gin Lys Leu Thr Glu Met He 1 5 10 15 Thr Pro Lys Lys Thr Val Pro Thr Thr Phe Glu Phe Thr Asp He Ala 20 25 30 Gly He Val Lys Gly Ala Ser Lys Gly Glu Gly Leu Gly Asn Lys Phe 35 40 45 Leu Ala Asn He Arg Glu Val Asp Ala He Val His Val Val Arg Ala 50 55 60 Phe Asp Asp Glu Asn Val Met Arg Glu Gin Gly Arg Glu Asp Ala Phe 65 70 75 80 Val Asp Pro Leu Ala Asp He Asp Thr He Asn Leu Glu Leu He Leu 85 90 95 Ala Asp Leu Glu Ser Val Asn Lys Arg Tyr Ala Arg Val Glu Lys Met 100 105 110 Ala Arg Thr Gin Lys Asp Lys Glu Ser Val Ala Glu Phe Asn Val Leu 115 120 125 Gin Lys He Lys Pro Val Leu Glu Asp Gly Lys Ser Ala Arg Thr He 130 135 140 Glu Phe Thr Asp Glu Glu Gin Lys Val Val Lys Gly Leu Phe Leu Leu 145 150 155 160 Thr Thr Lys Pro Val Leu Tyr Val Ala Asn Val Asp Glu Asp Val Val 165 170 175 Ser Glu Pro Asp Ser He Asp Tyr Val Lys Gin He Arg Glu Phe Ala 180 185 190 Ala Thr Glu Asn Ala Glu Val Val Val He Ser Ala Arg Ala Glu Glu 195 200 205 Glu He Ser Glu Leu Asp Asp Glu Asp Lys Lys Glu Phe Leu Glu Ala 210 215 220 He Gly Leu Thr Glu Ser Gly Val Asp Lys Leu Thr Arg Ala Ala Tyr 225 230 235 240 His Leu Leu Gly Leu Gly Thr Tyr Phe Thr Ala Gly Glu Lys Glu Val 245 250 255 Arg Ala Trp Thr Phe Lys Arg Gly Met Lys Ala Pro Gin Ala Ala Gly 260 265 270 He He His Ser Asp Phe Glu Lys Gly Phe He Arg Ala Val Thr Met 275 280 285 Ser Tyr Glu Asp Leu Val Lys Tyr Gly Ser Glu Lys Ala Val Lys Glu 290 295 300 Ala Gly Arg Leu Arg Glu Glu Gly Lys Glu Tyr He Val Gin Asp Gly 305 310 315 320 Asp He Met Glu Phe Arg Phe Asn Val 325 (2) INFORMATION FOR SEQ ID NO: 124: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 189 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 124: Met Ser Ala Ser Glu Gly Arg Asp Pro Tyr Glu Asp Tyr Leu Ala He 1 5 10 15 Asn Lys Glu Leu Glu Ser Tyr Asn Leu Arg Leu Met Glu Arg Pro Gin 20 25 30 He He Val Thr Asn Lys Met Asp Met Pro Glu Ser Gin Glu Asn Leu 35 40 45 Glu Glu Phe Lys Lys Lys Leu Ala Glu Asn Tyr Asp Glu Phe Glu Glu 50 55 60 Leu Pro Ala He Phe Pro He Ser Gly Leu Thr Lys Gin Gly Leu Ala 65 70 75 80 Thr Leu Leu Asp Ala Thr Ala Glu Leu Leu Asp Lys Thr Pro Glu Phe 85 90 95 Leu Leu Tyr Asp Glu Ser Asp Met Glu Glu Glu Val Tyr Tyr Gly Phe 100 105 110 Asp Glu Glu Glu Lys Ala Phe Glu He Ser Arg Asp Asp Asp Ala Thr 115 120 125 Trp Val Leu Ser Gly Glu Lys Leu Met Lys Leu Phe Asn Met Thr Asn 130 135 140 Phe Asp Arg Asp Glu Ser Val Met Lys Phe Ala Arg Gin Leu Arg Gly 145 150 155 160 Met Gly Val Asp Glu Ala Leu Arg Ala Arg Gly Ala Lys Asp Gly Asp 165 170 175 Leu Val Arg He Gly Lys Phe Glu Phe Glu Phe Val Asp 180 185 (2) INFORMATION FOR SEQ ID NO: 125: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 226 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:125: Met Asn He Gin Gin Leu Arg Tyr Val Val Ala He Ala Asn Ser Gly 1 5 10 15 Thr Phe Arg Glu Ala Ala Glu Lys Met Tyr Val Ser Gin Pro Ser Leu 20 25 30 Ser He Ser Val Arg Asp Leu Glu Lys Glu Leu Gly Phe Lys He Phe 35 40 45 Arg Arg Thr Ser Ser Gly Thr Phe Leu Thr Arg Arg Gly Met Glu Phe 50 55 60 Tyr Glu Lys Ala Gin Glu Leu Val Lys Gly Phe Asp He Phe Gin Asn 65 70 75 80 Gin Tyr Ala Asn Pro Glu Glu Glu Lys Asp Glu Phe Ser Val Ala Ser 85 90 95 Gin His Tyr Asp Phe Leu Pro Pro Thr He Thr Ala Phe Ser Glu Arg 100 105 110 Tyr Pro Asp Tyr Lys Asn Phe Arg He Phe Glu Ser Thr Thr Val Gin 115 120 125 He Leu Asp Glu Val Ala Gin Gly His Ser Glu He Gly He He Tyr 130 135 140 Leu Asn Asn Gin Asn Lys Lys Gly He Met Gin Arg Val Glu Lys Leu 145 150 155 160 Gly Leu Glu Val He Glu Leu He Pro Phe His Thr His He Tyr Leu 165 170 175 Cys Glu Gly His Pro Leu Ala Gin Lys Glu Glu Leu Val Met Glu Asp 180 185 190 Leu Ala Asp Leu Pro Thr Val Arg Phe Thr Gin Glu Lys Asp Glu Tyr 195 200 205 Leu Tyr Tyr Ser Glu Asn Phe Val Asp Thr Ser Ala Thr His Arg Cys 210 215 220 Leu Met 225 (2) INFORMATION FOR SEQ ID NO: 126: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 119 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 126: Met Lys Lys Arg Ala He Val Ala Val He Val Leu Leu Leu He Gly 1 5 10 15 Leu Asp Gin Leu Val Lys Ser Tyr He Val Gin Gin He Pro Leu Gly 20 25 30 Glu Val Arg Ser Trp He Pro Asn Phe Val Ser Leu Thr Tyr Leu Gin 35 40 45 Asn Arg Gly Ala Ala Phe Ser He Leu Gin Asp Gin Gin Leu Leu Phe 50 55 60 Ala Val He Thr Leu Val Val Val He Gly Ala He Trp Tyr Leu His 65 70 75 80 Lys His Met Glu Asp Ser Phe Trp Met Val Leu Gly Leu Thr Leu He 85 90 95 He Ala Gly Gly Pro Gly Asn Phe He Asp Arg Val Ser Gin Gly Phe 100 105 110 Val Val Asp Met Phe His Leu 115 (2) INFORMATION FOR SEQ ID NO: 127: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 170 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 127: Met Ser Lys Tyr Leu Leu Lys Leu Leu Val Tyr Cys Phe Ser Ala Leu 1 5 10 15 Thr Phe Gly Ser Leu Phe Leu He He Gly Phe He Leu He Lys Gly 20 25 30 Leu Pro His Leu Ser Leu Ser Leu Phe Ser Trp Thr Tyr Thr Ser Glu 35 40 45 Asn He Ser Leu Met Pro Ala He He Ser Thr Val He Leu Val Phe 50 55 60 Gly Ala Leu Leu Leu Ala Leu Pro He Gly He Phe Ala Gly Phe Tyr 65 70 75 80 Leu Val Glu Tyr Thr Lys Lys Asp Ser Leu Cys Val Lys He Met Arg 85 90 95 Leu Ala Ser Asp Thr Leu Ser Gly He Pro Ser He Val Phe Gly Leu 100 105 110 Phe Gly Met Leu Phe Phe Val Val Phe Leu Gly Phe Gin Tyr Ser Leu 115 120 125 Leu Ser Gly He Leu Thr Ser Val He Met Val Leu Pro Val He He 130 135 140 Arg Ser Thr Glu Glu Ala Leu Leu Ser Val Ser Asp Ser Met Arg Gin 145 150 155 160 Ala Ser Tyr Gly Leu Gly Ala Leu Ser Tyr 165 170 (2) INFORMATION FOR SEQ ID NO: 128: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 154 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 128: Met Lys Thr Glu Gin Thr Ala Ser Lys Thr Ser Ala Leu Lys Gly Lys 1 5 10 15 Glu Val Ala Asp Phe Glu Leu Met Gly Val Asp Gly Lys Thr Tyr Arg 20 25 30 Leu Ser Asp Tyr Lys Gly Lys Lys Val Tyr Leu Lys Phe Trp Ala Ser 35 40 45 Trp Cys Ser He Cys Leu Ala Ser Leu Pro Asp Thr Asp Glu He Ala 50 55 60 Lys Glu Ala Gly Asp Asp Tyr Val Val Leu Thr Val Val Ser Pro Gly 65 70 75 80 His Lys Gly Glu Gin Ser Glu Ala Asp Phe Lys Asn Trp Tyr Lys Gly 85 90 95 Leu Asp Tyr Lys Asn Leu Pro Val Leu Val Asp Pro Ser Gly Lys Leu 100 105 110 Leu Glu Thr Tyr Gly Val Arg Ser Tyr Pro Thr Gin Ala Phe He Asp 115 120 125 Lys Glu Gly Lys Leu Val Lys Thr His Pro Gly Phe Met Glu Lys Asp 130 135 140 Ala He Leu Gin Thr Leu Lys Glu Leu Ser 145 150 (2) INFORMATION FOR SEQ ID NO: 129: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 181 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 129: Met Lys Lys Glu Gin He Pro Asn Leu Leu Thr He Gly Arg He Leu 1 5 10 15 Phe He Pro He Phe He Phe He Leu Thr He Gly Asn Ser He Glu 20 25 30 Ser His He Val Ala Ala He He Phe Ala Val Ala Ser He Thr Asp 35 40 45 Tyr Leu Asp Gly Tyr Leu Ala Arg Lys Trp Asn Val Val Ser Asn Phe 50 55 60 Gly Lys Phe Ala Asp Pro Met Ala Asp Lys Leu Leu Val Met Ser Ala 65 70 75 80 Phe He Met Leu He Glu Leu Gly Met Ala Pro Ala Trp He Val Ala 85 90 95 Val He He Cys Arg Glu Leu Ala Val Thr Gly Leu Arg Leu Leu Leu 100 105 110 Val Glu Thr Gly Gly Thr He Leu Ala Ala Ala Met Pro Gly Lys He 115 120 125 Lys Thr Phe Ser Gin Met Phe Ala He He Phe Leu Leu Leu His Trp 130 135 140 Thr Leu Leu Gly Gin Val Leu Leu Tyr Val Ala Leu Phe Phe Thr He 145 150 155 160 Tyr Ser Gly Tyr Asp Tyr Phe Lys Gly Ser Ala Tyr Val Phe Lys Gly 165 170 175 Thr Phe Gly Ser Lys 180 (2) INFORMATION FOR SEQ ID NO: 130: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 111 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 130: Leu Arg Leu Lys Glu Met Asn Gly Asp Met He His Ala Ala Tyr Asp 1 5 10 15 Leu Gly Ala Ser Gin Phe Gin Met Phe Lys Glu He Met Leu Pro Tyr 20 25 30 Leu Thr Pro Ser He He Ala Gly Tyr Phe Met Ala Phe Thr Tyr Ser 35 40 45 Leu Asp Asp Phe Ala Val Thr Phe Phe Val Thr Gly Asn Gly Phe Ser 50 55 60 Thr Leu Ser Val Glu He Tyr Ser Arg Ala Arg Lys Gly He Ser Leu 65 70 75 Glu He Asn Ala Leu Ser Ala Leu Val Phe Leu Phe Ser He He Leu 85 90 95 Val Val Gly Tyr Tyr Phe He Ser Arg Glu Lys Glu Glu Gin Ala 100 105 110 (2) INFORMATION FOR SEQ ID NO: 131: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 59 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:131: Pro Gin Phe Thr Glu Glu Thr Gly He Gin Val Gin Tyr Glu Ala Phe 1 5 10 15 Asp Ser Asn Glu Ala Met Tyr Thr Lys He Lys Gin Gly Gly Thr Thr 20 25 30 Tyr Asp He Ala He Pro Ser Glu Tyr Met He Asn Lys Met Lys Asp 35 40 45 Glu Asp Leu Leu Val Pro Leu Asp Tyr Ser Lys 50 55 (2) INFORMATION FOR SEQ ID NO: 132: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 232 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 132: Met Gin Thr Gin Glu Lys His Ser Gin Ala Ala Val Leu Gly Leu Gin 1 5 10 15 His Leu Leu Ala Met Tyr Ser Gly Ser He Leu Val Pro He Met He 20 25 30 Ala Thr Ala Leu Gly Tyr Ser Ala Glu Gin Leu Thr Tyr Leu He Ser 35 40 45 Thr Asp He Phe Met Cys Gly Val Ala Thr Phe Leu Gin Leu Gin Leu 50 55 60 Asn Lys Tyr Phe Gly He Gly Leu Pro Val Val Leu Gly Val Ala Phe 65 70 75 80 Gin Ser Val Ala Pro Leu He Met He Gly Gin Ser His Gly Ser Gly 85 90 95 Ala Met Phe Gly Ala Leu He Ala Ser Gly He Tyr Val Val Leu Val 100 105 110 Ser Gly He Phe Ser Lys Val Ala Asn Leu Phe Pro Ser He Val Thr 115 120 125 Gly Ser Val He Thr Thr He Gly Leu Thr Leu He Pro Val Ala He 130 135 140 Gly Asn Met Gly Asn Asn Val Pro Glu Pro Thr Gly Gin Ser Leu Leu 145 150 155 160 Leu Ala Ala He Thr Val Leu He He Leu Leu He Asn He Phe Thr 165 170 175 Lys Gly Phe He Lys Ser He Ser He Leu He Gly Leu Val Val Gly 180 185 190 Thr Ala He Ala Ala Thr Met Gly Leu Val Asp Phe Ser Pro Val Ala 195 200 205 Val Val His Leu Ser Met Ser Gin Leu His Ser Thr Leu Gly Cys Gin 210 215 220 Pro Leu Lys Ser His Leu Leu Ser 225 230 (2) INFORMATION FOR SEQ ID NO: 133: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 343 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 133: Lys Val Pro Val Tyr Leu Gly Ser Ser Phe Ala Phe He Thr Ala Met 1 5 10 15 Ser Leu Ala Met Lys Glu Met Gly Gly Asp Val Ser Ala Ala Gin Thr 20 25 30 Gly Val He Leu Thr Gly Leu Val Tyr Val Leu Val Ala Thr Ser He 35 40 45 Arg Phe Val Gly Thr Lys Trp He Asp Lys Leu Leu Pro Pro He He 50 55 60 He Gly Pro Met He He Val He Gly Leu Gly Leu Ala Gly Ser Ala 65 70 75 80 Val Thr Asn Ala Gly Leu Val Ala Asp Gly Asn Trp Lys Asn Ala Leu 85 90 95 Val Ala Val Val Thr Phe Leu He Ala Ala Phe He Asn Thr Lys Gly 100 105 110 Lys Gly Phe Leu Arg He He Pro Phe Leu Phe Ala He He Gly Gly 115 120 125 Tyr Leu Phe Ala Leu Thr Leu Gly Leu Val Asp Phe Thr Pro Val Leu 130 135 140 Lys Ala Asn Trp Phe Glu He Pro Gly Phe Tyr Leu Pro Phe Ser Thr 145 150 155 160 Gly Gly Ala Phe Lys Glu Tyr Asn Leu Tyr Phe Gly Pro Glu Ala He 165 170 175 Ala He Leu Pro He Ala He Val Thr He Ser Glu His He Gly Asp 180 185 190 His Thr Val Leu Gly Gin He Cys Gly Arg Gin Phe Leu Lys Glu Pro 195 200 205 Gly Leu His Arg Thr Leu Leu Gly Asp Gly He Ala Thr Ser Val Ser 210 215 220 Ala Phe Leu Gly Gly Pro Ala Asn Thr Thr Tyr Gly Glu Asn Thr Gly 225 230 235 240 Val He Gly Met Thr Arg He Ala Ser Val Ser Val He Arg Asn Ala 245 250 255 Ala Phe He Ala He Ala Leu Ser Phe Leu Gly Lys Phe Thr Ala Leu 260 265 270 He Ser Thr He Pro Asn Ala Val Leu Gly Gly Met Ser He Leu Leu 275 280 285 Tyr Gly Val He Ala Ser Asn Gly Leu Lys Val Leu He Lys Glu Arg 290 295 300 Val Asp Phe Ala Gin Met Arg Asn Leu He He Ala Ser Ala Met Leu 305 310 315 320 Val Leu Gly Leu Gly Gly Ala He Leu Lys Leu Gly Pro Val His Phe 325 330 335 Gin Val Leu Pro Phe Gin Pro 340 (2) INFORMATION FOR SEQ ID NO: 134: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 184 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 134: Ser Leu He He Ala Leu Ala Thr Thr Leu He Ala He He He Ser 1 5 10 15 Ala Met Ala Ala Tyr Gly He Val Arg Phe Phe Pro Lys Leu Gly Ala 20 25 30 He Met Ser Arg Leu Leu Val He Thr Tyr He Phe Pro Pro He Leu 35 40 45 Leu Ala He Pro Tyr Ser He Ala He Ala Lys Val Gly Leu Thr Asn 50 55 60 Ser Leu Phe Gly Leu Met Met Val Tyr Leu Ser Phe Ser Val Pro Tyr 65 70 75 80 Ala Val Trp Leu Leu Val Gly Phe Phe Gin Thr Val Pro He Gly He 85 90 95 Glu Glu Ala Ala Arg He Asp Gly Ala Asn Lys Phe Val Thr Phe Tyr 100 105 110 Lys Val Val Leu Pro He Val Ala Pro Gly He Val Ala Thr Ala He 115 120 125 Tyr Thr Phe He Asn Ala Trp Asn Glu Phe Leu Tyr Ala Leu He Leu 130 135 140 He Asn Asn Thr Gly Lys Met Thr Val Ala Val Ala Leu Arg Ser Leu 145 150 155 160 Asn Gly Ser Glu He Leu Asp Trp Gly Asp Met Met Ala Ala Ser Val 165 170 175 He Val Val Leu Pro Ser He He 180 (2) INFORMATION FOR SEQ ID NO: 135: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 155 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 135: Asp Glu Leu Ala Asp Leu Met Met Val Ala Ser Lys Glu Val Glu Asp 1 5 10 15 Ala He He Arg Leu Gly Gin Lys Ala Arg Ala Ala Gly He His Met 20 25 30 He Leu Ala Thr Gin Arg Pro Ser Val Asp Val He Ser Gly Leu He 35 40 45 Lys Ala Asn Val Pro Ser Arg Val Ala Phe Ala Val Ser Ser Gly Thr 50 55 60 Asp Ser Arg Thr He Leu Asp Glu Asn Gly Ala Glu Lys Leu Leu Gly 65 70 75 80 Arg Gly Asp Met Leu Phe Lys Pro He Asp Glu Asn His Pro Val Arg 85 90 95 Leu Gin Gly Ser Phe He Ser Asp Asp Asp Val Glu Arg He Val Asn 100 105 110 Phe He Lys Thr Gin Ala Asp Ala Asp Tyr Asp Glu Ser Phe Asp Pro 115 120 125 Gly Glu Val Ser Glu Asn Glu Gly Glu Phe Ser Asp Gly Asp Ala Gly 130 135 140 Gly Asp Pro Leu Phe Glu Glu Ala Lys Ser Leu 145 150 155 (2) INFORMATION FOR SEQ ID NO: 136: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 154 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 136: Met Thr Glu Asn Thr Pro Lys Ala Leu Val Gin Val Asn Gin Lys Pro 1 5 10 15 Leu He Glu Tyr Gin He Glu Phe Leu Lys Glu Lys Gly He Asn Asp 20 25 30 Ile He He He Val Gly Tyr Leu Lys Glu Gin Phe Asp Tyr Leu Lys 35 40 45 Glu Lys Tyr Gly Val Arg Leu Val Phe Asn Asp Lys Tyr Ala Asp Tyr 50 55 60 Asn Asn Phe Tyr Ser Leu Tyr Leu Val Lys Glu Glu Leu Ala Asn Ser 65 70 75 80 Tyr Val He Asp Ala Asp Asn Tyr Leu Phe Lys Asn Met Phe Arg Asn 85 90 95 Asp Leu Thr Arg Ser Thr Tyr Phe Ser Val Tyr Arg Glu Asp Cys Thr 100 105 110 Asn Glu Trp Phe Leu Val Tyr Gly Asp Asp Tyr Lys Val Gin Asp He 115 120 125 He Val Asp Ser Lys Ala Gly Arg He Leu Ser Gly Val Ser Phe Trp 130 135 140 Asp Ala Pro Thr Ala Glu Lys He Val Ser 145 150 (2) INFORMATION FOR SEQ ID NO: 137: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 286 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 137: Met Ser Asp Asn Ser Lys Thr Arg Val Val Val Gly Met Ser Gly Gly 1 5 10 15 Val Asp Ser Ser Val Thr Ala Leu Leu Leu Lys Glu Gin Gly Tyr Asp 20 25 30 Val He Gly He Phe Met Lys Asn Trp Asp Asp Thr Asp Glu Asn Gly 35 40 45 Val Cys Thr Ala Thr Glu Asp Tyr Lys Asp Val Val Ala Val Ala Asp 50 55 60 Gin He Gly He Pro Tyr Tyr Ser Val Asn Phe Glu Lys Glu Tyr Trp 65 70 75 80 Asp Arg Val Phe Glu Tyr Phe Leu Ala Glu Tyr Arg Ala Gly Arg Thr 85 90 95 Pro Asn Pro Asp Val Met Cys Asn Lys Glu He Lys Phe Lys Ala Phe 100 105 110 Leu Asp Tyr Ala Met Thr Leu Gly Ala Asp Tyr Val Ala Thr Gly His 115 120 125 Tyr Ala Arg Val Ala Arg Asp Glu Asp Gly Thr Val His Met Leu Arg 130 135 140 Gly Val Asp Asn Gly Lys Asp Gin Thr Tyr Phe Leu Ser Gin Leu Ser 145 150 155 160 Gin Glu Gin Leu Gin Lys Thr Met Phe Pro Leu Gly His Leu Lys Lys 165 170 175 Pro Glu Val Arg Lys Leu Ala Glu Glu Ala Gly Leu Ser Thr Ala Lys 180 185 190 Lys Lys Asp Ser Thr Gly He Cys Phe He Gly Glu Lys Asn Phe Lys 195 200 205 Asn Phe Leu Ser Asn Tyr Leu Pro Ala Gin Pro Gly Arg Met Met Thr 210 215 220 Val Asp Gly Arg Asp Met Gly Glu His Ala Gly Leu Met Tyr Tyr Thr 225 230 235 240 He Gly Gin Arg Gly Gly Leu Gly He Gly Gly Gin His Gly Gly Asp 245 250 255 Asn Ala Pro Trp Phe Val Val Gly Lys Asp Leu Ser Lys Asn He Leu 260 265 270 Tyr Val Gly Gin Gly Phe Tyr His Asp Ser Leu Met Ser Thr 275 280 285 (2) INFORMATION FOR SEQ ID NO: 138: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 648 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 138: Met Glu Val Phe Glu Ser Leu Lys Ala Asn Leu Val Gly Lys Asn Ala 1 5 10 15 Arg He Val Leu Pro Glu Gly Glu Glu Pro Arg He Leu Gin Ala Thr 20 25 30 Lys Arg Leu Val Lys Glu Thr Glu Val He Pro Val Leu Leu Gly Asn 35 40 45 Pro Glu Lys He Lys He Tyr Leu Glu He Glu Gly He Met Asp Gly 50 55 60 Tyr Glu Val He Asp Pro Gin His Tyr Pro Gin Phe Glu Glu Met Val 65 70 75 80 Ser Ala Leu Val Glu Arg Arg Lys Gly Lys Met Thr Glu Glu Asp Val 85 90 95 Arg Lys Val Leu Val Glu Asp Val Asn Tyr Phe Gly Val Met Leu Val 100 105 110 Tyr Leu Gly Leu Val Asp Gly Met Val Ser Gly Ala He His Ser Thr 115 120 125 Ala Ser Thr Val Arg Pro Ala Leu Gin He He Lys Thr Arg Pro Asn 130 135 140 Val Thr Arg Thr Ser Gly Ala Phe Leu Met Val Arg Gly Thr Glu Arg 145 150 155 160 Tyr Leu Phe Gly Asp Cys Ala He Asn He Asn Pro Asp Ala Glu Ala 165 170 175 Leu Ala Glu He Ala He Asn Ser Ala He Thr Ala Lys Met Phe Gly 180 185 190 He Glu Pro Lys He Ala Met Leu Ser Tyr Ser Thr Lys Gly Ser Gly 195 200 205 Phe Gly Glu Ser Val Asp Lys Val Val Glu Ala Thr Lys He Ala His 210 215 220 Asp Leu Arg Pro Asp Leu Glu He Asp Gly Glu Leu Gin Phe Asp Ala 225 230 235 240 Ala Phe Val Pro Glu Thr Ala Ala Leu Lys Ala Pro Gly Ser Thr Val 245 250 255 Ala Gly Gin Ala Asn Val Phe He Phe Pro Gly He Glu Ala Gly Asn 260 265 270 He Gly Tyr Lys Met Ala Glu Arg Leu Gly Gly Phe Ala Ala Val Gly 275 280 285 Pro Val Leu Gin Gly Leu Asn Lys Pro Val Asn Asp Leu Ser Arg Gly 290 295 300 Cys Asn Ala Asp Asp Val Tyr Lys Leu Thr Leu He Thr Ala Ala Gin 305 310 315 320 Ala Val His Gin Met Glu Val Phe Glu Ser Leu Lys Ala Asn Leu Val 325 330 335 Gly Lys Asn Ala Arg He Val Leu Pro Glu Gly Glu Glu Pro Arg He 340 345 350 Leu Gin Ala Thr Lys Arg Leu Val Lys Glu Thr Glu Val He Pro Val 355 360 365 Leu Leu Gly Asn Pro Glu Lys He Lys He Tyr Leu Glu He Glu Gly 370 375 380 He Met Asp Gly Tyr Glu Val He Asp Pro Gin His Tyr Pro Gin Phe 385 390 395 400 Glu Glu Met Val Ser Ala Leu Val Glu Arg Arg Lys Gly Lys Met Thr 405 410 415 Glu Glu Asp Val Arg Lys Val Leu Val Glu Asp Val Asn Tyr Phe Gly 420 425 430 Val Met Leu Val Tyr Leu Gly Leu Val Asp Gly Met Val Ser Gly Ala 435 440 445 He His Ser Thr Ala Ser Thr Val Arg Pro Ala Leu Gin He He Lys 450 455 460 Thr Arg Pro Asn Val Thr Arg Thr Ser Gly Ala Phe Leu Met Val Arg 465 470 475 480 Gly Thr Glu Arg Tyr Leu Phe Gly Asp Cys Ala He Asn He Asn Pro 485 490 495 Asp Ala Glu Ala Leu Ala Glu He Ala He Asn Ser Ala He Thr Ala 500 505 510 Lys Met Phe Gly He Glu Pro Lys He Ala Met Leu Ser Tyr Ser Thr 515 520 525 Lys Gly Ser Gly Phe Gly Glu Ser Val Asp Lys Val Val Glu Ala Thr 530 535 540 Lys He Ala His Asp Leu Arg Pro Asp Leu Glu He Asp Gly Glu Leu 545 550 555 560 Gin Phe Asp Ala Ala Phe Val Pro Glu Thr Ala Ala Leu Lys Ala Pro 565 570 575 Gly Ser Thr Val Ala Gly Gin Ala Asn Val Phe He Phe Pro Gly He 580 585 590 Glu Ala Gly Asn He Gly Tyr Lys Met Ala Glu Arg Leu Gly Gly Phe 595 600 605 Ala Ala Val Gly Pro Val Leu Gin Gly Leu Asn Lys Pro Val Asn Asp 610 615 620 Leu Ser Arg Gly Cys Asn Ala Asp Asp Val Tyr Lys Leu Thr Leu He 625 630 635 640 Thr Ala Ala Gin Ala Val His Gin 645 (2) INFORMATION FOR SEQ ID NO: 139: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 135 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 139: Met Arg Asn Leu Lys Ser He Leu Arg Arg His He Ser Leu Leu Gly 1 5 10 15 Phe Leu Gly Val Leu Ser He Trp Gin Leu Ala Gly Phe Leu Lys Leu 20 25 30 Leu Pro Lys Phe He Leu Pro Thr Pro Leu Glu He Leu Gin Pro Phe 35 40 45 Val Arg Asp Arg Glu Phe Leu Trp His His Ser Trp Ala Thr Leu Arg 50 55 60 Val Ala Leu Leu Gly Leu He Leu Gly Val Leu He Ala Cys Leu Met 65 70 75 80 Ala Val Leu Met Asp Ser Leu Thr Trp Leu Asn Asp Leu He Tyr Pro 85 90 95 Met Met Val Val He Gin Thr He Pro Thr He Ala He Ala Pro He 100 105 110 Leu Val Leu Trp Leu Gly Tyr Gly He Phe Ala Gin Asp Cys Leu Asp 115 120 125 Tyr Leu Asn Asn Asn Leu Ser 130 135 (2) INFORMATION FOR SEQ ID NO: 140: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 279 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 140: Pro Trp Ser Leu Val Asp Glu Tyr Glu Gin Leu Tyr Ala Thr He Gly 1 5 10 15 Trp His Pro Thr Glu Ala Gly Thr Tyr Thr Glu Glu Val Glu Ala Tyr 20 25 30 Leu Leu Asp Lys Leu Lys His Ser Lys Val Val Ala Leu Gly Glu He 35 40 45 Gly Leu Asp Tyr His Trp Met Thr Ala Pro Glu Val Gin Glu Gin Val 50 55 60 Phe Arg Arg Gin He Gin Leu Ser Lys Asp Leu Asp Leu Pro Phe Val 65 70 75 80 Val His Thr Arg Asp Ala Leu Glu Asp Thr Tyr Glu He He Lys Ser 85 90 95 Glu Gly Val Gly Pro Arg Gly Gly He Met His Ser Phe Ser Gly Thr 100 105 110 Leu Glu Trp Ala Arg Tyr Arg Asp Leu Gly Met Thr He Ser Phe Ser 115 120 125 Gly Val Val Thr Phe Lys Lys Ala Thr Asp Leu Gin Glu Ala Ala Lys 130 135 140 Glu Leu Pro Leu Asp Lys Met Leu Val Glu Thr Asp Ala Pro Tyr Leu 145 150 155 160 Ala Pro Val Pro Lys Arg Gly Arg Glu Asn Lys Thr Ala Tyr Thr Arg 165 170 175 Tyr Val Val Asp Phe He Ala Asp Leu Arg Gly Met Thr Thr Glu Glu 180 185 190 Leu Ala Val Ala Thr Thr Ala Asn Ala Glu Arg He Phe Gly He Gly 195 200 205 Gin Gin Val Met Lys Glu Arg He Ser Gin Val He Val Val Glu Gly 210 215 220 Arg Asp Asp Thr Val Asn Leu Lys Arg Tyr Phe Asp Val Glu Thr Tyr 225 230 235 240 Glu Thr Arg Gly Ser Ala He Asn Asp Gin Asp He Glu Arg He Gin 245 250 255 Arg Leu His Gin Arg His Gly Val He Val Phe Thr Asp Pro Asp Phe 260 265 270 Asn Gly Asp Gly Phe Gly Ala 275 (2) INFORMATION FOR SEQ ID NO: 141: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 147 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 141: Met Lys He He He Gin Arg Val Lys Lys Ala Gin Val Ser He Glu 1 5 10 15 Gly Gin He Gin Gly Lys He Asn Gin Gly Leu Leu Leu Leu Val Gly 20 25 30 Val Gly Pro Glu Asp Gin Glu Glu Asp Leu Asp Tyr Ala Val Arg Lys 35 40 45 Leu Val Asn Met Arg He Phe Ser Asp Ala Glu Gly Lys Met Asn Leu 50 55 60 Ser Val Lys Asp He Glu Gly Glu He Leu Ser He Ser Gin Phe Thr 65 70 75 80 Leu Phe Ala Asp Thr Lys Lys Gly Asn Arg Pro Ala Phe Thr Gly Ala 85 90 95 Ala Lys Pro Asp Met Ala Ser Asp Phe Tyr Asp Ala Phe Asn Gin Lys 100 105 110 Leu Ala Gin Glu Val Pro Val Gin Thr Gly He Phe Gly Ala Asp Met 115 120 125 Gin Val Glu Leu Val Asn Asn Gly Pro Val Thr He He Leu Asp Thr 130 135 140 Lys Lys Arg 145 (2) INFORMATION FOR SEQ ID NO: 142: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 238 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 142: Met He Leu Ser Met Val Ser Thr Pro Leu Pro Ser Ser Pro Cys Lys 1 5 10 15 Tyr Arg Lys Gin Leu Tyr Leu Gin Glu Asp Leu Arg Gly Lys Asn Val 20 25 30 Glu Lys Val Lys Glu Leu Ala Thr Glu Lys Lys Val Ser He Ser Trp 35 40 45 Thr Ser Lys Lys Ser Leu Ser Glu Met Thr Glu Gly Ala Val His Gin 50 55 60 Gly Phe Val Leu Arg Val Ser Glu Phe Ala Tyr Ser Glu Leu Asp Tyr 65 70 75 80 He Leu Ala Lys Thr Arg Gin Glu Glu Asn Pro Leu Leu Leu He Leu 85 90 95 Asp Gly Leu Thr Asp Pro His Asn Leu Gly Ser He Leu Arg Thr Ala 100 105 110 Asp Ala Thr Asn Val Ser Gly Val He He Pro Lys His Arg Ala Val 115 120 125 Gly Val Thr Pro Val Val Ala Lys Thr Ala Thr Gly Ala He Glu His 130 135 140 Val Pro He Ala Arg Val Thr Asn Leu Ser Gin Thr Leu Asp Lys Leu 145 150 155 160 Lys Asp Glu Gly Phe Trp Thr Phe Gly Thr Asp Met Asn Gly Thr Pro 165 170 175 Cys His Lys Trp Asn Thr Lys Gly Lys He Ala Leu He He Gly Asn 180 185 190 Glu Gly Lys Gly He Ser Ser Asn He Lys Lys Gin Val Asp Glu Met 195 200 205 He Thr He Pro Met Asn Gly His Val Gin Ser Leu Asn Ala Ser Val 210 215 220 Ala Ala Ala He Leu Met Tyr Glu Val Phe Arg Asn Arg Leu 225 230 235 (2) INFORMATION FOR SEQ ID NO:143: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 345 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 143: Met Val Gin Gin Ala Ala Thr Val Ser Leu Met Val Leu Phe Leu Val 1 5 10 15 Pro Gin Leu Arg Asn Ala Tyr Gly Thr Ala Ala He Gly He He Cys 20 25 30 Gly Leu Tyr Trp Ala Val Ser Ser Asn Met Thr Val Glu Ala Thr Gin 35 40 45 Arg Leu Thr Gly Gly Gly Gly Phe Ala He Gly His Gin Gin Gin Phe 50 55 60 Ala He Trp Phe Val Asp Lys Val Ala Gly Arg Phe Gly Lys Lys Glu 65 70 75 80 Glu Ser Leu Asp Asn Leu Lys Leu Pro Lys Phe Leu Ser He Phe His 85 90 95 Asp Thr Val Val Ala Ser Ala Thr Leu Met Leu Val Phe Phe Gly Ala 100 105 110 He Leu Leu He Leu Gly Pro Asp He Met Ser Asn Lys Glu Val He 115 120 125 Thr Ser Gly Thr Leu Phe Asn Pro Ala Lys Gin Asp Phe Phe Met Tyr 130 135 140 He He Gin Thr Ala Phe Thr Phe Ser Val Tyr Leu Phe Val Leu Met 145 150 155 160 Gin Gly Val Arg Met Phe Val Ser Glu Leu Thr Asn Ala Phe Gin Gly 165 170 175 He Ser Asn Lys Leu Leu Pro Gly Ser Phe Pro Ala Val Asp Val Ala 180 185 190 Ala Ser Tyr Gly Phe Gly Ser Pro Asn Ala Val Leu Ser Gly Phe Thr 195 200 205 Phe Gly Leu He Gly Gin Leu He Thr He Val Leu Leu He Val Phe 210 215 220 Lys Asn Pro He Leu He He Thr Gly Phe Val Pro Val Phe Phe Asp 225 230 235 240 Asn Ala Ala He Ala Val Tyr Ala Asp Lys Arg Gly Gly Trp Lys Ala 245 250 255 Ala Val He Leu Ser Phe He Ser Gly Val Leu Gin Val Ala Leu Gly 260 265 270 Ala Leu Cys Val Ala Leu Leu Asp Leu Ala Ser Tyr Gly Gly Tyr His 275 280 285 Gly Asn He Asp Phe Glu Phe Pro Trp Leu Gly Phe Gly Tyr He Phe 290 295 300 Lys Tyr Leu Gly He Val Gly Tyr Val Leu Val Cys Leu Phe Leu Leu 305 310 315 320 Val He Pro Gin Leu Gin Phe Ala Lys Ala Lys Asp Lys Glu Lys Tyr 325 330 335 Tyr Asn Gly Glu Val Gin Glu Glu Ala 340 345 (2) INFORMATION FOR SEQ ID NO: 144: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 287 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 144: Met Val Arg Pro He Gly He Tyr Glu Lys Ala Thr Pro Thr His Phe 1 5 10 15 Thr Trp Leu Glu Arg Leu Asn Phe Ala Lys Glu Leu Gly Phe Asp Phe 20 25 30 Val Glu Met Ser He Asp Glu Arg Asp Glu Arg Leu Ala Arg Leu Asp 35 40 45 Trp Ser Lys Glu Glu Arg Leu Glu Val Val Lys Ala He Tyr Glu Thr 50 55 60 Gly Val Arg He Pro Ser He Cys Phe Ser Gly His Arg Arg Tyr Pro 65 70 75 80 Leu Gly Ser Lys Asp Pro Val Leu Glu Glu Lys Ser Leu Glu Leu Met 85 90 95 Lys Lys Cys He Glu Leu Ala Gin Asp Leu Gly Val Arg Thr He Gin 100 105 110 Leu Ala Gly Tyr Asp Val Tyr Tyr Glu Glu Lys Ser Pro Gin Thr Arg 115 120 125 Gin Arg Phe He Lys Asn Leu Arg Lys Ala Cys Asp Trp Ala Glu Glu 130 135 140 Ala Gin Val Val Leu Ala He Glu He Met Asp Asp Pro Phe He Asn 145 150 155 160 Ser He Glu Lys Tyr Leu Ala He Glu Lys Glu He Asp Ser Pro Phe 165 170 175 Leu Phe Val Tyr Pro Asp He Gly Asn Val Ser Ala Trp His Asn Asp 180 185 190 He Tyr Ser Glu Phe Tyr Leu Gly His His Ala He Ala Ala Leu His 195 200 205 Leu Lys Asp Thr Tyr Ala Val Thr Glu Ser Ser Lys Gly Gin Phe Arg 210 215 220 Asp Val Pro Phe Gly Gin Gly Cys Val Lys Trp Glu Glu Ala Phe Asp 225 230 235 240 He Leu Lys Glu Thr Asn Tyr Asn Gly Pro Phe Leu He Glu Met Trp 245 250 255 Ser Glu Asn Cys Glu Thr Val Glu Glu Thr Arg Ala Ala Val Gin Glu 260 265 270 Ala Gin Ala Phe Leu Tyr Pro Leu He Lys Lys Ala Gly Leu Met 275 280 285 (2) INFORMATION FOR SEQ ID NO: 145: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 221 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 145: Met Thr Lys Arg He Pro Asn Leu Gin Val Ala Leu Asp His Ser Asp 1 5 10 15 Leu Gin Gly Ala He Lys Ala Ala Val Ser Val Gly Gin Glu Val Asp 20 25 30 He He Glu Ala Gly Thr Val Cys Leu Leu Gin Val Gly Ser Glu Leu 35 40 45 Ala Glu Val Leu Arg Ser Leu Phe Pro Asp Lys He He Val Ala Asp 50 55 60 Thr Lys Cys Ala Asp Ala Gly Gly Thr Val Ala Lys Asn Asn Ala Val 65 70 75 80 Arg Gly Ala Asp Trp Met Thr Cys He Cys Cys Ala Thr He Pro Thr 85 90 95 Met Glu Ala Ala Leu Lys Ala He Lys Thr Glu Arg Gly Glu Arg Gly 100 105 110 Glu He Gin He Glu Leu Tyr Gly Asp Trp Thr Phe Glu Gin Ala Gin 115 120 125 Leu Trp Leu Asp Ala Gly He Ser Gin Ala He Tyr His Gin Ser Arg 130 135 140 Asp Ala Leu Leu Ala Gly Glu Thr Trp Gly Glu Lys Asp Leu Asn Lys 145 150 155 160 Val Lys Lys Leu He Asp Met Gly Phe Arg Val Ser Val Thr Gly Gly 165 170 175 Leu Asp Val Asp Thr Leu Lys Leu Phe Glu Gly Val Asp Val Phe Thr 180 185 190 Phe He Ala Gly Arg Gly He Thr Glu Ala Ala Asp Pro Ala Gly Ala 195 200 205 Ala Arg Ala Phe Lys Asp Glu He Lys Arg He Trp Gly 210 215 220 (2) INFORMATION FOR SEQ ID NO: 146: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 161 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 146: Met Asn Leu Lys Gin Ala Leu He Asp Asn Asp Ser He Arg Leu Gly 1 5 10 15 Leu Glu Ala Asn Asn Trp Lys Glu Ala Val Lys Val Ala Val Asp Pro 20 25 30 Leu He Glu Ser Gly Ala He Leu Pro Glu Tyr Tyr Asp Ala He He 35 40 45 Glu Ser Thr Glu Glu Tyr Gly Pro Tyr Tyr He Leu Met Pro Gly Met 50 55 60 Ala Met Pro His Ala Arg Pro Glu Ala Gly Val Gin Ser Asp Ala Phe 65 70 75 80 Ser Leu He Thr Leu Gin Asn Pro Val Val Phe Ser Asp Gly Lys Glu 85 90 95 Val Ser Val Leu Leu Ala Leu Ala Ala Thr Ser Ser Lys He His Thr 100 105 110 Ser Val Ala He Pro Gin He He Ala Leu Phe Glu Leu Glu Asp Ser 115 120 125 He Ala Arg Leu Gin Ala Cys Gin Thr Lys Glu Asp Val Leu Ala Met 130 135 140 He Glu Glu Ser Lys Asp Ser Pro Tyr Leu Glu Gly Leu Asp Leu Glu 145 150 155 160 Ser (2) INFORMATION FOR SEQ ID NO: 147: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 293 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 147: Met Ser Arg Asp He He Lys Leu Asp Gin He Asp Val Thr Phe His 1 5 10 15 Gin Lys Lys Arg Thr He Thr Ala Val Lys Asp Val Thr He His He 20 25 30 Gin Glu Gly Asp He Tyr Gly He Val Gly Tyr Ser Gly Ala Gly Lys 35 40 45 Ser Thr Leu Val Arg Val He Asn Leu Leu Gin Lys Pro Ser Ala Gly 50 55 60 Lys He Thr He Asp Asp Asp Val He Phe Asp Gly Lys Val Thr Leu 65 70 75 80 Thr Ala Glu Gin Leu Arg Arg Lys Arg Gin Asp He Gly Met He Phe 85 90 95 Gin His Phe Asn Leu Met Ser Gin Lys Thr Ala Glu Glu Asn Val Ala 100 105 110 Phe Ala Leu Lys His Ser Gly Leu Ser Lys Glu Glu Lys Lys Ala Lys 115 120 125 Val Ala Lys Leu Leu Asp Leu Val Gly Leu Ala Asp Arg Ala Glu Asn 130 135 140 Tyr Pro Ser Gin Leu Ser Gly Gly Gin Lys Gin Arg Val Ala He Ala 145 150 155 160 Arg Ala Leu Ala Asn Asp Pro Lys He Leu He Ser Asp Glu Ser Thr 165 170 175 Ser Ala Leu Asp Pro Lys Thr Thr Lys Gin He Leu Ala Leu Leu Gin 180 185 190 Asp Leu Asn Gin Lys Leu Gly Leu Thr Val Val Leu He Thr His Glu 195 200 205 Met Gin He Val Lys Asp He Ala Asn Arg Val Ala Val Met Gin Asp 210 215 220 Gly His Leu He Glu Glu Gly Ser Val Leu Glu He Phe Ser Asn Pro 225 230 235 240 Lys Gin Pro Leu Thr Gin Asp Phe He Ser Thr Ala Thr Gly He Asp 245 250 255 Glu Ala Met Val Lys He Glu Lys Gin Glu He Val Glu His Leu Ser 260 265 270 Glu Asn Ser Leu Leu Val Gin Leu Gin Val Arg Trp Ser Phe Asn Arg 275 280 285 Arg Ala Thr Phe Glu 290 (2) INFORMATION FOR SEQ ID NO: 148: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 209 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 148: Arg Asp Val Asn Phe Glu He Glu Lys Gly Glu Leu Val He He Leu 1 5 10 15 Gly Ala Ser Gly Ala Gly Lys Ser Thr Val Leu Asn Leu Leu Gly Gly 20 25 30 Met Asp Thr Asn Asp Glu Gly Glu He Trp He Asp Gly Val Asn He 35 40 45 Ala Asp Tyr Ser Ser His Gin Arg Thr Asn Tyr Arg Arg Asn Asp Val 50 55 60 Gly Phe Val Phe Gin Phe Tyr Asn Leu Val Ser Asn Leu Thr Ala Lys 65 70 75 80 Glu Asn Val Glu Leu Ser Glu He Val Thr Asp Ala Leu Asn Ser Asp 85 90 95 Gin Val Leu Thr Asp Val Gly Leu Ala His Arg Leu Asn Asn Phe Pro 100 105 110 Ala Gin Leu Ser Gly Gly Glu Gin Gin Arg Val Ser He Ala Arg Ala 115 120 125 Val Ala Lys Asn Pro Lys He Leu Leu Cys Asp Glu Pro Thr Gly Ala 130 135 140 Leu Asp Tyr Gin Thr Gly Lys Gin Val Leu Lys He Leu Gin Asp Met 145 150 155 160 Ser Arg Gin Lys Gly Ala Thr Val He He Val Thr His Asn Gly Ala 165 170 175 Leu Ala Pro He Ala Asp Arg Val He Gin Met His Asp Ala Ser Val 180 185 190 Lys Asp Val Val Leu Asn Gin His Pro Gin Asp He Asp Ser Leu Glu 195 200 205 Tyr (2) INFORMATION FOR SEQ ID NO: 149: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 213 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO ( iv) ANTI-SENSE : NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 149: Met He Glu Leu Lys Asn He Thr Lys Thr He Gly Gly Lys Val He 1 5 10 15 Leu Asp Asn Leu Ser Leu Arg He Asp Gin Gly Asp Leu Val Ala He 20 25 30 Val Gly Lys Ser Gly Ser Gly Lys Ser Thr Leu Leu Asn Leu Leu Gly 35 40 45 Leu He Asp Gly Asp Tyr Ser Gly Arg Tyr Glu He Phe Gly Gin Thr 50 55 60 Asn Leu Ala Val Asn Ser Ala Lys Ser Gin Thr He He Arg Glu His 65 70 75 80 He Ser Tyr Leu Phe Gin Asn Phe Ala Leu He Asp Asp Glu Thr Val 85 90 95 Glu Tyr Asn Leu Met Leu Ala Leu Lys Tyr Val Lys Leu Pro Lys Lys 100 105 110 Asp Lys Leu Lys Lys Val Glu Glu He Leu Glu Arg Val Gly Leu Ser 115 120 125 Ala Thr Leu His Gin Arg Val Ser Glu Leu Ser Gly Gly Glu Gin Gin 130 135 140 Arg He Ala Val Ala Arg Ala He Leu Lys Pro Ser Gin Leu He Leu 145 150 155 160 Ala Asp Glu Pro Thr Gly Ser Leu Asp Pro Glu Asn Arg Asp Leu Val 165 170 175 Leu Lys Phe Leu Leu Glu Met Asn Arg Glu Gly Lys Thr Val He He 180 185 190 Val Thr His Asp Ala Tyr Val Ala Gin Gin Cys His Arg Val He Glu 195 200 205 Leu Gly Glu Gly Lys 210 (2) INFORMATION FOR SEQ ID NO: 150: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 84 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 150: Ala Lys Pro Lys Gin Leu Ser Gly Gly Gin Lys Gin Arg Val Ala He 1 5 10 15 Ala Arg Ala Leu Ser Met Asn Pro Asp Ala He Leu Phe Asp Glu Pro 20 25 30 Thr Ser Ala Leu Asp Pro Glu Met Val Gly Glu Val Leu Lys He Met 35 40 45 Gin Asp Leu Ala Gin Glu Gly Leu Thr Met He Val Val Thr His Glu 50 55 60 Met Glu Phe Ala Arg Asp Val Ser His Arg Val He Phe Met Asp Lys 65 70 75 80 Gly Val He Pro (2) INFORMATION FOR SEQ ID NO: 151: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 118 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 151: Tyr Tyr Gly Asp Tyr His Ala Leu Arg Asn He Asn Leu Arg Phe Glu 1 5 10 15 Lys Gly Gin Val Val Val Leu Leu Gly Pro Ser Gly Ser Gly Lys Ser 20 25 30 Thr Leu He Arg Thr He Asn Gly Leu Glu Ala Val Asp Lys Gly Ser 35 40 45 Leu Leu Val Asn Gly His Gin Val Ala Gly Ala Ser Gin Lys Asp Leu 50 55 60 Val Pro Leu Arg Lys Glu Val Gly Met Val Phe Gin His Phe Asn Leu 65 70 75 80 Tyr Pro His Lys Thr Val Leu Glu Asn Val Thr Leu Ala Pro He Lys 85 90 95 Val Leu Gly He Asp Lys Lys Glu Ala Glu Lys Thr Ala Gin Lys Tyr 100 105 110 Leu Glu Phe Val Asn Met 115 (2) INFORMATION FOR SEQ ID NO: 152: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 237 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 152: Met Thr Lys Lys Gin Leu His Leu Val He Val Thr Gly Met Gly Gly 1 5 10 15 Ala Gly Lys Thr Val Ala He Gin Ser Phe Glu Asp Leu Gly Tyr Phe 20 25 30 Thr He Asp Asn Met Pro Pro Ala Leu Leu Pro Lys Phe Leu Gin Leu 35 40 45 Val Glu He Lys Glu Asp Asn Pro Lys Leu Ala Leu Val Val Asp Met 50 55 60 Arg Ser Arg Ser Phe Phe Ser Glu He Gin Ala Val Leu Asp Glu Leu 65 70 75 80 Glu Asn Gin Asp Gly Leu Asp Phe Lys He Leu Phe Leu Asp Ala Ala 85 90 95 Asp Lys Glu Leu Val Ala Arg Tyr Lys Glu Thr Arg Arg Ser His Pro 100 105 110 Leu Ala Ala Asp Gly Arg He Leu Asp Gly He Lys Leu Glu Arg Glu 115 120 125 Leu Leu Ala Pro Leu Lys Asn Met Ser Gin Asn Val Val Asp Thr Thr 130 135 140 Glu Leu Thr Pro Arg Glu Leu Arg Lys Thr Leu Ala Glu Gin Phe Ser 145 150 155 160 Asp Gin Glu Gin Ala Gin Ser Phe Arg He Glu Val Met Ser Phe Gly 165 170 175 Phe Lys Tyr Gly He Pro He Asp Ala Asp Leu Val Phe Asp Val Arg 180 185 190 Phe Leu Pro Asn Pro Tyr Tyr Leu Pro Glu Leu Arg Asn Gin Thr Gly 195 200 205 Val Asp Glu Pro Val Tyr Asp Tyr Val Met Asn His Pro Glu Ser Glu 210 215 220 Asp Phe Tyr Gin His Leu Leu Ala Leu He Glu Pro He 225 230 235 (2) INFORMATION FOR SEQ ID NO: 153: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 180 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 153: Met Leu Glu Asn Asp He Lys Lys Val Leu Val Ser His Asp Glu He 1 5 10 15 Thr Glu Ala Ala Lys Lys Leu Gly Ala Gin Leu Thr Lys Asp Tyr Ala 20 25 30 Gly Lys Asn Pro He Leu Val Gly He Leu Lys Gly Ser He Pro Phe 35 40 45 Met Ala Glu Leu Val Lys His He Asp Thr His He Glu Met Asp Phe 50 55 60 Met Met Val Ser Ser Tyr His Gly Gly Thr Ala Ser Ser Gly Val He 65 70 75 80 Asn He Lys Gin Asp Val Thr Gin Asp He Lys Gly Arg His Val Leu 85 90 95 Phe Val Glu Asp He He Asp Thr Gly Gin Thr Leu Lys Asn Leu Arg 100 105 110 Asp Met Phe Lys Glu Arg Glu Ala Ala Ser Val Lys He Ala Thr Leu 115 120 125 Leu Asp Lys Pro Glu Gly Arg Val Val Glu He Glu Ala Asp Tyr Thr 130 135 140 Cys Phe Thr He Pro Asn Glu Phe Val Val Gly Tyr Gly Leu Asp Tyr 145 150 155 160 Lys Glu Asn Tyr Arg Asn Leu Pro Tyr He Gly Val Leu Lys Glu Glu 165 170 175 Val Tyr Ser Asn 180 (2) INFORMATION FOR SEQ ID NO: 154: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 193 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 154: Met Lys He Gly He Leu Ala Leu Gin Gly Ala Phe Ala Glu His Ala 1 5 10 15 Lys Val Leu Asp Gin Leu Gly Val Glu Ser Val Glu Leu Arg Asn Leu 20 25 30 Asp Asp Phe Gin Gin Asp Gin Ser Asp Leu Ser Gly Leu He Leu Pro 35 40 45 Gly Gly Glu Ser Thr Thr Met Gly Lys Leu Leu Arg Asp Gin Asn Met 50 55 60 Leu Leu Pro He Arg Glu Ala He Leu Ser Gly Leu Pro Val Phe Gly 65 70 75 80 Thr Cys Ala Gly Leu He Leu Leu Ala Lys Glu He Thr Ser Gin Lys 85 90 95 Glu Ser His Leu Gly Thr Met Asp Met Val Val Glu Arg Asn Ala Tyr 100 105 110 Gly Arg Gin Leu Gly Ser Phe Tyr Thr Glu Ala Glu Cys Lys Gly Val 115 120 125 Gly Lys He Pro Met Thr Phe He Arg Gly Pro He He Ser Ser Val 130 135 140 Gly Glu Gly Val Glu He Leu Ala He Val Asn Asn Gin He Val Ala 145 150 155 160 Ala Gin Glu Lys Asn Met Leu Val Ser Ser Phe His Pro Glu Leu Thr 165 170 175 Asp Asp Val Arg Leu His Gin Tyr Phe He Asn Met Cys Lys Glu Lys 180 185 190 Ser (2) INFORMATION FOR SEQ ID NO: 155: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 189 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 155: Glu Ser Glu Val Leu Ser Pro Ala Asp Asp Arg Phe His Val Asp Lys 1 5 10 15 Lys Glu Phe Gin Val Pro Phe Val Cys Gly Ala Lys Asp Leu Gly Glu 20 25 30 Ala Leu Arg Arg He Ala Glu Gly Ala Ser Met He Arg Thr Lys Gly 35 40 45 Glu Pro Gly Thr Gly Asp He Val Gin Ala Val Arg His Met Arg Met 50 55 60 Met Asn Gin Glu He Arg Arg He Gin Asn Leu Arg Glu Asp Glu Leu 65 70 75 80 Tyr Val Ala Ala Lys Asp Leu Gin Val Pro Val Glu Leu Val Gin Tyr 85 90 95 Val His Glu His Gly Lys Leu Pro Val Val Asn Phe Ala Ala Gly Gly 100 105 110 Val Ala Thr Pro Ala Asp Ala Ala Leu Met Met Gin Leu Gly Ala Glu 115 120 125 Gly Val Phe Val Gly Ser Gly He Phe Lys Ser Gly Asp Pro Val Lys 130 135 140 Arg Ala Ser Ala He Val Lys Ala Val Thr Asn Phe Arg Asn Pro Gin 145 150 155 160 He Leu Ala Gin He Ser Glu Asp Leu Gly Glu Ala Met Val Gly He 165 170 175 Asn Glu Asn He Gin He Leu Met Ala Glu Arg Gly Lys 180 185 (2) INFORMATION FOR SEQ ID NO: 156: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 162 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 156: Asp Lys Gly Trp Phe Val Leu Gin Thr Tyr Ser Gly Tyr Glu Asn Lys 1 5 10 15 Val Lys Glu Asn Leu Leu Gin Arg Ala Gin Thr Tyr Asn Met Leu Asp 20 25 30 Asn He Leu Arg Val Glu He Pro Thr Gin Thr Val Gin Val Glu Lys 35 40 45 Asn Gly Lys Arg Lys Glu Val Glu Glu Asn Arg Phe Pro Gly Tyr Val 50 55 60 Leu Val Glu Met Val Met Thr Asp Glu Ala Trp Phe Val Val Arg Asn 65 70 75 80 Ala Gin Ser Pro Thr Lys Phe He Ser Glu Gin Thr Ala Tyr Glu He 85 90 95 Asp Glu Glu Val Arg Ser Leu Leu Asn Glu Ala Arg Asn Lys Ala Ala 100 105 110 Glu He He Gin Ser Asn Arg Glu Thr His Lys Leu He Ala Glu Ala 115 120 125 Leu Leu Lys Tyr Glu Thr Leu Asp Ser Thr Gin He Lys Ala Leu Tyr 130 135 140 Glu Thr Gly Lys Met Pro Glu Ser Ser Arg Arg Gly He Ser Cys Thr 145 150 155 160 He Leu (2) INFORMATION FOR SEQ ID NO: 157: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 208 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 157: Val Asn Ser Ser Ser Val Pro Gly Asp Arg Phe Ser Val Leu Leu Glu 1 5 10 15 His Lys Gly He His Pro He Val Tyr He Ser Lys Met Asp Leu Leu 20 25 30 Glu Asp Arg Gly Glu Leu Asp Phe Tyr Gin Gin Thr Tyr Gly Asp He 35 40 45 Gly Tyr Asp Phe Val Thr Ser Lys Glu Glu Leu Leu Ser Leu Leu Thr 50 55 60 Gly Lys Val Thr Val Phe Met Gly Gin Thr Gly Val Gly Lys Ser Thr 65 70 75 80 Leu Leu Asn Lys He Ala Pro Asp Leu Asn Leu Glu Thr Gly Glu He 85 90 95 Ser Asp Ser Leu Gly Arg Gly Arg His Thr Thr Arg Ala Val Ser Phe 100 105 110 Tyr Asn Leu Asn Gly Gly Lys He Ala Asp Thr Pro Gly Phe Ser Ser 115 120 125 Leu Asp Tyr Glu Val Ser Arg Ala Glu Asp Leu Asn Gin Ala Phe Pro 130 135 140 Glu He Ala Thr Val Ser Arg Asp Cys Lys Phe Arg Thr Cys Thr His 145 150 155 160 Thr His Glu Pro Ser Cys Ala Val Lys Pro Ala Val Glu Glu Gly Val 165 170 175 He Ala Thr Phe Arg Phe Asp Asn Tyr Leu Gin Phe Leu Ser Glu He 180 185 190 Glu Asn Arg Arg Glu Thr Tyr Lys Lys Val Ser Lys Lys He Pro Lys 195 200 205 (2) INFORMATION FOR SEQ ID NO: 158: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 403 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 158: Gin Gin Ser Val Lys Lys Lys Val Leu Pro Ala He Glu Arg Arg He 1 5 10 15 Arg Thr Glu Leu Thr Glu Lys Ala Glu Glu Gly Ala He Gin Leu Phe 20 25 30 Ser Asp Asn Leu Arg Asn Leu Leu Leu Val Ala Pro Leu Lys Gly Arg 35 40 45 Val Val Leu Gly Phe Asp Pro Ala Phe Arg Thr Gly Ala Lys Leu Ala 50 55 60 Val Val Asp Ala Thr Gly Lys Met Leu Thr Thr Gin Val He Tyr Pro 65 70 75 80 Val Lys Pro Ala Ser Ala Arg Gin He Glu Glu Ala Lys Lys Asp Leu 85 90 95 Ala Asp Leu He Gly Gin Tyr Gly Val Glu He He Ala He Gly Asn 100 105 110 Gly Thr Ala Ser Arg Glu Ser Glu Ala Phe Val Ala Glu Val Leu Lys 115 120 125 Asp Phe Pro Glu Val Ser Tyr Val He Val Asn Glu Ser Gly Ala Ser 130 135 140 Val Tyr Ser Ala Ser Glu Leu Ala Arg Gin Glu Phe Pro Asp Leu Thr 145 150 155 160 Val Glu Lys Arg Ser Ala He Ser He Ala Arg Arg Leu Gin Asp Pro 165 170 175 Leu Ala Glu Leu Val Lys He Asp Pro Lys Ser He Gly Val Gly Gin 180 185 190 Tyr Gin His Asp Val Ser Gin Lys Lys Leu Ser Glu Ser Leu Asp Phe 195 200 205 Val Val Asp Thr Val Val Asn Gin Val Gly Val Asn Val Asn Thr Ala 210 215 220 Ser Pro Ala Leu Leu Ser His Val Ala Gly Leu Asn Lys Thr He Ser 225 230 235 240 Glu Asn He Val Lys Tyr Arg Glu Glu Glu Gly Lys He Thr Ser Arg 245 250 255 Ala Gin He Lys Lys Val Pro Arg Leu Gly Ala Lys Ala Phe Glu Gin 260 265 270 Ala Ala Gly Phe Leu Arg He Pro Glu Ser Ser Asn He Leu Asp Asn 275 280 285 Thr Gly Val His Pro Glu Asn Tyr Thr Ala Val Lys Leu Phe Lys Arg 290 295 300 Leu Asp He Lys Asp Leu Asn Glu Glu Ala Ser Lys Leu Lys Ser Leu 305 310 315 320 Ser Val Lys Glu Met Ala Gin Glu Leu Asp Leu Gly Pro Glu Thr Leu 325 330 335 Lys Asp He He Ala Asp Leu Leu Lys Pro Gly Arg Asp Phe Arg Asp 340 345 350 Ser Phe Asp Ala Pro Val Leu Arg Gin Asp Val Leu Asp He Lys Asp 355 360 365 Leu Val Val Gly Gin Lys Leu Glu Gly Val Val Arg Asn Val Val Asp 370 375 380 Phe Gly Ala Phe Val Asp He Gly Val His Glu Asp Gly Leu He His 385 390 395 400 He Leu He (2) INFORMATION FOR SEQ ID NO: 159: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 179 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 159: Met Phe Arg Ala Ala Met Ala Asn Gin Thr Glu Met Gly Val Leu Ala 1 5 10 15 Lys Ser Tyr He Asp Lys Gly Glu Leu Val Pro Asp Glu Val Thr Asn 20 25 30 Gly He Val Lys Glu Arg Leu Ser Gin Asp Asp He Lys Glu Thr Gly 35 40 45 Phe Leu Leu Asp Gly Tyr Pro Arg Thr He Glu Gin Ala His Ala Leu 50 55 60 Asp Lys Thr Leu Ala Glu Leu Gly He Glu Leu Glu Gly He He Asn 65 70 75 80 He Glu Val Asn Pro Asp Ser Leu Leu Glu Arg Leu Ser Gly Arg He 85 90 95 Ile His Arg Val Thr Gly Glu Thr Phe His Lys Val Phe Asn Pro Pro 100 105 110 Val Asp Tyr Lys Glu Glu Asp Tyr Tyr Gin Arg Glu Asp Asp Lys Pro 115 120 125 Glu Thr Val Lys Arg Arg Leu Asp Val Asn He Ala Gin Gly Glu Pro 130 135 140 He He Ala His Tyr Arg Ala Lys Gly Leu Val His Asp He Glu Gly 145 150 155 160 Asn Gin Asp He Asn Asp Val Phe Ser Asp He Glu Lys Val Leu Thr 165 170 175 Asn Leu Lys (2) INFORMATION FOR SEQ ID NO: 160: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 191 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 160: Met He Glu Phe Glu Lys Pro Asn He Thr Lys He Asp Glu Asn Lys 1 5 10 15 Asp Tyr Gly Lys Phe Val He Glu Pro Leu Glu Arg Gly Tyr Gly Thr 20 25 30 Thr Leu Gly Asn Ser Leu Arg Arg Val Leu Leu Ala Ser Leu Pro Gly 35 40 45 Ala Ala Val Thr Ser He Asn He Asp Gly Val Leu His Glu Phe Asp 50 55 60 Thr Val Pro Gly Val Arg Glu Asp Val Met Gin He He Leu Asn He 65 70 75 80 Lys Gly He Ala Val Lys Ser Tyr Val Glu Asp Glu Lys He He Glu 85 90 95 Leu Asp Val Glu Gly Pro Ala Glu Val Thr Ala Gly Asp He Leu Thr 100 105 110 Asp Ser Asp He Glu He Val Asn Pro Asp His Tyr Leu Phe Thr He 115 120 125 Gly Glu Gly Ser Ser Leu Lys Ala Thr Met Thr Val Asn Ser Gly Arg 130 135 140 Gly Tyr Val Pro Ala Asp Glu Asn Lys Lys Asp Asn Ala Pro Val Gly 145 150 155 160 Thr Leu Ala Val Asp Ser He Tyr Thr Pro Val Thr Lys Val Asn Tyr 165 170 175 Gin Val Glu Pro Ala Arg Val Gly Ser Asn Asp Gly Phe Asp Ser 180 185 190 (2) INFORMATION FOR SEQ ID NO: 161: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 335 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 161: Glu Tyr Leu Gly Ala Thr Val Gin Val He Pro His He Thr Asp Ala 1 5 10 15 Leu Lys Glu Lys He Lys Ser Ala Ala Leu Thr Thr Asp Ser Asp Val 20 25 30 He He Thr Glu Val Gly Gly Thr Val Gly Asp He Glu Ser Leu Pro 35 40 45 Phe Leu Glu Ala Leu Arg Gin Met Lys Ala Asp Val Gly Ala Asp Asn 50 55 60 Val Met Tyr He His Thr Thr Leu Pro Tyr Leu Lys Ala Ala Gly Glu 65 70 75 80 Met Lys Lys Pro Thr Gin His Ser Val Lys Leu Arg Gly Leu Gly He 85 90 95 Gin Pro Asn Met Leu Val He Arg Thr Glu Glu Pro Ala Gly Gin Gly 100 105 110 He Lys Asn Lys Leu Ala Gin Phe Cys Asp Val Ala Pro Glu Ser Leu 115 120 125 He Glu Ser Leu Asp Val Glu His Leu Tyr Gin He Pro Leu Asn Leu 130 135 140 Gin Ala Gin Gly Met Asp Gin He Val Cys Asp His Leu Lys Leu Asp 145 150 155 160 Ala Pro Ala Ala Asp Met Thr Glu Trp Ser Ala Met Val Asp Lys Val 165 170 175 Met Asn Leu Lys Lys Gin Val Lys He Ser Leu Val Gly Lys Tyr Val 180 185 190 Glu Leu Gin Asp Ala Tyr He Ser Val Val Glu Ala Leu Lys His Ser 195 200 205 Gly Tyr Val Asn Asp Val Glu Val Lys He Asn Trp Val Asn Ala Asn 210 215 220 Asp Val Thr Ala Glu Asn Val Ala Glu Leu Leu Ser Asp Ala Asp Gly 225 230 235 240 He He Val Pro Gly Gly Phe Gly Gin Arg Gly Thr Glu Gly Lys He 245 250 255 Gin Ala He Arg Tyr Ala Arg Glu Asn Asp Val Pro Met Leu Gly Val 260 265 270 Cys Leu Gly Met Gin Leu Thr Cys He Glu Phe Ala Arg His Val Leu 275 280 285 Gly Leu Glu Gly Ala Asn Ser Ala Glu Leu Ala Pro Glu Thr Lys Tyr 290 295 300 Pro He He Asp He Met Arg Asp Gin He Asp He Glu Asp Met Gly 305 310 315 320 Gly Thr Leu Arg Leu Gly Leu Tyr Pro Ser Lys Leu Lys Arg Leu 325 330 335 (2) INFORMATION FOR SEQ ID NO: 162: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 301 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 162: Met Ser Glu Lys Leu Val Glu He Lys Asp Leu Glu He Ser Phe Gly 1 5 10 15 Glu Gly Ser Lys Lys Phe Val Ala Val Lys Asn Ala Asn Phe Phe He 20 25 30 Asn Lys Gly Glu Thr Phe Ser Leu Val Gly Glu Ser Gly Ser Gly Lys 35 40 45 Thr Thr He Gly Arg Ala He He Gly Leu Asn Asp Thr Ser Asn Gly 50 55 60 Asp He He Phe Asp Gly Gin Lys He Asn Gly Lys Lys Ser Arg Glu 65 70 75 80 Gin Ala Ala Glu Leu He Arg Arg He Gin Met He Phe Gin Asp Pro 85 90 95 Ala Ala Ser Leu Asn Glu Arg Ala Thr Val Asp Tyr He He Ser Glu 100 105 110 Gly Leu Tyr Asn His Arg Leu Phe Lys Asp Glu Glu Glu Arg Lys Glu 115 120 125 Lys Val Gin Ser He He Arg Glu Val Gly Leu Leu Ala Glu His Leu 130 135 140 Thr Arg Tyr Pro His Glu Phe Ser Gly Gly Gin Arg Gin Arg He Gly 145 150 155 160 He Ala Arg Ala Leu Val Met Gin Pro Asp Phe Val He Ala Asp Glu 165 170 175 Pro He Ser Ala Leu Asp Val Ser Val Arg Ala Gin Val Leu Asn Leu 180 185 190 Leu Lys Lys Phe Gin Lys Glu Leu Gly Leu Thr Tyr Leu Phe He Ala 195 200 205 His Asp Leu Ser Val Val Arg Phe He Ser Asp Arg He Ala Val He 210 215 220 Tyr Lys Gly Val He Val Glu Val Ala Glu Thr Glu Glu Leu Phe Asn 225 230 235 240 Asn Pro He His Pro Tyr Thr Gin Ala Leu Leu Ser Ala Val Pro He 245 250 255 Pro Asp Pro He Leu Glu Arg Lys Lys Val Leu Lys Val Tyr Asp Pro 260 265 270 Ser Gin His Asp Tyr Glu Thr Asp Lys Pro Ser Met Val Glu He Arg 275 280 285 Pro Gly His Tyr Val Trp Ala Asn Gin Ala Glu Leu Ala 290 295 300 (2) INFORMATION FOR SEQ ID NO: 163: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 151 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 163: Gin He Gin Lys Ser Phe Lys Gly Gin Ser Pro Tyr Gly Lys Leu Tyr 1 5 10 15 Leu Val Ala Thr Pro He Gly Asn Leu Asp Asp Met Thr Phe Arg Ala 20 25 30 He Gin Thr Leu Lys Glu Val Asp Trp He Ala Ala Glu Asp Thr Arg 35 40 45 Asn Thr Gly Leu Leu Leu Lys His Phe Asp He Ser Thr Lys Gin He 50 55 60 Ser Phe His Glu His Asn Ala Lys Glu Lys He Pro Asp Leu He Gly 65 70 75 80 Phe Leu Lys Ala Gly Gin Ser He Ala Gin Val Ser Asp Ala Gly Leu 85 90 95 Pro Ser He Ser Asp Pro Gly His Asp Leu Val Lys Ala Ala He Glu 100 105 110 Glu Glu He Ala Val Val Thr Val Pro Gly Ala Ser Ala Gly He Ser 115 120 125 Ala Leu He Ala Ser Gly Leu Ala Pro Gin Pro His He Phe Tyr Gly 130 135 140 Phe Leu Pro Arg Lys Ser Gly 145 150 (2) INFORMATION FOR SEQ ID NO: 164: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 258 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 164: Ser Arg Lys Asp Lys Gin Glu Arg He Ser Lys Glu Thr Met Glu He 1 5 10 15 Tyr Ala Pro Leu Ala His Arg Leu Gly He Ser Ser Val Lys Trp Glu 20 25 30 Leu Glu Asp Leu Ser Phe Arg Tyr Leu Asn Pro Thr Glu Phe Tyr Lys 35 40 45 Ile Thr His Met Met Lys Glu Lys Arg Arg Glu Arg Glu Ala Leu Val 50 55 60 Asp Glu Val Val Thr Lys Leu Glu Glu Tyr Thr Thr Glu Arg His Leu 65 70 75 80 Lys Gly Lys He Tyr Gly Arg Pro Lys His He Tyr Ser He Phe Arg 85 90 95 Lys Met Gin Asp Lys Arg Lys Arg Phe Glu Glu He Tyr Asp Leu He 100 105 110 Ala He Arg Cys He Leu Asp Thr Gin Ser Asp Val Tyr Ala Met Leu 115 120 125 Gly Tyr Val His Glu Phe Trp Lys Pro Met Pro Gly Arg Phe Lys Asp 130 135 140 Tyr He Ala Asn Arg Lys Ala Asn Gly Tyr Gin Ser He His Thr Thr 145 150 155 160 Val Tyr Gly Pro Lys Gly Pro He Glu Phe Gin He Arg Thr Lys Glu 165 170 175 Met His Glu Val Ala Glu Tyr Gly Val Ala Ala His Trp Ala Tyr Lys 180 185 190 Lys Gly He Lys Gly Gin Val Asn Ser Lys Glu Ser Ala He Gly Met 195 200 205 Asn Trp He Lys Glu Met Met Glu Leu Gin Asp Gin Ala Asp Asp Ala 210 215 220 Lys Glu Phe Val Asp Ser Val Lys Glu Asn Tyr Leu Ala Glu Glu He 225 230 235 240 Thr Val Leu Pro Gin Met Glu Leu Ser Val Pro Ser Gin Arg Phe Arg 245 250 255 Thr Asp (2) INFORMATION FOR SEQ ID NO: 165: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 289 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 165: Thr Lys Val Gly Gly Glu Ala Asp Tyr Leu Val Phe Pro Arg Asn Arg 1 5 10 15 Phe Glu Leu Ala Arg Val Val Lys Phe Ala Asn Gin Glu Asn He Pro 20 25 30 Trp Met Val Leu Gly Asn Ala Ser Asn He He Val Arg Asp Gly Gly 35 40 45 He Arg Gly Phe Val He Leu Cys Asp Lys Leu Asn Asn Val Ser Val 50 55 60 Asp Gly Tyr Thr He Glu Ala Glu Ala Gly Ala Asn Leu He Glu Thr 65 70 75 80 Thr Arg He Ala Leu Arg His Ser Leu Thr Gly Phe Glu Phe Ala Cys 85 90 95 Gly He Pro Gly Ser Val Gly Gly Ala Val Phe Met Asn Ala Gly Ala 100 105 110 Tyr Gly Gly Glu He Ala His He Leu Gin Ser Cys Lys Val Leu Thr 115 120 125 Lys Asp Gly Glu He Glu Thr Leu Ser Ala Lys Asp Leu Ala Phe Gly 130 135 140 Tyr Arg His Ser Ala He Gin Glu Ser Gly Ala Val Val Leu Ser Val 145 150 155 160 Lys Phe Ala Leu Ala Pro Gly Thr His Gin Val He Lys Gin Glu Met 165 170 175 Asp Arg Leu Thr His Leu Arg Glu Leu Lys Gin Pro Leu Glu Tyr Pro 180 185 190 Ser Cys Gly Ser Val Phe Lys Arg Pro Val Gly His Phe Ala Gly Gin 195 200 205 Leu He Ser Glu Ala Gly Leu Lys Gly Tyr Arg He Gly Gly Val Glu 210 215 220 Val Ser Glu Lys His Ala Gly Phe Met He Asn Val Ala Asp Gly Thr 225 230 235 240 Ala Lys Asp Tyr Glu Asp Leu He Gin Ser Val He Glu Lys Val Lys 245 250 255 Glu His Ser Gly He Thr Leu Glu Arg Glu Val Arg He Leu Gly Glu 260 265 270 Ser Leu Ser Val Ala Lys Met Tyr Ala Gly Gly Phe Thr Pro Cys Lys 275 280 285 Arg (2) INFORMATION FOR SEQ ID NO: 166: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 114 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 166: Ala Lys Arg Arg Lys Leu Val Lys Ser Thr Thr Leu Leu Leu Ala Cys 1 5 10 15 Leu Gin Lys Pro Phe Leu Thr Thr Leu Leu Pro Thr He Trp He Cys 20 25 30 Val Lys Ser Ser Met Phe Thr Leu Leu Arg Leu Asn Thr Trp He Lys 35 40 45 Asp Phe His Ser Pro Ser Ser Cys Val Val Thr Phe Gin Lys Ala Phe 50 55 60 Thr Asn Gly Arg Gly Lys He Asn Lys Arg His Val Thr Cys Pro Ser 65 70 75 80 Phe Val Thr Met Pro Leu Thr Arg Glu Ser Ser Leu Ser Thr Thr Ser 85 90 95 Val Pro Leu Gin Met Thr Val Glu Lys Ser Ala Pro Thr Asn Val Lys 100 105 110 Ala Val (2) INFORMATION FOR SEQ ID NO: 167: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 253 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 167: Met Leu Lys Gin Glu Lys Leu Ala Lys He Leu Glu He Val Asn Ser 1 5 10 15 Lys Gly Thr He Thr Val Lys Gin He Met Asp Glu He Ala Val Ser 20 25 30 Asp Met Thr Ala Arg Arg Tyr Leu Gin Glu Leu Ala Asp Lys Asp Leu 35 40 45 Leu He Arg Val His Gly Gly Ala Glu Lys Leu Arg Thr Asn Ser Leu 50 55 60 Leu Thr Asn Glu Arg Ser Asn He Glu Lys Gin Ala Leu Gin Thr Ala 65 70 75 80 Glu Lys Gin Glu He Ala His Phe Ala Gly Ser Leu Val Glu Glu Arg 85 90 95 Glu Thr He Phe He Gly Pro Gly Thr Thr Leu Glu Phe Phe Ala Arg 100 105 110 Glu Leu Pro He Asp Asn He Arg Val Val Thr Asn Ser Leu Pro Val 115 120 125 Phe Leu He Leu Ser Glu Arg Lys Leu Thr Asp Leu He Leu He Gly 130 135 140 Gly Asn Tyr Arg Asp He Thr Gly Ala Phe Val Gly Thr Leu Thr Leu 145 150 155 160 Gin Asn Leu Ser Asn Leu Gin Phe Ser Lys Ala Phe Val Ser Cys Asn 165 170 175 Gly He Gin Asn Gly Ala Leu Ala Thr Phe Ser Glu Glu Glu Gly Glu 180 185 190 Ala Gin Arg He Ala Leu Asn Asn Ser Asn Lys Lys Tyr Leu Leu Ala 195 200 205 Asp His Ser Lys Phe Asn Lys Phe Asp Phe Tyr Thr Phe Tyr Asn He 210 215 220 Ser Asn Leu Asp Thr He Val Ser Asp Ser Lys Leu Ser Asp Ser He 225 230 235 240 Leu Phe Lys Leu Ser Lys His He Lys Val He Lys Pro 245 , 250 (2) INFORMATION FOR SEQ ID NO: 168: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 320 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 168: Met Glu Thr Tyr Tyr Lys Ala He Asn Trp Asn Ala He Glu Asp Val 1 5 10 15 He Asp Lys Ser Thr Trp Glu Lys Leu Thr Glu Gin Phe Trp Leu Asp 20 25 30 Thr Arg He Pro Leu Ser Asn Asp Leu Asp Asp Trp Arg Lys Leu Ser 35 40 45 Asn Lys Glu Lys Asp Leu Val Gly Lys Val Phe Gly Gly Leu Thr Leu 50 55 60 Leu Asp Thr Met Gin Ser Glu Thr Gly Val Gin Ala Leu Arg Ala Asp 65 70 75 80 He Arg Thr Pro His Glu Glu Ala Val Phe Asn Asn He Gin Phe Met 85 90 95 Glu Ser Val His Ala Lys Ser Tyr Ser Ser He Phe Ser Thr Leu Asn 100 105 110 Thr Lys Ala Glu He Glu Glu He Phe Glu Trp Thr Asn Thr Asn Pro 115 120 125 Tyr Leu Gin Lys Lys Ala Glu He Val Asn Glu He Tyr Leu Asn Gly 130 135 140 Ser Pro Leu Glu Lys Lys Val Ala Ser Val Phe Leu Glu Thr Phe Leu 145 150 155 160 Phe Tyr Ser Gly Phe Phe Thr Pro Leu Tyr Tyr Leu Gly Asn Asn Lys 165 170 175 Leu Ala Asn Val Ala Glu He He Lys Leu He He Arg Asp Glu Ser 180 185 190 Val His Gly Thr Tyr He Gly Tyr Lys Phe Gin Leu Gly Phe Asn Glu 195 200 205 Leu Pro Glu Glu Glu Gin Glu Lys Leu Lys Glu Trp Met Tyr Asp Leu 210 215 220 Leu Tyr Thr Leu Tyr Glu Asn Glu Glu Gly Tyr Thr Glu Ser Leu Tyr 225 230 235 240 Asp Gly Val Gly Trp Thr Glu Glu Val Lys Thr Phe Leu Arg Tyr Asn 245 250 255 Ala Asn Lys Ala Leu Met Asn Met Gly Gin Asp Pro Leu Phe Pro Asp 260 265 270 Ser Ala Glu Asp Val Asn Pro He Val Met Asn Gly He Ser Thr Gly 275 280 285 Thr Ser Asn His Asp Phe Phe Ser Gin Val Gly Asn Gly Tyr Leu Leu 290 295 300 Gly Glu Val Glu Ala Met Gin Asp Asp Asp Tyr Asn Tyr Gly Leu Asp 305 310 315 320 (2) INFORMATION FOR SEQ ID NO: 169: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 240 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 169: He Glu Glu Gly Val Lys Val Val Thr Thr Gly Ala Gly Asn Pro Ser 1 5 10 15 Lys Tyr Met Glu Arg Phe His Glu Ala Gly He He Val He Pro Val 20 25 30 Val Pro Ser Val Ala Leu Ala Lys Arg Met Glu Lys He Gly Ala Asp 35 40 45 Ala Val He Ala Glu Gly Met Glu Ala Gly Gly His He Gly Lys Leu 50 55 60 Thr Thr Met Thr Leu Val Arg Gin Val Ala Thr Ala Val Ser He Pro 65 70 75 80 Val He Ala Ala Gly Gly He Ala Asp Gly Glu Gly Ala Ala Ala Gly 85 90 95 Phe Met Leu Gly Ala Glu Ala Val Gin Val Gly Thr Arg Phe Val Val 100 105 110 Ala Lys Glu Ser Asn Ala His Pro Asn Tyr Lys Glu Lys He Leu Lys 115 120 125 Ala Arg Asp He Asp Thr Thr He Ser Ala Gin His Phe Gly His Ala 130 135 140 Val Arg Ala He Lys Asn Gin Leu Thr Arg Asp Phe Glu Leu Ala Glu 145 150 155 160 Lys Asp Ala Phe Lys Gin Glu Asp Pro Asp Leu Glu He Phe Glu Gin 165 170 175 Met Gly Ala Gly Ala Leu Ala Lys Ala Val Val His Gly Asp Val Glu 180 185 190 Gly Gly Ser Val Met Ala Gly Gin He Ala Gly Leu Val Ser Lys Glu 195 200 205 Glu Thr Ala Glu Glu He Leu Lys Asp Leu Tyr Tyr Gly Ala Ala Lys 210 215 220 Lys He Gin Glu Glu Ala Ser Arg Trp Thr Gly Val Val Arg Asn Asp 225 230 235 240 (2) INFORMATION FOR SEQ ID NO: 170: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 243 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 170: Met Lys Leu Glu His Lys Asn He Phe He Thr Gly Ser Ser Arg Gly 1 5 10 15 He Gly Leu Ala He Ala His Lys Phe Ala Gin Ala Gly Ala Asn He 20 25 30 Val Leu Asn Ser Arg Gly Ala He Ser Glu Glu Leu Leu Ala Glu Phe 35 40 45 Ser Asn Tyr Gly He Lys Val Val Pro He Ser Gly Asp Val Ser Asp 50 55 60 Phe Ala Asp Ala Lys Arg Met He Asp Gin Ala He Ala Glu Leu Gly 65 70 75 80 Ser Val Asp Val Leu Val Asn Asn Ala Gly He Thr Gin Asp Thr Leu 85 90 95 Met Leu Lys Met Thr Glu Ala Asp Phe Glu Lys Val Leu Lys Val Asn 100 105 110 Leu Thr Gly Ala Phe Asn Met Thr Gin Ser Val Leu Lys Pro Met Met 115 120 125 Lys Ala Arg Glu Gly Ala He He Asn Met Ser Ser Val Val Gly Leu 130 135 140 Met Gly Asn He Gly Gin Ala Asn Tyr Ala Ala Ser Lys Ala Gly Leu 145 150 155 160 He Gly Phe Thr Lys Ser Val Ala Arg Glu Val Ala Ser Arg Asn He 165 170 175 Arg Val Asn Val He Ala Pro Gly Met He Glu Ser Asp Met Thr Ala 180 185 190 He Leu Ser Asp Lys He Lys Glu Ala Thr Leu Ala Gin He Pro Met 195 200 205 Lys Glu Phe Gly Gin Ala Glu Gin Val Ala Asp Leu Thr Val Phe Leu 210 215 220 Ala Gly Gin Asp Tyr Leu Thr Gly Gin Val He Ala He Asp Gly Gly 225 230 235 240 Leu Ser Met (2) INFORMATION FOR SEQ ID NO: 171: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 306 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 171: Met Thr Lys Thr Ala Phe Leu Phe Ala Gly Gin Gly Ala Gin Tyr Leu 1 5 10 15 Gly Met Gly Arg Asp Phe Tyr Asp Gin Tyr Pro He Val Lys Glu Thr 20 25 30 He Asp Arg Ala Ser Gin Val Leu Gly Tyr Asp Leu Arg Tyr Leu He 35 40 45 Asp Thr Glu Glu Asp Lys Leu Asn Gin Thr Arg Tyr Thr Gin Pro Ala 50 55 60 He Leu Ala Thr Ser Val Ala He Tyr Arg Leu Leu Gin Glu Lys Gly 65 70 75 80 Tyr Gin Pro Asp Met Val Ala Gly Leu Ser Leu Gly Glu Tyr Ser Ala 85 90 95 Leu Val Ala Ser Gly Ala Leu Asp Phe Glu Asp Ala Val Ala Leu Val 100 105 110 Ala Lys Arg Gly Ala Tyr Met Glu Glu Ala Ala Pro Ala Asp Ser Gly 115 120 125 Lys Met Val Ala Val Leu Asn Thr Pro Val Glu Val He Glu Glu Ala 130 135 140 Cys Gin Lys Ala Ser Glu Leu Gly Val Val Thr Pro Ala Asn Tyr Asn 145 150 155 160 Thr Pro Ala Gin He Val He Ala Gly Glu Val Val Ala Val Asp Arg 165 170 175 Ala Val Glu Leu Leu Gin Glu Ala Gly Ala Lys Arg Leu He Pro Leu 180 185 190 Lys Val Ser Gly Pro Phe His Thr Ser Leu Leu Glu Pro Ala Ser Gin 195 200 205 Lys Leu Ala Glu Thr Leu Ala Gin Val Ser Phe Ser Asp Phe Thr Cys 210 215 220 Pro Leu Val Gly Asn Thr Glu Ala Ala Val Met Gin Lys Glu Asp He 225 230 235 240 Ala Gin Leu Leu Thr Arg Gin Val Lys Glu Pro Val Arg Phe Tyr Glu 245 250 255 Ser He Gly Val Met Gin Glu Ala Gly He Ser Asn Phe He Glu He 260 265 270 Gly Pro Gly Lys Val Leu Ser Gly Phe Val Lys Lys He Asp Gin Thr 275 280 285 Ala His Leu Ala His Val Glu Asp Gin Ala Ser Leu Val Ala Leu Leu 290 295 300 Glu Lys 305 (2) INFORMATION FOR SEQ ID NO: 172: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 318 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 172: Met Lys Leu Asn Arg Val Val Val Thr Gly Tyr Gly Val Thr Ser Pro 1 5 10 15 He Gly Asn Thr Pro Glu Glu Phe Trp Asn Ser Leu Ala Thr Gly Lys 20 25 30 He Gly He Gly Gly He Thr Lys Phe Asp His Ser Asp Phe Asp Val 35 40 45 His Asn Ala Ala Glu He Gin Asp Phe Pro Phe Asp Lys Tyr Phe Val 50 55 60 Lys Lys Asp Thr Asn Arg Phe Asp Asn Tyr Ser Leu Tyr Ala Leu Tyr 65 70 75 80 Ala Ala Gin Glu Ala Val Asn His Ala Asn Leu Asp Val Glu Ala Leu 85 90 95 Asn Arg Asp Arg Phe Gly Val He Val Ala Ser Gly He Gly Gly He 100 105 110 Lys Glu He Glu Asp Gin Val Leu Arg Leu His Glu Lys Gly Pro Lys 115 120 125 Arg Val Lys Pro Met Thr Leu Pro Lys Ala Leu Pro Asn Met Ala Ser 130 135 140 Gly Asn Val Ala Met Arg Phe Gly Ala Asn Gly Val Cys Lys Ser He 145 150 155 160 Asn Thr Ala Cys Ser Ser Ser Asn Asp Ala He Gly Asp Ala Phe Arg 165 170 175 Ser He Lys Phe Gly Phe Gin Asp Val Met Leu Val Gly Gly Thr Glu 180 185 190 Ala Ser He Thr Pro Phe Ala He Ala Gly Phe Gin Ala Leu Thr Ala 195 200 205 Leu Ser Thr Thr Glu Asp Pro Thr Arg Ala Ser He Pro Phe Asp Lys 210 215 220 Asp Arg Asn Gly Phe Val Met Gly Glu Gly Ser Gly Met Leu Val Leu 225 230 235 240 Glu Ser Leu Glu His Ala Glu Lys Arg Gly Ala Thr He Leu Ala Glu 245 250 255 Val Val Gly Tyr Gly Asn Thr Cys Asp Ala Tyr His Met Thr Ser Pro 260 265 270 His Pro Glu Gly Gin Gly Ala He Lys Ala He Lys Leu Ala Leu Glu 275 280 285 Glu Ala Glu He Ser Pro Glu Gin Val Ala Met Leu Met Leu Thr Glu 290 295 300 Arg Gin Leu Leu Pro Met Lys Lys Glu Lys Val Val Leu Ser 305 310 315 (2) INFORMATION FOR SEQ ID NO: 173: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 396 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 173: Met Gin Ala Val Glu His Phe He Lys Gin Phe Val Pro Glu His Tyr 1 5 10 15 Asp Leu Phe Leu Asp Leu Ser Arg Glu Thr Lys Thr Phe Ser Gly Lys 20 25 30 Val Thr He Thr Gly Gin Ala Gin Ser Asp Arg He Ser Leu His Gin 35 40 45 Lys Asp Leu Glu He Thr Ser Val Glu Val Ala Gly Gin Ala Arg Pro 50 55 60 Phe Thr Val Asp His Asp Asn Glu Ala Leu His He Glu Leu Ala Glu 65 70 75 80 Ala Gly Gin Val Glu Leu Val Leu Ala Phe Ser Gly Lys He Thr Asp 85 90 95 Asn Met Thr Gly He Tyr Pro Ser Tyr Tyr Thr Val Asp Gly Val Lys 100 105 110 Lys Glu Val Leu Ser Thr Gin Phe Glu Ser His Phe Ala Arg Glu Ala 115 120 125 Phe Pro Cys Val Asp Glu Pro Glu Ala Lys Ala Thr Phe Asp Leu Ser 130 135 140 Leu Arg Phe Asp Gin Ala Glu Gly Glu Leu Ala Leu Ser Asn Met Pro 145 150 155 160 Glu He Asp Val Glu Asn Arg Lys Glu Thr Gly He Trp Lys Phe Glu 165 170 175 Thr Thr Pro Arg Met Ser Ser Tyr Leu Leu Ala Phe Val Ala Gly Asp 180 185 190 Leu Gin Gly Val Thr Ala Lys Thr Lys Asn Gly Thr Leu Val Gly Val 195 200 205 Tyr Ser Thr Lys Ala His Pro Leu Ser Asn Leu Asp Phe Ser Leu Asp 210 215 220 He Ala Val Arg Ser He Glu Phe Tyr Glu Asp Tyr Tyr Gly Val Lys 225 230 235 240 Tyr Pro He Pro Gin Ser Leu His He Ala Leu Pro Asp Phe Ser Ala 245 250 255 Gly Ala Met Glu Asn Trp Gly Leu Val Thr Tyr Arg Glu Val Tyr Leu 260 265 270 Val Val Asp Glu Asn Ser Thr Phe Ala Ser Arg Gin Gin Val Ala Leu 275 280 285 Val Val Ala His Glu Leu Ala His Gin Trp Phe Gly Asn Leu Val Thr 290 295 300 Met Lys Trp Trp Asp Asp Leu Trp Leu Asn Glu Ser Phe Ala Asn Met 305 310 315 320 Met Glu Tyr Val Cys Val Asp Thr He Glu Pro Ser Trp Asn He Phe 325 330 335 Glu Asp Phe Gin Thr Gly Gly Val Pro Leu Ala Leu Glu Arg Asp Ala 340 345 350 Thr Asp Gly Val Gin Ser Val His Val Glu Val Lys His Pro Asp Glu 355 360 365 He Asn Thr Leu Phe Asp Gly Ala He Val Tyr Ala Arg Lys Arg Leu 370 375 380 Met His Met Leu Arg Val Ala Arg Asp Ala Asp Leu 385 390 395 (2) INFORMATION FOR SEQ ID NO: 174: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 127 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 174: Met Asp Phe Leu Leu Phe Tyr Asp Ser Lys Lys Lys Gly Asp Thr Met 1 5 10 15 Thr Tyr Leu Glu Lys Trp Phe Asp Phe Asn Arg Arg Gin Lys Glu He 20 25 30 Glu Ser Leu Leu Glu Glu Thr He Ala Gin Gin Ser Glu Gin Ser Leu 35 40 45 Thr Leu Lys Glu Phe Tyr Leu Leu Tyr Tyr Leu Asp Leu Ala Glu Glu 50 55 60 Lys Ser Leu Arg Gin He Asp Leu Pro Asp Lys Leu His Leu Ser Pro 65 70 75 80 Ser Ala Val Ser Arg Met Val Ala Arg Leu Glu Ala Lys Asn Cys Gly 85 90 95 Leu Leu Ser Arg Met Cys Cys His Gin Asp Arg Arg Ser Ser Phe He 100 105 110 Cys Leu Thr Asn Asp Gly Gin Lys Thr Leu Ala Ser Leu Gin Lys 115 120 125 (2) INFORMATION FOR SEQ ID NO: 175: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 373 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 175: Met Leu Tyr Asp Tyr Gly Asn Ser Val Trp Leu Ala Ser Met Gly Thr 1 5 10 15 He Gly Gin Thr Val Leu Gly Met Tyr Gin He Ser Glu Leu Val Thr 20 25 30 Ser He Leu Val Asn Pro Phe Gly Gly Val He Ser Asp Arg Phe Ser 35 40 45 Arg Arg Lys He Leu Met Thr Ala Asp Leu Val Cys Gly He Leu Cys 50 55 60 Leu Ala He Ser Phe He Arg Asn Asp Ser Trp Met He Gly Ala Leu 65 70 75 80 He Val Ala Asn He Val Gin Ala He Ala Phe Ala Phe Ser Arg Thr 85 90 95 Ala Asn Lys Ala He He Thr Glu Val Val Glu Lys Asn Glu He Val 100 105 110 He Tyr Asn Ser Arg Leu Glu Leu Val Leu Gin Val Val Gly Val Ser 115 120 125 Ser Pro Val Leu Ser Phe Leu Val Leu Gin Phe Ala Ser Leu His Met 130 135 140 Thr Leu Leu Leu Asp Ser Leu Thr Phe Phe He Ala Phe Val Leu Val 145 150 155 160 Ala Phe Leu Pro Lys Glu Glu Ala Lys Val Gin Glu Lys Lys Ala Phe 165 170 175 Thr Gly Arg Asp He Phe Val Asp He Lys Asp Gly Leu His Tyr He 180 185 190 Trp His Gin Gin Glu He Phe Phe Leu Leu Leu Val Ala Ser Ser Val 195 200 205 Asn Phe Phe Phe Ala Ala Phe Glu Phe Leu Leu Pro Phe Ser Asn Gin 210 215 220 Leu Tyr Gly Ser Glu Gly Ala Tyr Ala Ser He Leu Thr Met Gly Ala 225 230 235 240 He Gly Ser He He Gly Ala Leu Leu Ala Ser Lys He Lys Ala Asn 245 250 255 He Tyr Asn Leu Leu He Leu Leu Ala Leu Thr Gly Val Gly Val Phe 260 265 270 Met Met Gly Leu Pro Leu Pro Thr Phe Leu Ser Phe Ser Gly Asn Leu 275 280 285 Val Cys Glu Leu Phe Met Thr He Phe Asn He His Phe Phe Thr Gin 290 295 300 Val Gin Thr Lys Val Glu Ser Glu Phe Leu Gly Arg Val Leu Ser Thr 305 310 315 320 He Phe Thr Leu Ala He Leu Phe Met Pro He Ala Lys Gly Phe Met 325 330 335 Thr Val Leu Pro Ser Val His Leu Ser Ser Phe Leu He He Gly Ser 340 345 350 Gly Val He He Leu Ser Cys He Ser Phe He Tyr Val Arg Thr His 355 360 365 Phe Glu Lys Leu He 370 (2) INFORMATION FOR SEQ ID NO: 176: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 427 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO ( iv) ANTI-SENSE : NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 176: Met Ser Val Ser Phe Glu Asn Lys Glu Thr Asn Arg Gly Val Leu Thr 1 5 10 15 Phe Thr He Ser Gin Asp Gin He Lys Pro Glu Leu Asp Arg Val Phe 20 25 30 Lys Ser Val Lys Lys Ser Leu Asn Val Pro Gly Phe Arg Lys Gly His 35 40 45 Leu Pro Arg Pro He Phe Asp Gin Lys Phe Gly Glu Glu Ala Leu Tyr 50 55 60 Gin Asp Ala Met Asn Ala Leu Leu Pro Asn Ala Tyr Glu Ala Ala Val 65 70 75 80 Lys Glu Ala Gly Leu Glu Val Val Ala Gin Pro Lys He Asp Val Thr 85 90 95 Ser Met Glu Lys Gly Gin Asp Trp Val He Thr Ala Glu Val Val Thr 100 105 110 Lys Pro Glu Val Lys Leu Gly Asp Tyr Lys Asn Leu Glu Val Ser Val 115 120 125 Asp Val Glu Lys Glu Val Thr Asp Ala Asp Val Glu Glu Arg He Glu 130 135 140 Arg Glu Arg Asn Asn Leu Ala Glu Leu Val He Lys Glu Ala Ala Ala 145 150 155 160 Glu Asn Gly Asp Thr Val Val He Asp Phe Val Gly Ser He Asp Gly 165 170 175 Val Glu Phe Asp Gly Gly Lys Gly Glu Asn Phe Ser Leu Gly Leu Gly 180 185 190 Ser Gly Gin Phe He Pro Gly Phe Glu Asp Gin Leu Val Gly His Ser 195 200 205 Ala Gly Glu Thr Val Asp Val He Val Thr Phe Pro Glu Asp Tyr Gin 210 215 220 Ala Glu Asp Leu Ala Gly Lys Glu Ala Lys Phe Val Thr Thr He His 225 230 235 240 Glu Val Lys Ala Lys Glu Val Pro Ala Leu Asp Asp Glu Leu Ala Lys 245 250 255 Asp He Asp Glu Glu Val Glu Thr Leu Ala Asp Leu Lys Glu Lys Tyr 260 265 270 Arg Lys Glu Leu Ala Ala Ala Lys Glu Glu Thr Tyr Lys Asp Ala Val 275 280 285 Glu Gly Ala Ala He Asp Thr Ala Val Glu Asn Ala Glu He Val Glu 290 295 300 Leu Pro Glu Glu Met He His Glu Glu Val His Arg Ser Val Asn Glu 305 310 315 320 Phe Leu Gly Asn Leu Gin Arg Gin Gly He Asn Pro Asp Met Tyr Phe 325 330 335 Gin He Thr Gly Thr Thr Gin Glu Asp Leu His Asn Gin Tyr Gin Ala 340 345 350 Glu Ala Glu Ser Arg Thr Lys Thr Asn Leu Val He Glu Ala Val Ala 355 360 365 Lys Ala Glu Gly Phe Asp Ala Ser Glu Glu Glu He Gin Lys Glu Val 370 375 380 Glu Gin Leu Ala Ala Asp Tyr Asn Met Glu Val Ala Gin Val Gin Asn 385 390 395 400 Leu Leu Ser Ala Asp Met Leu Lys His Asp He Thr He Lys Lys Ala 405 410 415 Val Glu Leu He Thr Ser Thr Ala Thr Val Lys 420 425 (2) INFORMATION FOR SEQ ID NO: 177: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 207 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 177: Gly Gly Asp Lys Asp Phe Leu Thr Ser He Cys Leu Thr Asn Asp Pro 1 5 10 15 Phe Leu Gly Phe Arg Ala Leu Arg He Ser He Ser Glu Thr Gly Asp 20 25 30 Ala Met Phe Arg Thr Gin He Arg Ala Leu Leu Arg Ala Ser Val His 35 40 45 Gly Gin Leu Arg He Met Phe Pro Met Val Ala Leu Leu Lys Glu Phe 50 55 60 Arg Ala Ala Lys Ala Val Phe Asp Glu Glu Lys Ala Asn Leu Leu Ala 65 70 75 80 Glu Gly Val Ala Val Ala Asp Asn He Gin Val Gly He Met He Glu 85 90 95 He Pro Ala Ala Ala Met Leu Ala Asp Gin Phe Ala Lys Glu Val Asp 100 105 110 Phe Phe Ser He Gly Thr Asn Asp Leu He Gin Tyr Thr Met Ala Ala 115 120 125 Asp Arg Met Asn Glu Gin Val Ser Tyr Leu Tyr Gin Pro Tyr Asn Pro 130 135 140 Ser He Leu Arg Leu He Asn Asn Val He Lys Ala Ala His Ala Glu 145 150 155 160 Gly Lys Trp Ala Gly Met Cys Gly Glu Met Ala Gly Asp Gin Gin Ala 165 170 175 Val Pro Leu Leu Val Gly Met Gly Leu Asp Glu Phe Ser Met Ser Ala 180 185 190 Thr Cys Thr Ser Tyr Thr Gin Leu Asp Glu Glu Thr Arg His Ser 195 200 205 (2) INFORMATION FOR SEQ ID NO: 178: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 283 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 178: Met Gin Met Ala Tyr Arg Cys Asn Leu Arg Asn Asn Gly Lys Arg Arg 1 5 10 15 He Gly He Arg Glu Met Thr Glu Met Leu Lys Gly He Ala Ala Ser 20 25 30 Asp Gly Val Ala Val Ala Lys Ala Tyr Leu Leu Val Gin Pro Asp Leu 35 40 45 Ser Phe Glu Thr He Thr Val Glu Asp Thr Asn Ala Glu Glu Ala Arg 50 55 60 Leu Asp Ala Ala Leu Gin Ala Ser Gin Asp Glu Leu Ser Val He Arg 65 70 75 80 Glu Lys Ala Val Gly Thr Leu Gly Glu Glu Ala Ala Gin Val Phe Asp 85 90 95 Ala His Leu Met Val Leu Ala Asp Pro Glu Met He Ser Gin He Lys 100 105 110 Glu Thr He Arg Ala Lys Lys Val Asn Ala Glu Ala Gly Leu Lys Glu 115 120 125 Val Thr Asp Met Phe He Thr He Phe Glu Gly Met Glu Asp Asn Pro 130 135 140 Tyr Met Gin Glu Arg Ala Arg Asp He Arg Asp Val Thr Lys Arg Val 145 150 155 160 Leu Ala Asn Leu Leu Gly Lys Lys Leu Pro Asn Pro Ala Ser He Asn 165 170 175 Glu Glu Val He Val He Ala His Asp Leu Thr Pro Ser Asp Thr Ala 180 185 190 Gin Leu Asp Lys Asn Phe Val Lys Ala Phe Val Thr Asn He Gly Gly 195 200 205 Arg Thr Ser His Ser Ala He Met Ala Arg Thr Leu Glu He Ala Ala 210 215 220 Val Leu Gly Thr Asn Asn He Thr Glu He Val Lys Asp Gly Asp He 225 230 235 240 Leu Ala Val Asn Gly He Thr Gly Glu Val He He Asn Pro Thr Asp 245 250 255 Glu Gin Ala Ala Glu Phe Lys Ala Ala Gly Glu Ala Tyr Ala Thr Lys 260 265 270 Ala Glu Trp Ala Leu Leu Lys Asp Ala Gin Gin 275 280 (2) INFORMATION FOR SEQ ID NO: 179: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 168 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 179: Met He Gly Arg Leu Ala Pro Tyr Asp Lys Gly Gin He He Tyr Asp 1 5 10 15 Gly Thr Ser Leu Lys Asp He Lys Pro Ser Val Phe Phe Arg Asp Tyr 20 25 30 Leu Gly Tyr Leu Phe Gin Asp Phe Gly Leu He Glu Ser Gin Thr Val 35 40 45 Lys Glu Asn Leu Asn Leu Gly Leu Val Gly Lys Lys Leu Lys Glu Lys 50 55 60 Glu Lys He Ser Leu Met Lys Gin Ala Leu Asn Arg Val Asn Leu Ser 65 70 75 80 Tyr Leu Asp Leu Lys Gin Pro He Phe Glu Leu Ser Gly Gly Glu Ala 85 90 95 Gin Arg Val Ala Leu Ala Lys He He Leu Lys Asp Pro Pro Leu He 100 105 110 Leu Ala Asp Glu Pro Thr Ala Ser Leu Asp Pro Lys Asn Ser Glu Glu 115 120 125 Leu Leu Ser He Leu Glu Ser Leu Lys Asn Pro Asn Arg Thr He He 130 135 140 He Ala Thr His Asn Pro Leu He Trp Glu Gin Val Asp Gin Val He 145 150 155 160 Arg Val Thr Asp Leu Ser His Arg 165 (2) INFORMATION FOR SEQ ID NO: 180: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 210 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:180: Met Lys Ala His Val Ser Tyr Leu Ser Met Gly Glu Lys Arg Phe Val 1 5 10 15 Tyr Asn Asn Gly Glu Asn Pro Val Ser Thr Gin Tyr Leu Thr Asp Pro 20 25 30 He Leu Val Val Phe Thr Pro Thr Ser Thr Gly Asp Ser Phe He Ser 35 40 45 Leu Ser Ser Trp Ser He Asn Ala Gly Lys Gin Leu Phe He Lys Gly 50 55 60 Tyr Glu Ser Gly Leu Glu Leu Leu Lys Lys Ala Gly He Tyr Glu Gin 65 70 75 80 Val Ser Tyr Leu Lys Glu Gly Arg Ser Val Tyr Leu Thr Arg Tyr Asn 85 90 95 Glu Val Gin Thr Glu Thr Ala Thr Leu He Leu Gly Ala He Val Gly 100 105 110 He Ala Ser Ser Leu Leu Leu Phe Tyr Ser Val Asn Leu Leu Tyr Phe 115 120 125 Glu Gin Phe Arg Arg Asp He Leu He Lys Arg He Ser Gly Leu Arg 130 135 140 Phe Phe Glu Thr His Ala Gin Tyr Met Val Ser Gin Phe Ala Ser Phe 145 150 155 160 Val Phe Gly Ala Ser Leu Phe He Leu Ser Ser Arg Asp Leu Val He 165 170 175 Gly Leu Leu Thr Leu Leu Val Phe Leu Ala Ser Ala Val Leu Thr Leu 180 185 190 Tyr Arg Gin Ala Gin Lys Glu Ser Arg Val Ser Met Thr He Met Lys 195 200 205 Gly Lys 210 (2) INFORMATION FOR SEQ ID NO: 181: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 227 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:181: Glu Phe Gin Glu Ala Ser Gin Glu Ser Arg Glu Arg Ser Asp Pro Leu 1 5 10 15 Asn Ser Tyr Leu Leu Leu Ser Gly Ser Leu Thr Lys Glu Lys Leu Ala 20 25 30 Asp Lys Leu Gly Asp Leu Gly Tyr Lys Ala Ser Ala Asp Arg Lys He 35 40 45 Pro Pro Tyr Phe Leu Ala Phe Arg He Leu Leu Asn Pro Leu He Leu 50 55 60 He Ser Leu Ala He Phe Gly Leu Ser Phe Phe Ala Leu Val He He 65 70 75 80 Thr Arg He Lys Glu Met Arg Ala Ala Gly He Lys Leu Phe Ser Gly 85 90 95 Gin Thr Leu Leu Ser He Met Gly His Ser Leu Ser Thr Asp He Lys 100 105 110 Trp Leu Leu Leu Ser Ala Leu Leu Ser Phe Leu Gly Gly Gly Val Val 115 120 125 Leu Phe Ser Gin Gly Leu Phe Tyr Pro He Leu Leu Ala Thr Tyr Gly 130 135 140 Phe Gly He Ser Phe Tyr Leu Leu Phe Leu Leu Ala He Ser He Leu 145 150 155 160 Leu Met Leu Leu Tyr Leu Met Ser Leu Asn Lys Ala Leu Val Pro Val 165 170 175 He Arg Gly Arg Phe Pro Leu Leu Met Thr Leu Phe Gin Pro Val Phe 180 185 190 Ser Val Gly Tyr Ala Lys Thr Gly Leu Thr Ser Tyr Gin Arg Leu Lys 195 200 205 Glu Leu Glu He Ser Gin Trp Gin Asp Arg Val Asp Tyr Tyr His Asp 210 215 220 Phe Phe Thr 225 (2) INFORMATION FOR SEQ ID NO: 182: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 396 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 182: Met Ser Lys Asp Lys Lys Asn Glu Asp Lys Glu Thr Leu Glu Glu Leu 1 5 10 15 Lys Glu Leu Ser Glu Trp Gin Lys Arg Asn Gin Glu Tyr Leu Lys Lys 20 25 30 Lys Ala Glu Glu Glu Val Ala Leu Ala Glu Glu Lys Glu Lys Glu Arg 35 40 45 Gin Ala Arg Met Gly Glu Glu Ser Glu Lys Ser Glu Asp Lys Gin Asp 50 55 60 Gin Glu Ser Glu Thr Asp Gin Glu Asp Ser Glu Ser Ala Lys Glu Glu 65 70 75 80 Ser Glu Glu Lys Val Ala Ser Ser Glu Ala Asp Lys Glu Lys Glu Glu 85 90 95 Pro Glu Ser Lys Glu Lys Glu Glu Gin Asp Lys Lys Leu Ala Lys Lys 100 105 110 Ala Thr Lys Glu Lys Pro Ala Lys Ala Lys He Pro Gly He His He 115 120 125 Leu Arg Ala Phe Thr He Leu Phe Pro Ser Leu Leu Leu Leu He Val 130 135 140 Ser Ala Tyr Leu Leu Ser Pro Tyr Ala Thr Met Lys Asp He Arg Val 145 150 155 160 Glu Gly Thr Val Gin Thr Thr Ala Asp Asp He Arg Gin Ala Ser Gly 165 170 175 He Gin Asp Ser Asp Tyr Thr He Asn Leu Leu Leu Asp Lys Ala Lys 180 185 190 Tyr Glu Lys Gin He Lys Ser Asn Tyr Trp Val Glu Ser Ala Gin Leu 195 200 205 Val Tyr Gin Phe Pro Thr Lys Phe Thr He Lys Val Lys Glu Tyr Asp 210 215 220 He Val Ala Tyr Tyr He Ser Gly Glu Asn His Tyr Pro He Leu Ser 225 230 235 240 Ser Gly Gin Leu Glu Thr Ser Ser Val Ser Leu Asn Ser Leu Pro Glu 245 250 255 Thr Tyr Leu Ser Val Leu Phe Asn Asp Ser Glu Gin He Lys Val Phe 260 265 270 Val Ser Glu Leu Ala Gin He Ser Pro Glu Leu Lys Ala Ala He Gin 275 280 285 Lys Val Glu Leu Ala Pro Ser Lys Val Thr Ser Asp Leu He Arg Leu 290 295 300 Thr Met Asn Asp Ser Asp Glu Val Leu Val Pro Leu Ser Glu Met Ser 305 310 315 320 Lys Lys Leu Pro Tyr Tyr Ser Lys He Lys Pro Gin Leu Ser Glu Pro 325 330 335 Ser Val Val Asp Met Glu Ala Gly He Tyr Ser Tyr Thr Val Ala Asp 340 345 350 Lys Leu He Met Glu Ala Glu Glu Lys Ala Lys Gin Glu Ala Lys Glu 355 360 365 Ala Glu Lys Lys Gin Glu Glu Glu Gin Lys Lys Gin Glu Glu Glu Ser 370 375 380 Asn Arg Asn Gin Thr Asn Gin Arg Ser Ser Arg Arg 385 390 395 (2) INFORMATION FOR SEQ ID NO: 183: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 165 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 183: Met Glu Arg Val Val Asp He Leu Lys Ala Glu Phe Asp Arg Ser Phe 1 5 10 15 Lys Leu He Asn Ser Lys Thr Tyr Pro Val Ser Gly Gly Glu Leu Asn 20 25 30 Pro Ala Asn Val Asp Ser Glu He Glu Ala Phe Ala Gin Leu Gly Val 35 40 45 Ser Arg Gly Leu Asp Ser Lys Glu Ala His Tyr Leu Ala Asn Leu Tyr 50 55 60 Gly Ser Asn Ala Pro Lys Val Phe Ala Leu Ala His Ser Leu Glu Gin 65 70 75 80 Ala Pro Gly Leu Ser Leu Ala Asp Thr Leu Ser Leu His Tyr Ala Met 85 90 95 Arg Asn Glu Leu Ala Leu Ser Pro Val Asp Phe Leu Leu Arg Arg Thr 100 105 110 Asn His Met Leu Phe Met Arg Asp Ser Leu Asp Ser He Val Glu Pro 115 120 125 Val Leu Asp Glu Met Gly Arg Phe Tyr Asp Trp Thr Glu Glu Glu Lys 130 135 140 Ala Thr Tyr Arg Ala Asp Val Glu Ala Ala Leu Ala Asn Asn Asp Leu 145 150 155 160 Ala Glu Leu Lys Asn 165 (2) INFORMATION FOR SEQ ID NO: 184: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 233 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iϋ) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 184: Met Asn Glu Leu Phe Gly Glu Phe Leu Gly Thr Leu He Leu He Leu 1 5 10 15 Leu Gly Asn Gly Val Val Ala Gly Val Val Leu Pro Lys Thr Lys Ser 20 25 30 Asn Ser Ser Gly Trp He Val He Thr Met Gly Trp Gly He Ala Val 35 40 45 Ala Val Ala Val Phe Val Ser Gly Lys Leu Ser Pro Ala His Leu Asn 50 55 60 Pro Ala Val Thr He Gly Val Ala Leu Lys Gly Gly Leu Pro Trp Ala 65 70 75 80 Ser Val Leu Pro Tyr He Leu Ala Gin Phe Ala Gly Ala Met Leu Gly 85 90 95 Gin He Leu Val Trp Leu Gin Phe Lys Pro His Tyr Glu Ala Glu Glu 100 105 110 Asn Ala Gly Asn He Leu Ala Thr Phe Ser Thr Gly Pro Ala He Lys 115 120 125 Asp Thr Val Ser Asn Leu He Ser Glu He Leu Gly Thr Phe Val Leu 130 135 140 Val Leu Thr He Phe Ala Leu Gly Leu Tyr Asp Phe Gin Ala Gly He 145 150 155 160 Gly Thr Phe Ala Val Gly Thr Leu He Val Gly He Gly Leu Ser Leu 165 170 175 Gly Gly Thr Thr Gly Tyr Ala Leu Asn Pro Ala Arg Asp Leu Gly Pro 180 185 190 Arg He Met His Ser He Leu Pro He Pro Asn Lys Gly Asp Gly Asp 195 200 205 Trp Ser Tyr Ala Trp He Pro Val Val Gly Pro Val He Gly Ala Ala 210 215 220 Leu Ala Val Leu Val Leu Ser Leu Phe 225 230 (2) INFORMATION FOR SEQ ID NO: 185: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 135 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant ( ii ) MOLECULE TYPE : peptide ( iii ) HYPOTHETICAL : NO ( iv) ANTI -SENSE : NO ( xi ) SEQUENCE DESCRI PTION : SEQ ID NO : 185 : Thr Thr Asp Asn Val He Asp Leu Phe Glu His He Phe Lys Met Phe 1 5 10 15 Asn Glu Asn He Val Met Ala Gly Lys Val Asn Leu Leu Asn Phe Ala 20 25 30 Asn Leu Ala Ala Tyr Gin Phe Phe Asp Gin Pro Gin Lys Val Ala Leu 35 40 45 Glu He Arg Glu Gly Leu Arg Glu Asp Gin Met Gin Asn Val Arg Val 50 55 60 Ala Asp Gly Gin Glu Ser Cys Leu Ala Asp Leu Ala Val He Ser Ser 65 70 75 80 Lys Phe Leu He Pro Tyr Arg Gly Val Gly He Leu Ala He He Gly 85 90 95 Pro Val Asn Leu Asp Tyr Gin Gin Leu He Asn Gin He Asn Val Val 100 105 110 Asn Arg Val Leu Thr Met Lys Leu Thr Asp Phe Tyr Arg Tyr Leu Ser 115 120 125 Ser Asn His Tyr Glu Val His 130 135 (2) INFORMATION FOR SEQ ID NO: 186: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 153 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iϋ) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 186: Met He Ala Lys Glu Phe Glu Thr Phe Leu Leu Gly Gin Glu Glu Thr 1 5 10 15 Phe Leu Thr Pro Ala Lys Asn Leu Ala Val Leu He Asp Thr His Asn 20 25 30 Ala Asp His Ala Thr Leu Leu Leu Ser Gin Met Thr Tyr Thr Arg Val 35 40 45 Pro Val Val Thr Asp Glu Lys Gin Phe Val Gly Thr He Gly Leu Arg 50 55 60 Asp He Met Ala Tyr Gin Met Glu His Asp Leu Ser Gin Glu He Met 65 70 75 80 Ala Asp Thr Asp He Val His Met Thr Lys Thr Asp Val Ala Val Val 85 90 95 Ser Pro Asp Phe Thr He Thr Glu Val Leu His Lys Leu Val Asp Glu 100 105 110 Ser Phe Leu Pro Val Val Asp Ala Glu Gly He Phe Gin Gly He He 115 120 125 Thr Arg Lys Ser He Leu Lys Ala Val Asn Ala Leu Leu His Asp Phe 130 135 140 Ser Lys Glu Tyr Glu He Arg Cys Gin 145 150 (2) INFORMATION FOR SEQ ID NO: 187: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 173 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 187: Met Ala Lys Gin Thr He He Val Met Ser Asp Ser His Gly Asp Ser 1 5 10 15 Leu He Val Glu Glu Val Arg Asp Arg Tyr Val Gly Lys Val Asp Ala 20 25 30 Val Phe His Asn Gly Asp Ser Glu Leu Arg Pro Asp Ser Pro Leu Trp 35 40 45 Glu Gly He Arg Val Val Lys Gly Asn Met Asp Phe Tyr Ala Gly Tyr 50 55 60 Pro Glu Arg Leu Val Thr Glu Leu Gly Ser Thr Lys He He Gin Thr 65 70 75 80 His Gly His Leu Phe Asp He Asn Phe Asn Phe Gin Lys Leu Asp Tyr 85 90 95 Trp Ala Gin Glu Glu Glu Ala Ala He Cys Leu Tyr Gly His Leu His 100 105 110 Val Pro Ser Ala Trp Met Glu Gly Lys He Leu Phe Leu Asn Pro Gly 115 120 125 Ser He Ser Gin Pro Arg Gly Thr He Arg Glu Cys Leu Tyr Ala Arg 130 135 140 Val Glu He Asp Asp Ser Tyr Phe Lys Val Asp Phe Leu Thr Arg Asp 145 150 155 160 His Glu Val Tyr Pro Gly Leu Ser Lys Glu Phe Ser Arg 165 170 (2) INFORMATION FOR SEQ ID NO: 188: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 189 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 188: Met Ser Thr Leu Ala Lys He Glu Ala Leu Leu Phe Val Ala Gly Glu 1 5 10 15 Asp Gly He Arg Val Arg Gin Leu Ala Glu Leu Leu Ser Leu Pro Pro 20 25 30 Thr Gly He Gin Gin Ser Leu Gly Lys Leu Ala Gin Lys Tyr Glu Lys 35 40 45 Asp Pro Asp Ser Ser Leu Ala Leu He Glu Thr Ser Gly Ala Tyr Arg 50 55 60 Leu Val Thr Lys Pro Gin Phe Ala Glu He Leu Lys Glu Tyr Ser Lys 65 70 75 80 Ala Pro He Asn Gin Ser Leu Ser Arg Ala Ala Leu Glu Thr Leu Ser 85 90 95 He He Ala Tyr Lys Gin Pro He Thr Arg He Glu He Asp Ala He 100 105 110 Arg Gly Val Asn Ser Ser Gly Ala Leu Ala Lys Leu Gin Ala Phe Asp 115 120 125 Leu He Lys Glu Asp Gly Lys Lys Glu Val Leu Gly Arg Pro Asn Leu 130 135 140 Tyr Val Thr Thr Asp Tyr Phe Leu Asp Tyr Met Gly He Asn His Leu 145 150 155 160 Glu Glu Leu Pro Val He Asp Glu Leu Glu He Gin Ala Gin Glu Ser 165 170 175 Gin Leu Phe Gly Glu Arg He Glu Glu Asp Glu Asn Gin 180 185 (2) INFORMATION FOR SEQ ID NO: 189: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 214 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 189: Met Arg Asp Arg He Ser Ala Phe Leu Glu Glu Lys Gin Gly Leu Ser 1 5 10 15 Val Asn Ser Lys Gin Ser Tyr Lys Tyr Asp Leu Glu Gin Phe Leu Asp 20 25 30 Met Val Gly Glu Arg He Ser Glu Thr Ser Leu Lys He Tyr Gin Ala 35 40 45 Gin Leu Ala Asn Leu Lys He Ser Ala Gin Lys Arg Lys He Ser Ala 50 55 60 Cys Asn Gin Phe Leu Tyr Phe Leu Tyr Gin Lys Gly Glu Val Asp Ser 65 70 75 80 Phe Tyr Arg Leu Glu Leu Ala Lys Gin Ala Glu Lys Lys Thr Glu Lys 85 90 95 Pro Glu He Leu Tyr Leu Asp Ser Phe Trp Gin Glu Ser Asp His Pro 100 105 110 Glu Gly Arg Leu Leu Ala Leu Leu He Leu Glu Met Gly Leu Leu Pro 115 120 125 Ser Glu He Leu Ala He Lys Val Ala Asp He Asn Leu Asp Phe Gin 130 135 140 Val Leu Arg He Ser Lys Ala Ser Gin Gin Arg He Val Thr He Pro 145 150 155 160 Thr Ala Leu Leu Ser Glu Leu Glu Pro Leu Met Gly Gin Thr Tyr Leu 165 170 175 Phe Glu Arg Gly Glu Lys Pro Tyr Ser Arg Gin Trp Ala Phe Arg Gin 180 185 190 Leu Glu Ser Phe Val Arg Arg Arg Phe Pro Ser Leu Ser Ala Gin Val 195 200 205 Leu Arg Asp Ser Leu Phe 210 (2) INFORMATION FOR SEQ ID NO: 190: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 239 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 190: Met Arg He Asn Lys Tyr He Ala His Ala Gly Val Ala Ser Arg Arg 1 5 10 15 Lys Ala Glu Glu Leu He Lys Gin Gly Leu Val Thr Val Asn Gly Gin 20 25 30 Val Val Arg Glu Leu Ala Thr Thr He Lys Ser Gly Asp Lys Val Glu 35 40 45 Val Glu Gly Gin Pro He Tyr Asn Glu Glu Lys Val Tyr Tyr Leu Leu 50 55 60 Asn Lys Pro Arg Gly Val He Ser Ser Val Thr Asp Asp Lys Gly Arg 65 70 75 80 Lys Thr Val Val Asp Leu Leu Pro Asn Val Lys Glu Arg He Tyr Pro 85 90 95 Val Gly Arg Leu Asp Trp Asp Thr Ser Gly Val Leu He Leu Thr Asn 100 105 110 Asp Gly Asp Phe Thr Asp Glu Met He His Pro Arg Asn Glu He Asp 115 120 125 Lys Val Tyr Val Ala Arg Val Lys Gly Val Ala Asn Lys Asp Asn Leu 130 135 140 Arg Pro Leu Thr Arg Gly Leu Glu He Asp Gly Lys Lys Thr Lys Pro 145 150 155 160 Ala Val Tyr Glu He Leu Lys Val Asp Pro Val Lys Asn Arg Ser Val 165 170 175 Val Gin Leu Thr He His Glu Gly Arg Asn His Gin Val Lys Lys Met 180 185 190 Phe Glu Ala Val Gly Leu Gin Val Asp Lys Leu Ser Arg Thr Arg Phe 195 200 205 Gly His Leu Asp Leu Thr Leu Arg Pro Gly Glu Ser Arg Arg Leu Asn 210 215 220 Lys Lys Glu He Ser Gin Leu His Thr Met Ala Val Thr Lys Lys 225 230 235 (2) INFORMATION FOR SEQ ID NO: 191: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 243 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 191: Met Asp He Lys Leu Lys Arg Phe Leu Lys Asp Pro Gly Leu Ala Leu 1 5 10 15 Cys He Trp Phe Leu Ser Thr Lys Met Asp He Tyr Asp Val Pro He 20 25 30 Thr Glu Val He Glu Gin Tyr Leu Ala Tyr Val Ser Thr Leu Gin Ala 35 40 45 Met Arg Leu Glu Val Thr Gly Glu Tyr Met Val Met Ala Ser Gin Leu 50 55 60 Met Leu He Lys Ser Arg Lys Leu Leu Pro Lys Val Ala Glu Val Thr 65 70 75 80 Asp Leu Gly Asp Asp Leu Glu Gin Asp Leu Leu Ser Gin He Glu Glu 85 90 95 Tyr Arg Lys Phe Lys Leu Leu Gly Glu His Leu Glu Ala Lys His Gin 100 105 110 Glu Arg Ala Gin Tyr Tyr Ser Lys Ala Pro Thr Glu Leu He Tyr Glu 115 120 125 Asp Ala Glu Leu Val His Asp Lys Thr Thr He Asp Leu Phe Leu Ala 130 135 140 Phe Ser Asn He Leu Ala Lys Lys Lys Glu Glu Phe Ala Gin Asn His 145 150 155 160 Thr Thr He Leu Arg Asp Glu Tyr Lys He Glu Asp Met Met He He 165 170 175 Val Lys Glu Ser Leu He Gly Arg Asp Gin Leu Arg Leu Gin Asp Leu 180 185 190 Phe Lys Glu Ala Gin Asn Val Gin Glu Val He Thr Leu Phe Leu Ala 195 200 205 Thr Leu Glu Leu He Lys Thr Gin Glu Leu He Leu Val Gin Glu Glu 210 215 220 Ser Phe Gly Asp He Tyr Leu Met Glu Lys Lys Glu Glu Ser Gin Val 225 230 235 240 Pro Gin Ser (2) INFORMATION FOR SEQ ID NO: 192: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 336 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 192: Met Ala Gly Lys Arg Asp Ser Cys Gly Ala Cys Arg He Met Thr Asn 1 5 10 15 Lys He Tyr Glu Tyr Lys Asp Asp Gin Asn Trp Tyr Val Gly Ser Tyr 20 25 30 Ser He Phe Gly Gly Val Asn Ser Leu Ser Asp Tyr Lys Ala Asp Phe 35 40 45 Pro Leu Phe Glu Phe Ser Lys He Phe Gly Asp Glu Glu Tyr Gly Phe 50 55 60 Pro Leu Ser Val Thr Val Leu Arg Tyr Gly Ser Thr Tyr Arg Leu Phe 65 70 75 80 Ser Phe Val Val Asp Met Leu Asn Gin Glu Met Gly Arg Asn Leu Glu 85 90 95 Val He Gin Arg His Gly Ala Leu Leu Leu Val Glu Asn Gly Gin Leu 100 105 110 Leu Tyr Val Glu Leu Pro Lys Glu Gly Val Asn Val His Asp Phe Phe 115 120 125 Glu Thr Ser Lys Val Arg Glu Thr Leu Leu He Ala Thr Arg Asn Glu 130 135 140 Gly Lys Thr Lys Glu Phe Arg Ala He Phe Asp Lys Leu Gly Tyr Asp 145 150 155 160 Val Glu Asn Leu Asn Asp Tyr Pro Asp Leu Pro Glu Val Ala Glu Thr 165 170 175 Gly Met Thr Phe Glu Glu Asn Ala Arg Leu Lys Ala Glu Thr He Ser 180 185 190 Gin Leu Thr Gly Lys Met Val Leu Ala Asp Asp Ser Gly Leu Lys Val 195 200 205 Asp Val Leu Gly Gly Leu Pro Gly Val Trp Ser Ala Arg Phe Ala Gly 210 215 220 Val Gly Ala Thr Asp Arg Glu Asn Asn Ala Lys Leu Leu His Glu Leu 225 230 235 240 Ala Met Val Phe Glu Leu Lys Asp Arg Ser Ala Gin Phe His Thr Thr 245 250 255 Leu Val Val Ala Ser Pro Asn Lys Glu Ser Leu Val Val Glu Ala Asp 260 265 270 Trp Ser Gly Tyr He Asn Phe Glu Pro Lys Gly Glu Asn Gly Phe Gly 275 280 285 Tyr Asp Pro Leu Phe Leu Val Gly Glu Thr Gly Glu Ser Ser Ala Glu 290 295 300 Leu Thr Leu Glu Glu Lys Asn Ser Gin Ser His Arg Ala Leu Ala Val 305 310 315 320 Lys Lys Leu Leu Glu Val Phe Pro Ser Trp Gin Ser Lys Pro Ser Leu 325 330 335 (2) INFORMATION FOR SEQ ID NO: 193: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 219 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 193: Glu Asn Asn Tyr Glu Pro Gin Tyr He Asn He Arg Gly Lys Gly Pro 1 5 10 15 Leu He Asn Asp Leu Lys Lys Glu Ala Lys Lys Ala Asn Lys Val Phe 20 25 30 Leu Ala Ser Asp Pro Asp Arg Glu Gly Glu Ala He Ser Trp His Leu 35 40 45 Ala His He Leu Asn Leu Asp Glu Asn Asp Ala Asn Arg Val Val Phe 50 55 60 Asn Glu He Thr Lys Asp Ala Val Lys Asn Ala Phe Lys Glu Pro Arg 65 70 75 80 Lys He Asp Met Asp Leu Val Asp Ala Gin Gin Ala Arg Arg He Leu 85 90 95 Asp Arg Leu Val Gly Tyr Ser He Ser Pro He Leu Trp Lys Lys Val 100 105 110 Lys Lys Gly Leu Ser Ala Gly Arg Val Gin Ser He Ala Leu Lys Leu 115 120 125 He He Asp Arg Glu Asn Glu He Asn Ala Phe Gin Pro Glu Glu Tyr 130 135 140 Trp Thr Val Asp Ala Val Phe Lys Lys Gly Thr Lys Gin Phe His Ala 145 150 155 160 Ser Phe Tyr Gly Val Asp Gly Lys Lys Met Lys Leu Thr Ser Asn Asn 165 170 175 Glu Val Lys Glu Val Leu Ser Arg Leu Thr Ser Lys Asp Phe Ser Val 180 185 190 Asp Gin Val Asp Lys Lys Glu Arg Lys Ala Asn Ala Pro Leu Pro Tyr 195 200 205 Thr Thr Ser Ser Met Gin Met Gly Cys Cys Gin 210 215 (2) INFORMATION FOR SEQ ID NO: 194: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 236 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 194: Met Ser He His He Ala Ala Gin Gin Gly Glu He Ala Asp Lys He 1 5 10 15 Leu Leu Pro Gly Asp Pro Leu Arg Ala Lys Phe He Ala Glu Asn Phe 20 25 30 Leu Gly Asp Ala Val Cys Phe Asn Glu Val Arg Asn Met Phe Gly Tyr 35 40 45 Thr Gly Thr Tyr Lys Gly His Arg Val Ser Val Met Gly Thr Gly Met 50 55 60 Gly Met Pro Ser He Ser He Tyr Ala Arg Glu Leu He Val Asp Tyr 65 70 75 80 Gly Val Lys Lys Leu He Arg Val Gly Thr Ala Gly Ser Leu Asn Glu 85 90 95 Glu Val His Val Arg Glu Leu Val Leu Ala Gin Ala Ala Ala Thr Asn 100 105 110 Ser Asn He Val Arg Asn Asp Trp Pro Gin Tyr Asp Phe Pro Gin He 115 120 125 Ala Ser Phe Asp Leu Leu Asp Lys Ala Tyr His He Ala Lys Glu Leu 130 135 140 Gly Met Thr Thr His Val Gly Asn Val Leu Ser Ser Asp Val Phe Tyr 145 150 155 160 Ser Asn Tyr Phe Glu Lys Asn He Glu Leu Gly Lys Trp Gly Val Lys 165 170 175 Ala Val Glu Met Glu Ala Ala Ala Leu Tyr Tyr Leu Ala Ala Gin Tyr 180 185 190 His Val Asp Ala Leu Ala He Met Thr He Ser Asp Ser Leu Val Asn 195 200 205 Pro Asp Glu Asp Thr Thr Ala Glu Glu Arg Gin Asn Thr Phe Thr Asp 210 215 220 Met Met Lys Val Gly Leu Glu Thr Leu He Ala Glu 225 230 235 (2) INFORMATION FOR SEQ ID NO: 195: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 477 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 195: He He Phe Pro He Leu Thr Gly Thr Tyr Val Ala Arg Val Leu Asp 1 5 10 15 Arg Thr Asp Tyr Gly Tyr Phe Asn Ser Val Asp Thr He Leu Ser Phe 20 25 30 Phe Leu Pro Phe Ala Thr Tyr Gly Val Tyr Asn Tyr Gly Leu Arg Ala 35 40 45 He Ser Asn Val Lys Asp Asn Lys Lys Asp Leu Asn Arg Thr Phe Ser 50 55 60 Ser Leu Phe Tyr Leu Cys He Ala Cys Thr He Leu Thr Thr Ala Val 65 70 75 80 Tyr He Leu Ala Tyr Pro Leu Phe Phe Thr Asp Asn Pro He Val Lys 85 90 95 Lys Val Tyr Leu Val Met Gly He Gin Leu He Ala Gin He Phe Ser 100 105 110 He Glu Trp Val Asn Glu Ala Leu Glu Asn Tyr Ser Phe Leu Phe Tyr 115 120 125 Lys Thr Ala Phe He Arg He Leu Met Leu Val Ser He Phe Leu Phe 130 135 140 Val Lys Asn Glu His Asp He Val Val Tyr Thr Leu Val Met Ser Leu 145 150 155 160 Ser Thr Leu He Asn Tyr Leu He Ser Tyr Phe Trp He Lys Arg Asp 165 170 175 He Lys Leu Val Lys He His Leu Ser Asp Phe Lys Pro Leu Phe Leu 180 185 190 Pro Leu Thr Ala Met Leu Val Phe Ala Asn Ala Asn Met Leu Phe Thr 195 200 205 Phe Leu Asp Arg Leu Phe Leu Val Lys Thr Gly He Asp Val Asn Val 210 215 220 Ser Tyr Tyr Thr He Ala Gin Arg He Val Thr Val He Ala Gly Val 225 230 235 240 Val Thr Gly Ala He Gly Val Ser Val Pro Arg Leu Ser Tyr Tyr Leu 245 250 255 Gly Lys Gly Asp Lys Glu Ala Tyr Val Ser Leu Val Asn Arg Gly Ser 260 265 270 Arg He Phe Asn Phe Phe He He Pro Leu Ser Phe Gly Leu Met Val 275 280 285 Leu Gly Pro Asn Ala He Leu Leu Tyr Gly Ser Glu Lys Tyr He Gly 290 295 300 Gly Gly He Leu Thr Ser Leu Phe Ala Phe Arg Thr He He Leu Ala 305 310 315 320 Leu Asp Thr He Leu Gly Ser Gin He Leu Phe Thr Asn Gly Tyr Glu 325 330 335 Lys Arg He Thr Val Tyr Thr Val Phe Ala Gly Leu Leu Asn Leu Gly 340 345 350 Leu Asn Ser Leu Leu Phe Phe Asn His He Val Ala Pro Glu Tyr Tyr 355 360 365 Leu Leu Thr Thr Met Leu Ser Glu Thr Ser Leu Leu Val Phe Tyr He 370 375 380 He Phe He His Arg Lys Gin Leu He His Leu Gly His He Phe Ser 385 390 395 400 Tyr Thr Val Arg Tyr Ser Leu Phe Ser Leu Ser Phe Val Ala He Tyr 405 410 415 Phe Leu He Asn Phe Val Tyr Pro Val Asp Met Val He Asn Leu Pro 420 425 430 Phe Leu He Asn Thr Gly Leu He Val Leu Leu Ser Ala He Ser Tyr 435 440 445 He Ser Leu Leu Val Phe Thr Lys Asp Ser He Phe Tyr Glu Phe Leu 450 455 460 Asn His Val Leu Ala Leu Lys Asn Lys Phe Lys Lys Ser 465 470 475 (2) INFORMATION FOR SEQ ID NO: 196: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 148 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 196: Phe Pro He Asp Arg Phe Asp Asp Pro Lys Val He Asp Thr Cys Tyr 1 5 10 15 Lys Leu Glu Ser Phe Lys Leu Leu Ser Phe Ser Lys His Lys Asn He 20 25 30 Val Tyr Lys Asp Ser Leu Leu Lys Asp Trp He Arg Thr Ala Phe Trp 35 40 45 Leu Leu Leu Arg Pro Val Ser Pro Arg Tyr Phe Ala Asn Lys He Glu 50 55 60 Lys Glu He Gin Lys Tyr Ser Arg Glu Asn Gly Gin Tyr Met Ala Phe 65 70 75 80 He Pro Ser Lys Phe Lys Glu Lys Glu Val Phe Pro Ser Gly Thr Phe 85 90 95 Asp Lys Thr He Asp Leu Pro Phe Glu Asn Leu Ser Leu Pro Ala Pro 100 105 110 Glu Lys Phe Asp Thr He Leu Thr Gin Phe Tyr Gly Asp Tyr Met Thr 115 120 125 Leu Pro Pro Glu Glu Lys Arg Phe Tyr Ser His Glu Phe His Ala Tyr 130 135 140 Lys Leu Glu Asp 145 (2) INFORMATION FOR SEQ ID NO: 197: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 280 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 197: Met Asn Phe Thr Leu He Asn Trp Arg He Arg Met Gin Tyr Leu Glu 1 5 10 15 Lys Lys Glu He Lys Glu He Gin Leu Ala Leu Leu Asp Tyr He Asp 20 25 30 Glu Thr Cys Lys Lys His Asp He Pro Tyr Phe Leu Ser Tyr Gly Thr 35 40 45 Met Leu Gly Ala He Arg His Lys Gly Met He Pro Trp Asp Asp Asp 50 55 60 He Asp He Ser Leu Tyr Arg Glu Asp Tyr Glu Arg Leu Leu Lys He 65 70 75 80 He Glu Glu Glu Asn His Pro Arg Tyr Lys Val Leu Ser Tyr Asp Thr 85 90 95 Ser Ser Trp Tyr Phe His Asn Phe Ala Ser He Leu Asp Thr Ser Thr 100 105 110 Val He Glu Asp His Val Lys Tyr Lys Arg His Asp Thr Ser Leu Phe 115 120 125 He Asp Val Phe Pro He Asp Arg Phe Thr Asp Leu Ser He Val Asp 130 135 140 Lys Ser Tyr Lys Tyr Val Ala Leu Arg Gin Leu Ala Tyr He Lys Lys 145 150 155 160 Ser Arg Ala Val His Gly Asp Ser Lys Leu Lys Asp Phe Leu Arg Leu 165 170 175 Cys Ser Trp Tyr Ala Leu Arg Phe Val Asn Pro Arg Tyr Phe Tyr Lys 180 185 190 Lys He Asp Gin Leu Val Lys Asn Ala Val Thr Asn Thr Pro Gin Tyr 195 200 205 Glu Gly Gly Val Gly He Gly Lys Glu Gly Met Lys Glu He Phe Pro 210 215 220 Val Asp Thr Phe Lys Glu Leu He Leu Thr Glu Phe Glu Gly Arg Met 225 230 235 240 Leu Pro Val Pro Lys Lys Tyr Asp Gin Phe Leu Thr Gin Met Tyr Gly 245 250 255 Asp Tyr Met Thr Pro Pro Ser Lys Glu Met Gin Glu Trp Tyr Ser His 260 265 270 Ser He Lys Ala Tyr Arg Lys Asn 275 280 (2) INFORMATION FOR SEQ ID NO: 198: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 223 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 198: Lys Gly Phe He Pro Trp Asp Asp Asp Leu Asp Phe Phe Met Pro Arg 1 5 10 15 Lys Asp Tyr Glu Lys Leu Ala Glu Leu Trp Pro Arg Tyr Ala Asp Glu 20 25 30 Arg Tyr Phe Leu Ser Lys Ser His Lys Asp Phe Val Asp Arg Asn Leu 35 40 45 Phe He Thr He Arg Asp Lys Lys Thr Thr Cys He Lys Pro Tyr Gin 50 55 60 Gin Asp Leu Asp Leu Pro His Gly Leu Ala Leu Asp Val Leu Pro Leu 65 70 75 80 Asp Tyr Tyr Pro Lys Asn Pro Ala Glu Arg Lys Lys Gin Val Arg Trp 85 90 95 Ala Leu He Tyr Ser Leu Phe Cys Ala Gin Thr He Pro Glu Lys His 100 105 110 Gly Asp Leu Met Lys Trp Gly Ser Arg He Leu Leu Gly Leu Thr Pro 115 120 125 Lys Ser Leu Arg Tyr Arg He Trp Lys Lys Ala Glu Lys Glu Met Thr 130 135 140 Lys Tyr Asp Leu Ala Asp Cys Asp Gly He Thr Glu Leu Cys Ser Gly 145 150 155 160 Pro Gly Tyr Met Arg Asn Lys Tyr Pro He Thr Ser Phe Glu Asp Asn 165 170 175 Leu Phe Leu Pro Phe Glu Gly Thr Glu Met Pro He Pro He Gly Tyr 180 185 190 Asp Val Tyr Leu Arg Thr Ala Phe Gly Asp Tyr Met Thr Pro Pro Pro 195 200 205 Ala Asp Lys Gin Val Pro His His Asp Thr Val Thr Ala Asp Met 210 215 220 (2) INFORMATION FOR SEQ ID NO: 199: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 835 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 199: Gly Phe Asp Asp Tyr His Pro Ser Cys Gly Arg He Leu Ser Val Val 1 5 10 15 Thr Ser Gly Gly Glu Asp He Ala Asp Ala He He He Leu Ala Val 20 25 30 Val He He Asn Ala Ala Phe Gly Val Tyr Gin Glu Gly Lys Ala Glu 35 40 45 Glu Ala He Glu Ala Leu Lys Ser Met Ser Ser Pro Val Ala Arg Val 50 55 60 Leu Arg Asp Gly His Met Ala Glu He Asp Ser Lys Glu Leu Val Pro 65 70 75 80 Gly Asp He Val Ala Leu Glu Ala Gly Asp Val Val Pro Ala Asp Leu 85 90 95 Arg Leu He Glu Ala Asn Ser Leu Lys He Glu Glu Ala Ala Leu Thr 100 105 110 Gly Glu Ser Val Pro Val Glu Lys Asp Leu Ser Val Asp Leu Ala Thr 115 120 125 Asp Ala Gly He Gly Asp Arg Val Asn Met Ala Phe Gin Asn Ser Asn 130 135 140 Val Thr Tyr Gly Arg Gly Met Gly Val Val Val Asn Thr Gly Met Tyr 145 150 155 160 Thr Glu Val Gly His He Ala Gly Met Leu Gin Asp Ala Asp Glu Thr 165 170 175 Asp Thr Pro Leu Lys Gin Asn Leu Asn Asn Leu Ser Lys Val Leu Thr 180 185 190 Tyr Ala He Leu Val He Ala Leu Val Thr Phe Val Val Gly Val Phe 195 200 205 He Gin Gly Lys Asn Pro Leu Gly Glu Leu Leu Thr Ser Val Ala Leu 210 215 220 Ala Val Ala Ala He Pro Glu Gly Leu Pro Ala He Val Thr He Val 225 230 235 240 Leu Ser Leu Gly Thr Gin Val Leu Ala Lys Arg His Ser He Val Arg 245 250 255 Lys Leu Pro Ala Val Glu Thr Leu Gly Ser Thr Glu He He Ala Ser 260 265 270 Asp Lys Thr Gly Thr Leu Thr Met Asn Lys Met Thr Val Glu Lys Val 275 280 285 Phe Tyr Asp Ala Val Leu His Asp Ser Ala Asp Asp He Glu Leu Gly 290 295 300 Leu Glu Met Pro Leu Leu Arg Ser Val Val Leu Ala Asn Asp Thr Lys 305 310 315 320 He Asp Val Glu Gly Asn Leu He Gly Asp Pro Thr Glu Thr Ala Phe 325 330 335 He Gin Tyr Ala Leu Asp Lys Gly Tyr Asp Val Lys Gly Phe Leu Glu 340 345 350 Lys Tyr Pro Arg Val Ala Glu Leu Pro Phe Asp Ser Asp Arg Lys Leu 355 360 365 Met Ser Thr Val His Pro Leu Pro Asp Ser Arg Phe Leu Val Ala Val 370 375 380 Lys Gly Ala Pro Asp Gin Leu Leu Lys Arg Cys Leu Leu Arg Asp Lys 385 390 395 400 Ala Gly Asp He Ala Pro He Asp Glu Lys Val Thr Asn Leu He His 405 410 415 Thr Asn Asn Ser Glu Met Ala His Gin Ala Leu Arg Val Leu Ala Gly 420 425 430 Ala Tyr Lys He He Asp Ser He Pro Glu Asn Leu Thr Ser Glu Glu 435 440 445 Leu Glu Asn Asp Leu He Phe Thr Gly Leu He Gly Met He Asp Pro 450 455 460 Glu Arg Pro Glu Ala Ala Glu Ala Val Arg Val Ala Lys Glu Ala Gly 465 470 475 480 He Arg Pro He Met He Thr Gly Asp His Gin Asp Thr Ala Glu Ala 485 490 495 He Ala Lys Arg Leu Gly He He Asp Ala Asn Asp Thr Glu Gly His 500 505 510 Val Leu Thr Gly Ala Glu Leu Asn Glu Leu Ser Asp Glu Glu Phe Glu 515 520 525 Lys Val Val Gly Gin Tyr Ser Val Tyr Ala Arg Val Ser Pro Glu His 530 535 540 Lys Val Arg He Val Lys Ala Trp Gin Lys Gin Gly Lys Val Val Ala 545 550 555 560 Met Thr Gly Asp Gly Val Asn Asp Ala Pro Ala Leu Lys Thr Ala Asp 565 570 575 He Gly He Gly Met Gly He Thr Gly Thr Glu Val Ser Lys Gly Ala 580 585 590 Ser Asp Met He Leu Ala Asp Asp Asn Phe Ala Thr He He Val Ala 595 600 605 Val Glu Glu Gly Arg Lys Val Phe Ser Asn He Gin Lys Thr He Gin 610 615 620 Tyr Leu Leu Ser Ala Asn Thr Ala Glu Val Leu Thr He Phe Leu Ser 625 630 635 640 Thr Leu Phe Gly Trp Asp Val Leu Gin Pro Val His Leu Leu Trp He 645 650 655 Asn Leu Val Thr Asp Thr Phe Pro Ala He Ala Leu Gly Val Glu Pro 660 665 670 Ala Glu Pro Gly Val Met Asn His Lys Pro Arg Gly Arg Lys Ala Ser 675 680 685 Phe Phe Ser Gly Gly Val Leu Ser Ser He He Tyr Gin Gly Val Leu 690 695 700 Gin Ala Ala Leu Val Met Ser Val Tyr Gly Leu Ala He Ala Tyr Pro 705 710 715 720 Val His Val Gly Asp Asn His Ala He His Ala Asp Ala Leu Thr Met 725 730 735 Ala Phe Ala Thr Leu Gly Leu He Gin Leu Phe His Ala Tyr Asn Val 740 745 750 Lys Ser Val Tyr Gin Ser He Leu Thr Val Gly Pro Phe Lys Ser Lys 755 760 765 Thr Phe Asn Trp Ser He Leu Val Ser Phe He Leu Leu Met Ala Thr 770 775 780 He Val Val Glu Pro Leu Glu Gly He Phe His Val Thr Lys Leu Asp 785 790 795 800 Leu Ser Gin Trp Gly He Val Met Ala Gly Ser Phe Ser Met He He 805 810 815 He Val Glu He Val Lys Phe He Gin Arg Lys Leu Gly Phe Asp Lys 820 825 830 Asn Ala He 835 (2) INFORMATION FOR SEQ ID NO: 200: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 525 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 200: Gly Phe He Leu Phe Phe Val Leu Leu Gly Ala Val Phe Glu Glu Lys 1 5 10 15 Met Arg Lys Asn Thr Ser Gin Ala Val Glu Lys Leu Leu Asp Leu Gin 20 25 30 Ala Lys Thr Ala Glu Val Leu Ser Asp Asp Ser Tyr Val Gin Val Pro 35 40 45 Leu Glu Gin Val Lys Val Gly Asp Leu He Arg Val Arg Pro Gly Glu 50 55 60 Lys He Ala Val Asp Gly Val Val Val Glu Gly Val Ser Ser He Asp 65 70 75 80 Glu Ser Met Val Thr Gly Glu Ser Leu Pro Val Asp Lys Thr Val Gly 85 90 95 Asp Thr Val He Gly Ser Thr He Asn His Ser Gly Thr Leu Val Phe 100 105 110 Arg Ala Glu Lys Val Gly Ser Glu Thr Val Leu Ala Gin He Val Asp 115 120 125 Phe Val Lys Lys Ala Gin Thr Ser Arg Ala Pro He Gin Asp Leu Thr 130 135 140 Asp Lys He Ser Gly He Phe Val Pro Val Val Val He Leu Gly He 145 150 155 160 Met Thr Phe Trp Val Trp Phe Val Leu Leu Arg Asp Ser Val Val Val 165 170 175 Leu Gly Ala Ser Phe Val Ser Ser Leu Leu Tyr Gly Val Ala Val Leu 180 185 190 He He Ala Cys Pro Cys Ala Leu Gly Leu Ala Thr Pro Thr Ala Leu 195 200 205 Met Val Gly Thr Gly Arg Ser Ala Lys Met Gly Val Leu Leu Lys Asn 210 215 220 Gly Thr Val Leu Gin Glu He Gin Lys Val Gin Thr Leu Val Phe Asp 225 230 235 240 Lys Thr Gly Thr Leu Thr Glu Gly Lys Pro Val Val Thr Asp He He 245 250 255 Gly Asp Glu Val Glu Val Phe Gly Leu Ala Ala Ser Leu Glu Asp Ala 260 265 270 Ser Gin His Pro Leu Ala Glu Ala He Val Lys Arg Ala Ser Glu Ala 275 280 285 Gly Leu Glu Phe Gin Thr Val Glu Asn Phe Gin Ala Leu His Gly Lys 290 295 300 Gly Val Ser Gly Arg He Asn Gly Lys Gin Val Leu Leu Gly Asn Ala 305 310 315 320 Lys Met Leu Asp Gly Met Asp He Ser Asn Thr Tyr Gin Asp Lys Leu 325 330 335 Glu Glu Leu Glu Lys Glu Ala Lys Thr Val Val Phe Leu Ala Val Asp 340 345 350 Asn Glu He Lys Gly Leu Leu Ala Leu Gin Asp He Pro Lys Glu Asn 355 360 365 Ala Lys Leu Ala He Ser Gin Leu Lys Lys Arg Gly Leu Arg Thr Val 370 375 380 Met Leu Thr Gly Asp Asn Ala Gly Val Ala Arg Ala He Ala Asp Gin 385 390 395 400 He Gly He Glu Glu Val He Ala Gly Val Leu Pro Glu Glu Lys Ala 405 410 415 His Glu He His Lys Leu Gin Ala Ala Gly Lys Val Ala Phe Val Gly 420 425 430 Asp Gly He Asn Asp Ala Pro Ala Leu Ser Val Ala Asp Val Gly He 435 440 445 Ala Met Gly Ala Gly Thr Asp He Ala He Glu Ser Ala Asp Leu Val 450 455 460 Leu Thr Thr Asn Asn Leu Leu Gly Val Val Arg Ala Phe Asp Met Ser 465 470 475 480 Lys Lys Thr Phe His Arg He Leu Leu Asn Leu Phe Trp Ala Phe He 485 490 495 Tyr Asn Val Val Gly He Pro He Ala Ala Gly Val Phe Ser Gly Val 500 505 510 Gly Trp Leu Ser Thr Gin He Gly Lys Ala Ser Pro Met 515 520 525 (2) INFORMATION FOR SEQ ID NO:201: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 362 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:201: Asn Asp He He Glu Phe Met Asp Lys Asn Lys He Met Gly Leu Thr 1 5 10 15 Gin Arg Glu Val Lys Glu Arg Gin Ala Glu Gly Leu Val Asn Asp Phe 20 25 30 Thr Ala Ser Ala Ser Thr Ser Thr Trp Gin He Val Lys Arg Asn Val 35 40 45 Phe Thr Leu Phe Asn Ala Leu Asn Phe Ala He Ala Leu Ala Leu Ala 50 55 60 Phe Val Gin Ala Trp Ser Asn Leu Val Phe Phe Ala Val He Cys Phe 65 70 75 80 Asn Ala Phe Ser Gly He Val Thr Glu Leu Arg Ala Lys His Met Val 85 90 95 Asp Lys Leu Asn Leu Met Thr Lys Glu Lys Val Lys Thr He Arg Asp 100 105 110 Gly Gin Glu Val Ala Leu Asn Pro Glu Glu Leu Val Leu Gly Asp Val 115 120 125 He Arg Leu Ser Ala Gly Glu Gin He Pro Ser Asp Ala Leu Val Leu 130 135 140 Glu Gly Phe Ala Glu Val Asn Glu Ala Met Leu Thr Gly Glu Ser Asp 145 150 155 160 Leu Val Gin Lys Glu Val Asp Gly Leu Leu Leu Ser Gly Ser Phe Leu 165 170 175 Ala Ser Gly Ser Val Leu Ser Gin Val His His Val Gly Ala Asp Asn 180 185 190 Tyr Ala Ala Lys Leu Met Leu Glu Ala Lys Thr Val Lys Pro He Asn 195 200 205 Ser Arg He Met Lys Ser Leu Asp Lys Leu Ala Gly Phe Thr Gly Lys 210 215 220 He He He Pro Phe Gly Leu Ala Leu Leu Leu Glu Ala Leu Leu Leu 225 230 235 240 Lys Gly Leu Pro Leu Lys Ser Ser Val Val Asn Ser Ser Thr Ala Leu 245 250 255 Leu Gly Met Leu Pro Lys Gly He Ala Leu Leu Thr He Thr Ser Leu 260 265 270 Leu Thr Ala Val He Lys Leu Gly Leu Lys Lys Val Leu Val Gin Glu 275 280 285 Met Tyr Ser Val Glu Thr Leu Ala Arg Val Asp Met Leu Cys Leu Asp 290 295 300 Lys Thr Gly Thr He Thr Gin Gly Lys Met Gin Val Glu Ala Val Leu 305 310 315 320 Pro Leu Thr Glu Thr Tyr Gly Glu Glu Ala He Ala Ser He Leu Thr 325 330 335 Ser Tyr Met Ala His Ser Glu Asp Lys Asn Pro Thr Ala Gin Ala He 340 345 350 Arg Gin Arg Leu Trp Glu Met Leu Leu He 355 360 (2) INFORMATION FOR SEQ ID NO:202: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 243 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 202: Ala Ser Asn He Met Phe Met Leu Asp Leu Gly Asn His Leu Asp Gin 1 5 10 15 Trp Ser Leu Lys Lys Thr Ala Thr Asp Leu Glu Gin Ser Leu Leu Ala 20 25 30 Lys Glu Ser Asp Val Phe Leu Val Gin Gly Asp Thr Val Val Ser He 35 40 45 Lys Ser Ser Asp Val Gin He Gly Asp Val Leu He Leu Ser Gin Gly 50 55 60 Asn Glu He Leu Phe Asp Gly Gin Val Val Ser Gly Leu Gly Met Val 65 70 75 80 Asn Glu Ser Ser Leu Thr Gly Glu Ser Phe Pro Val Glu Lys Arg Glu 85 90 95 Ser Asp Leu Val Cys Ala Asn Thr Val Leu Glu Thr Gly Glu Leu Arg 100 105 110 He Arg Val Thr Asp Asn Gin Met Asn Ser Arg He Leu Gin Leu He 115 120 125 Glu Leu Met Lys Lys Ser Glu Glu Asn Lys Lys Thr Lys Gin Arg Tyr 130 135 140 Phe He Lys Met Ala Asp Lys Val Val Lys Tyr Asn Phe Leu Gly Ser 145 150 155 160 Gly Leu Thr Tyr Leu Leu Thr Gly Ser Phe Ser Lys Ala He Ser Phe 165 170 175 Leu Leu Val Asp Phe Ser Cys Ala Leu Lys He Ser Thr Pro Val Ala 180 185 190 Tyr Leu Thr Val He Lys Val Gly Leu Asn Arg Glu Met Val He Lys 195 200 205 Asp Gly Asp Val Leu Glu Lys Tyr Leu Val Val Asp Thr Phe Leu Phe 210 215 220 Asp Lys Thr Gly Pro He Thr Thr Ser Tyr Pro He Val Glu Lys Val 225 230 235 240 Tyr Pro Leu (2) INFORMATION FOR SEQ ID NO: 203: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 307 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 203: Lys Gin He Glu Val Val Asp Lys Asp Asn Lys Ser Glu Thr Ala Glu 1 5 10 15 Ala Ala Ser Val Thr Thr Asn Leu Val Thr Gin Ser Lys Val Ser Ala 20 25 30 Val Val Gly Pro Ala Thr Ser Gly Ala Thr Ala Ala Ala Val Ala Asn 35 40 45 Ala Thr Lys Ala Gly Val Pro Leu He Ser Pro Ser Ala Thr Gin Asp 50 55 60 Gly Leu Thr Lys Gly Gin Asp Tyr Leu Phe He Gly Thr Phe Gin Asp 65 70 75 80 Ser Phe Gin Gly Lys He He Ser Asn Tyr Val Ser Glu Lys Leu Asn 85 90 95 Ala Lys Lys Val Val Leu Tyr Thr Asp Asn Ala Ser Asp Tyr Ala Lys 100 105 110 Gly He Ala Lys Ser Phe Arg Glu Ser Tyr Lys Gly Glu He Val Ala 115 120 125 Asp Glu Thr Phe Val Ala Gly Asp Thr Asp Phe Gin Ala Ala Leu Thr 130 135 140 Lys Met Lys Gly Lys Asp Phe Asp Ala He Val Val Pro Gly Tyr Tyr 145 150 155 160 Asn Glu Ala Gly Lys He Val Asn Gin Ala Arg Gly Met Gly He Asp 165 170 175 Lys Pro He Val Gly Gly Asp Gly Phe Asn Gly Glu Glu Phe Val Gin 180 185 190 Gin Ala Thr Ala Glu Lys Ala Ser Asn He Tyr Phe He Ser Gly Phe 195 200 205 Ser Thr Thr Val Glu Val Ser Ala Lys Ala Lys Ala Phe Leu Asp Ala 210 215 220 Tyr Arg Ala Lys Tyr Asn Glu Glu Pro Ser Thr Phe Ala Ala Leu Ala 225 230 235 240 Tyr Asp Ser Val His Leu Val Ala Asn Ala Ala Lys Gly Ala Lys Asn 245 250 255 Ser Gly Glu He Lys Asn Asn Leu Ala Lys Thr Lys Asp Phe Glu Gly 260 265 270 Val Thr Gly Gin Thr Ser Phe Asp Ala Asp His Asn Thr Val Lys Thr 275 280 285 Ala Tyr Met Met Thr Met Asn Asn Gly Lys Val Glu Ala Ala Glu Val 290 295 300 Val Lys Pro 305 (2) INFORMATION FOR SEQ ID NO: 204: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 289 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:204: Met Leu Gin Gin Leu Val Asn Gly Leu He Leu Gly Ser Val Tyr Ala 1 5 10 15 Leu Leu Ala Leu Gly Tyr Thr Met Val Tyr Gly He He Lys Leu He 20 25 30 Asn Phe Ala His Gly Asp He Tyr Met Met Gly Ala Phe He Gly Tyr 35 40 45 Phe Leu He Asn Ser Phe Gin Met Asn Phe Phe Val Ala Leu He Val 50 55 60 Ala Met Leu Ala Thr Ala He Leu Gly Val Val He Glu Phe Leu Ala 65 70 75 80 Tyr Arg Pro Leu Arg His Ser Thr Arg He Ala Val Leu He Thr Ala 85 90 95 He Gly Val Ser Phe Leu Leu Glu Tyr Gly Met Val Tyr Leu Val Gly 100 105 110 Ala Asn Thr Arg Ala Phe Pro Gin Ala He Gin Thr Val Arg Tyr Asp 115 120 125 Leu Gly Pro He Ser Leu Thr Asn Val Gin Leu Met He Leu Gly He 130 135 140 Ser Leu He Leu Met He Leu Leu Gin Val He Val Gin Lys Thr Lys 145 150 155 160 Met Gly Lys Ala Met Arg Ala Val Ser Val Asp Ser Asp Ala Ala Gin 165 170 175 Leu Met Gly He Asn He Asn Arg Thr He Ser Phe Thr Phe Ala Leu 180 185 190 Gly Ser Ala Leu Ala Gly Ala Ala Gly Val Leu He Ala Leu Tyr Tyr 195 200 205 Asn Ser Leu Glu Pro Leu Met Gly Val Thr Pro Gly Leu Lys Ser Phe 210 215 220 Val Ala Ala Val Leu Gly Gly He Gly He He Pro Gly Ala Ala Leu 225 230 235 240 Gly Gly Phe Val He Gly Leu Leu Glu Thr Phe Ala Thr Ala Phe Gly 245 250 255 Met Ser Asp Phe Arg Asp Ala He Val Tyr Gly He Leu Leu Leu He 260 265 270 Leu He Val Arg Pro Ala Gly He Leu Gly Lys Asn Val Lys Glu Lys 275 280 285 Val (2) INFORMATION FOR SEQ ID NO:205: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 106 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:205: Ser Gin Asp Gin Thr Trp Tyr Ala Leu Ala Tyr Asp Gly Ala Glu Val 1 5 10 15 He Gly Phe Leu Thr Val Gin Glu Thr Leu Phe Glu Ala Glu Val Leu 20 25 30 Gin He Ala Val Lys Gly Ala Tyr Gin Gly Gin Gly He Ala Ser Ala 35 40 45 Leu Phe Ala Gin Leu Pro Thr Asp Lys Glu He Phe Leu Glu Val Arg 50 55 60 Gin Ser Asn Gin Arg Ala Gin Ala Phe Tyr Lys Lys Glu Lys Met Ala 65 70 75 80 Val He Ala Glu Arg Lys Ala Tyr Tyr His Asp Pro Val Glu Asp Ala 85 90 95 He He Met Lys Arg Glu He Asp Glu Gly 100 105 (2) INFORMATION FOR SEQ ID NO:206: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 45 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:206: Lys Thr Leu Lys Gly His Gly Gin Phe Leu His Ala Lys Thr Leu Gly 1 5 10 15 Phe Thr His Pro Arg Thr Gly Lys Thr Leu Glu Phe Lys Ala Asp He 20 25 30 Pro Glu He Phe Lys Glu Thr Leu Glu Arg Leu Arg Lys 35 40 45 (2) INFORMATION FOR SEQ ID NO: 207: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 163 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:207: Arg Glu Met Val Val His Pro Ser Ala Gly His Thr Ser Gly Thr Leu 1 5 10 15 Val Asn Ala Leu Met Tyr His He Lys Asp Leu Ser Gly He Asn Gly 20 25 30 Val Leu Arg Pro Gly He Val His Arg He Asp Lys Asp Thr Ser Gly 35 40 45 Leu Leu Met He Ala Lys Asn Asp Asp Ala His Leu Val Leu Ala Gin 50 55 60 Glu Leu Lys Asp Lys Lys Ser Leu Arg Lys Tyr Trp Ala He Val His 65 70 75 80 Gly Asn Leu Pro Asn Asp Arg Gly Val He Glu Ala Pro He Gly Arg 85 90 95 Ser Glu Lys Asp Arg Lys Lys Gin Ala Val Thr Ala Lys Gly Lys Pro 100 105 110 Ala Val Thr Arg Phe His Val Leu Glu Arg Phe Gly Asp Tyr Ser Leu 115 120 125 Val Glu Leu Gin Leu Glu Thr Gly Arg Thr His Gin He Arg Val His 130 135 140 Met Ala Tyr He Gly His Pro Val Ala Gly Asp Glu Val Tyr Gly Pro 145 150 155 160 Ala Arg Leu (2) INFORMATION FOR SEQ ID NO: 208: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 224 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 208: Leu Gly Thr Arg Gly Ser Ser Arg Val Asp Asn He Asn Leu Gin Val 1 5 10 15 Asp Glu Arg Asp Arg He Ala Leu Val Gly Lys Asn Gly Ala Gly Lys 20 25 30 Ser Thr Leu Leu Lys He Leu Val Gly Glu Glu Glu Pro Thr Ser Gly 35 40 45 Glu He Asn Lys Lys Lys Asp He Ser Leu Ser Tyr Leu Ala Gin Asp 50 55 60 Ser Arg Phe Glu Ser Glu Asn Thr He Tyr Asp Glu Met Leu His Val 65 70 75 80 Phe Asn Asp Leu Arg Arg Thr Glu Arg Gin Leu Arg Gin Met Glu Leu 85 90 95 Glu Met Gly Glu Lys Ser Gly Glu Asp Leu Asp Lys Leu Met Ser Asp 100 105 110 Tyr Asp Arg Leu Ser Glu Asn Phe Arg Gin Ala Gly Gly Phe Thr Tyr 115 120 125 Glu Ala Asp He Arg Ala He Leu Asn Gly Phe Lys Phe Asp Glu Ser 130 135 140 Met Trp Gin Met Lys He Ala Glu Leu Ser Gly Gly Gin Asn Thr Arg 145 150 155 160 Leu Ala Leu Ala Lys Met Leu Leu Glu Lys Pro Asn Leu Leu Val Leu 165 170 175 Asp Glu Pro Thr Asn His Leu Asp He Glu Thr He Ala Trp Leu Glu 180 185 190 Asn Tyr Leu Val Asn Tyr Ser Gly Ala Leu He He Val Ser His Asp 195 200 205 Arg Tyr Phe Leu Asp Lys Val Ala Thr He Thr Leu Asp Leu Thr Ser 210 215 220 (2) INFORMATION FOR SEQ ID NO:209: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 192 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:209: Ser Thr Thr His His Leu Leu Val Lys Lys Val Asn Gly Leu Leu Val 1 5 10 15 Arg Trp Lys Asn Ala Cys Arg Gin Asn Cys Lys Gin Thr Phe Xaa Phe 20 25 30 Val Leu Thr Gin Leu He His Ala Asp Lys Trp Thr Val Ser Gly Arg 35 40 45 Gly Glu Leu His Leu Ser He Leu He Glu Thr Met Arg Arg Glu Gly 50 55 60 Tyr Glu Leu Gin Val Ser Arg Pro Glu Val He Val Lys Glu He Asp 65 70 75 80 Gly Val Lys Cys Glu Pro Phe Glu Arg Val Gin He Asp Thr Pro Glu 85 90 95 Glu Tyr Gin Gly Ser Val He Gin Ser Leu Ser Glu Arg Lys Gly Glu 100 105 110 Met Leu Asp Met He Ser Thr Gly Asn Gly Gin Thr Arg Leu Val Phe 115 120 125 Leu Val Pro Ala Arg Gly Leu Xaa Trp He Leu Asn Val Leu Val Asn 130 135 140 Asp Ser Trp Leu Arg Tyr His Glu Pro Tyr Leu Arg Pro He Leu Ala 145 150 155 160 He Asp Ser Arg Gly Asn Trp Trp Thr Ser Pro Trp Cys Pro Cys Phe 165 170 175 Tyr Arg Cys Trp Gly Tyr Asn Leu Leu Asn Leu Leu Leu Ser Thr Leu 180 185 190 (2) INFORMATION FOR SEQ ID NO: 210: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 252 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:210: Met Phe Gly Phe Phe Lys Lys Asp Lys Ala Val Glu Val Glu Val Pro 1 5 10 15 Thr Gin Val Pro Ala His He Gly He He Met Asp Gly Asn Gly Arg 20 25 30 Trp Ala Lys Lys Arg Met Gin Pro Arg Val Phe Gly His Lys Ala Gly 35 40 45 Met Glu Ala Leu Gin Thr Val Thr Lys Ala Ala Asn Lys Leu Gly Val 50 55 60 Lys Val He Thr Val Tyr Ala Phe Ser Thr Glu Asn Trp Thr Arg Pro 65 70 75 80 Asp Gin Glu Val Lys Phe Xaa Met Asn Leu Pro Val Glu Phe Tyr Asp 85 90 95 Asn Tyr Val Pro Glu Leu His Ala Asn Asn Val Lys He Gin Met He 100 105 110 Gly Glu Thr Asp Arg Leu Pro Lys Gin Thr Phe Glu Ala Leu Thr Lys 115 120 125 Ala Glu Glu Leu Thr Lys Asn Asn Thr Gly Leu He Leu Asn Phe Ala 130 135 140 Leu Asn Tyr Gly Gly Arg Ala Glu He Thr Gin Ala Leu Lys Leu He 145 150 155 160 Ser Gin Asp Val Leu Asp Ala Lys He Asn Pro Gly Asp He Thr Glu 165 170 175 Glu Leu He Gly Asn Tyr Leu Phe Thr Gin His Leu Pro Lys Asp Leu 180 185 190 Arg Asp Pro Asp Leu He He Arg Thr Ser Gly Glu Leu Arg Leu Ser 195 200 205 Asn Phe Leu Pro Trp Gin Gly Ala Tyr Ser Glu Leu Tyr Phe Thr Asp 210 215 220 Thr Leu Trp Pro Asp Phe Asp Glu Ala Ala Leu Gin Glu Ala He Leu 225 230 235 240 Ala Tyr Asn Arg Arg His Arg Arg Phe Gly Gly Val 245 250 (2) INFORMATION FOR SEQ ID NO: 211: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 67 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 211: Val Glu Gin Lys Leu Arg Gly Arg Asn Glu Asn Glu He Gin Ser Glu 1 5 10 15 Asp He Gly Ser Leu Val Met Glu Glu Leu Ala Glu Leu Asp Glu He 20 25 30 Thr Tyr Val Arg Phe Ala Ser Val Tyr Arg Ser Phe Lys Asp Val Ser 35 40 45 Glu Leu Glu Ser Leu Leu Gin Gin He Thr Gin Ser Ser Lys Lys Lys 50 55 60 Lys Glu Arg 65 (2) INFORMATION FOR SEQ ID NO: 212: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 75 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 212: Val Asp Ser Arg Gin Ala Glu Glu Gly Asn Thr He Arg Arg Arg Arg 1 5 10 15 Glu Cys Asp Glu Cys Gin His Arg Phe Thr Thr Tyr Glu Arg Val Glu 20 25 30 Glu Arg Thr Leu Val Val Val Lys Lys Asp Gly Thr Arg Glu Gin Phe 35 40 45 Ser Arg Asp Lys He Phe Asn Gly He He Arg Ser Ala Gin Lys Arg 50 55 60 Pro Val Ser Ser Asp Glu He Asn Met Val He 65 70 75 (2) INFORMATION FOR SEQ ID NO:213: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 63 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 213: Phe Ala Gin Val Pro Lys Val Ala Gin Lys Val Met Lys Val Thr Lys 1 5 10 15 Ala Ala Gly Met Asn He He Ser Asn Cys Glu Glu Val Ala Gly Gin 20 25 30 Thr Val Phe His Thr His Val His Leu Val Pro Arg Tyr Ser Ala Asp 35 40 45 Asp Asp Leu Lys He Asp Phe He Ala His Glu Thr Asp Phe Asp 50 55 60 (2) INFORMATION FOR SEQ ID NO: 214: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 67 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 214: Met Ser Asp Cys He Phe Cys Lys He He Ala Gly Glu He Pro Ala 1 5 10 15 Ser Lys Val Tyr Glu Asp Glu Gin Val Leu Ala Phe Leu Asp He Ser 20 25 30 Gin Val Thr Leu Gly His Thr Leu Val Val Pro Lys Glu His Tyr Arg 35 40 45 Asn Leu Leu Glu Met Asp Ala Thr Ser Ala Thr Asn Ser Leu Pro Lys 50 55 60 Tyr Gin Lys 65 (2) INFORMATION FOR SEQ ID NO: 215: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 212 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:215: He Gin Ala Val Arg Asp Val Ser Phe Glu Val Asn Glu Gly Glu Val 1 5 10 15 Val Ser Leu He Gly Ala Asn Gly Ala Gly Lys Thr Thr He Leu Arg 20 25 30 Thr Leu Ser Gly Leu Val Arg Pro Ser Ser Gly Lys He Glu Phe Leu 35 40 45 Gly Gin Glu He Gin Lys Met Pro Ala Gin Lys He Val Ala Gly Gly 50 55 60 Leu Ser Gin Val Pro Glu Gly Arg His Val Phe Pro Gly Leu Thr Val 65 70 75 80 Met Glu Asn Leu Glu Met Gly Ala Phe Leu Lys Lys Asn Arg Glu Glu 85 90 95 Asn Gin Ala Asn Leu Lys Lys Val Phe Ser Arg Phe Pro Arg Leu Glu 100 105 110 Glu Arg Lys Asn Gin Asp Ala Ala Thr Leu Ser Gly Gly Glu Gin Gin 115 120 125 Met Leu Ala Met Gly Arg Ala Leu Met Ser Thr Pro Lys Leu Leu Leu 130 135 140 Leu Asp Glu Pro Ser Met Gly Leu Ala Pro He Phe He Gin Glu He 145 150 155 160 Phe Asp He He Gin Asp He Gin Lys Gin Gly Thr Thr Val Leu Leu 165 170 175 He Glu Gin Asn Ala Asn Lys Ala Leu Ala He Ser Asp Arg Gly Tyr 180 185 190 Val Leu Glu Gin Gly Asn Arg Leu Ser Gly Thr Gly Lys Asp Ser Leu 195 200 205 He Arg Gly Val 210 (2) INFORMATION FOR SEQ ID NO-.216: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 43 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:216: Leu Leu Ser Leu He Asp He Leu Val Asp Gly Arg Tyr Asp Arg Thr 1 5 10 15 Lys Arg Asn Leu Met Leu Gin Phe Arg Gly Ser Ser Asn Gin Arg He 20 25 30 He Asp Ser Arg Gly Ser Pro Gly Thr Glu Leu 35 40 (2) INFORMATION FOR SEQ ID NO: 217: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 130 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 217: Met Asn Asn Pro Lys Pro Gin Glu Trp Lys Ser Glu Glu Leu Ser Gin 1 5 10 15 Gly Arg He He Asp Tyr Lys Ala Phe Asn Phe Val Asp Gly Glu Gly 20 25 30 Val Arg Asn Ser Leu Tyr Val Ser Gly Cys Met Phe His Cys Glu Gly 35 40 45 Cys Tyr Asn Val Ala Thr Trp Ser Phe Asn Ala Gly He Pro Tyr Thr 50 55 60 Ala Glu Leu Glu Glu Gin He Met Ala Asp Leu Ala Gin Pro Tyr Val 65 70 75 80 Gin Gly Leu Thr Leu Leu Gly Gly Glu Pro Phe Leu Asn Thr Gly He 85 90 95 Leu Leu Pro Leu Val Lys Arg He Arg Lys Glu Leu Pro Asp Lys Asp 100 105 110 He Trp Ser Trp Thr Gly Tyr Thr Trp Glu Glu Met He Pro Gly Asn 115 120 125 Ser Arg 130 (2) INFORMATION FOR SEQ ID NO: 218: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 126 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:218: Met Val Asn His Phe Arg He Asp Arg Val Gly Met Glu He Lys Arg 1 5 10 15 Glu Val Asn Glu He Leu Gin Lys Lys Val Arg Asp Pro Arg Val Gin 20 25 30 Gly Val Thr He Thr Asp Val Gin Met Leu Gly Asp Leu Ser Val Ala 35 40 45 Lys Val Tyr Tyr Thr He Leu Ser Asn Leu Ala Ser Asp Asn Gin Lys 50 55 60 Ala Gin He Gly Leu Glu Lys Ala Thr Gly Thr He Lys Arg Glu Leu 65 70 75 80 Gly Arg Asn Leu Lys Leu Tyr Xaa He Pro Asp Leu Thr Phe Val Lys 85 90 95 Asp Glu Ser He Glu Xaa Gly Thr Lys He Asp Glu Met Leu Arg Asn 100 105 110 Leu Asp Lys Thr Lys Glu Glu Gly Val Ala Pro Leu Phe Trp 115 120 125 (2) INFORMATION FOR SEQ ID NO: 219: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 267 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:219: Phe His His Val Thr Val Leu Leu His Glu Thr He Asp Met Leu Asp 1 5 10 15 Val Lys Pro Glu Gly He Tyr Val Asp Ala Thr Leu Gly Gly Ala Gly 20 25 30 His Ser Glu Tyr Leu Leu Ser Lys Leu Ser Glu Lys Gly His Leu Tyr 35 40 45 Ala Phe Asp Gin Asp Gin Asn Ala He Asp Asn Ala Gin Lys Arg Leu 50 55 60 Ala Pro Tyr He Glu Lys Gly Met Val Thr Phe He Lys Asp Asn Phe 65 70 75 80 Arg His Leu Gin Ala Arg Leu Arg Glu Ala Gly Val Gin Glu He Asp 85 90 95 Gly He Cys Tyr Asp Leu Gly Val Ser Ser Pro Gin Leu Asp Gin Arg 100 105 110 Glu Arg Gly Phe Ser Tyr Lys Lys Asp Ala Pro Leu Asp Met Arg Met 115 120 125 Asn Gin Asp Ala Ser Leu Thr Ala Tyr Glu Val Val Asn His Tyr Asp 130 135 140 Tyr His Asp Leu Val Arg He Phe Phe Lys Tyr Gly Glu Asp Lys Phe 145 150 155 160 Ser Lys Gin He Ala Arg Lys He Glu Gin Ala Arg Glu Val Lys Pro 165 170 175 He Glu Thr Thr Thr Glu Leu Ala Glu He He Lys Leu Val Lys Pro 180 185 190 Ala Lys Glu Leu Lys Lys Lys Gly His Pro Ala Lys Gin He Phe Gin 195 200 205 Ala He Arg He Glu Val Asn Asp Glu Leu Gly Ala Ala Asp Glu Ser 210 215 220 He Gin Gin Ala Met Asp Met Leu Ala Leu Asp Gly Arg He Ser Val 225 230 235 240 He Thr Phe His Ser Leu Glu Asp Arg Leu Thr Lys Gin Leu Phe Lys 245 250 255 Xaa Ala Ser Thr Val Glu Val Pro Lys Gly Leu 260 265 (2) INFORMATION FOR SEQ ID NO:220: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 165 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:220: Leu Met His Val Thr Val Gly Glu Leu He Gly Asn Phe He Leu He 1 5 10 15 Thr Gly Ser Phe He Leu Leu Leu Val Leu He Lys Lys Phe Ala Trp 20 25 30 Ser Asn He Thr Gly He Phe Glu Glu Arg Ala Glu Lys He Ala Ser 35 40 45 Asp He Asp Arg Ala Glu Glu Ala Arg Gin Lys Ala Glu Val Leu Ala 50 55 60 Gin Lys Arg Glu Asp Glu Leu Ala Gly Ser Arg Lys Glu Ala Lys Thr 65 70 75 80 He He Glu Asn Ala Lys Glu Thr Ala Glu Gin Ser Lys Ala Asn He 85 90 95 Leu Ala Asp Ala Lys Leu Glu Ala Gly His Leu Lys Glu Lys Ala Asn 100 105 110 Gin Glu He Ala Gin Asn Lys Val Glu Ala Leu Gin Ser Val Lys Gly 115 120 125 Glu Val Ala Asp Leu Thr He Ser Leu Ala Gly Lys He He Ser Gin 130 135 140 Asn Leu Asp Ser His Ala His Lys Ala Leu He Asp Gin Tyr He Asp 145 150 155 160 Gin Leu Gly Glu Ala 165 (2) INFORMATION FOR SEQ ID NO: 221: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 629 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 221: Met Gin Arg Leu Val Ser Leu Leu He Trp Ser Leu Leu Glu Thr Ser 1 5 10 15 He Leu Ser He His Gly Leu Gly Pro Leu Thr Lys Arg Phe Gly Val 20 25 30 Ala Leu Glu His His His Met Ala Asn Tyr Asp Ala Glu Ala Thr Gly 35 40 45 Arg Leu Leu Phe He Phe He Lys Glu Val Ala Glu Lys His Gly Val 50 55 60 Thr Asp Leu Ala Arg Leu Asn He Asp Leu He Ser Pro Asp Ser Tyr 65 70 75 80 Lys Lys Ala Arg He Lys His Ala Thr He Tyr Val Lys Asn Gin Val 85 90 95 Gly Leu Lys Asn He Phe Lys Leu Val Ser Leu Ser Asn Thr Lys Tyr 100 105 110 Phe Glu Gly Val Ser Arg He Pro Arg Thr Val Leu Asp Ala His Arg 115 120 125 Glu Gly Leu He Leu Gly Ser Ala Cys Ser Glu Gly Glu Val Phe Asp 130 135 140 Val Val Val Ser Gin Gly Val Asp Ala Ala Val Glu Val Ala Lys Tyr 145 150 155 160 Tyr Asp Phe He Glu Val Met Pro Pro Ala He Tyr Ala Pro Leu He 165 170 175 Ala Lys Glu Gin Val Lys Asp Met Glu Glu Leu Gin Thr He He Lys 180 185 190 Ser Leu He Glu Val Gly Asp Arg Leu Gly Lys Pro Val Leu Ala Thr 195 200 205 Gly Asn Val His Tyr He Glu Pro Glu Glu Glu He Tyr Arg Glu He 210 215 220 He Val Arg Ser Leu Gly Gin Gly Ala Met He Asn Arg Thr He Gly 225 230 235 240 His Gly Glu His Ala Gin Pro Ala Pro Leu Pro Lys Ala His Phe Arg 245 250 255 Thr Thr Asn Glu Met Leu Asp Glu Phe Ala Phe Leu Gly Glu Glu Leu 260 265 270 Ala Arg Lys Leu Val He Glu Asn Thr Asn Ala Leu Ala Glu He Phe 275 280 285 Glu Pro Val Glu Val Val Lys Gly Asp Leu Tyr Thr Pro Phe He Asp 290 295 300 Lys Ala Glu Glu Thr Val Ala Glu Leu Thr Tyr Lys Lys Ala Phe Glu 305 310 315 320 He Tyr Gly Asn Pro Leu Pro Asp He Val Asp Leu Arg He Glu Lys 325 330 335 Glu Leu Thr Ser He Leu Gly Asn Gly Phe Ala Val He Tyr Leu Ala 340 345 350 Ser Gin Met Leu Val Gin Arg Ser Asn Glu Arg Gly Tyr Leu Val Gly 355 360 365 Ser Arg Gly Ser Val Gly Ser Ser Phe Val Ala Thr Met He Gly He 370 375 380 Thr Glu Val Asn Pro Leu Ser Pro His Tyr Val Cys Gly Gin Cys Gin 385 390 395 400 Tyr Ser Glu Phe He Thr Asp Gly Ser Tyr Gly Ser Gly Phe Asp Met 405 410 415 Pro His Lys Asp Cys Pro Asn Cys Gly His Lys Leu Ser Lys Asn Gly 420 425 430 Gin Asp He Pro Phe Glu Thr Phe Leu Gly Phe Asp Gly Asp Lys Val 435 440 445 Pro Asp He Asp Leu Asn Phe Ser Gly Glu Asp Gin Pro Ser Ala His 450 455 460 Leu Asp Val Arg Asp He Phe Gly Glu Glu Tyr Ala Phe Arg Ala Gly 465 470 475 480 Thr Val Gly Thr Val Ala Ala Lys Thr Ala Tyr Gly Phe Val Lys Gly 485 490 495 Tyr Glu Arg Asp Tyr Gly Lys Phe Tyr Arg Asp Ala Glu Val Glu Arg 500 505 510 Leu Ala Gin Gly Ala Ala Gly Val Lys Arg Thr Thr Gly Gin His Pro 515 520 525 Gly Gly He Val Val He Pro Asn Tyr Met Asp Val Tyr Asp Phe Thr 530 535 540 Pro Val Gin Tyr Pro Ala Asp Asp Val Thr Ala Glu Trp Gin Thr Thr 545 550 555 560 His Phe Asn Phe His Asp He Asp Glu Asn Val Leu Lys Leu Asp Val 565 570 575 Leu Gly His Asp Asp Pro Thr Met He Arg Lys Leu Gin Asp Leu Ser 580 585 590 Gly He Asp Pro Asn Lys He Pro Met Asp Asp Glu Gly Val Met Ala 595 600 605 Leu Phe Ser Gly Thr Asp Val Leu Gly Val Thr Pro Glu Gin He Gly 610 615 620 Thr Leu Arg Val Cys 625 (2) INFORMATION FOR SEQ ID NO: 222: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 693 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 222: Met Ala Arg Glu Phe Ser Leu Glu Lys Thr Arg Asn He Gly He Met 1 5 10 15 Ala His Val Asp Ala Gly Lys Thr Thr Thr Thr Glu Arg He Leu Tyr 20 25 30 Tyr Thr Gly Lys He His Lys He Gly Glu Thr His Glu Gly Ala Ser 35 40 45 Gin Met Asp Trp Met Glu Gin Glu Gin Glu Arg Gly He Thr He Thr 50 55 60 Ser Ala Ala Thr Thr Ala Gin Trp Asn Asn His Arg Val Asn He He 65 70 75 80 Asp Thr Pro Gly His Val Asp Phe Thr He Glu Val Gin Arg Ser Leu 85 90 95 Arg Val Leu Asp Gly Ala Val Thr Val Leu Asp Ser Gin Ser Gly Val 100 105 110 Glu Pro Gin Thr Glu Thr Val Trp Arg Gin Ala Thr Glu Tyr Gly Val 115 120 125 Pro Arg He Val Phe Ala Asn Lys Met Asp Lys He Gly Ala Asp Phe 130 135 140 Leu Tyr Ser Val Ser Thr Leu His Asp Arg Leu Gin Ala Asn Ala His 145 150 155 160 Pro He Gin Leu Pro He Gly Ser Glu Asp Asp Phe Arg Gly He He 165 170 175 Asp Leu He Lys Met Lys Ala Glu He Tyr Thr Asn Asp Leu Gly Thr 180 185 190 Asp He Leu Glu Glu Asp He Pro Ala Glu Tyr Leu Asp Gin Ala Gin 195 200 205 Glu Tyr Arg Glu Lys Leu He Glu Ala Val Ala Glu Thr Asp Glu Glu 210 215 220 Leu Met Met Lys Tyr Leu Glu Gly Glu Glu He Thr Asn Glu Glu Leu 225 230 235 240 Lys Ala Gly He Arg Lys Ala Thr He Asn Val Glu Phe Phe Pro Val 245 250 255 Leu Cys Gly Ser Ala Phe Lys Asn Lys Gly Val Gin Leu Met Leu Asp 260 265 270 Ala Val He Asp Tyr Leu Pro Ser Pro Leu Asp He Pro Ala He Lys 275 280 285 Gly He Asn Pro Asp Thr Asp Ala Glu Glu He Arg Pro Ala Ser Asp 290 295 300 Glu Glu Pro Phe Ala Ala Leu Ala Phe Lys He Met Thr Asp Pro Phe 305 310 315 320 Val Gly Arg Leu Thr Phe Phe Arg Val Tyr Ser Gly Val Leu Gin Ser 325 330 335 Gly Ser Tyr Val Leu Asn Thr Ser Lys Gly Lys Arg Glu Arg He Gly 340 345 350 Arg He Leu Gin Met His Ala Asn Ser Arg Gin Glu He Asp Thr Val 355 360 365 Tyr Ser Gly Asp He Ala Ala Ala Val Gly Leu Lys Asp Thr Thr Thr 370 375 380 Gly Asp Ser Leu Thr Asp Glu Lys Ala Lys He He Leu Glu Ser He 385 390 395 400 Asn Val Pro Glu Pro Val He Gin Leu Met Val Glu Pro Lys Ser Lys 405 410 415 Ala Asp Gin Asp Lys Met Gly He Ala Leu Gin Lys Leu Ala Glu Glu 420 425 430 Asp Pro Thr Phe Arg Val Glu Thr Asn Val Glu Thr Gly Glu Thr Val 435 440 445 He Ser Gly Met Gly Glu Leu His Leu Asp Val Leu Val Asp Arg Met 450 455 460 Arg Arg Glu Phe Lys Val Glu Ala Asn Val Gly Ala Pro Gin Val Ser 465 470 475 480 Tyr Arg Glu Thr Phe Arg Ala Ser Thr Gin Ala Arg Gly Phe Phe Lys 485 490 495 Arg Gin Ser Gly Gly Lys Gly Gin Phe Gly Asp Val Trp He Glu Phe 500 505 510 Thr Pro Asn Glu Glu Gly Lys Gly Phe Glu Phe Glu Asn Ala He Val 515 520 525 Gly Gly Val Val Pro Arg Glu Phe He Pro Ala Val Glu Lys Gly Leu 530 535 540 Val Glu Ser Met Ala Asn Gly Val Leu Ala Gly Tyr Pro Met Val Asp 545 550 555 560 Val Lys Ala Lys Leu Tyr Asp Gly Ser Tyr His Asp Val Asp Ser Ser 565 570 575 Glu Thr Ala Phe Lys He Ala Ala Ser Leu Ser Leu Lys Glu Ala Ala 580 585 590 Lys Ser Ala Gin Pro Ala He Leu Glu Pro Met Met Leu Val Thr He 595 600 605 Thr Val Pro Glu Glu Asn Leu Gly Asp Val Met Gly His Val Thr Ala 610 615 620 Arg Arg Gly Arg Val Asp Gly Met Glu Ala His Gly Asn Ser Gin He 625 630 635 640 Val Arg Ala Tyr Val Pro Leu Ala Glu Met Phe Gly Tyr Ala Thr Val 645 650 655 Leu Arg Ser Ala Ser Gin Gly Arg Gly Thr Phe Met Met Val Phe Asp 660 665 670 His Tyr Glu Asp Val Pro Lys Ser Val Gin Glu Glu He He Lys Lys 675 680 685 Asn Lys Gly Glu Asp 690 (2) INFORMATION FOR SEQ ID NO: 223: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 274 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:223: Ala Tyr Lys Gly His Gin Glu Tyr Val Leu Pro Gin Ala Ala Arg Lys 1 5 10 15 He Tyr Ala Tyr Arg Arg Tyr Asp Leu Asn Glu Ser Pro Lys Thr Ala 20 25 30 Leu Asp Leu He He Pro Asp Leu Phe Leu His He Leu Asn Pro Ala 35 40 45 Glu Arg Glu Arg Lys Leu Lys Arg Glu Gly Val Glu Glu Leu Tyr Leu 50 55 60 Leu Asp Phe Ser Ser Gin Phe Ala Ser Leu Thr Ala Gin Glu Phe Phe 65 70 75 80 Ala Thr Tyr He Lys Ala Met Asn Ala Lys He He Val Ala Gly Phe 85 90 95 Asp Tyr Thr Phe Gly Ser Asp Lys Lys Thr Ala Glu Asp Leu Lys Asp 100 105 110 Tyr Phe Asp Gly Glu Val He He Val Pro Pro Val Glu Asp Glu Lys 115 120 125 Gly Lys He Ser Ser Thr Arg He Arg Gin Ala He Leu Asp Gly Asn 130 135 140 Val Lys Glu Ala Gly Lys Leu Leu Gly Ala Pro Leu Pro Ser Arg Gly 145 150 155 160 Met Val Val His Gly Asn Ala Arg Gly Arg Thr He Gly Tyr Pro Thr 165 170 175 Ala Asn Leu Val Leu Leu Asp Arg Thr Tyr Met Pro Ala Asp Gly Val 180 185 190 Tyr Val Val Asp Val Glu He Gin Arg Gin Lys Tyr Arg Ala Met Ala 195 200 205 Ser Val Gly Lys Asn Val Thr Phe Asp Gly Glu Glu Ala Arg Phe Glu 210 215 220 Val Asn He Phe Asp Phe Asn Gin Asp He Tyr Gly Glu Thr Val Met 225 230 235 240 Val Tyr Trp Leu Asp Arg He Arg Asp Met Thr Lys Phe Asp Ser Val 245 250 255 Asp Gin Leu Val Asp Gin Leu Lys Ala Asp Glu Glu Val Thr Arg Asn 260 265 270 Trp Ser (2) INFORMATION FOR SEQ ID NO: 224: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 124 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 224: Leu Arg Lys Glu Pro Ser Met Ala Lys Gly Glu Gly Lys Val Val Ala 1 5 10 15 Gin Asn Lys Lys Ala Arg His Asp Tyr Thr He Val Asp Thr Leu Glu 20 25 30 Ala Gly Met Val Leu Thr Gly Thr Glu He Lys Ser Val Arg Ala Ala 35 40 45 Arg He Asn Leu Lys Asp Gly Phe Ala Gin Val Lys Asn Gly Glu Val 50 55 60 Trp Leu Ser Asn Val His He Ala Pro Tyr Glu Glu Gly Asn He Trp 65 70 75 80 Asn Gin Glu Pro Glu Arg Arg Arg Lys Leu Leu Leu His Lys Lys Gin 85 90 95 He Gin Lys Leu Glu Gin Glu Thr Lys Gly Thr Gly Met Thr Leu Val 100 105 110 Pro Leu Lys Val Tyr Met Ala Thr Leu Ser Phe Phe 115 120 (2) INFORMATION FOR SEQ ID NO: 225: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 441 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:225: He Val Lys Glu Glu Lys Gly Leu Lys Glu Lys Gin Phe Trp Asn Arg 1 5 10 15 He Leu Glu Phe Ala Gin Glu Arg Leu Thr Arg Ser Met Tyr Asp Phe 20 25 30 Tyr Ala He Gin Ala Glu Leu He Lys Val Glu Glu Asn Val Ala Thr 35 40 45 He Phe Leu Pro Arg Ser Glu Met Glu Met Val Trp Glu Lys Gin Leu 50 55 60 Lys Asp He He Val Val Ala Gly Phe Glu He Tyr Asp Ala Glu He 65 70 75 80 Thr Pro His Tyr He Phe Thr Lys Pro Gin Asp Thr Thr Ser Ser Gin 85 90 95 Val Glu Glu Ala Thr Asn Leu Thr Leu Tyr Asp Tyr Ser Pro Lys Leu 100 105 110 Val Ser He Pro Tyr Ser Asp Thr Gly Leu Lys Glu Lys Tyr Thr Phe 115 120 125 Asp Asn Phe He Gin Gly Asp Gly Asn Val Trp Ala Val Ser Ala Ala 130 135 140 Leu Ala Val Ser Glu Asp Leu Ala Leu Thr Tyr Asn Pro Leu Phe He 145 150 155 160 Tyr Gly Gly Pro Gly Leu Gly Lys Thr His Leu Leu Asn Ala He Gly 165 170 175 Asn Glu He Leu Lys Asn He Pro Asn Ala Arg Val Lys Tyr He Pro 180 185 190 Ala Glu Ser Phe He Asn Asp Phe Leu Asp His Leu Arg Leu Gly Glu 195 200 205 Met Glu Lys Phe Lys Lys Thr Tyr Arg Ser Leu Asp Leu Leu Leu He 210 215 220 Asp Asp He Gin Ser Leu Ser Gly Lys Lys Val Ala Thr Gin Glu Glu 225 230 235 240 Phe Phe Asn Thr Phe Asn Ala Leu His Asp Lys Gin Lys Gin He Val 245 250 255 Leu Thr Ser Asp Arg Ser Pro Lys His Leu Glu Gly Leu Glu Glu Arg 260 265 270 Leu Val Thr Arg Phe Ser Trp Gly Leu Thr Gin Thr He Thr Pro Pro 275 280 285 Asp Phe Glu Thr Arg He Ala He Leu Gin Ser Lys Thr Glu His Leu 290 295 300 Gly Tyr Asn Phe Gin Ser Asp Thr Leu Glu Tyr Leu Ala Gly Gin Phe 305 310 315 320 Asp Ser Asn Val Arg Asp Leu Glu Gly Ala He Asn Asp He Thr Leu 325 330 335 He Ala Arg Val Lys Lys He Lys Asp He Thr He Asp He Ala Ala 340 345 350 Glu Ala He Arg Ala Arg Lys Gin Asp Val Ser Gin Met Leu Val He 355 360 365 Pro He Asp Lys He Gin Thr Glu Val Gly Asn Phe Tyr Gly Val Ser 370 375 380 He Lys Glu Met Lys Gly Ser Arg Arg Leu Gin Asn He Val Leu Ala 385 390 395 400 Arg Gin Val Ala Met Tyr Leu Ser Arg Glu Leu Thr Asp Asn Ser Leu 405 410 415 Pro Lys He Gly Lys Glu Leu Gly Glu Lys Ser Tyr His Ser His Ser 420 425 430 Cys Pro Cys Gin Asn Lys He Leu Asn 435 440 (2) INFORMATION FOR SEQ ID NO: 226: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 201 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 226: Glu Leu Val Ser Thr Met Tyr Phe Arg Phe Asp Tyr Tyr Ser Gin Asn 1 5 10 15 Leu Gly Glu He Phe Ala He Gly Met Val Val Gly His Leu Arg Trp 20 25 30 Leu He Thr Gly Ala Leu Val Leu Tyr He Phe Ala Asp Arg Lys Leu 35 40 45 He Asn Thr Trp Asp Phe Leu Asp He Ala Ala Pro Ser Val Met He 50 55 60 Ala Gin Ser Leu Gly Arg Trp Gly Asn Phe Phe Asn Gin Glu Ala Tyr 65 70 75 80 Gly Ala Thr Val Asp Asn Leu Asp Tyr Leu Pro Gly Phe He Arg Asp 85 90 95 Gin Met Tyr He Glu Gly Ser Tyr Arg Gin Pro Thr Phe Leu Tyr Glu 100 105 110 Ser Leu Trp Asn Leu Leu Gly Phe Ala Leu He Leu He Phe Arg Arg 115 120 125 Lys Trp Lys Ser Leu Arg Arg Gly His He Thr Ala Phe Tyr Leu He 130 135 140 Trp Tyr Gly Phe Gly Arg Met Val He Glu Gly Met Arg Thr Asp Ser 145 150 155 160 Leu Met Phe Phe Gly Leu Arg Val Ser Gin Trp Leu Ser Val Val Leu 165 170 175 He Gly Leu Gly He Met He Val He Tyr Gin Asn Arg Lys Lys Ala 180 185 190 Pro Tyr Tyr He Thr Glu Glu Glu Asn 195 200 (2) INFORMATION FOR SEQ ID NO: 227: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 491 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:227: Leu Glu Asp Phe Pro Leu Ser Val Thr Asn Pro Tyr Gly Arg Thr Lys 1 5 10 15 Leu Met Leu Glu Glu He Leu Thr Asp He Tyr Lys Ala Asp Ser Glu 20 25 30 Trp Asn Val Val Leu Leu Arg Tyr Phe Asn Pro He Gly Val His Glu 35 40 45 Ser Gly Asp Leu Gly Glu Asn Pro Asn Gly He Pro Asn Asn Leu Leu 50 55 60 Pro Tyr Val Thr Gin Val Ala Val Gly Lys Leu Glu Gin Val Gin Val 65 70 75 80 Phe Gly Asp Asp Tyr Asp Thr Glu Asp Gly Thr Gly Val Arg Asp Tyr 85 90 95 He His Val Val Asp Leu Ala Lys Gly His Val Ala Ala Leu Lys Lys 100 105 110 He Gin Lys Gly Ser Gly Leu Asn Val Tyr Asn Leu Gly Thr Gly Lys 115 120 125 Gly Tyr Ser Val Leu Glu He He Gin Asn Met Glu Lys Ala Val Gly 130 135 140 Cys Pro He Pro Tyr Arg He Val Glu Arg Arg Pro Gly Asp He Ala 145 150 155 160 Ala Cys Tyr Ser Asp Pro Ala Lys Ala Lys Ala Glu Leu Gly Trp Glu 165 170 175 Ala Glu Leu Asp He Thr Gin Met Cys Glu Gly His Gly Val Gly Arg 180 185 190 Ala Ser He Gin Met Asp Leu Lys Thr Lys Met Met He Ser He He 195 200 205 Val Pro Cys Leu Asn Glu Glu Glu Val Leu Pro Leu Phe Tyr Gin Ala 210 215 220 Leu Glu Ala Leu Leu Pro Asp Leu Glu Thr Glu He Glu Tyr Val Phe 225 230 235 240 Val Asp Asp Gly Ser Ser Asp Gly Thr Leu Glu Leu Leu Lys Ala Tyr 245 250 255 Arg Glu Gin Asn Pro Ala Val His Tyr He Ser Phe Ser Arg Asn Phe 260 265 270 Gly Lys Glu Ala Ala Leu Tyr Ala Gly Leu Gin Tyr Ala Thr Gly Asp 275 280 285 Leu Val Val Val Met Asp Ala Asp Leu Gin Asp Pro Pro Ser Met Leu 290 295 300 Phe Glu Met Lys Asn Val Leu Asp Lys Asn Val Asp Leu Asp Cys Val 305 310 315 320 Gly Thr Arg Arg Thr Ser Arg Glu Gly Glu Pro Phe Phe Arg Ser Phe 325 330 335 Cys Ala Val Leu Phe Tyr Arg Leu Met Gin Lys He Ser Pro Val Ala 340 345 350 Leu Pro Ser Gly Val Arg Asp Phe Arg Met Met Arg Arg Ser Val Val 355 360 365 Asp Ala He Leu Ser Leu Thr Glu Ser Asn Arg Phe Ser Lys Gly Leu 370 375 380 Phe Ala Trp Val Gly Phe Lys Thr His Tyr Leu Asp Tyr Pro Asn Val 385 390 395 400 Glu Arg Gin Ala Gly Lys Thr Ser Trp Ser Phe Arg Gin Leu Phe Phe 405 410 415 Tyr Ser He Glu Gly He Val Asn Phe Ser Asp Phe Pro Leu Thr He 420 425 430 Ala Phe Val Ala Gly Leu Leu Ser Cys Phe Leu Ser Leu Leu Met Thr 435 440 445 Phe Phe Val Val Val Arg Thr Leu He Leu Gly Asn Pro Thr Ser Gly 450 455 460 Trp Thr Ser Leu Met Ala Val He Leu Tyr Leu Gly Gly He Gin Leu 465 470 475 480 Leu Thr He Gly He Leu Gly Lys Tyr Asn Gin 485 490 (2) INFORMATION FOR SEQ ID NO: 228: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 277 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: not relevant (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO:228: Val He He He Asp Asp Asn Tyr Ser Asn Val Asn Leu Arg Asn Lys 1 5 10 15 He He His Gin Phe Gly Tyr Thr Asn His Arg He Lys Leu He Leu 20 25 30 Ser Asn Glu Asp Leu Gly Ala Thr Asn Ala Arg Asn He Gly He Lys 35 40 45 Asn Ser Arg Gly Lys Tyr He Ser Phe Leu Asp Asp Asp Asp Glu Tyr 50 55 60 Met Pro Asp Arg He Leu Lys Leu Met Ala Cys Phe Lys Lys Ser Arg 65 70 75 80 Met Lys Asn Leu Ala Leu Val Tyr Ser Tyr Gly He He He Tyr Pro 85 90 95 Asn Gly Thr Arg Glu Glu Glu Lys Thr Asp Phe Val Gly Asn Pro Leu 100 105 110 Phe Val Gin Met Val His Asn He Ala Gly Thr Ser Phe Trp Leu Cys 115 120 125 Lys Lys Glu Val Leu Glu Leu He Asn Gly Phe Glu Lys He Asp Ser 130 135 140 His Gin Asp Gly Val Val Leu Leu Lys Leu Leu Ala Gin Gly Tyr Gin 145 150 155 160 He Asp He Val Arg Glu Phe Leu Val Asn Tyr Tyr Ala His Ser Lys 165 170 175 Glu Asn Gly He Thr Gly Val Thr Gin Lys Thr He Asn Ala Asp Glu 180 185 190 Glu Tyr Tyr Asn Tyr Cys Arg Lys Tyr Phe Asn Leu Leu Ser Phe Asn 195 200 205 Glu Arg He Leu Val Thr Lys Lys Tyr Tyr Ser Leu Asn He Lys Arg 210 215 220 Leu Leu Leu He Gly Asp Lys Cys Lys Ala Leu Lys Val He Lys Lys 225 230 235 240 Ala Arg Glu Glu Lys He Phe Asn Glu Phe Leu Phe Leu Lys Tyr Met 245 250 255 Leu Leu Tyr Arg Ser Phe Phe Tyr Cys He Tyr Asp Asn Tyr Val Gin 260 265 270 Leu Lys Phe Arg Lys 275

Claims: CLAIMS 1. An isolated nucleic acid compound comprising a sequence identical to or substantially identical to a sequence selected from the group consisting of SEQ ID NO:l through SEQ ID NO: 86. 2. An isolated nucleic acid compound comprising a sequence identical to or substantially identical to a sequence selected from the group consisting of SEQ ID NO: 87, SEQ ID NO: 89, SEQ ID NO: 91, SEQ ID NO: 93, SEQ ID NO: 95, SEQ ID NO: 97, SEQ ID NO: 99, SEQ ID NO: 101, SEQ ID NO: 103, SEQ ID NO: 105, SEQ ID NO: 107, SEQ ID NO: 109, SEQ ID NO: 111, SEQ ID NO: 113, SEQ ID NO: 115, SEQ ID NO: 117, SEQ ID NO: 119, and SEQ ID NO:121. 3. A substantially purified protein or fragment thereof from S. pneumoniae wherein said protein is selected from the group consisting of SEQ ID NO: 88, SEQ ID NO: 90, SEQ ID NO: 92, SEQ ID NO: 94, SEQ ID NO: 96, SEQ ID NO: 98, SEQ ID NO: 100, SEQ ID NO: 102, SEQ ID NO: 104, SEQ ID NO: 106, SEQ ID NO: 108, SEQ ID NO: 110, SEQ ID NO: 112, SEQ ID NO: 114, SEQ ID NO: 116, SEQ ID NO: 118, SEQ ID NO: 120, SEQ ID NO: 122, and SEQ ID NO: 123 through SEQ ID NO: 228. 4. An isolated nucleic acid compound encoding any one of the proteins or fragments thereof of Claim 3. 5. A vector comprising any one of the nucleic acid compounds of claims 1, 2, or 4. 6. A recombinant host containing any one of the vectors of claim 5. 7. A substantially purified protein from Streptococcus pneumoniae as in Claim 3 wherein said protein is an external target protein selected from Table 1. 8. A substantially purified protein from Streptococcus pneumoniae as in Claim 3 wherein said protein is a hypothetical protein selected from Table 1. 9. A substantially purified protein from Streptococcus pneumoniae as in Claim 3 wherein said protein is a cell wall synthetic protein selected from Table 1. 10. A substantially purified protein from Streptococcus pneumoniae as in Claim 3 wherein said protein is a minimal gene set protein selected from Table 1. 11. A DNA chip having arrayed thereon any at least 15 base pair fragment of any one or more of the nucleic acids of claim 1. 12. A DNA chip having arrayed thereon any at least 15 base pair fragment of any one or more of the nucleic acids of claim 2. 13. A method for evaluating gene expression in Streptococcus pneumoniae comprising the step of incubating a DNA chip of claim 11 or Claim 12 with cDNA prepared from Streptococcus pneumoniae under conditions suitable for hybridization of complementary nucleic acid sequences. 14. A computer readable medium having recorded thereon any one or more of the nucleotide sequences of Claims 1 or Claim 2. 15. A method for identifying virulence genes in S. pneumoniae, comprising the steps of: a) preparing a DNA chip as in claim 11, b) preparing labeled cDNAs from i) S . pneumoniae cells recovered from an in vivo environment, and ii) S. pneumoniae cells grown in vitro, c) hybridizing individually the cDNAs of steps (b) (i) and (b) (ii) to a chip of step (a) ; and d) identifying a genomic DNA fragment or fragments on said chip that hybridize to the cDNAs of (b) (i) but not with the cDNAs of (b) (ii) . 16. An antibody that selectively binds to a protein or peptide of Claim 3. 17. An antibody that selectively binds to an external target protein, or fragment thereof, identified in Table 1. 18. A DNA chip of Claim 11 or Claim 12 further comprising a layer of S. pneumoniae cells wherein said layer contacts with said nucleic acids.

Inventors: BALTZ RICHARD H, BURGETT STANLEY G, DEHOFF BRADLEY S, HOSKINS JO ANN, JASKUNAS STANLEY R JR, MILLS BRADLEY J, NORRIS FRANKLIN H, PEERY ROBERT B, ROCKEY PAMELA K, ROSTECK PAUL R JR, SKATRUD PAUL L, SMITH MICHELE C, SOLENBERG PATRICIA J, TREADWAY PATTI J, YOUNG BELLIDO MICHELE L, BALTZ, RICHARD, H., BURGETT, STANLEY, G., DEHOFF, BRADLEY, S., HOSKINS, JO, ANN, JASKUNAS, STANLEY, R., JR., MILLS, BRADLEY, J., NORRIS, FRANKLIN, H., PEERY, ROBERT, B., ROCKEY, PAMELA, K., ROSTECK, PAUL, R., JR., SKATRUD, PAUL, L., SMITH, MICHELE, C., SOLENBERG, PATRICIA, J., TREADWAY, PATTI, J., YOUNG BELLIDO, MICHELE, L.
Applicants: BALTZ RICHARD H, BURGETT STANLEY G, DEHOFF BRADLEY S, HOSKINS JO ANN, JASKUNAS STANLEY R JR, LILLY CO ELI, MILLS BRADLEY J, NORRIS FRANKLIN H, PEERY ROBERT B, ROCKEY PAMELA K, ROSTECK PAUL R JR, SKATRUD PAUL L, SMITH MICHELE C, SOLENBERG PATRICIA J, TREADWAY PATTI J, YOUNG BELLIDO MICHELE L, BALTZ, RICHARD, H., BURGETT, STANLEY, G., DEHOFF, BRADLEY, S., ELI LILLY AND COMPANY, HOSKINS, JO, ANN, JASKUNAS, STANLEY, R., JR., MILLS, BRADLEY, J., NORRIS, FRANKLIN, H., PEERY, ROBERT, B., ROCKEY, PAMELA, K., ROSTECK, PAUL, R., JR., SKATRUD, PAUL, L., SMITH, MICHELE, C., SOLENBERG, PATRICIA, J., TREADWAY, PATTI, J., YOUNG BELLIDO, MICHELE, L.
Application year: 1997
Main classification: C12N15
IPC codes: C07K14, C12N9, C12N15, G01N33